Sentence,class,file
Nat Genet 2006; 38:1440-5; PMID:17099714; http://dx.doi.org/ 10.1038/ng1915 65.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
Cell 1993; 72:527-40; PMID: 8440019; http://dx.doi.org/10.1016/0092-8674(93) 90072-X 67.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
Cell 1984; 37:979-91; PMID: 6430570; http://dx.doi.org/10.1016/0092-8674(84) 90432-X 69.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
BMC Mol Biol 2008; 9:36; PMID:18412953; http://dx.doi.org/ 10.1186/1471-2199-9-36 72.,Non-OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
Development 2010; 137:3775-84; PMID:20943709; http://dx.doi.org/10.1242/dev.049312 75.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
Cell 2010; 141:536-48; PMID:20434990; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
Nat Methods 2011; 8:405-7; PMID:21460824; http://dx.doi.org/10.1038/ nmeth.1592 79.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
PLoS One 2007; 2:e275; PMID: 17342209; http://dx.doi.org/10.1371/journal.pone.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
Genes Dev 1999; 13:1342-53; PMID:10346822; http://dx.doi.org/10.1101/gad.13.10.,OADS,/arxiv_data1/oa_pdf/15/2e/spmg-2-11.PMC3341242.pdf
"In order to identify the mechanism responsible for testis immune privilege, various components were explored including the lower temperature of the scrotum,9,15impaired lymphatic drainage,9,16locally produced hormones,17,18Leydig cells,18*Correspondence to: Jannette M. Dufour; Email: jannette.dufour@ttuhsc.edu Submitted: 11/15/11; Revised: 12/19/11; Accepted: 12/19/11 http://dx.doi.org/10.4161/spmg.2.1.19119REVIEW Spermatogenesis 2:1, 1 –9; January/February/March 2012; G2012 Landes Bioscience www.landesbioscience.com Spermatogenesis 1",Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Adv Immunol 1977; 25:1-54; PMID:345773; http://dx.doi.org/10.1016/S0065-2776(08)60930-X 2.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Reproduction 2010; 139:495-504; PMID: 19995832; http://dx.doi.org/10.1530/REP-09-0384 3.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Cell Transplant 2010; 19: 1645-57; PMID:20719072; http://dx.doi.org/10.3727/ 096368910X516628 4.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Gene Ther 2004; 11:694-700; PMID:14724669; http://dx.doi.org/10.1038/sj.gt.3302218 6.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
J Reprod Immunol 1990; 18:9- 18; PMID:2213734; http://dx.doi.org/10.1016/0165- 0378(90)90021-W 7.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 1983; 36:423-31; PMID:6353710; http://dx.doi.org/10.1097/00007890-198310000-00014 8.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 1985; 40:269-75; PMID:3898493; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 1981; 32:227-32; PMID:6269257; http://dx.doi.org/10.1097/00007890-198109000-00009 15.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Horm Metab Res 1988; 20:562-5; PMID: 3143654; http://dx.doi.org/10.1055/s-2007-101088518.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 1990; 50: 649-53; PMID:2171164; http://dx.doi.org/10.1097/ 00007890-199010000-00024 19.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Semin Cell Dev Biol 1998; 9:411-6; PMID:9813187; http://dx.doi.org/10.1006/scdb.1998.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Dev Biol 1977; 55:347-58; PMID:838124; http://dx.doi.org/10.1016/0012-1606(77)90178-6 21.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Mol Cell Endocrinol 2011; 335:60-8; PMID:20363290; http://dx.doi.org/10.1016/j.mce.2010.03.022 23.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Biol Reprod 2012; 86:1-14; PMID:21900683; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Biol Reprod 2005; 72: 1224-31; PMID:15659703; http://dx.doi.org/10.1095/ biolreprod.104.038315 25.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Diabetes 1997; 46:317-22; PMID: 9000711; http://dx.doi.org/10.2337/diabetes.46.2.317 27.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 2003; 75: 1594-6; PMID:12792521; http://dx.doi.org/10.1097/ 01.TP.0000058748.00707.88 28.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 2011; 92: 1309-15; PMID:22037619; http://dx.doi.org/10.1097/ TP.0b013e3182384ab0 29.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 1999; 67:815-20; PMID:10199728; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
AAPS PharmSciTech 2001; 2:E15; PMID: 14727874; http://dx.doi.org/10.1208/pt020315 31.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transpl Int 2005; 18:1001-9; PMID:16008752; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Brain Res 1999; 822:246-50; PMID:10082904; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Xenotransplantation 2007; 14:619-26; PMID:17991150; http://dx.doi.org/ 10.1111/j.1399-3089.2007.00435.x 35.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Cell Transplant 2006; 15:45-53; PMID:16700329; http://dx.doi.org/10.3727/000000006783982205 36.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
J Heart Lung Transplant 2009; 28:72-8; PMID:19134534; http://dx.doi.org/10.1016/j.healun.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Immunol Invest 2003; 32:275-97; PMID:14603995; http://dx.doi.org/10.1081/IMM-120025106 39.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 2003; 75:613-8; PMID:12640298; http://dx.doi.org/10.1097/01.TP.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Biol Reprod 2002; 66: 21-8; PMID:11751259; http://dx.doi.org/10.1095/ biolreprod66.1.21 41.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Reprod Domest Anim 2006; 41:124-8; PMID: 16519717; http://dx.doi.org/10.1111/j.1439-0531.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Biol Reprod 2003; 69:1260-4; PMID:12801978; http://dx.doi.org/10.1095/biolreprod.103.018788 44.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Reproduction 2006; 132:617- 24; PMID:17008473; http://dx.doi.org/10.1530/rep.1.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Reproduction 2008; 136:823-31; PMID:18768666; http://dx.doi.org/10.1530/REP-08-0226 46.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Reprod Domest Anim 2009; 44:612-20; PMID:18694428; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Biol Reprod 2009; 81:898-905; PMID:19571259; http://dx.doi.org/10.1095/biolreprod.109.078279 48.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Tissue Cell 1999; 31:461-72; PMID:10612257; http://dx.doi.org/10.1054/tice.1999.0060 49.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Biol Reprod 2003; 68:167-73; PMID:12493709; http://dx.doi.org/10.1095/biolreprod.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Eur J Endocrinol 2005; 153:419-27; PMID:16131605; http://dx.doi.org/10.1530/eje.1.01982 54.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Nat Med 2002; 8:1047; PMID: 12357221; http://dx.doi.org/10.1038/nm1002-1047 55.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Xenotransplantation 2003; 10:577-86; PMID:14708526; http://dx.doi.org/ 10.1034/j.1399-3089.2003.00059.x 57.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Exp Neurol 1997; 146:299-304; PMID:9270038; http://dx.doi.org/10.1006/exnr.1997.6493 58.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Transplantation 2009; 88:339-45; PMID:19667935; http://dx.doi.org/10.1097/ TP.0b013e3181ae5dcf 59.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Nat Rev Genet 2003; 4:346-58; PMID:12728277; http://dx.doi.org/10.1038/nrg106660.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Nat Rev Genet 2000; 1:91-9; PMID: 11253666; http://dx.doi.org/10.1038/35038533 61.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Gene Ther 2010; 17:295- 304; PMID:19907498; http://dx.doi.org/10.1038/gt.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Nat Med 2006; 12:342-7; PMID:16474400; http://dx.doi.org/10.1038/nm1358 64.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
J Gene Med 2007; 9:362-8; PMID:17380490; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Mol Ther 2010; 18:143-50; PMID:19724265; http://dx.doi.org/ 10.1038/mt.2009.190 66.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
N Engl J Med 2003; 348:255-6; PMID:12529469; http://dx.doi.org/ 10.1056/NEJM200301163480314 67.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Gene Ther 2009; 16:1285-91; PMID:19776764; http://dx.doi.org/10.1038/gt.2009.127 68.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Science 2011; 334:29-30; PMID: 21980087; http://dx.doi.org/10.1126/science.334.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Science 2003; 300:1749-51; PMID: 12805549; http://dx.doi.org/10.1126/science.1083413 70.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
PLoS Pathog 2006; 2:e60; PMID:16789841; http://dx.doi.org/10.1371/journal.ppat.0020060 71.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Curr Opin Allergy Clin Immunol 2011; 11:545-50; PMID:21971332; http://dx.doi.org/ 10.1097/ACI.0b013e32834c230c 72.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Mol Ther 2011; 19:28-35; PMID:21045810; http://dx.doi.org/ 10.1038/mt.2010.232 73.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Mol Ther 2009; 17:844-50; PMID:19259065; http://dx.doi.org/ 10.1038/mt.2009.16 76.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Science 2009; 326:818-23; PMID: 19892975; http://dx.doi.org/10.1126/science.1171242 77.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Mol Ther 2009; 17:1305-6; PMID: 19644491; http://dx.doi.org/10.1038/mt.2009.162 78.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Science 2009; 326:1468-9; PMID:20007873; http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Cancer Lett 2011; 305: 8-20; PMID:21396770; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Gene Ther 2010; 17:692-708; PMID: 20220785; http://dx.doi.org/10.1038/gt.2010.10 81.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Adv Drug Deliv Rev 2010; 62:1156-66; PMID:20828588; http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Hum Gene Ther 1997; 8:1417-27; PMID:9287142; http://dx.doi.org/10.1089/hum.1997.8.12-1417 83.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Mol Endocrinol 1992; 6:1403-11; PMID:1331774; http://dx.doi.org/10.1210/me.6.9.1403 86.,Non-OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Curr Opin Pharmacol 2006; 6:598-605; PMID:16987706; http://dx.doi.org/ 10.1016/j.coph.2006.08.003 87.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
Hum Gene Ther 1996; 7: 1261-80; PMID:8793551; http://dx.doi.org/10.1089/ hum.1996.7.10-1261 89.,OADS,/arxiv_data1/oa_pdf/0f/d2/spmg-2-23.PMC3341243.pdf
"Nevertheless, the role of such junctions (also adherens*Correspondence to: Richard Ivell; Email: ivell@fbn-dummerstorf.de Submitted: 12/21/11; Revised: 01/16/12; Accepted: 01/17/12 http://dx.doi.org/10.4161/spmg.2.1.19383REVIEW Spermatogenesis 2:1, 1 –12; January/February/March 2012; G2012 Landes Bioscience www.landesbioscience.com Spermatogenesis 1",Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Theriogenology 2007; 67:6-15; PMID:17092551; http://dx.doi.org/ 10.1016/j.theriogenology.2006.09.027 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Nature 2011; 471: 504-7; PMID:21430778; http://dx.doi.org/10.1038/ nature098504.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Reproduction 2005; 130:15-28; PMID: 15985628; http://dx.doi.org/10.1530/rep.1.00358 6.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Horm Res 2006; 66:153-61; PMID: 16804315; http://dx.doi.org/10.1159/0000941427.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Exp Zool 1988; 246: 65-70; PMID:3290387; http://dx.doi.org/10.1002/ jez.1402460109 10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Exp Cell Res 1991; 194:90-4; PMID: 1901796; http://dx.doi.org/10.1016/0014-4827(91) 90134-G 11.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2002; 66: 14-20; PMID:11751258; http://dx.doi.org/10.1095/ biolreprod66.1.14 12.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Exp Zool 1995; 272:363-73; PMID:7673874; http://dx.doi.org/10.1002/jez.1402720506 13.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Exp Zool 1995; 272:374-83; PMID:7673875; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Zoolog Sci 2004; 21:691-704; PMID:15277712; http://dx.doi.org/10.2108/zsj.21.691 15.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Dev Growth Differ 1997; 39:337-44; PMID:9227900; http://dx.doi.org/10.1046/j.1440- 169X.1997.t01-2-00009.x 17.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Zoolog Sci 2002; 19:321-9; PMID:12125930; http://dx.doi.org/ 10.2108/zsj.19.321 18.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 1998; 13:634-8; PMID:9572425; http://dx.doi.org/10.1093/humrep/ 13.3.634 20.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Andrologia 2004; 36:269-76; PMID:15458544; http://dx.doi.org/10.1111/j.1439-0272.2004.00617.x 21.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Cell Biol 1984; 98: 619-28; PMID:6363426; http://dx.doi.org/10.1083/ jcb.98.2.619 22.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 1999; 14:2808-11; PMID:10548627; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 1999; 61:225-30; PMID:10377053; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Reproduction 2002; 124:791-9; PMID: 12530917; http://dx.doi.org/10.1530/rep.0.1240791 27.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Science 2010; 328:62-7; PMID:20299552; http://dx.doi.org/10.1126/science.1182868 30.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Proc Natl Acad Sci U S A 2004; 101:16489-94; PMID:15520394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2005; 72:985-91; PMID: 15601913; http://dx.doi.org/10.1095/biolreprod.104.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Nat Cell Biol 2009; 11:190-6; PMID:19098901; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Dev Biol 2004; 274:158-70; PMID:15355795; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2010; 82:363-72; PMID: 19846602; http://dx.doi.org/10.1095/biolreprod.109.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Endocrinology 1999; 140:5894-900; PMID: 10579355; http://dx.doi.org/10.1210/en.140.12.5894 37.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Reproduction 2006; 131: 489-99; PMID:16514192; http://dx.doi.org/10.1530/ rep.1.0096838.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Exp Cell Res 1999; 252:175-85; PMID:10502410; http://dx.doi.org/10.1006/excr.1999.4630 40.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2006; 74:945-53; PMID:16467492; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Methods Mol Biol 2009; 558:279-97; PMID: 19685331; http://dx.doi.org/10.1007/978-1-60761- 103-5_17 44.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Clin Endocrinol Metab 1997; 82:2314-21; PMID: 9215313; http://dx.doi.org/10.1210/jc.82.7.2314 48.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Clin Endo- crinol Metab 1998; 83:4467-73; PMID:9851795; http://dx.doi.org/10.1210/jc.83.12.4467 49.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Endocrinology 1997; 138:1259-66; PMID: 9048634; http://dx.doi.org/10.1210/en.138.3.1259 50.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Reproduction 2007; 133:1169-79; PMID:17636171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Endocrinology 2005; 146:2674-83; PMID:15761038; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Proc Natl Acad Sci U S A 2004; 101:1327-32; PMID:14745012; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Cell Biol 1985; 101:1511-22; PMID:4044644; http://dx.doi.org/10.1083/jcb.101.4.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biochem Biophys Res Commun 1991; 179: 1115-21; PMID:1898392; http://dx.doi.org/10.1016/ 0006-291X(91)91935-6 57.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Dev Dyn 1992; 193:49-57; PMID:1540705; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2003; 69: 169-76; PMID:12620938; http://dx.doi.org/10.1095/ biolreprod.102.015099 59.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2001; 65:873-8; PMID:11514353; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2006; 21:471-6; PMID: 16210386; http://dx.doi.org/10.1093/humrep/dei319 61.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2002; 17:161-72; PMID:11756382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2008; 79:962-75; PMID: 18667755; http://dx.doi.org/10.1095/biolreprod.107.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Mol Cell Endocrinol 1975; 3:57-70; PMID:168104; http://dx.doi.org/10.1016/0303-7207 (75)90031-3 64.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 1986; 34:195-206; PMID: 3955136; http://dx.doi.org/10.1095/biolreprod34.1.19565.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Exp Cell Res 1996; 225:411-21; PMID: 8660930; http://dx.doi.org/10.1006/excr.1996.0192 67.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Endocrinology 2005; 146:5304-12; PMID:16166216; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Asian J Androl 2007; 9:312-20; PMID:17486271; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Cell 1993; 75:997-1006; PMID:7504588; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Cell Tissue Res 2004; 315: 249-57; PMID:14652734; http://dx.doi.org/10.1007/ s00441-003-0834-x 71.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Fertil Steril 2003; 79(Suppl 1):795-801; PMID:12620493; http://dx.doi.org/10.1016/S0015- 0282(02)04833-1 72.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 1999; 14:1287-93; PMID: 10325279; http://dx.doi.org/10.1093/humrep/14.5.1287 73.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2001; 16:1938- 44; PMID:11527901; http://dx.doi.org/10.1093/ humrep/16.9.1938 74.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Nature 1991; 353:750-2; PMID: 1719421; http://dx.doi.org/10.1038/353750a0 75.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Cell Sci 2011; 124:2357- 66; PMID:21693582; http://dx.doi.org/10.1242/jcs.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2004; 71:942-7; PMID:15151932; http://dx.doi.org/10.1095/biolreprod.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2003; 68:2207-14; PMID:12606373; http://dx.doi.org/10.1095/biolreprod.102.014050 78.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2011; 26:2598-605; PMID:21771775; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Ann N Y Acad Sci 1984; 438:515-8; PMID:6598338; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Histochem Cytochem 1986; 34:1029-35; PMID: 3734416; http://dx.doi.org/10.1177/34.8.3734416 82.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 1998; 59:379-87; PMID:9687311; http://dx.doi.org/ 10.1095/biolreprod59.2.379 83.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Reprod Biol Endocrinol 2009; 7:67; PMID: 19563643; http://dx.doi.org/10.1186/1477-7827-7-67 84.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Reprod Fertil 1979; 56:99-104; PMID:38338; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2010; 83:261-7; PMID:20393168; http://dx.doi.org/10.1095/biolreprod.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Exp Cell Res 2000; 260:85-95; PMID: 11010813; http://dx.doi.org/10.1006/excr.2000.4998 89.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Dev Biol 2000; 220:225-37; PMID:10753512; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Cell Tissue Res 1990; 261:539-47; PMID:2245453; http://dx.doi.org/ 10.1007/BF00313533 91.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2000; 15:1713-6; PMID:10920091; http://dx.doi.org/10.1093/humrep/ 15.8.1713 93.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2000; 15:1350-4; PMID:10831567; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Ann Anat 2009; 191:532-40; PMID: 19765961; http://dx.doi.org/10.1016/j.aanat.2009.08.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2003; 68:272-81; PMID:12493723; http://dx.doi.org/10.1095/biolre- prod.102.004986 98.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2004; 71:722-31; PMID:15115718; http://dx.doi.org/10.1095/biolreprod.104.029207 99.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Reproduction 2010; 139:287-301; PMID:19759174; http://dx.doi.org/10.1530/REP-09-0281 100.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2006; 21:1009-11; PMID:16361294; http://dx.doi.org/10.1093/humrep/dei405 102.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Exp Biol Med (Maywood) 2010; 235:139-47; PMID: 20404028; http://dx.doi.org/10.1258/ebm.2009.009251104.,Non-OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Am J Hum Genet 2004; 74:599-609; PMID:14991528; http://dx.doi.org/10.1086/382897 105.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Hum Reprod 2010; 25:2647-54; PMID:20685756; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Curr Biol 2000; 10:475-8; PMID:10801417; http://dx.doi.org/10.1016/S0960- 9822(00)00448-6 107.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2011; 84:5-6; PMID:20944084; http://dx.doi.org/10.1095/ biolreprod.110.088864 109.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2010; 83:951-7; PMID: 20702852; http://dx.doi.org/10.1095/biolreprod.109.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Androl 2006; 27:611-8; PMID:16582408; http://dx.doi.org/10.2164/jandrol.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Dev Biol 1990; 140:318- 27; PMID:2373256; http://dx.doi.org/10.1016/0012- 1606(90)90082-T 113.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
J Tissue Eng Regen Med 2011; 5:130-7; PMID:20603864; http://dx.doi.org/10.1002/ term.297 114.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biomaterials 2006; 27:2845-53; PMID:16430959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
Biol Reprod 2001; 65:829-38; PMID: 11514348; http://dx.doi.org/10.1095/biolreprod65.3.,OADS,/arxiv_data1/oa_pdf/a3/4f/spmg-2-32.PMC3341244.pdf
"Wong; Email: awong1@hku.hk Submitted: 12/19/11; Revised: 01/18/12; Accepted: 01/18/12 http://dx.doi.org/10.4161/spmg.2.1.19413REVIEW Spermatogenesis 2:1, 1 –9; January/February/March 2012; G2012 Landes Bioscience www.landesbioscience.com Spermatogenesis 1",Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Circ Res 2007; 100:782-94; PMID:17395884; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nat Immunol 2005; 6:1182-90; PMID: 16369557; http://dx.doi.org/10.1038/ni1275 4.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biochim Biophys Acta 2007; 1773:642-52; PMID: 16926057; http://dx.doi.org/10.1016/j.bbamcr.2006.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Cell Sci 2005; 118:4917-9; PMID:16254237; http://dx.doi.org/10.1242/jcs.02662 6.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Oncogene 2011; 30:2420-32; PMID:21258406; http://dx.doi.org/ 10.1038/onc.2010.615 8.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Proc Natl Acad Sci U S A 1988; 85:406-10; PMID:3257566; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Proc Natl Acad Sci U S A 1996; 93: 13694-8; PMID:8942996; http://dx.doi.org/10.1073/ pnas.93.24.13694 12.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Biol 2002; 12:1448-61; PMID:12225660; http://dx.doi.org/10.1016/S0960- 9822(02)01091-6 13.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
EMBO J 2003; 22: 3073-83; PMID:12805221; http://dx.doi.org/10.1093/ emboj/cdg298 14.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
FEBS Lett 1997; 410:78-82; PMID:9247127; http://dx.doi.org/10.1016/S0014- 5793(97)00323-215.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Proc Natl Acad Sci U S A 1992; 89:7282-6; PMID:1496022; http://dx.doi.org/10.1073/ pnas.89.15.7282 16.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1998; 273:16621-9; PMID:9632736; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Biol 1998; 8:69-81; PMID:9427642; http://dx.doi.org/10.1016/S0960- 9822(98)70037-5 20.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1995; 270:21396-403; PMID:7545671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Opin Cell Biol 1997; 9:782-7; PMID:9425342; http://dx.doi.org/10.1016/S0955- 0674(97)80078-6 26.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Exp Cell Res 1999; 253:100-9; PMID:10579915; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1999; 274:36843-51; PMID:10601235; http://dx.doi.org/ 10.1074/jbc.274.52.36843 28.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biochem J 1999; 344:427-31; PMID:10567225; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1999; 274:37400-6; PMID:10601311; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Science 1998; 279: 707-10; PMID:9445476; http://dx.doi.org/10.1126/ science.279.5351.707 31.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1999; 274:34493-8; PMID:10567431; http://dx.doi.org/10.1074/jbc.274.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nature 1994; 370:71-5; PMID:8015612; http://dx.doi.org/10.1038/370071a0 35.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1998; 273:15077-84; PMID:9614117; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 2002; 277:23065-75; PMID:11940578; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 2001; 276:20913-23; PMID:11279232; http://dx.doi.org/ 10.1074/jbc.M009047200 39.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Biol 1998; 8:R248-50; PMID:9545190; http://dx.doi.org/ 10.1016/S0960-9822(98)70152-6 40.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
BMC Genomics 2008; 9:252; PMID:18510738; http://dx.doi.org/10.1186/ 1471-2164-9-252 41.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1999; 274:1708-14; PMID:9880551; http://dx.doi.org/10.1074/jbc.274.3.1708 42.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
EMBO J 2004; 23:1761-9; PMID:15071500; http://dx.doi.org/10.1038/sj.emboj.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
EMBO J 2001; 20: 4370-9; PMID:11500364; http://dx.doi.org/10.1093/ emboj/20.16.4370 44.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Science 1999; 285:2126-9; PMID:10497130; http://dx.doi.org/10.1126/science.285.5436.2126 45.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
EMBO J 1998; 17:6649-59; PMID: 9822608; http://dx.doi.org/10.1093/emboj/17.22.6649 46.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Biol 2004; 14:1540-9; PMID:15341740; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nature 1993; 363:170-2; PMID:8483501; http://dx.doi.org/10.1038/ 363170a0 48.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Cell 1992; 69:1227-36; PMID:1377606; http://dx.doi.org/ 10.1016/0092-8674(92)90643-Q 49.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nature 1992; 358:70-3; PMID:1614535; http://dx.doi.org/ 10.1038/358070a0 50.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Science 1992; 257:973-7; PMID: 1380182; http://dx.doi.org/10.1126/science.1380182 51.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 1999; 274: 26776-82; PMID:10480882; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Science 1997; 278:687-9; PMID:9381178; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
"J Cell Physiol 2006; 209:261-5; PMID:16883576; http://dx.doi.org/ 10.1002/jcp.20749 55. de Groot RP, Ballou LM, Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen- induced gene expression.",Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Cell 1994; 79:81-91; PMID: 7923380; http://dx.doi.org/10.1016/0092-8674(94) 90402-2 56.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Cell Biol 2004; 166:213-23; PMID: 15249583; http://dx.doi.org/10.1083/jcb.200403069 57.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
"Science 1992; 258:955-64; PMID: 1439807; http://dx.doi.org/10.1126/science.1439807 58. dos Remedios CG, Chhabra D, Kekic M, Dedova IV, Tsubakihara M, Berry DA, et al.",OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Opin Struct Biol 1995; 5: 172-80; PMID:7648318; http://dx.doi.org/10.1016/ 0959-440X(95)80072-7 60.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Science 2003; 302:1704-9; PMID:14657486; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Cell 1999; 97:221-31; PMID: 10219243; http://dx.doi.org/10.1016/S0092-8674(00) 80732-1 62.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Cell Biol 2000; 150:1299- 310; PMID:10995436; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nature 2002; 418:790-3; PMID:12181570; http://dx.doi.org/ 10.1038/nature00859 64.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 2001; 276:26448-52; PMID:11340081; http://dx.doi.org/ 10.1074/jbc.M103856200 65.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Biol 2000; 10:1273-82; PMID:11069108; http://dx.doi.org/10.1016/S0960-9822(00)00749-1 66.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Cell Biol 2000; 150:1001-12; PMID:10973991; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Curr Opin Cell Biol 2003; 15:23-30; PMID:12517700; http://dx.doi.org/10.1016/S0955-0674(02)00015-7 68.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nature 1998; 393:805-9; PMID:9655397; http://dx.doi.org/10.1038/31729 69.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 2000; 275:3577-82; PMID:10652353; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Mol Cell 2000; 5:13-25; PMID:10678165; http://dx.doi.org/10.1016/S1097-2765(00)80399-8 72.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Nat Cell Biol 1999; 1:136-43; PMID:10559899; http://dx.doi.org/10.1038/ 11056 73.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Cell 1996; 85:573-83; PMID: 8653792; http://dx.doi.org/10.1016/S0092-8674(00) 81257-X 74.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Exp Cell Res 2004; 296:183-95; PMID:15149849; http://dx.doi.org/10.1016/j.yexcr.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biochem Biophys Res Commun 1997; 233: 193-9; PMID:9144421; http://dx.doi.org/10.1006/ bbrc.1997.6419 76.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Philos Trans R Soc Lond B Biol Sci 2010; 365:1581-92; PMID: 20403871; http://dx.doi.org/10.1098/rstb.2009.0261 77.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Adv Exp Med Biol 2008; 636:186-211; PMID:19856169; http://dx.doi.org/10.1007/978-0- 387-09597-4_11 80.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Dev Dyn 2008; 237:2170-6; PMID:18651670; http://dx.doi.org/10.1002/dvdy.21622 82.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
FASEB J 2009; 23:2555-67; PMID:19293393; http://dx.doi.org/ 10.1096/fj.06-070573 85.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Tissue Cell 1991; 23:235-46; PMID:1853336; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Proc Natl Acad Sci U S A 2010; 107:11411-6; PMID:20534520; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Endocrinology 2009; 150:4724-33; PMID: 19574397; http://dx.doi.org/10.1210/en.2008-1779 88.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biochim Biophys Acta 2003; 1593: 121-9; PMID:12581856; http://dx.doi.org/10.1016/ S0167-4889(02)00348-8 89.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Anat Rec 1979; 194:233-46; PMID:464324; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Arch Histol Cytol 2004; 67:271-84; PMID: 15700535; http://dx.doi.org/10.1679/aohc.67.271 92.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biol Reprod 2004; 71:548-59; PMID:15084482; http://dx.doi.org/10.1095/biolreprod.104.028803 93.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Anat Rec 1979; 194:213-32; PMID: 464323; http://dx.doi.org/10.1002/ar.1091940204 94.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biol Reprod 2009; 80:153-61; PMID:18799755; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Cell Commun Adhes 2002; 9:189-204; PMID:12699088; http://dx.doi.org/10.1080/1541906021601697.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biol Reprod 2004; 70: 805-12; PMID:14627549; http://dx.doi.org/10.1095/ biolreprod.103.022723 98.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Hum Reprod 2004; 19:2594-604; PMID:15471936; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Mol Endocrinol 2005; 19:1812- 20; PMID:15774499; http://dx.doi.org/10.1210/me.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Reproduction 2007; 133:763-73; PMID: 17504920; http://dx.doi.org/10.1530/rep.1.01091 102.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Annu Rev Immunol 2009; 27:519-50; PMID:19302047; http://dx.doi.org/ 10.1146/annurev.immunol.021908.132612 103.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 2005; 280:25029-47; PMID:15870075; http://dx.doi.org/10.1074/jbc.M501049200 105.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Differentiation 2000; 66:116-25; PMID:11100902; http://dx.doi.org/10.1046/j.1432- 0436.2000.660206.x 106.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Dev Biol 2005; 286: 1-15; PMID:16153630; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Cell Biochem Funct 2006; 24:113-7; PMID: 16329156; http://dx.doi.org/10.1002/cbf.1306 109.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Biol Chem 2000; 275:25572-6; PMID:10849422; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Dev Biol 2004; 276:158-71; PMID:15531371; http://dx.doi.org/10.1016/j.ydbio.2004.08.034 111.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Cell Sci 2003; 116:3363-72; PMID:12857787; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Reprod Biol Endocrinol 2008; 6:7; PMID:18254942; http://dx.doi.org/10.1186/1477-7827-6-7 114.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Mol Carcinog 2003; 38:25-32; PMID:12949840; http://dx.doi.org/10.1002/ mc.10140 115.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Cell Physiol 2008; 216:253-60; PMID: 18265003; http://dx.doi.org/10.1002/jcp.21400 117.,OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Androl 2007; 28:866-74; PMID:17609297; http://dx.doi.org/10.2164/jandrol.107.002865 118.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Endocrinology 2006; 147: 2557-66; PMID:16469801; http://dx.doi.org/10.1210/ en.2005-1404 119.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
J Endocrinol 2007; 192: 405-19; PMID:17283241; http://dx.doi.org/10.1677/ JOE-06-0076 120.,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
Biochem Biophys Res Commun 1987; 146: 575-81; PMID:3039983; http://dx.doi.org/10.1016/ 0006-291X(87)90567-5 www.landesbioscience.com Spermatogenesis 9,Non-OADS,/arxiv_data1/oa_pdf/f6/71/spmg-2-44.PMC3341245.pdf
"The number of apoptotic cells increased rapidly in a stage and cell specific manner one day after treatment but returned to normal level by day 9.25The number of proliferating cells as detected by proliferating cell nuclear antigen (PCNA) staining decreased after heat-treatment28or in experimentally induced cryptorchid testis in mice.29 In humans, a transient increase in scrotal temperatures by occupational exposure, lifestyle, clothing or cryptorchidism was correlated with low sperm concentrations,30,31reduced sperm motility32and reduced percentage of normal morphology,33 although some of the associations remained controversial.34,35 We hypothesize that electroacupuncture (EA) increases prolifera- tion and decreases apoptosis of the germ cells in the heat-treated *Correspondence to: Kai-Fai Lee; Email: ckflee@hku.hk Submitted: 11/22/11; Revised: 01/06/12; Accepted: 01/06/12 http://dx.doi.org/10.4161/spmg.2.1.19282REPORT Spermatogenesis 2:1, 1 –10; January/February/March 2012; G2012 Landes Bioscience www.landesbioscience.com Spermatogenesis 1",Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Best Pract Res Clin Endocrinol Metab 2011; 25:271-85; PMID:21397198; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Trends Pharmacol Sci 2011; 32:290-9; PMID:21324536; http://dx.doi.org/10.1016/j.tips.2011.01.0013.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Lancet 1997; 349: 787-90; PMID:9074589; http://dx.doi.org/10.1016/ S0140-6736(96)08341-95.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Complement Ther Med 2001; 9:2-11; PMID:11264963; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
J Altern Complement Med 2006; 12:639-48; PMID:16970534; http://dx.doi.org/ 10.1089/acm.2006.12.639 8.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
BMC Public Health 2008; 8:105; PMID:18377663; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Complement Ther Med 2002; 10: 84-93; PMID:12481956; http://dx.doi.org/10.1054/ ctim.2002.0519 10.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Fertil Steril 2008; 90:1-13; PMID:18440533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Acupunct Med 2010; 28:180-4; PMID:20959311; http://dx.doi.org/ 10.1136/aim.2009.002022 12.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Fertil Steril 2011; 95:583-7; PMID: 20646688; http://dx.doi.org/10.1016/j.fertnstert.2010.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Hum Reprod 2005; 20:339-49; PMID:15539440; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
J Huazhong Univ Sci Technolog Med Sci 2002; 22:228-30; PMID: 12658811; http://dx.doi.org/10.1007/BF02828187 20.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Fertil Steril 2009; 92: 1340-3; PMID:19394002; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Fertil Steril 2005; 84:141-7; PMID:16009169; http://dx.doi.org/10.1016/j.fertnstert.2004.12.056 23.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Geburtshilfe Frauenheilkd 1984; 44:510-2; PMID:6566639; http://dx.doi.org/10.1055/ s-2008-1036707 24.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
J Reprod Fertil 1998; 114:179-94; PMID:10070346; http://dx.doi.org/10.1530/jrf.0.1140179 25.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Endocrinology 1999; 140:1709-17; PMID:10098507; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Reproduction 2002; 124:133-40; PMID: 12090926; http://dx.doi.org/10.1530/rep.0.1240133 27.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Reproduction 2001; 122:255-63; PMID:11467976; http://dx.doi.org/10.1530/rep.0.1220255 28.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Reproduction 2005; 129:505-14; PMID: 15798026; http://dx.doi.org/10.1530/rep.1.00531 31.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Reprod Toxicol 2002; 16:215-21; PMID:12128094; http://dx.doi.org/10.1016/S0890-6238(02)00025-4 32.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Br J Urol 1982; 54:49-55; PMID:7059758; http://dx.doi.org/10.1111/j.1464-410X.1982.tb13510.x 33.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
"Am J Ind Med 1996; 30:750-8; PMID: 8914722; http://dx.doi.org/10.1002/(SICI)1097-0274 (199612)30:6 ,750::AID-AJIM12 .3.0.CO;2-1 34.",Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Reprod Toxicol 1992; 6:517-23; PMID: 1288761; http://dx.doi.org/10.1016/0890-6238(92) 90036-S 36.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Apoptosis 2005; 10:395-405; PMID:15843900; http://dx.doi.org/10.1007/s10495-005-0813-7 37.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
J Reprod Dev 2006; 52:219-28; PMID:16415524; http://dx.doi.org/10.1262/jrd.1707338.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
"J Reprod Fertil 1993; 97:381-7; PMID: 8501709; http://dx.doi.org/10.1530/jrf.0.0970381 40. de Rooij DG, Okabe M, Nishimune Y.",OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Biol Reprod 1999; 61: 842-7; PMID:10456866; http://dx.doi.org/10.1095/ biolreprod61.3.842 41.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Physiol Genomics 2007; 30:102-10; PMID:17341691; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Biol Reprod 2002; 66: 14-20; PMID:11751258; http://dx.doi.org/10.1095/ biolreprod66.1.14 48.,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Int J Androl 1988; 11:73-85; PMID:3128488; http://dx.doi.org/10.1111/j.1365-2605.1988.tb01218.x 50.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Brain Res 2005; 1037:164-70; PMID:15777765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Hum Reprod 2003; 18:1454-60; PMID:12832372; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Int J Androl 1995; 18:120-6; PMID:7558374; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Mol Hum Reprod 2008; 14:465-74; PMID:18621766; http://dx.doi.org/10.1093/molehr/ gan04162.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Biochem Biophys Res Commun 2003; 312:843-9; PMID:14680842; http://dx.doi.org/10.1016/j.bbrc.2003.10.191 63.,OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
Hum Reprod 1998; 13:142-5; PMID:9512246; http://dx.doi.org/10.1093/ humrep/13.1.142 10 Spermatogenesis Volume 2 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/eb/d9/spmg-2-53.PMC3341246.pdf
"Do not distribute.In search of suitable in vitro models to study germ cell movement across the blood-testis barrier Dolores D. Mruk* and C. Yan Cheng Center for Biomedical Research; The Population Council; New York, NY USA Keywords: germ cell, Sertoli cell, blood-testis barrier, testis, cell junction Abbreviations: BTB, blood-testis barrier; ECM, extracellular matrix; ES, ectoplasmic specialization; FAK, focal adhesion kinase; TJ, tight junction Submitted: 12/15/2011 Revised: 02/21/2012 Accepted: 03/02/2012 http://dx.doi.org/10.4161/spmg.2.1.19878 *Correspondence to: Dolores D. Mruk; Email: mruk@popcbr.rockefeller.eduThe movement of preleptotene/lepto- tene spermatocytes across the blood- testis barrier, also known as the Sertoli cell barrier, during stages VIII to XI of the seminiferous epithelial cycle is one of the most important cellular events taking place in the mammalian testis.",Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Endocrinol 2006; 190:759- 70; PMID:17003277; http://dx.doi.org/10.1677/joe.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocrinology 2003; 144:2141-63; PMID:12697723; http://dx.doi.org/10.1210/en.2002- 221035 4.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Cell Sci 2010; 123:1385-8; PMID:20410370; http://dx.doi.org/10.1242/jcs.066183 5.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Am J Anat 1977; 148:313-28; PMID:857632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocr Rev 2004; 25:747-806; PMID:15466940; http://dx.doi.org/10.1210/er.2003- 0022 7.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
FASEB J 2008; 22:1945-59; PMID:18192323; http://dx.doi.org/10.1096/fj.06-070342 8.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Proc Natl Acad Sci U S A 2009; 106:10213-8; PMID:19509333; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Int J Biochem Cell Biol 2009; 42:975-86; http://dx.doi.org/10.1016/j.biocel.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
FASEB J 2011; 25:1244-53; PMID:21191089; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Dev Biol 2009; 327:48-61; PMID:19103189; http://dx.doi.org/ 10.1016/j.ydbio.2008.11.028 13.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Biomaterials 2010; 31:4492- 505; PMID:20206992; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Androl 2006; 27:611-8; PMID:16582408; http://dx.doi.org/10.2164/jandrol.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocr Rev 1991; 12:45-77; PMID:2026122; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Proc Natl Acad Sci U S A 1985; 82:114-8; PMID:3855533; http://dx.doi.org/ 10.1073/pnas.82.1.114 18.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocrinology 1988; 123:2100-10; PMID:2458250; http://dx.doi.org/10.1210/endo-123-4-2100 19.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocrinology 1994; 134:149-57; PMID: 7903930; http://dx.doi.org/10.1210/en.134.1.149 20.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Cell Biol 1985; 100:1941-7; PMID:3889013; http://dx.doi.org/10.1083/jcb.100.6.1941 23.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Cell Biol 1985; 101:1511-22; PMID:4044644; http://dx.doi.org/10.1083/jcb.101.4.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Cell Physiol 1993; 156:1-11; PMID:8314850; http://dx.doi.org/10.1002/ jcp.1041560102 26.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Mol Hum Reprod 2009; 15:521-9; PMID:19561342; http://dx.doi.org/10.1093/molehr/gap052 28.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Cell Physiol 2011; 226:2150-8; PMID:21520067; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Tissue Eng Part B Rev 2011; 17:263-80; PMID:21495897; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Toxicol In Vitro 2011; 25:825-32; PMID: 21315144; http://dx.doi.org/10.1016/j.tiv.2011.02.002 31.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Biotechnol Bioeng 2010; 107:683-95; PMID: 20589846; http://dx.doi.org/10.1002/bit.22850 32.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Methods Mol Biol 2011; 695:1-15; PMID:21042962; http://dx.doi.org/10.1007/ 978-1-60761-984-0_1 35.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocrinology 1991; 129:1489-96; PMID: 1908377; http://dx.doi.org/10.1210/endo-129-3-1489 36.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Endocrinology 2003; 144:3114-29; PMID:12810568; http://dx.doi.org/10.1210/en.2002- 0167 38.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
J Biol Chem 2005; 280:25029-47; PMID:15870075; http://dx.doi.org/10.1074/jbc.M501049200 39.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
"J Cell Physiol 1999; 181:258-72; PMID: 10497305; http://dx.doi.org/10.1002/(SICI)1097- 4652(199911)181:2 ,258::AID-JCP8 .3.0.CO;2-Q 42.",OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Biol Reprod 2001; 65:1340-51; PMID: 11673248; http://dx.doi.org/10.1095/biolreprod65.5.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Reproduction 2007; 133:1169-79; PMID:17636171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Cell 2011; 145:1012-22; PMID:21703446; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
Cell Tissue Res 2005; 322: 21-31; PMID:16047158; http://dx.doi.org/10.1007/ s00441-005-0009-z www.landesbioscience.com Spermatogenesis 5,Non-OADS,/arxiv_data1/oa_pdf/a7/83/spmg-2-6.PMC3341247.pdf
"Zyxin is an 82 kDa protein that is known to concentrate at focal adhesions.7It has been described as a mechanosensitive protein due to its ability to mobilize and relocate from focal adhesions to actin stress fibers in response to mechanical cues.7 Zyxin is reported to be present at smooth muscle podosomes.8 In smooth muscle cells, phorbol ester triggers the conversion of focal adhesions into podosomes.8At discrete microdomains on the ventral surface of the plasma membrane, podosomes form near the sites where stress fibers insert into adhesion plaques.9These structures are reported to contain a-actinin, F-actin, and vinculin *Correspondence to: Wayne Vogl; Email: vogl@mail.ubc.ca Submitted: 11/04/11; Revised: 01/16/12; Accepted: 01/17/12 http://dx.doi.org/10.4161/spmg.2.1.19391REPORT Spermatogenesis 2:1, 1 –6; March 1, 2012; G2012 Landes Bioscience www.landesbioscience.com Spermatogenesis 1",Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Biol Reprod 2004; 71:548-59; PMID:15084482; http://dx.doi.org/10.1095/biolreprod.104.028803 2.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Am J Anat 1979; 155:259-79; PMID: 474448; http://dx.doi.org/10.1002/aja.1001550208 3.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Anat Rec 1976; 185:259-78; PMID:937734; http://dx.doi.org/10.1002/ar.1091850302 4.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Biol Reprod 2009; 80:162-74; PMID:18799754; http://dx.doi.org/10.1095/biolreprod.108.0706235.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Nat Rev Mol Cell Biol 2004; 5:647-57; PMID:15366708; http://dx.doi.org/10.1038/nrm1436 6.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
J Cell Physiol 2007; 210:644-54; PMID: 17133358; http://dx.doi.org/10.1002/jcp.20855 7.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
J Cell Biol 2005; 171:209- 15; PMID:16247023; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
J Cell Sci 2003; 116:4915-24; PMID:14625385; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Am J Physiol Cell Physiol 2005; 289:C898-907; PMID:15944209; http://dx.doi.org/10.1152/ajpcell.00095.2005 10.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Exp Cell Res 2002; 280:64-74; PMID:12372340; http://dx.doi.org/10.1006/excr.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Biol Reprod 2009; 80:153-61; PMID:18799755; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Cell 1994; 79:211- 9; PMID:7954790; http://dx.doi.org/10.1016/0092- 8674(94)90191-0 18.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
J Cell Biol 1997; 138:1139- 47; PMID:9281590; http://dx.doi.org/10.1083/jcb.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Mol Cell Biol 2003; 23:70-9; PMID:12482962; http://dx.doi.org/10.1128/MCB.23.,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Exp Cell Res 2005; 304:443-56; PMID:15748890; http://dx.doi.org/10.1016/j.yexcr.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Nat Cell Biol 2010; 12:902-8; PMID:20729836; http://dx.doi.org/10.1038/ncb2094 23.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Trends Cell Biol 2003; 13:376- 85; PMID:12837608; http://dx.doi.org/10.1016/ S0962-8924(03)00128-4 24.,OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
Nat Rev Mol Cell Biol 2004; 5:647-57; PMID:15366708; http://dx.doi.org/10.1038/nrm1436 6 Spermatogenesis Volume 2 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/a6/e4/spmg-2-63.PMC3341248.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/60/djs177.PMC3341307.pdf
"Based on published data, genes in the ATM ( 18),  FA/HR ( 21,22), NER ( 23), and TLS ( 24) pathways were selected  from the set of 151 genes for the development of a score predictive  of outcomes following platinum-based therapy.Patient Samples We extracted clinical data for 511 patients with serous ovarian  cystadenocarcinoma from The Cancer Genome Atlas (TCGA)  database ( 44) website ( http://tcga-data.nci.nih.gov ) on February  17, 2011, representing the largest available dataset of epithelial  ovarian cancer gene expression profiles (see Supplementary Table 2,  available online, for further details on which ovarian cancer sam - ples were included in this study).",OADS,/arxiv_data1/oa_pdf/3f/60/djs177.PMC3341307.pdf
"of patients Median OS (95% CI), y Age (median 59, range 30–89), y      ≤59 262 4.1 (3.7 to 4.5) 242 4.1 (3.6 to 4.4)  ≥60 242 3.2 (2.8 to 3.5) 222 3.0 (2.8 to 3.4) Stage†      I 15 6.7 (6.7 to ∞) — —  II 23 5.9 (3.7 to ∞) — —  III 383 3.7 (3.3 to 4.0) 383 3.7 (3.3 to 4.0)  IV 81 2.7 (2.2 to 4.2) 81 2.7 (2.2 to 4.2) Grade‡      1 5 5.4 (4.5 to 6.2) 5 5.4 (4.5 to 6.2)  2 61 4.6 (3.5 to 6.8) 49 4.0 (3.2 to 5.1)  3 428 3.5 (3.2 to 4.0) 398 3.4 (3.0 to 3.8) Initial chemotherapy      Platinum and taxane 331 4.0 (3.6 to 4.5) 304 3.8 (3.4 to 4.2)  Cisplatin 43 3.8 (3.0 to 4.7) 42 3.8 (3.0 to 4.7)  Carboplatin 286 4.0 (3.5 to 4.4) 260 3.7 (3.2 to 4.1)  Oxaliplatin 2 — 2 —  Non-platinum and taxane 126 3.7 (3.1 to 4.1) 121 3.5 (3.0 to 4.0) Response to primary therapy      Platinum and taxane 289 4.2 (3.7 to 4.6) 264 4.0 (1.8 to 3.0)  CR 208 4.8 (4.1 to 5.9) 188 4.8 (4.1 to 5.7)  Non-CR 81 2.8 (1.8 to 3.2) 78 2.7 (1.8 to 3.0)  Non-platinum and taxane 121 4.0 (3.3 to 4.5) 101 3.6 (3.0 to 4.3)  CR 80 4.7 (4.0 to 5.9) 67 4.4 (3.7 to 4.9)  Non-CR 41 2.5 (1.9 to 3.2) 34 2.5 (1.7 to 3.1) Surgical debulking      0–10 mm residual tumor 329 3.7 (3.4 to 4.0) 300 3.5 (3.2 to 3.8)  ≥11 mm residual tumor 128 3.0 (2.6 to 3.5) 116 3.1 (2.6 to 3.6) TCGA tumor/gene subtype      Differentiated 134 3.7 (3.2 to 4.0) 83 3.5 (2.9 to 4.0)  Immunoreactive 104 4.3 (3.3 to 5.9) 68 4.2 (3.0 to 5.9)  Mesenchymal 107 3.4 (2.6 to 4.1) 67 3.8 (2.4 to 5.2)  Proliferative 135 3.5 (3.0 to 4.0) 79 4.1 (3.2 to 5.0)  N/A 24 6.2 (2.8 to ∞) 7 3.6 (0.8 to 6.2) * We extracted clinical data for 511 patients with serous ovarian cystadenocarcinoma from TCGA (44) website (http://tcga-data.nci.nih.gov) on February 17, 2011.",Non-OADS,/arxiv_data1/oa_pdf/3f/60/djs177.PMC3341307.pdf
"Traditional epidemio- logic studies measure the strength of association between a risk  factor and a disease in relative terms such as relative risk and odds Review http://dx.doi.org/10.4070/kcj.2012.42.4.223 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Clinical Utility of Novel Biomarkers in the Prediction   of Coronary Heart Disease Hyeon Chang Kim, MD Department of Preventive Medicine, Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea   Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Coronary heart disease (CHD) is a significant cause of morbidity and mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/48/a2/kcj-42-223.PMC3341417.pdf
"224 Novel Biomarkers and Coronary Heart Disease Prediction http://dx.doi.org/10.4070/kcj.2012.42.4.223 www.e-kcj.org terol, and high density lipoprotein-cholesterol (HDL-C) with differ - ent points (coefficients) in order to assess an individual’s 10-year  coronary heart disease (CHD) risk.4) The third Report of the Nation - al Cholesterol Education Program Expert Panel on Detection, Eval - uation, and Treatment of High Blood Cholesterol in Adults {Adult  Treatment Panel III (ATP-III) } and many other guidelines for CHD risk  assessment and prevention are largely based on the Framingham  equations to predict an individual’s 10-year risk of CHD.5-7) For exam - ple, according to the ATP-III guidelines, individuals can be catego - rized into one of 3 risk categories shown in Fig.",Non-OADS,/arxiv_data1/oa_pdf/48/a2/kcj-42-223.PMC3341417.pdf
"225 Hyeon Chang Kim http://dx.doi.org/10.4070/kcj.2012.42.4.223 www.e-kcj.org squared difference between the observed outcome and fitted prob - ability; smaller values indicate better fit), and the integrated dis - crimination improvement.28)29) “Calibration” refer to how close the  predicted disease risks are to the actual observed risks.",Non-OADS,/arxiv_data1/oa_pdf/48/a2/kcj-42-223.PMC3341417.pdf
"226 Novel Biomarkers and Coronary Heart Disease Prediction http://dx.doi.org/10.4070/kcj.2012.42.4.223 www.e-kcj.org ses in the Nurses’ Health Study and in the Health Professional Fol - low-up Study observed that CRP level was independently associated  with CHD risk in men, but not in women.34) In the British Women’s  Heart and Health Study, CRP was not significantly associated with  either CHD or CVD, and it did not improve the identification of risk in  women.35) In the Women’s Health Study, CRP levels ≥3 mg/L were  significantly associated with CVD risk, independent of metabolic  abnormalities.33) However, those relationships were not observed in  the nested case-control studies performed in the Nurses’ Health Study.34) In the Women’s Health Initiative datasets, CRP was not sig- nificantly associated with CHD after adjustment for traditional risk  factors (p=0.767), and did not improve discriminative power of CHD  prediction (p=0.296).2) According to a systematic review by Shah et  al.,38) CRP level is consistently associated with CHD risk, but CRP  testing provides only limited information for risk prediction than  tests of association alone might suggest.",Non-OADS,/arxiv_data1/oa_pdf/48/a2/kcj-42-223.PMC3341417.pdf
"227 Hyeon Chang Kim http://dx.doi.org/10.4070/kcj.2012.42.4.223 www.e-kcj.org incidence but mortality, and the biomarker panel included cystatin C,  troponins, and NT-proBNP reflect existing cardiac or renal damage.",OADS,/arxiv_data1/oa_pdf/48/a2/kcj-42-223.PMC3341417.pdf
228 Novel Biomarkers and Coronary Heart Disease Prediction http://dx.doi.org/10.4070/kcj.2012.42.4.223 www.e-kcj.org 12.,Non-OADS,/arxiv_data1/oa_pdf/48/a2/kcj-42-223.PMC3341417.pdf
"Moreover, there is no evidence supporting the hypothesis that the Editorial http://dx.doi.org/10.4070/kcj.2012.42.4.229 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Efonidipine, Another Beauty Relieving the Pressure Jinho Shin, MD Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea Correspondence: Jinho Shin, MD, Division of Cardiology, Department of In - ternal Medicine, Hanyang University College of Medicine, 222 Wangsimni- ro, Seongdong-gu, Seoul 133-792, Korea Tel: 82-2-2290-8308, Fax: 82-2-2298-9183 E-mail: jhs2003@hanyang.ac.kr • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/18/40/kcj-42-229.PMC3341418.pdf
"230 Efonidipine, Another Beauty Relieving the Pressure http://dx.doi.org/10.4070/kcj.2012.42.4.229  www.e-kcj.orgtion, modest efonidipine efficacy on nocturnal blood pressure  needs to be considered for individualized patient care.",Non-OADS,/arxiv_data1/oa_pdf/18/40/kcj-42-229.PMC3341418.pdf
"231 Copyright © 2012 The Korean Society of CardiologyKorean Circulation Journal Introduction Dihydropyridine (DHP)-derivative calcium channel blockers (CCBs)  are widely used as first-line antihypertensive agents.1) The currently  known voltage-gated calcium channel subtypes include L-, T-, N-,  P/Q-, and R-types.2) Efonidipine, a DHP-derivative CCB, has been pro- ven to exert a blocking effect on L- type as well as T-type calcium ch-Original Article http://dx.doi.org/10.4070/kcj.2012.42.4.231 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Effect of an L- and T-Type Calcium Channel Blocker on 24-Hour   Systolic Blood Pressure and Heart Rate in Hypertensive Patients Masae Komukai, MD1, Takeshi Tsutsumi, MD2, Mio Ebado, MD3, and Youichi Takeyama, MD4 1Division of Cardiology, Showa University Fujigaoka Hospital, Yokohama,  2Department of Ischemic Circulatory Physiology, University of Tokyo, Tokyo,  3Division of Cardiology, Showa University Fujigaoka Hospital, Yokohama,  4Division of Cardiology, Showa University Fujigaoka Rehabilitation Hospital, Yokohama, Japan Background and Objectives:  The aim of this study was to evaluate the effects of an L- and T-type calcium channel blocker (CCB) on 24- hour systolic blood pressure (24-hour SBP) and heart rate (24-hour HR) profiles in essential hypertensive patients.",Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
232 L- and T-CCB and Hypertension  http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org efonidipine in patients with essential hypertension.,Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org The best-fit curve  A commercial computer program (MemCalc; Suwa Trust Co. Ltd.,  Tokyo, Japan) was applied to generate the best-fit curve for chang - es in the 24-hour SBP or HR (ΔSBP, ΔHR) every 30 minutes before  and after administration of the drug.",OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
"234 L- and T-CCB and Hypertension  http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org Hg (p<0.01) and from 90.6 ±10.2 to 86.3 ±9.5 mm Hg (p<0.01), re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org dilol; 5-10 mg/day) or an angiotensin II receptor blocker (candesar - tan; 8 mg/day).,Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
236 L- and T-CCB and Hypertension  http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org elevated after waking (6:30 a.m.).,Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org before and after treatment were 1 1.2% and 1 1.0% for nifedipine  GITS, and 5.1% and 5.7% for amoldipine.20)21) Thus, the hypotensive  effect of efonidipine on nocturnal SBP reduction in dipper cases was  weaker than that of typical long-lasting drugs.",Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
"238 L- and T-CCB and Hypertension  http://dx.doi.org/10.4070/kcj.2012.42.4.231 www.e-kcj.org 1,4-dihydropyridine derivative: correlation between dihydropyridine  receptor binding and inhibition of calcium uptake in rabbit aorta.",Non-OADS,/arxiv_data1/oa_pdf/f0/60/kcj-42-231.PMC3341419.pdf
"In diabetes, endothelial dys - function is characterized by a reduced availability of endothelium- derived vasodilating factors, such as nitric oxide.2)3) Impaired endo -Original Article http://dx.doi.org/10.4070/kcj.2012.42.4.239 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Krüppel-Like Factor 2 Suppression by High Glucose   as a Possible Mechanism of Diabetic Vasculopathy Hae-Young Lee, MD1,2, Seock-Won Youn, PhD1, Byung-Hee Oh, MD2, and Hyo-Soo Kim, MD1,2 1Cardiovascular Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul,  2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Background and Objectives:  Endothelial dysfunction is widely observed in diabetes mellitus, resulting in diabetic vascular complica - tions.",Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
240 KLF2 Suppression in Diabetes http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org expression of KLF2 in endothelial cells cultured in high glucose and  investigated its functional implication in a diabetic animal model.,Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org ranging from 5 mM to 100 mM.,Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
"242 KLF2 Suppression in Diabetes http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org Shear flow induced Krüppel-like factor 2 expression was  inhibited under high glucose conditions Next, we evaluated the effect of high glucose under shear stress,  which is one of the main physiologic stimuli of KLF2.9) A total of 12  dynes/cm2 of shear stress was applied for 24 hours using an orbital  shaker.",Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org tion, the body weight was also significantly greater in the OLETF rats  than in the LETO rats.",Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
244 KLF2 Suppression in Diabetes http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org owed these in vitro  findings could be extrapolated to an in vivo  sit- uation.,Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.239 www.e-kcj.org preventing diabetic vascular dysfunction.,Non-OADS,/arxiv_data1/oa_pdf/33/34/kcj-42-239.PMC3341420.pdf
"Plaque dis-Original Article http://dx.doi.org/10.4070/kcj.2012.42.4.246 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Low Density Lipoprotein-Cholesterol/High Density   Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability   in Patients With Stable Angina Jeong Hun Kim, MPH1,2, Myung Ho Jeong, MD1,3, Young Joon Hong, MD1, Ki Hong Lee, MD1, In Soo Kim, MS1,  Yun Ha Choi, RN1, Min Goo Lee, MD1, Keun-Ho Park, MD1, Doo Sun Sim, MD1, Ju Han Kim, MD1,  Youngkeun Ahn, MD1, Jeong Gwan Cho, MD1, Jong Chun Park, MD1, and Jung Chaee Kang, MD1 1The Heart Center of Chonnam National University Hospital, 2Department of Public Health, Chonnam National University Medical School,  3Korea Cardiovascular Stent Research Institute of Chonnam National University, Gwangju, Korea Background and Objectives:  The relationship between lipid profile and coronary plaque tissue characteristics in patients with stable an - gina pectoris (SAP) is unclear.",Non-OADS,/arxiv_data1/oa_pdf/fd/38/kcj-42-246.PMC3341421.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.246 www.e-kcj.org ported that an elevated LDL-C/HDL-C ratio may be a positive pre - dictor for coronary lipid-rich plaques and plaque vulnerability in pa - tients with chronic CAD.,Non-OADS,/arxiv_data1/oa_pdf/fd/38/kcj-42-246.PMC3341421.pdf
248 Coronary Plaque in Stable Angina http://dx.doi.org/10.4070/kcj.2012.42.4.246 www.e-kcj.org tient baseline variables were entered into the regression model if  they were statistically significant (p<0.2) by univariate analysis.,OADS,/arxiv_data1/oa_pdf/fd/38/kcj-42-246.PMC3341421.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.246 www.e-kcj.org of the lesion segment (18.0 ±6.7 mm2 vs. 13.1 ±3.9 mm2, p=0.001),  percent plaque area of the MLA (77.7 ±7.0% vs. 71.1 ±9.6%, p=  0.001), and the EEM CSA of the distal reference segment (13.7 ±6.6  mm2 vs. 1 1.0 ±4.0 mm2, p=0.037) were significantly larger in the UP  group than in the SP group.",OADS,/arxiv_data1/oa_pdf/fd/38/kcj-42-246.PMC3341421.pdf
250 Coronary Plaque in Stable Angina http://dx.doi.org/10.4070/kcj.2012.42.4.246 www.e-kcj.org IVUS were associated with the LDL-C/HDL-C ratio.,Non-OADS,/arxiv_data1/oa_pdf/fd/38/kcj-42-246.PMC3341421.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.246 www.e-kcj.org 22.,Non-OADS,/arxiv_data1/oa_pdf/fd/38/kcj-42-246.PMC3341421.pdf
"252 Copyright © 2012 The Korean Society of CardiologyKorean Circulation Journal Introduction Vascular rings are rare congenital anomalies that primarily result  from an embryological derangement of the paired aortic arches or  branching pulmonary arteries.1)2) The symptoms and physical find - ings produced by vascular rings are related to the structure(s) they Original Article http://dx.doi.org/10.4070/kcj.2012.42.4.252 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Clinical Course of Vascular Rings and   Risk Factors Associated With Mortality Yoon Jung Suh, MD1, Gi Beom Kim, MD1, Bo Sang Kwon, MD1, Eun Jung Bae, MD1, Chung Il Noh, MD1,  Hong Gook Lim, MD2, Woong Han Kim, MD2, Jeong Ryul Lee, MD2, and Yong Jin Kim, MD2 1Departments of Pediatrics and 2Thoracic and Cardiovascular Surgery, Seoul National University Children’s Hospital, Seoul, Korea Background and Objectives:  Vascular rings refer to anomalies of the great arteries that cause respiratory or feeding problems.",Non-OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.252 www.e-kcj.org structures compressed by the vascular ring, and associated anoma - lies were recorded for each patient.",OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
254 Clinical Course of Vascular Rings http://dx.doi.org/10.4070/kcj.2012.42.4.252 www.e-kcj.org current age among the patients who survived was 8.4 years (1.5- 22.5 years).,Non-OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.252 www.e-kcj.org er diagnoses.,OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
"256 Clinical Course of Vascular Rings http://dx.doi.org/10.4070/kcj.2012.42.4.252 www.e-kcj.org tory symptoms, eleven underwent surgical repair including airway  surgery.",Non-OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.252 www.e-kcj.org past.3)16) Currently, CT angiography is an important modality used in  our center.",Non-OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
258 Clinical Course of Vascular Rings http://dx.doi.org/10.4070/kcj.2012.42.4.252 www.e-kcj.org orac Cardiovasc Surg  1977;73:248.,Non-OADS,/arxiv_data1/oa_pdf/63/a2/kcj-42-252.PMC3341422.pdf
"259 Copyright © 2012 The Korean Society of CardiologyKorean Circulation Journal Introduction Among revascularization methods for critical lower limb ischemia  (CLI), surgical bypass is regarded as the gold standard, with better  anatomical and clinical durabilities.1-3) However, patients with CLI are Original Article http://dx.doi.org/10.4070/kcj.2012.42.4.259 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Clinical Outcomes of Infrapopliteal Angioplasty   in Patients With Critical Limb Ischemia Hyeon Min Ryu, MD1, Jung-Sun Kim, MD2, Young Guk Ko, MD2,  Myeong-Ki Hong, MD2, Yangsoo Jang, MD2, and Donghoon Choi, MD2 1Gumi CHA Medical Center, CHA University, Gumi, 2Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Background and Objectives:  With recent advances in equipment and techniques, infrapopliteal angioplasty has shown results that are  comparable to those of surgical bypass in patients with critical limb ischemia (CLI).",Non-OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
260 Infrapopliteal Angioplasty in Critical Limb Ischemia http://dx.doi.org/10.4070/kcj.2012.42.4.259 www.e-kcj.org as a primary choice of treatment in patients with CLI.,Non-OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.259 www.e-kcj.org tion rate was 54.2 ±33.1 mL/min/1.73 m2.,OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
"262 Infrapopliteal Angioplasty in Critical Limb Ischemia http://dx.doi.org/10.4070/kcj.2012.42.4.259 www.e-kcj.org (82% vs. 74%, p=0.726) irrespective of the presence or absence of  subintimal angioplasty.",Non-OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.259 www.e-kcj.org cerebrovascular accident (25% vs. 6%, p=0.007), more frequent cor - onary artery disease (71% vs. 49%, p=0.037), more frequent combined  intervention of ipsilateral lower extremity (68% vs. 36%, p=0.003),  and worse primary clinical success (68% vs. 88%, p=0.021) were as - sociated with poor 2 year survival (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
"264 Infrapopliteal Angioplasty in Critical Limb Ischemia http://dx.doi.org/10.4070/kcj.2012.42.4.259 www.e-kcj.org tients, did not show a significant difference with respect to amputa - tion-free survival, all-cause mortality and quality of life during short- term follow-up.13) However, most data about CLI included the proximal  segments as femoral or femopopliteal segments, and few reports have  focused on the infrapopliteal segment due to high technical failure  rates and low patency rates.",Non-OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.259 www.e-kcj.org Vasc Surg  1998;28:1066-71.,OADS,/arxiv_data1/oa_pdf/d8/18/kcj-42-259.PMC3341423.pdf
"There Original Article http://dx.doi.org/10.4070/kcj.2012.42.4.266 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Long-Term Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting  Stents in Patients With Acute Myocardial Infarction:   Four-Year Observational Study Gye-Sik Min, CRC, Jae-Hwan Lee, MD, Jae-Ho Park, MD, Ung-Lim Choi, MD, Young-Dal Lee, MD,   Seok-Woo Seong, MD, Seon-Ah Jin, MD, Soo-Jin Park, MD, Jun-Hyeong Kim, MD,   Jae-Hyeong Park, MD, Si Wan Choi, MD, Jin-Ok Jeong, MD, and In-Whan Seong, MD Department of Cardiology, Chungnam National University School of Medicine, Daejeon, Korea Background and Objectives:  The comparison of long-term clinical effects between Sirolimus-eluting stent (SES) and Paclitaxel-eluting  stents (PES) for treatment of acute myocardial infarction (AMI) remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.has been concern about the use of DES in highly thrombogenic situ - ations, such as acute myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org improvements in clinical and angiographic outcomes in the treat - ment of many coronary lesions, compared with BMS.2-4) However,  to date there is limited long term clinical data directly comparing  outcomes of SES with PES implantation, in the treatment of AMI  patients.",Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
268 Sirolimus- vs. Paclitaxel-Eluting Stents for AMI http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org Statistical analysis Data are expressed as mean ±SD or median (range) for continu - ous variables and as frequencies (percentages) for the categorical  variables.,OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org Reperfusion time The durations from symptom onset to emergency room (ER) ar - rival (pain-to-ER time) and from ER arrival to reperfusion (door-to-balloon time) are shown in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
270 Sirolimus- vs. Paclitaxel-Eluting Stents for AMI http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org Procedural characteristics Procedural characteristics are shown in Table 4.,Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org stent thrombosis or TVR were the same between the SES and PES  treated groups in 168 NSTEMI patients (Fig.,Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
272 Sirolimus- vs. Paclitaxel-Eluting Stents for AMI http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org Discussion This retrospective study compared four year clinical efficacy of  SES and PES in patients with AMI who underwent PCI.,Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.266 www.e-kcj.org We found no significant difference in the rate of stent thrombo - sis between the two DES groups (5.4 ±1.7% in the PES and 3.2 ±1.1%  in the SES, p=0.53), which was comparable to or somewhat higher  than previously reported rates (2.7-3.6% in the SES vs. 2.9-3.4%  in the PES).13)14) However, the PES group showed a trend towards  the occurrence of stent thrombosis after one year, while the SES  group showed a similar incidence.",Non-OADS,/arxiv_data1/oa_pdf/84/23/kcj-42-266.PMC3341424.pdf
"We describe the case of a 66-year old man presenting with  symptoms and signs of right-sided heart failure due to extrinsic com - pression of the right atrium caused by late-onset PPE.Case Report http://dx.doi.org/10.4070/kcj.2012.42.4.274 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Late-Onset Postpneumonectomy Empyema Presenting   as Right-Sided Heart Failure: Extrinsic Right Atrial Compression June Namgung, MD1, Jae-Jin Kwak, MD1, Hyunmin Choe, MD1, Sung Uk Kwon, MD1, Joon Hyung Doh, MD1,  Sung Yun Lee, MD1, Ji-Yoon Ryoo, MD2, Gham Hur, MD3, and Won Ro Lee, MD1  1Division of Cardiology, Departments of Internal Medicine, 2Thoracic Surgery, and 3Radiology, Inje University College of Medicine, Ilsan Paik Hospital, Goyang, Korea Although it is rare, the right atrium can be encroached on by abnormal mediastinal structures, including aortic aneurysms, carcinomas, he - patic cysts and diaphragmatic paralysis.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/kcj-42-274.PMC3341425.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.274 www.e-kcj.org spite conventional management, including oxygen and a bronchodi - lator, his condition became worse with worsening despnea at rest,  weight gain over 5 kg and increased pretibial pitting edema.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/kcj-42-274.PMC3341425.pdf
"276 Extrinsic Right Atrial Compression Caused by Postpneumonectomy Empyema http://dx.doi.org/10.4070/kcj.2012.42.4.274 www.e-kcj.org Discussion The heart is centrally located in the mediastinum, so it can be en - croached on by abnormal structures originating from the anterior,  posterior or superior mediastinum.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/kcj-42-274.PMC3341425.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.274 www.e-kcj.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/7b/kcj-42-274.PMC3341425.pdf
"Her initial blo-Case Report http://dx.doi.org/10.4070/kcj.2012.42.4.278 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Malignant Melanoma of Unknown Primary   Origin Presenting as Cardiac Metastasis Eun Young Lee, MD, Jin-Oh Choi, MD, Ha Na Park, MD, Eun-Jung Park, MD,   Gil Sun Lee, MD, Jun Young Park, MD, Jung-Sun Kim, MD, and Eun Seok Jeon, MD Department of Internal Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea Malignant melanoma has a very high propensity to metastasize to the heart.",OADS,/arxiv_data1/oa_pdf/75/a8/kcj-42-278.PMC3341426.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.278 www.e-kcj.org Discussion Malignant melanoma has aggressive biological behavior and the  greatest tendency for metastasis to the heart.1) Although autopsy  studies reported an incidence of 50% to 71%, cardiac metastasis is  diagnosed in less than 1% of patients with malignant melanoma be- cause less than 10% of these patients present with cardiac symp - toms.2) Such metastases most frequently occur after multifocal he - matological dissemination and may develop anywhere in the heart.3)  Melanotic metastases can invade the wall of any of the 4 cardiac  chambers, and the RA is involved most frequently.4) The clinical signs and symptoms of cardiac metastasis are un - clear and non-specific, although when present, the clinical signs and  symptoms include fatigue, weakness, pericardial effusion, congestive heart failure, cardiac arrhythmia, superior vena cava syndrome, right  ventricular outflow and inflow obstruction, and transient ischemic  attack.5) However, patients with malignant melanoma who have car - diac metastases may present symptoms only caused by tumors in  other organ systems.",Non-OADS,/arxiv_data1/oa_pdf/75/a8/kcj-42-278.PMC3341426.pdf
"280 Malignant Melanoma of Unknown Primary Origin Presenting as Cardiac Metastasis http://dx.doi.org/10.4070/kcj.2012.42.4.278 www.e-kcj.org mors when corresponding stages were compared.10-12) Those patients  with metastases to any other visceral sites are described to have a  1 year survival rate of 41% and a median survival of approximately  6 months.1 1)13)14) Accordingly, we expected that the outcome of this  patient might be very unfavorable.",Non-OADS,/arxiv_data1/oa_pdf/75/a8/kcj-42-278.PMC3341426.pdf
"Atrial fibrillation was detected during a recent medi- cal check up at a local clinic, and the patient was referred to our hos -Case Report http://dx.doi.org/10.4070/kcj.2012.42.4.281 Print ISSN 1738-5520  • On-line ISSN 1738-5555 A Rare Case of Aortic Valve Myxoma:   Easy to Confuse With Papillary Fibroelastoma Hyung Yoon Kim, MD1, Sung Uk Kwon, MD1, Woo-Ik Jang, MD2, Han-Seong Kim, MD3, Jin Suk Kim, MD1,  Han Sang Lee, MD1, Min Yong Park, MD1, Taewan Kim, MD1, Sung Yun Lee, MD1,  Joon Hyung Doh, MD1, June Namgung, MD1, and Won Roo Lee, MD1 1Division of Cardiology, Departments of Internal Medicine, 2Thoracic Surgery, and 3Pathology, Inje University College of Medicine, Ilsan Paik Hospital, Goyang, Korea Myxoma of the aortic valve is an exceedingly uncommon condition.",Non-OADS,/arxiv_data1/oa_pdf/c7/78/kcj-42-281.PMC3341427.pdf
282 A Rare Case of Aortic Valve Myxoma http://dx.doi.org/10.4070/kcj.2012.42.4.281 www.e-kcj.org eduled follow-up.,Non-OADS,/arxiv_data1/oa_pdf/c7/78/kcj-42-281.PMC3341427.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.281 www.e-kcj.org location, mobility, and attachment site of a cardiac mass as well as  the clinical presentation usually can differentiate these masses.",Non-OADS,/arxiv_data1/oa_pdf/c7/78/kcj-42-281.PMC3341427.pdf
"284 Copyright © 2012 The Korean Society of CardiologyKorean Circulation Journal Introduction Single anomalous origin of coronary artery is a rare congenital  anomaly of coronary circulation.1) The incidence of single anoma - lous origin is approximately 1% among patients undergoing cardi - ac catheterization, and an anomalous origin of the left coronary  artery is particularly less frequent than the right coronary artery  (RCA).2-7) We report on a rare case of anomalous left coronary artery  that originated from the right sinus of valsalva, with total occlusion  on the proximal RCA.Case Report http://dx.doi.org/10.4070/kcj.2012.42.4.284 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Successful Primary Percutaneous Coronary Intervention   in a Patient With Acute Myocardial Infarction and   Single Coronary Artery Ostium Donghan Kim, MD, Myung Ho Jeong, MD, Ki Hong Lee, MD, Min Goo Lee, MD, Keun-Ho Park, MD, Doo Sun Sim, MD,  Nam Sik Yoon, MD, Hyun Ju Yoon, MD, Kye Hun Kim, MD, Young Joon Hong, MD, Ju Han Kim, MD,   Youngkeun Ahn, MD, Jeong Gwan Cho, MD, Jong Chun Park, MD, and Jung Chaee Kang, MD Department of Cardiology, Chonnam National University Hospital, Korea Cardiovascular Stent Research Institute of Chonnam National University, Gwangju, Korea One of the single anomalous origins of coronary artery that has rarely been reported is a congenital anomaly of coronary circulation that  occurs in the left coronary artery originating from the right coronary sinus of valsalva.",Non-OADS,/arxiv_data1/oa_pdf/d4/89/kcj-42-284.PMC3341428.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.284 www.e-kcj.org 4.0×25 mm bare-metal stent (Coroflex blue®, Braun, Berlin, Ger - many) was deployed in critical fixed stenosis of the proximal RCA.",Non-OADS,/arxiv_data1/oa_pdf/d4/89/kcj-42-284.PMC3341428.pdf
"286 Primary PCI in Single Coronary Artery http://dx.doi.org/10.4070/kcj.2012.42.4.284 www.e-kcj.org 2 cm curve (AR2) guiding catheter, CAG revealed patent stent in  proximal RCA and a more resolved state of thrombi in PDA, as well  as improved distal flow in the posterolateral branch (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d4/89/kcj-42-284.PMC3341428.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.284 www.e-kcj.org milial clustering.,OADS,/arxiv_data1/oa_pdf/d4/89/kcj-42-284.PMC3341428.pdf
"It is ch- aracterized by a triad of features, including generalized arterial tor- tuosity, hypertelorism, and a bifid uvula or cleft palate.1)2) It is also  associated with a high risk of premature aggressive aortic aneurysm  and dissection or rupture at a young age, even when the aortic di - ameter is small.2)3) We describe the case of an adolescent, who un - derwent serial near total aortic replacement, from the aortic valve to  the descending aorta, with Loeys-Dietz syndrome confirmed by the  detection of a mutation in the TGF-ßR 2  gene.Case Report http://dx.doi.org/10.4070/kcj.2012.42.4.288 Print ISSN 1738-5520  • On-line ISSN 1738-5555 A Case of Near Total Aortic Replacement   in an Adolescent With Loeys-Dietz Syndrome Yoon Jung Suh, MD1, Hye Won Kwon, MD1, Gi Beom Kim, MD1, Bo Sang Kwon, MD1, Eun Jung Bae, MD1,  Chung Il Noh, MD1, Jung Yun Choi, MD1, Kyung Hwan Kim, MD2, Yong Jin Kim, MD2, and Sung Sup Park, MD3 1Departments of Pediatrics, 2Thoracic and Cardiovascular Surgery and, 3Laboratory Medicine, Seoul National University Children’s Hospital, Seoul, Korea Loeys-Dietz syndrome is a recently described autosomal dominant disorder caused by mutations in the genes for transforming growth  factor-beta receptor type 1 or 2 (TGF-ßR 1/2).",Non-OADS,/arxiv_data1/oa_pdf/65/bd/kcj-42-288.PMC3341429.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.288 www.e-kcj.org (Bentall operation) and aortic valve replacement was performed  with the St. Jude regent with a 23-mm graft interposition (St. Jude  Medical, Inc., MN, USA), due to aortic annular ectasia and significant  aortic regurgitation.",Non-OADS,/arxiv_data1/oa_pdf/65/bd/kcj-42-288.PMC3341429.pdf
290 Near Total Aortic Replacement in Loeys-Dietz Syndrome http://dx.doi.org/10.4070/kcj.2012.42.4.288 www.e-kcj.org tinues to do well.,Non-OADS,/arxiv_data1/oa_pdf/65/bd/kcj-42-288.PMC3341429.pdf
"http://dx.doi.org/10.4070/kcj.2012.42.4.288 www.e-kcj.org However, preventive surgical repair is still controversial.10) Patients  who present with symptoms of Loeys-Dietz syndrome at an early  age should undergo meticulous follow-up of their cardiovascular  status, through echocardiography and cardiac CT or magnetic res - onance imaging (MRI).3)5) References 1.",Non-OADS,/arxiv_data1/oa_pdf/65/bd/kcj-42-288.PMC3341429.pdf
"He was more than three hours away from the  nearest catheterization laboratory and thus received systemic th-Case Report http://dx.doi.org/10.4070/kcj.2012.42.4.292 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Received:  August 13, 201 1 Revision Received: September 13, 201 1 Accepted: September 27, 201 1 Correspondence: Vincent Roule, MD, Department of Cardiology, Univer - sity Hospital of Caen, Avenue Cote de Nacre 14033 Caen, France Tel: 2 31 06 30 48, Fax: 2 31 06 44 18 E-mail: v.roule@hotmail.fr • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/2a/c8/kcj-42-292.PMC3341430.pdf
http://dx.doi.org/10.4070/kcj.2012.42.4.292  www.e-kcj.orglerosis.,Non-OADS,/arxiv_data1/oa_pdf/2a/c8/kcj-42-292.PMC3341430.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.1 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:1-6  1Review Article www.cmj.ac.k r Molecular Mechanisms Involved in Depotentiation and Their  Relevance to Schizophrenia Thomas M Sanderson * Department of Brain & Cognitive Sciences, College of Natu ral Sciences,  Seoul National University, Seoul, Korea Long-term potentiation (LTP) and long-ter m depression (LTD) of synaptic trans- mission are forms of synaptic plasticity th at have been studied extensively and are  thought to contribute to learning and me mory.",Non-OADS,/arxiv_data1/oa_pdf/7e/5a/cmj-48-1.PMC3341431.pdf
"This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 March, 2012 accepted 10 April, 2012 Corresponding Author: Thomas M SandersonDepartment of Brain & Cognitive  Sciences, College of Natural Sciences,  Seoul National University,  Gwanak-gu, Seoul 151-746, Korea TEL: +82-2-880-9108 FAX: +82-2-871-9129 E-mail: thomassanderson@snu.ac.kr INTRODUCTION 　Synapses in the brain are able to change their strength  in response to neural activity and these modifications to synaptic strength are thought to contribute to memory for- mation and also to brain development.",Non-OADS,/arxiv_data1/oa_pdf/7e/5a/cmj-48-1.PMC3341431.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.15 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:15-20  15Original Article-Infection and immunology  www.cmj.ac.k r Knowledge of General Dentists and Senior Dental Students in Iran  about Prevention of Infective Endocarditis Fatemeh Ahmadi-Motamayel *, Samaneh Vaziri1 and Ghodratollah Roshanaei2 Research Center for Molecular Medicine, Department of Oral Medicine,  1Resident of Oral Medicine, School of Dentistry,  2Department of  Biostatistics and Epidemiology, School of Public Health , Hamadan University of Medical Sciences, Hamadan, Iran Infective endocarditis (IE) is an infection of the endothelial surf ace of the heart and  heart valves with serious, even fatal, complications and that often requires long-term and expensive treatment.",Non-OADS,/arxiv_data1/oa_pdf/72/4f/cmj-48-15.PMC3341432.pdf
"Key Words:  Hepatitis C, chronic; Endocardit is; Knowledge; Dentists; Students This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 11 March, 2012 accepted 9 April, 2012 Corresponding Author: Fatemeh Ahmadi-MotamayelResearch Center for Molecular  Medicine, Department of Oral  Medicine, Dental School Hamadan University of Medical Sciences,  Hamadan 65178-386877, Iran TEL: +98-881-8381084FAX: +98-811-8354220 E-mail:  Ahmadimotemayel@umsha.ac.ir fatahmadim@yahoo.com INTRODUCTION 　Infective endocarditis (IE) was described for the first time  by Lazare Riviere in 1646, and Osler applied the term malig-nant endocarditis because  the disease was severely fatal.",Non-OADS,/arxiv_data1/oa_pdf/72/4f/cmj-48-15.PMC3341432.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.21 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:21-26  21Original Article-Infection and immunology  www.cmj.ac.k r Body Mass Index and Nonresponse to Antiviral Treatment in Korean  Patients with Genotype 2 and 3 Chronic Hepatitis C Yeon Joo Kim, Sung Bum Cho, Sang Woo Park, Hyoung Ju Hong, Du Hyeon Lee, Eun Ae Cho,  HyunSoo Kim, Sung Kyu Choi * and Jong Sun Rew Department of Internal Medicine, Chonnam University Medical School, Gwangju, Korea Pegylated-interferon plus ribavirin is the standard treatment for chronic hepatitis C.  Sustained virological response (SVR) rates of up to 80% are reported in genotype 2 and  3 chronic hepatitis C cases.",Non-OADS,/arxiv_data1/oa_pdf/c9/a5/cmj-48-21.PMC3341433.pdf
"Our study showed that combination therapy with pegylate d-interferon and rib- avirin as an initial treatmen t for genotype 2 and 3 chronic hepatitis C is very effective  and safe, and that body mass index is an independent risk factor for nonresponse to  antiviral treatment in patients with genotype 2 and 3 chronic hepatitis C. Key Words:  Hepatitis C, chronic; Peginterferon al fa-2a; Ribavirin;  Body mass Index This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 29 December, 2011 accepted 6 February, 2012 Corresponding Author: Sung-Kyu Choi Department of Internal Medicine,  Chonnam University Medical School,  42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea  TEL: +82-62-220-6296 FAX: +82-62-228-1330E-mail: choisk@chonnam.ac.kr INTRODUCTION 　Hepatitis C virus (HCV) infection causes chronic liver  disease and cirrhosis in a propor tion of individuals, and its  complications may develop relatively rapidly.1 The World  Health Organization estimates that approximately 170 million persons (3% of the world’s population) are chroni-cally infected with HCV, with 3 to 4 million new infections occurring each year.",Non-OADS,/arxiv_data1/oa_pdf/c9/a5/cmj-48-21.PMC3341433.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.27 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:27-31  27Original Article-Metabolism www.cmj.ac.k r Effects of Gonadotropin-Releasing Hormone Agonist Therapy on  Body Mass Index and Height in Girls with Central Precocious Puberty  Seung Jae Lee, Eun Mi Yang, Ji Yeon Seo and Chan Jong Kim * Department of Pediatrics, Chonnam National University Medical School, Gwangju, Korea Treatment with gonadotropin-releasing horm one (GnRH) agonist is  the treatment of  choice for central precocious puberty (CPP).",Non-OADS,/arxiv_data1/oa_pdf/06/aa/cmj-48-27.PMC3341434.pdf
"Key Words:  Precocious puberty; Obesity; Go nadotropin-releasing hormone This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received  16 January, 2012 accepted 20 February, 2012 Corresponding Author: Chan Jong Kim Department of Pediatrics, Chonnam  National University Medical School, 42  Jebong-ro, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6645 FAX: +82-62-222-6103E-mail: cjkim@jnu.ac.kr INTRODUCTION 　Precocious puberty is define d as secondary sexual char- acteristics that come out more  quickly than two standard  deviations of the mean valu e; generally, precocious pub- erty is the onset of secondary sexual characteristics before 8 years of age in girls and 9 years in boys.",Non-OADS,/arxiv_data1/oa_pdf/06/aa/cmj-48-27.PMC3341434.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.32 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:32-38  32Original Article-Metabolism www.cmj.ac.k r Effects of Weight Change on Clinical Outcomes in Overweight and  Obese Patients with Acute Myocardial Infarction Who Underwent Successful Percutaneous Coronary Intervention Won Yu Kang, Seung Hwan Hwang, Sun Ho Hwang, Wan Kim, Keun Ho Park1,  Young Joon Hong1, Ju Han Kim1, Youngkeun Ahn1 and Myung Ho Jeong1* Cardiovascular Center of Gwangju Veterans Hospital, 1Cardiovascular Center of Chonnam National University, Gwangju, Korea Obesity is a well-established ri sk factor for many chronic di sorders.",Non-OADS,/arxiv_data1/oa_pdf/3d/2a/cmj-48-32.PMC3341435.pdf
"Key Words:  Myocardial infarction; Coronary artery disease; Obesity; Prognosis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 February, 2012 accepted 7 April, 2012 Corresponding Author: Myung Ho JeongCardiovascular Center of Chonnam  National University Hospital, 671  Jaebong-ro, Hak-dong, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6243 FAX: +82-62-228-7174E-mail: myungho@chollian.net INTRODUCTION 　Generally, overweight and ob esity are associated with  increased risk for developing cardiovascular disease, and  they are prevalent risk factors in patients with acute my-ocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/3d/2a/cmj-48-32.PMC3341435.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.39 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:39-46  39Original Article-Circulation and Hemodynamics www.cmj.ac.k r Is Myocardial Infarction in Patients without Significant Stenosis  on a Coronary Angiogram as Benign as Believed?",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/cmj-48-39.PMC3341436.pdf
"Key Words:  Coronary angiography; Myoc ardial infarction; Stenosis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 20 December, 2011 accepted 24 February, 2012 Corresponding Author: Youngkeun AhnDirector of Cardiovascular Center,  Principal Investigator of Stem Cell Research Center for Cardiovascular and  Neurologic disorders, Director of Program  in Gene and Cell Therapy, The Heart Center of Chonnam National University  Hospital, 671 Jaebong-ro, Dong-gu,  Gwangju 501-757, Korea TEL: +82-62-220-4764 FAX: +82-62-223-3105 E-mail: cecilyk@hanmail.net INTRODUCTION 　Acute myocardial infarction (AMI) typically results from  critical coronary occlusive diseases or a total coronary oc-clusion after acute plaque rupture.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/cmj-48-39.PMC3341436.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.47 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:47-51  47Original Article-Circulation and Hemodynamics www.cmj.ac.k r Clinical Outcome of Veterans with Acute Coronary Syndrome Who  Had Been Exposed to Agent Orange Jong Bum Kim, Won Yu Kang *, Se Gwon Moon, Hee Jong Kim, Kyung Hwan Kim,  Yeon Hwa Kim, Seung Hwan Hwang, Sun Ho Hwang and Wan Kim Department of Internal Medicine, Gwangju Veterans Hospital, Gwangju, Korea 2,3,7,8-Tetrachlorodibenzo- p-dioxin (TCDD), one of the components of Agent Orange,  has been reported to be a deadly poison despite its presence at extremely small doses.",Non-OADS,/arxiv_data1/oa_pdf/4e/ff/cmj-48-47.PMC3341437.pdf
"Key Words:  Acute coronary syndrome; TCDD; Angiography This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 December, 2011 accepted 19 March, 2012 Corresponding Author: Won Yu KangDepartment of Internal Medicine,  Gwangju Veterans Hospital, 887-1  Sanwol-dong, Gwangsan-gu, Gwangju 506-705, Korea TEL: +82-62-602-6288 FAX: +82-62-602-6931E-mail: gpkwy@naver.com INTRODUCTION 　Agent Orange is a herbicide and defoliant that was ex- tensively used by the Amer ican military during the  Vietnam War to defoliate trees to uncover enemy hideouts in dense jungles.",Non-OADS,/arxiv_data1/oa_pdf/4e/ff/cmj-48-47.PMC3341437.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.52 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:52-56 52Original Article-Neuroscience  www.cmj.ac.k r Outcome Evaluation of Intravenous Infusion of Urokinase for Acute  Ischemic Stroke Rae Seop Lee, Young Chul Ok, Jun Seob Lim, Byung Chan Lim, Kyu Yong Cho and Min Cheol Lee1* Department of Neurosurgery, Kwangju Christian Hospital, 1Department of Pathology, Chonnam National University Medical School,  Gwangju, Korea The aim of this study was to ev aluate the clinical effect of a continuous infusion of ur- okinase in cerebral stoke patients who were late admitted over 6 hours after onset.",Non-OADS,/arxiv_data1/oa_pdf/fa/f4/cmj-48-52.PMC3341438.pdf
"Key Words:  Stroke; Urokinase; Brain This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 November, 2011 accepted 24 November, 2011 Corresponding Author: Min Cheol LeeDepartment of Pathology, Chonnam National University Medical School, 5  Hak-dong, Dong-gu, Gwangju  501-757, KoreaTEL: +82-62-220-4000 FAX: +82-62-232-9708 E-mail: mclee@jnu.ac.kr INTRODUCTION In several Korean hospitals,  injecting urokinase intra- venously has been applied for stroke patients who are ad-mitted later than 6 hours afte r onset and in whom intra-  arterial thrombolysis or rt -PA (recombinant tissue-plas- minogen activator) is not indicated because of the ther-apeutic time window of the these drugs, which is within 3 hours or 6 hours.",Non-OADS,/arxiv_data1/oa_pdf/fa/f4/cmj-48-52.PMC3341438.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.57 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:57-59  57Images in Clinical Medicine www.cmj.ac.k r FIG.",Non-OADS,/arxiv_data1/oa_pdf/8b/77/cmj-48-57.PMC3341439.pdf
"Key Words:  Lymphocele; Kidney;  Transplantation  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received March 13, 2012 accepted March 20, 2012 Corresponding Author: Soo Wan Kim Department of Internal Medicine,  Chonnam National University Medical School, 671 Jebong-ro, Gwangju  501-757, Korea TEL: +82-62-220-6271FAX: +82-62-220-8578 E-mail: skimw@chonnam.ac.kr THE CASE: WHAT IS THE CAUSE OF IMPAIRED  RENAL FUNCTION?",Non-OADS,/arxiv_data1/oa_pdf/8b/77/cmj-48-57.PMC3341439.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.60 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:60-64  60Case Report www.cmj.ac.k r A Case of Papillary Thyroid Cancer Recurring as an Esophageal  Submucosal Tumor Hyeog Gyu Seoung, Ji Hye Kim, Jeong Cheon Choi, Sang Mi Kim, Sang Soo Kim,  Bo Hyun Kim, In Ju Kim, Geun Am Song and Gwang Ha Kim * Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea A 75-year-old woman who underwent a total thyroidectomy for papillary thyroid cancer  7 years previously presented with a palpab le neck mass.",Non-OADS,/arxiv_data1/oa_pdf/61/a9/cmj-48-60.PMC3341440.pdf
"Key Words:  Esophagus; Papillary thyroid cancer This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 17 March, 2012 accepted 23 March, 2012 Corresponding Author: Gwang Ha KimDepartment of Internal Medicine, Pusan Nation University School of  Medicine, 1-10 Ami-dong, Seo-gu,  Busan 602-739, KoreaTEL: +82-51-240-7869 FAX: +82-51-244-8180 E-mail: doc0224@chol.com  INTRODUCTION 　The incidence of esophageal  involvement by secondary  neoplasms has been reported as 3.2% in autopsy studies of patients with cancer.",Non-OADS,/arxiv_data1/oa_pdf/61/a9/cmj-48-60.PMC3341440.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.65 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:65-68  65Case Report www.cmj.ac.k r Lingual Squamous Cell Carcinoma Surrounded by Granular Cell  Tumor  Hee Young Son4, Jin Pyeong Kim1, Gyung Hyuck Ko3, Eun Jae Lee1 and Seung Hoon Woo1,2* 1Departments of Otolaryngology, 2Institute of Health Sciences, 3Department of Pathology, Gyeongsang National University, Jinju,  4Department of Otolaryngology, Thyroid/Head &Neck Cancer Center of The Dongnam Instit ute of Radiological & Medical Sciences  (DIRAMS), Pusan, Korea The granular cell tumor (GCT) is an uncommo n, benign lesion with a preference for  subcutaneous sites.",Non-OADS,/arxiv_data1/oa_pdf/38/f7/cmj-48-65.PMC3341441.pdf
"Key Words:  Tongue; Granular cell tumor;  Squamous cell carcinoma;  Excision,  pathology This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 February, 2012 accepted 3 April, 2012 Corresponding Author: Seung Hoon WooDepartment of Otorhinolaryngology, Gyeongsang National University, 90  Chilam-dong, Jinju 660-702, Korea  TEL: +82-55-750-8173FAX: +82-55-759-0613 E-mail: lesaby@hanmail.net  INTRODUCTION 　Granular cell tumor (GCT) is a soft-tissue neoplasm of  unclear origin.",Non-OADS,/arxiv_data1/oa_pdf/38/f7/cmj-48-65.PMC3341441.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.69 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:69-72 69Case Report www.cmj.ac.k r A Case of Painful Hashimoto Thyroiditis that Mimicked Subacute  Thyroiditis Hye Mi Seo, Miyeon Kim, Jaeseok Bae, Jo-Heon Kim1, Jeong Won Lee2, Sang Ah Lee, Gwanpyo  Koh and Dae Ho Lee * Departments of Internal Medicine, 1Pathology, and 2Nuclear Medicine, Jeju National University School of Medicine, Jeju, Korea Hashimoto thyroiditis (HT) is an autoimmune  thyroid disorder that usually presents  as a diffuse, nontender goiter, whereas suba cute thyroiditis (SAT ) is an uncommon dis- ease that is characterized by tender thyroi d enlargement, transient thyrotoxicosis, and  an elevated erythrocyte sedimentation rate (ESR).",Non-OADS,/arxiv_data1/oa_pdf/63/4e/cmj-48-69.PMC3341442.pdf
"Key Words:  Hashimoto thyroiditis; Subacute thyroiditis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 October, 2011 accepted 20 October, 2011 Corresponding Author: Dae Ho LeeDepartment of Internal Medicine, Jeju National University Hospital, 1753-3  Ara-1-dong, Jeju 690-716, Korea  TEL: +82-64-717-1521FAX: +82-64-717-1131 E-mail: drdhkso@hanmail.net INTRODUCTION Hashimoto thyroiditis is an autoimmune thyroid disorder  that is probably the most common cause of hypothyroidism.",Non-OADS,/arxiv_data1/oa_pdf/63/4e/cmj-48-69.PMC3341442.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.7 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:7-14  7Original Article-Cell and structural biology www.cmj.ac.k r The Expression of Toll-Like Receptors (TLRs) in Cultured Human  Skin Fibroblast is Modulated by Histamine  Sujeong Jang1, Jong-Sung Park1, Young-Ho Won, Sook-Jung Yun and Seong-Jin Kim * Departments of Dermatology and 1Physiology, Chonnam National University Medical School, Gwangju, Korea Fibroblasts are responsible for the synthesis and degradation of various connective tis- sue components and soluble mediators of ex tracellular matrix me tabolism.",OADS,/arxiv_data1/oa_pdf/97/66/cmj-48-7.PMC3341443.pdf
"Key Words:  Skin; Toll-like receptor; Fibroblast; Histamine This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 29 January, 2012 accepted 19 March, 2012 Corresponding Author: Seong-Jin Kim Department of Dermatology,  Chonnam National University Medical  School, 8 Hak-dong, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6683 FAX: +82-62-222-4058E-mail: seongkim@jnu.ac.kr INTRODUCTION 　Fibroblasts maintain a key role in extracellular matrix  metabolism, and their diverse cellular interact ions in the  dermal inflammatory reaction are important in various cu-taneous disorders.",Non-OADS,/arxiv_data1/oa_pdf/97/66/cmj-48-7.PMC3341443.pdf
"http://dx.doi.org/10.4068/cmj.2012.48.1.73 ⒸChonnam Medical Journal, 2012 Chonnam Med J 2012;48:73-75 73Case Report www.cmj.ac.k r A Case of Duodenal Anisakiasis with Duodenal Ulcer David Hwang, Seong Il Park, Seung Chul Pack, Ki Sang Lee, Sung Kyu Choi, Hoon Kang,  Chan Woong Park1 and Soong Lee * Department of Internal Medicine, Seonam University College of Medicine, Seonam University Namkwang Hospital, Gwangju, 121C Hana  Medical Clinic, Mokpo, Korea Humans can be incidentally parasitized by third-stage larvae of Anisakis  species fol- lowing the ingestion of raw or undercooked seafood.",Non-OADS,/arxiv_data1/oa_pdf/83/bf/cmj-48-73.PMC3341444.pdf
"Key Words:  Duodenum; Ulcer; Anisakiasis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 June, 2011 accepted 1 July, 2011 Corresponding Author: Soong Lee Department of Internal Medicine,  Division of Gastroenterology, College of Medicine, The Seonam University of  Korea, 120-1 Mareuk-dong, Seo-gu,  Gwangju  502-157, KoreaTEL: +82-62-370-7732 FAX: +82-62-371-3092 E-mail: lsmed@hanmail.net INTRODUCTION 　The disease anisakiasis was first recognized by Van  Thiel in 1960.1 It is caused by an infestation of the  third-stage larvae of Anisakis simplex.",Non-OADS,/arxiv_data1/oa_pdf/83/bf/cmj-48-73.PMC3341444.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  1 REVIEW http://dx.doi.org/10.5653/cerm.2012.39.1.1 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(1):1-9 Effect of electromagnetic field exposure on the  reproductive system Myung Chan Gye, Chan Jin Park Department of Life Science and Institute for Natural Sciences, Hanyang University, Seoul, Korea The safety of human exposure to an ever-increasing number and diversity of electromagnetic field (EMF) sources both at work and at home  has become a public health issue.",Non-OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
"Therefore, SLF-EMFs are the highest near the power cable and de -Received: Feb 7, 2012 ∙ Revised: Mar 8, 2012 ∙ Accepted: Mar 15, 2012 Corresponding author:  Myung Chan Gye Department of Life Science, College of Natural Sciences, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 133-791, Korea  Tel: +82-2-2220-0958  Fax: +82-2-2298-9646  E-mail: mcgye@hanyang.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.1 Clin Exp Reprod Med 2012;39(1):1-9 2crease rapidly by distance.,OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
"Most recently, the Bioini - tiative Report (http://www.bioinitiative.org/) has noted that the cur - rent safety guidelines for EMF exposure are not sufficient and should  be revised based on data from various toxicological tests [31].",Non-OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.1.1 Clin Exp Reprod Med 2012;39(1):1-9 4significant effect on the body, testicular, or epididymal weights, or  the sperm count or apoptosis of germ cells in adult Sprague-Dawley  rats [52].",Non-OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.1 Clin Exp Reprod Med 2012;39(1):1-9 6increased [68].,OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.1 Clin Exp Reprod Med 2012;39(1):1-9 8Anim Reprod Sci 2003;77:11-20.,OADS,/arxiv_data1/oa_pdf/b7/ab/cerm-39-1.PMC3341445.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  10 REVIEW http://dx.doi.org/10.5653/cerm.2012.39.1.10 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(1):10-14 Control of ovarian primordial follicle activation Jin Yeong Kim Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine, Seoul, Korea The ovarian follicles develop initially from primordial follicles.",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/cerm-39-10.PMC3341446.pdf
"Maintaining the dormancy of primordial  follicles The pool of primordial follicles is under inhibitory control, therefore,  when these inhibitory factors decrease or stimulatory factors increase, Received: Mar23,2012 ∙Revised: Mar30,2012 ∙Accepted: Mar30,2012 Corresponding author: JinYeong Kim Department ofObstetrics andGynecology, Cheil General Hospital, Kwandong  University College ofMedicine, 17Seoae-ro 1-gil, Jung-gu, Seoul 100-380, Korea Tel:+82-2-2000-7582 Fax:+82-2-2000-7790 E-mail: jinkim223@yahoo.co.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/cerm-39-10.PMC3341446.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.10 Clin Exp Reprod Med 2012;39(1):10-14 122.,OADS,/arxiv_data1/oa_pdf/d1/2f/cerm-39-10.PMC3341446.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.10 Clin Exp Reprod Med 2012;39(1):10-14 14ling in the ovary.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/cerm-39-10.PMC3341446.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  15 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2012.39.1.15 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(1):15-21 Tributyltin increases the expression of apoptosis-  and adipogenesis-related genes in rat ovaries Hyojin Lee, Sojeong Lim, Sujin Yun, Ayoung Yoon, Gayoung Park, Hyunwon Yang Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women’s University, Seoul, Korea Objective:  Tributyltin (TBT), an endocrine disrupting chemical, has been reported to decrease ovarian function by causing apoptosis in the ova - ry, but the mechanism is not fully understood.",Non-OADS,/arxiv_data1/oa_pdf/df/9c/cerm-39-15.PMC3341447.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/9c/cerm-39-15.PMC3341447.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.1.15 Clin Exp Reprod Med 2012;39(1):15-21 16With the reports that the aromatase in human ovarian granulosa  cells is inactivated by ligands for retinoid X receptor (RXR), a nuclear  hormone receptor, and for peroxisome proliferator-activated receptor  γ (PPARγ) as well as TBT, studies on the interactions of TBT and PPARγ  are actively underway [9,10].",Non-OADS,/arxiv_data1/oa_pdf/df/9c/cerm-39-15.PMC3341447.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.15 Clin Exp Reprod Med 2012;39(1):15-21 18Figure 2.,OADS,/arxiv_data1/oa_pdf/df/9c/cerm-39-15.PMC3341447.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.15 Clin Exp Reprod Med 2012;39(1):15-21 20References 1.,OADS,/arxiv_data1/oa_pdf/df/9c/cerm-39-15.PMC3341447.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  22 ORIGINALARTICLE http://dx.doi.org/10.5653/cerm.2012.39.1.22 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(1):22-27 Effectiveness of GnRH antagonist multiple dose  protocol applied during early and late follicular  phase compared with GnRH agonist long protocol   in non-obese and obese patients with polycystic   ovary syndrome undergoing IVF/ICSI  Chung-Hoon Kim1, Jei-Won Moon1, Hyuk-Jae Kang1, Jun-Woo Ahn2, Sung-Hoon Kim1, Hee-Dong Chae1, Byung-Moon Kang1 1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of  Medicine, Seoul; 2Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Ulsan University Hospital, University  of Ulsan College of Medicine, Ulsan, Korea Objective:  To evaluate the effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase (MDP-EL) in  comparison with standard GnRH agonist luteal long protocol (LP) in each non-obese and obese polycystic ovary syndrome (PCOS) women un - dergoing IVF .",Non-OADS,/arxiv_data1/oa_pdf/cb/98/cerm-39-22.PMC3341448.pdf
"Actually, Received: Mar23,2012 ∙Revised: Mar30,2012 ∙Accepted: Mar30,2012 Corresponding author: Chung-Hoon Kim Division ofReproductive Endocrinology andInfertility, Department ofObstetrics  andGynecology, Asan Medical Center, University ofUlsan College ofMedicine,  88Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel:+82-2-3010-3639 Fax:+82-2-3010-6944 E-mail: chnkim@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/98/cerm-39-22.PMC3341448.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.1.22 Clin Exp Reprod Med 2012;39(1):22-27 24rey, UK).",OADS,/arxiv_data1/oa_pdf/cb/98/cerm-39-22.PMC3341448.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.22 Clin Exp Reprod Med 2012;39(1):22-27 26stimulation option for PCOS patients.,Non-OADS,/arxiv_data1/oa_pdf/cb/98/cerm-39-22.PMC3341448.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  28 ORIGINALARTICLE http://dx.doi.org/10.5653/cerm.2012.39.1.28 pISSN2233-8233 ·eISSN2233-8241 ClinExpReprodMed2012;39(1):28-32 Serum biomarkers for predicting pregnancy outcome  in women undergoing IVF: human chorionic  gonadotropin, progesterone, and inhibin A   level at 11 days post-ET Jee Hyun Kim1, Mi Sun Shin1, Gwang Yi1, Byung Chul Jee1,2, Jung Ryeol Lee1,2, Chang Suk Suh1,2, Seok Hyun Kim2,3 Department of Obstetrics and Gynecology, 1Seoul National University Bundang Hospital, Seongnam; 2Seoul National University College of Medicine,  Seoul; 3Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Objective:  This study was performed to assess the prognostic value of serum hCG, progesterone, and inhibin A levels measured at 11 days post- ET for predicting pregnancy outcome in women participating in IVF .",Non-OADS,/arxiv_data1/oa_pdf/c2/ca/cerm-39-28.PMC3341449.pdf
"Numerous studies have revealed that pregnancies with low ini -Received: Feb26,2012 ∙Revised: Mar30,2012 ∙Accepted: Mar30,2012 Corresponding author: Byung ChulJee Department ofObstetrics andGynecology, Seoul National University Bundang  Hospital, 82Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea Tel:+82-31-787-7254 Fax:+82-31-787-4054 E-mail: blasto@snubh.org This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/ca/cerm-39-28.PMC3341449.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.1.28 Clin Exp Reprod Med 2012;39(1):28-32 30icantly lower when compared with the clinical abortion group ( p=  0.007), but the levels of the three serum markers in the two groups  were similar (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/c2/ca/cerm-39-28.PMC3341449.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.28 Clin Exp Reprod Med 2012;39(1):28-32 32al.,OADS,/arxiv_data1/oa_pdf/c2/ca/cerm-39-28.PMC3341449.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  33 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2012.39.1.33 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2012;39(1):33-39 Preliminary clinical outcome of novel strategy for the  maximization of cumulative pregnancy rates per  retrieval in normal responders Jong-Kil Joo1, Jong-Ryeol Choi1, Jung-Bin Son1, Gyoung-Rae Ko2, Kyu-Sup Lee1 1Department of Obstetrics and Gynecology, Medical Research Institute, Pusan National University School of Medicine; 2Infertility Clinic, Pusan National  University Hospital, Busan, Korea Objective:  We devised a novel strategy, a GnRH antagonist protocol with a GnRH agonist trigger followed by frozen-thawed blastocyst trans - fers with long zona dissection (LZD).",Non-OADS,/arxiv_data1/oa_pdf/41/33/cerm-39-33.PMC3341450.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/33/cerm-39-33.PMC3341450.pdf
" http://dx.doi.org/10.5653/cerm.2012.39.1.33 Clin Exp Reprod Med 2012;39(1):33-39 34fers owing to better embryo-endometrium synchrony [2,3].",Non-OADS,/arxiv_data1/oa_pdf/41/33/cerm-39-33.PMC3341450.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.33 Clin Exp Reprod Med 2012;39(1):33-39 36Results Table 1 shows the patient characteristics of group A (women aged  less than 35) and group B (women aged 35-39).,Non-OADS,/arxiv_data1/oa_pdf/41/33/cerm-39-33.PMC3341450.pdf
 http://dx.doi.org/10.5653/cerm.2012.39.1.33 Clin Exp Reprod Med 2012;39(1):33-39 38spectively.,Non-OADS,/arxiv_data1/oa_pdf/41/33/cerm-39-33.PMC3341450.pdf
"• Tel: (1507) 2655-7612  • Fax: (1507) 284-2174 • E-mail: baron.todd@mayo.edu This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/bb/kjr-13-S1.PMC3341452.pdf
A helpful web site  for information on publications is provided by the ICJME  (International Committee of Medical Journal Editors) at  http://www.icmje.org/.,Non-OADS,/arxiv_data1/oa_pdf/79/bb/kjr-13-S1.PMC3341452.pdf
In a manuscript http://dx.doi.org/10.3348/kjr.2012.13.S1.S1 pISSN 1229-6929  · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/79/bb/kjr-13-S1.PMC3341452.pdf
One way to create a complete literature search is to find  an article that addresses a similar topic using a medical  literature search engine such as PubMed (http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/79/bb/kjr-13-S1.PMC3341452.pdf
"Again, more  information can be found at http://www.icmje.org/.",Non-OADS,/arxiv_data1/oa_pdf/79/bb/kjr-13-S1.PMC3341452.pdf
"The  diameter of HCC was a significant prognostic factor for local recurrence.Index terms:  Hepatocellular carcinoma; Radiofrequency ablation; Transcatheter arterial chemoembolization  Received October 24, 2011; accepted after revision December 2, 2011.Corresponding author: Sang Soo Shin, MD, Department of  Radiology, Chonnam National University Medical School and Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea.• Tel: (8262) 220-5882  • Fax: (8262) 226-4380 • E-mail: kjradsss@dreamwiz.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/bd/kjr-13-S104.PMC3341453.pdf
Original Article Korean J Radiol 2012;13(S1):S104-S111http://dx.doi.org/10.3348/kjr.2012.13.S1.S104 pISSN 1229-6929  · eISSN 2005-8330부록-1-15 / 4교 3.5 (디자인1팀  박여진) prevalent malignancies worldwide (1).,Non-OADS,/arxiv_data1/oa_pdf/e4/bd/kjr-13-S104.PMC3341453.pdf
"• Tel: (8231) 787-7099  • Fax: (8231) 787-4055 • E-mail: hanhs@snubh.org This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/2e/kjr-13-S112.PMC3341454.pdf
Original Article Korean J Radiol 2012;13(S1):S112-S116http://dx.doi.org/10.3348/kjr.2012.13.S1.S112 pISSN 1229-6929  · eISSN 2005-8330 INTRODUCTION Choledochal cysts have different forms of manifestation  according to Todani’s classification (1).,Non-OADS,/arxiv_data1/oa_pdf/3b/2e/kjr-13-S112.PMC3341454.pdf
"• Tel: (822) 709-9861  • Fax: (822) 709-9696 • E-mail: ydcho@schmc.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/8f/kjr-13-S12.PMC3341455.pdf
"Thus, when a one-dimensionally  connected hard spring and soft spring are compressed, Korean J Radiol 2012;13(S1):S12-S16http://dx.doi.org/10.3348/kjr.2012.13.S1.S12 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/c5/8f/kjr-13-S12.PMC3341455.pdf
"With this coordinated approach, EC fistula can be controlled with acceptable morbidity and mortality.Index terms:  Intestinal fistula; Surgical procedures; Multidisciplinary approach Received October 21, 2011; accepted after revision December 5, 2011.Corresponding author: Suk-Hwan Lee, MD, PhD, Department of  Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea.• Tel: (822) 440-6134  • Fax: (822) 440-6295 • E-mail: leeshdr@khu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/20/kjr-13-S17.PMC3341456.pdf
Review Article Korean J Radiol 2012;13(S1):S17-S20http://dx.doi.org/10.3348/kjr.2012.13.S1.S17 pISSN 1229-6929  · eISSN 2005-8330 mortality.,Non-OADS,/arxiv_data1/oa_pdf/af/20/kjr-13-S17.PMC3341456.pdf
"• Tel: (8192) 642-5856  • Fax: (8192) 642-5087 • E-mail: shimizu@med.kyushu-u.ac.jp This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
Review Article Korean J Radiol 2012;13(S1):S21-S30http://dx.doi.org/10.3348/kjr.2012.13.S1.S21 pISSN 1229-6929  · eISSN 2005-8330 INTRODUCTION The term telemedicine refers to the utilization of  communication and information technology for medical  education and patient care through the transmission  of images and sounds (1).,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
"Although it is a  powerful and internationally authorized program, it is freely  downloadable (http://www.sfc.wide.ad.jp/DVTS/ software/).",Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
"So we need to prepare appropriate audio devices, such as a unidirectional microphone or  one with an on-and-off switch as an easy solution, or the  freely available EchoDamp solution (http://echodamp.com/ getechodamp.html).",Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.americantelemed.org/ files/public/abouttelemedicine/What_Is_Telemedicine.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.axis.com/files/whitepaper/wp_ videocompression_33085_en_0809_lo.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://en.wikipedia.org/wiki/Operating_ system 13.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://en.wikipedia.org/wiki/ITU-R_BT.470-7 17.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.nyu.edu/its/pubs/ architecture/nyu-dvts-eval-200512.pdfFig.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.temdec.med.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.apan.net/meetings/India2011/ Session/Slides/hdtv/1-3.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://conf.dvtsplus.org/user_manual.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
"Polycom, Inc. http://www.polycom.com/ 37.",Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
LifeSize Communications Inc. http://www.lifesize.com/ 38.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
Tandberg Inc. http://www.tandberg.com/  39.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
Sony Electronics Inc. http://pro.sony.com/bbsc/ssr/cat- videoconference/ 40.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
Cisco System Inc. http://www.cisco.com/en/US/products/ ps7060/products.html41.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
Vidyo Inc. http://www.vidyo.com/documents/resources/ vidyo_conferencing.pdf 44.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.apan.net/home/ aboutapan/APAN.php 53.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.koren.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.internet2.edu 56.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.geant2.net 57.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
http://www.mhlw.go.jp/shingi/2010/02/dl/s0202-4a.,Non-OADS,/arxiv_data1/oa_pdf/1e/50/kjr-13-S21.PMC3341457.pdf
"Interventional  radiologists need to be familiar with the choice of embolic materials, technical aspects of embolotherapy, and the factors affecting the favorable or unfavorable outcomes after embolotherapy for UGI bleeding.Index terms:  Upper gastrointestinal tract bleeding; Embolization; Embolic materials Received November 5, 2011; accepted after revision December 2, 2011.Corresponding author: Ji Hoon Shin, MD, Department of  Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea.• Tel: (822) 3010-4380  • Fax: (822) 476-0090 • E-mail: jhshin@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/fb/kjr-13-S31.PMC3341458.pdf
Review Article Korean J Radiol 2012;13(S1):S31-S39http://dx.doi.org/10.3348/kjr.2012.13.S1.S31 pISSN 1229-6929  · eISSN 2005-8330 Endoscopy is the primary invasive technique for the  diagnosis and treatment of UGI bleeding.,Non-OADS,/arxiv_data1/oa_pdf/35/fb/kjr-13-S31.PMC3341458.pdf
"• Tel: (822) 3010-5933  • Fax: (822) 485-5782 • E-mail: limys@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/f1/kjr-13-S40.PMC3341459.pdf
"GV are  categorized into 4 types based on the relationship with  esophageal varices, as well as by their location in the  stomach: gastroesophageal varix (GOV) type 1, GOV type 2, http://dx.doi.org/10.3348/kjr.2012.13.S1.S40 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/ec/f1/kjr-13-S40.PMC3341459.pdf
"• Tel: (1915) 309-4539  • Fax: (1210) 567-4194 • E-mail: BARGE@UTHSCSA.EDU This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/f8/kjr-13-S45.PMC3341460.pdf
Review Article Korean J Radiol 2012;13(S1):S45-S55http://dx.doi.org/10.3348/kjr.2012.13.S1.S45 pISSN 1229-6929  · eISSN 2005-8330 INTRODUCTION It has been estimated that there are more than 210000  admissions for acute pancreatitis and more than 56000  hospitalizations for chronic pancreatitis in the United  States each year (1).,Non-OADS,/arxiv_data1/oa_pdf/1d/f8/kjr-13-S45.PMC3341460.pdf
"2679  • Fax: (1416) 593-0502 • E-mail: Chia.ho@uhn.on.ca This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/4f/kjr-13-S56.PMC3341461.pdf
"How best to  achieve this drainage has been, and continues to be, the  primary concern for patients, physicians and other care-http://dx.doi.org/10.3348/kjr.2012.13.S1.S56 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/c0/4f/kjr-13-S56.PMC3341461.pdf
"• Tel: (8142) 748-9111  • Fax: (8142) 749-8690 • E-mail: m-kida@kitasato-u.ac.jp This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/40/kjr-13-S62.PMC3341462.pdf
Review Article Korean J Radiol 2012;13(S1):S62-S66http://dx.doi.org/10.3348/kjr.2012.13.S1.S62 pISSN 1229-6929  · eISSN 2005-8330 INTRODUCTION Since the initial report by Soehendra et al.,Non-OADS,/arxiv_data1/oa_pdf/b9/40/kjr-13-S62.PMC3341462.pdf
"• Tel: (662) 256-4265  • Fax: (662) 252-7839 • E-mail: Rungsun@pol.net This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/03/kjr-13-S67.PMC3341463.pdf
Bile leaks generally occur after hepato-biliary http://dx.doi.org/10.3348/kjr.2012.13.S1.S67 pISSN 1229-6929  · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/43/03/kjr-13-S67.PMC3341463.pdf
"Dr. Enéas de Carvalho Aguiar, 255-Cerqueira César-05403-000, São Paulo, SP-Brazil.• Tel: (5511) 3069-7579  • Fax: (5511) 2661-7579 • E-mail: eartifon@hotmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/d6/kjr-13-S74.PMC3341464.pdf
"Review Article Korean J Radiol 2012;13(S1):S74-S82http://dx.doi.org/10.3348/kjr.2012.13.S1.S74 pISSN 1229-6929  · eISSN 2005-8330 obstruction and surgically altered anatomy (gastric bypass,  Roux-en-Y reconstruction).",Non-OADS,/arxiv_data1/oa_pdf/9c/d6/kjr-13-S74.PMC3341464.pdf
"In 2 of 22 patients with successful passing of the sheath to the area of interest, stent placement failed because of failure in the negotiation of a guide wire through the obstruction.Conclusion:  Using a guiding sheath seems to be easy, safe and useful in fluoroscopic stent placement for patients with  malignant colorectal obstructions.Index terms:  Colon; Interventional procedure; Stenosis or obstructions; Stents and prostheses Received November 5, 2011; accepted after revision December 2, 2011.This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A101819).Corresponding author: Ho-Young Song, MD, Department of  Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea.• Tel: (822) 3010-4370  • Fax: (822) 476-0090 • E-mail: hysong@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/20/kjr-13-S83.PMC3341465.pdf
"Original Article Korean J Radiol 2012;13(S1):S83-S88http://dx.doi.org/10.3348/kjr.2012.13.S1.S83 pISSN 1229-6929  · eISSN 2005-8330 INTRODUCTION Recently, fluoroscopic or endoscopic placement of  expandable metallic stents has been increasingly used as  a safe preoperative or palliative treatment of malignant colorectal obstructions (1-5).",Non-OADS,/arxiv_data1/oa_pdf/4b/20/kjr-13-S83.PMC3341465.pdf
"Pre-operative perfusion CT does not reflect the MVD of CRCs.Index terms:  Colon cancer; CT; Perfusion; Angiogenesis Received October 24, 2011; accepted after revision December 2, 2011.Corresponding author: Yong Yeon Jeong, MD, Department of Diagnostic Radiology, Chonnam National University Medical School,  Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun 519-763, Korea.• Tel: (8261) 379-7102  • Fax: (8261) 379-7133 • E-mail: yjeong@chonnam.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/3b/kjr-13-S89.PMC3341466.pdf
Original Article Korean J Radiol 2012;13(S1):S89-S97http://dx.doi.org/10.3348/kjr.2012.13.S1.S89 pISSN 1229-6929  · eISSN 2005-8330 부록-13.indd   89 12.,Non-OADS,/arxiv_data1/oa_pdf/b6/3b/kjr-13-S89.PMC3341466.pdf
"• Tel: (8275) 231-5171 • Fax: (8275) 256-3451  • E-mail: s.morokawa.redcross@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/d6/kjr-13-S98.PMC3341467.pdf
MATERIALS AND METHODS Patients Patients who underwent SEMS placement from June 1998 http://dx.doi.org/10.3348/kjr.2012.13.S1.S98 pISSN 1229-6929  · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/2b/d6/kjr-13-S98.PMC3341467.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:271-280 http://dx.doi.org/10.4174/jkss.2012.82.5.271 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received November 11, 2011, Revised March 15, 2012, Accepted March 21, 2012 Correspondence to: Sun Wook Kim Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 135-71 0,  KoreaTel: ＋82-2-3410-1653, Fax: ＋82-2-6918-4653, E-mail: swkimmd@skku.edu cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/e8/70/jkss-82-271.PMC3341475.pdf
Biological pathway and gene function-based analysis were performed by using the protein analysis through evolutionary relati onships (PANTHER) database  (http://www.pantherdb.org).,OADS,/arxiv_data1/oa_pdf/e8/70/jkss-82-271.PMC3341475.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:281-287 http://dx.doi.org/10.4174/jkss.2012.82.5.281 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received January 6, 2012, Revised March 14, 2012, Accepted April 9, 2012 Correspondence to: Chi-Young Jeong Department of Surgery, Gyeongsang National University Hospital, 79 Gangnam-ro, Jinju 660-702, KoreaTel: ＋82-55-750-8447, Fax: ＋82-55-757-5442, E-mail: drjcy@hanmail.net cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/f4/db/jkss-82-281.PMC3341476.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:288-295 http://dx.doi.org/10.4174/jkss.2012.82.5.288 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received December 23, 2011, Revised March 14, 2012, Accepted March 21, 2012 Correspondence to: Byung Woog Kang Department of Oncology/Hematology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu 702-210, KoreaTel: ＋82-53-200-2622, Fax: ＋82-53-200-2029, E-mail: bwkang@knu.ac.kr *These authors contributed equally to this article.cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/b0/3a/jkss-82-288.PMC3341477.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:296-301 http://dx.doi.org/10.4174/jkss.2012.82.5.296 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 11, 2011, Revised February 9, 2012, Accepted March 14, 2012 Correspondence to: Husnu Alptekin Department of Surgery, Selcuklu Medical Faculty, Selc uk University, Genel Cerrahi A.D., 42075 Konya, Turkey Tel: ＋90 332 241 50 00, Fax: ＋90 332 241 21 84, E-mail: halptekin@hotmail.com cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/8a/c1/jkss-82-296.PMC3341478.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:302-305 http://dx.doi.org/10.4174/jkss.2012.82.5.302 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received January 9, 2012, Revised February 22, 2012, Accepted March 2, 2012 Correspondence to: Seung Jae Byun Department of Vascular Surgery, Wonkwang University School of Medicine & Hospital, 895 Muwang-ro, Iksan 570-974, Korea Tel: ＋82-63-859-1490, Fax: ＋82-63-855-2386, E-mail: polarisking@hanmail.net cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/88/48/jkss-82-302.PMC3341479.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:306-311 http://dx.doi.org/10.4174/jkss.2012.82.5.306 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received December 20, 2011, Revised January 16, 2012, Accepted February 2, 2012 Correspondence to: Young-Wook Kim Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyu nkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: ＋82-2-3410-3461, Fax: ＋82-2-3410-0040, E-mail: ywkim@skku.edu cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/18/21/jkss-82-306.PMC3341480.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:312-316 http://dx.doi.org/10.4174/jkss.2012.82.5.312 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received December 1, 2011, Revised January 1, 2012, Accepted February 2, 2012 Correspondence to: Ioannis Christakis Division of Investigative Science, Department of Medicine, Im perial College London Faculty of Medicine, Hammersmith Campus,  Commonwealth Building, Du Cane Road, London W12 0NN, UKTel: ＋44-(0)-20-8383-3242, Fax: ＋44-(0)-20-8383-3142, E-mail: i.christakis@imperial.ac.uk  cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/a7/ba/jkss-82-312.PMC3341481.pdf
"CASE REPORT Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:317-320 http://dx.doi.org/10.4174/jkss.2012.82.5.317JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 11, 2011, Revised November 28, 2011, Accepted December 5, 2011 Correspondence to: Hang-Seok Chang Thyroid Cancer Center, Department of Surgery, Gangnam Severanc e Hospital, Yonsei University College of Medicine, 211 Eonju-ro,  Gangnam-gu, Seoul 135-720, KoreaTel: ＋82-2-2019-3370, Fax: ＋82-2-3462-5994, E-mail: medilys@hanmail.net *These two authors contributed equally to this article.cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/41/1c/jkss-82-317.PMC3341482.pdf
"CASE REPORT Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:321-324 http://dx.doi.org/10.4174/jkss.2012.82.5.321JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 5, 2011, Revised October 16, 2011, Accepted December 12, 2011 Correspondence to: Do Joong Park Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, KoreaTel: ＋82-31-787-7097, Fax: ＋82-31-787-4055, E-mail: djpark@snubh.org cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/c1/83/jkss-82-321.PMC3341483.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:325-329 http://dx.doi.org/10.4174/jkss.2012.82.5.325 CASE REPORTJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 9, 2011, Revised December 6, 2011, Accepted December 16, 2011 Correspondence to: Gyu-Seog Choi  Colorectal Cancer Center, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu 702-210, KoreaTel: ＋82-53-420-5619, Fax: ＋82-53-421-0510, E-mail: kyuschoi@mail.knu.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/80/40/jkss-82-325.PMC3341484.pdf
http://dx.doi.org/10.1016/j.jemermed.2009.11.026.,OADS,/arxiv_data1/oa_pdf/80/40/jkss-82-325.PMC3341484.pdf
"CASE REPORT Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;82:330-334 http://dx.doi.org/10.4174/jkss.2012.82.5.330JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 11, 2011, Revised December 7, 2011, Accepted December 22, 2011 Correspondence to: Sung Yong Kim Department of Surgery, Cheonan Hospital, Soonchunhyang University College of Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, KoreaTel: ＋82-41-570-2140, Fax: ＋82-41-571-0129, E-mail: sykim@schmc.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/64/b9/jkss-82-330.PMC3341485.pdf
2.7.2MEN2 MEN2isanautosomaldominantsyndromeassociated withmutations oftheRETgene.TheRETgeneconsists of21exons[167].AllRETmutations described inthe literaturetodatemaybefoundonhttp://arup.utah.edu/ database/MEN2/MEN2_displa y.php?sort=1.Thereare atotalofthreesubtypes.,OADS,/arxiv_data1/oa_pdf/5d/b2/CTO-10-03.PMC3341580.pdf
2011. http://www.nycris.nhs.uk/ (accessed 14 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/01/38/bmjopen-2011-000410.PMC3341592.pdf
To view this ﬁle please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2011-000809).,Non-OADS,/arxiv_data1/oa_pdf/5a/12/bmjopen-2011-000809.PMC3341593.pdf
"Funding This study was funded by NHS Grampian through the Scottish Government: nutrition of women of childbearing age, pregnant women and children under 5 years in disadvantaged areas dfunding allocation 2008e2011, NHS Health Scotland (http://www.sehd.scot.nhs.",Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
http://www.who.int/nutrition/topics/global_strategy/en/ index.html (accessed Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
"UK: The Information Centre, Government Statistical Service, 2007.http://www.ic.nhs.uk/webﬁles/publications/ifs06/2005%20Infant% 20Feeding%20Survey%20%28ﬁnal%20version%29.pdf (accessed Feb 2012).",Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
2011. http://guidance.nice.org.uk/PH11 (accessed Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
2008. http://www.scotland.gov.uk/Resource/ Doc/231209/0063075.pdf (accessed Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
"London: Medical Research Council, 2008. http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d¼MRC004871 (accessed Feb 2012).",Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
"Edinburgh: NHS Health Scotland, 2010. http://www.healthscotland.com/documents/4720.aspx (accessed Feb 2012).",Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
http://www.scotland.gov.uk/Topics/Statistics/SIMD/ SIMDPostcodeLookup (accessed Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
2010. http://www.isdscotland.org/isd/ 1761.html 29.,Non-OADS,/arxiv_data1/oa_pdf/7d/61/bmjopen-2011-000652.PMC3341594.pdf
To view this ﬁle please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001039).,Non-OADS,/arxiv_data1/oa_pdf/c4/89/bmjopen-2012-001039.PMC3341595.pdf
"children under ﬁve in disadvantaged areas dfunding allocation 2008 e2011, NHS Health Scotland (http://www.sehd.scot.nhs.uk/mels/CEL2008_36.pdf).NHS Grampian and the University of Aberdeen worked in partnership toimplement the study.",Non-OADS,/arxiv_data1/oa_pdf/c4/89/bmjopen-2012-001039.PMC3341595.pdf
"London: National Childbirth Trust, 2010. http://www.nct.org.uk/sites/default/ﬁles/related_documents/PostnatalCareSurveyReport5.pdf 7.",Non-OADS,/arxiv_data1/oa_pdf/c4/89/bmjopen-2012-001039.PMC3341595.pdf
2011. http://guidance.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/c4/89/bmjopen-2012-001039.PMC3341595.pdf
2007. http://www.babyfriendly.org.uk 30.,Non-OADS,/arxiv_data1/oa_pdf/c4/89/bmjopen-2012-001039.PMC3341595.pdf
http://www.nice.org.uk/CG037 (accessed Jul 2010).,Non-OADS,/arxiv_data1/oa_pdf/c4/89/bmjopen-2012-001039.PMC3341595.pdf
To view these ﬁles please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2011-000611).,Non-OADS,/arxiv_data1/oa_pdf/60/c8/bmjopen-2011-000611.PMC3341596.pdf
"ADNI is the results of efforts by many co-investigators from a broad range of academicinstitutions and private corporations, and subjects havebeen recruited from over 50 sites across the USA and Canada (for additional information about ADNI, see http://www.adni-info.org).",Non-OADS,/arxiv_data1/oa_pdf/63/7e/bmjopen-2011-000773.PMC3341597.pdf
ADNI participants Data used in the preparation of this article were obtained from the ADNI Database (http://www.loni.ucla.edu/ADNI).,OADS,/arxiv_data1/oa_pdf/63/7e/bmjopen-2011-000773.PMC3341597.pdf
"Data sets of clinical and baseline FDG-PET recruited from a total of 200 MCI patients (meanage, 75.2 67.1 years; 134 men, 66 women) were down- loaded from the ADNI public website (http://www.loni.ucla.edu/ADNI/).",OADS,/arxiv_data1/oa_pdf/63/7e/bmjopen-2011-000773.PMC3341597.pdf
"Scans of MCI patients were comparedwith a normative reference database, controlling forglobal activity using iSSP software (http://MediPhysics.com) and then Z scores of FDG uptake were calculatedvoxel by voxel.",OADS,/arxiv_data1/oa_pdf/63/7e/bmjopen-2011-000773.PMC3341597.pdf
"TBSS analysis of DTI DCM2MII was used to convert diffusion tensor images from the proprietary scanner format to the NIFTI f o r m a t .T h e n ,t h ei m a g e sw e r ep r o c e s s e du s i n gt h eF S L 4.1.5 software package (http://www.fmrib.ox.ac.uk/fsl/).The images were realigned to the b-value (b0) image byafﬁne transformations using FMRIB’s diffusion toolbox 17 to minimise distortions and reduce head motion artefacts.",OADS,/arxiv_data1/oa_pdf/e5/d8/bmjopen-2012-000844.PMC3341600.pdf
"2012, 8      http://www.biolsci.org  596  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2012; 8(5):596-605. doi: 10.7150/ ijbs.4176   Research Paper   The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by  Cross -talking with H-RasV12    Shuting Jia, Lanjun Zhao , Wenru Tang, Ying Luo  Faculty of Environmental Science and Engineering & Laboratory of Molecular Genetics of Aging & Tumor, Faculty of Life  Science and Technology , Kunming University of Science & Technology , 727 Jing Ming Nan Road, Chenggong County ,  Kunming, Yunnan Province, China , 650500.",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  597  and gain of function of different p 53 mutants will  provide the basis for personalized  treatments  of ca n- cer patients .",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  598  (p53-/-+S+Ras), fast growing tumors were generated in  1-2 weeks ( Figure 2A, left upper panel).",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  599    Figure 2. p53 S mutant promoted tumorigenesis cooperating with H -RasV12 .",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  600  erative cells, and p53-/-+S+Ras had a bit more proli f- erative cells than p53-/-+vector+Ras tumor cells (Figure  3B, C).",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  601    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  602  in p53-/- background resulted in an enhanced  expre s- sion of H -RasV12 compa ring with overexpression of  H-RasV12 itself, provided us a direct evidence for the  cooperation between p53S and H -RasV12 (Figure 4B,  Ras).",OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  603  research es found that p53 inactivation induced the  RasV12 pathway through  diverse mechanisms i n- volving the p 53 targets BTG2 and  ATF3 , which in turn  facilitated the malignant transformed  phenotype of  cells and the accentuated  expression of chemokines,  CXCL1; interleukins, IL -1β; ECM -related  genes,  MMP3  [24].",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  604  anti-Rb (1:500, BD Transduction Laboratories, CA),  anti-Ras (1:500, BD Transduction Laboratories, CA),   anti-cMyc (9E10) (1:500, Santa Cruz, CA), anti - p16Ink4a  (M-156) (1:500, Santa Cruz, CA), anti - p21 (F-5) (1:500,  Santa Cruz, CA), anti -p53 Ab1(clone PAb240 ) (1:250,  Neomarker, CA), anti -phospho -p53 (Ser15) (1:500,  Cell Signaling, MA), anti -Hsp70 (1:1000, Stressgen,  Canada), anti-Hsp90 (1:1000, Stressgen, Canada), an- ti-PCNA  (1:1000, Upstate , NY), anti-p19 (1:1250, Up- state , NY), anti-γ-H2AX  (1:1000, Upstate , NY), an- ti-γ-tubulin (1:5000, Upstate , NY).",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
"2012, 8    http://www.biolsci.org  605  Competing  Interest s  The authors have declared that no competing  interest exists .",Non-OADS,/arxiv_data1/oa_pdf/e2/93/ijbsv08p0596.PMC3341601.pdf
http://www.biolsci.org/v0 8p0606s1.pdf   Acknowledgement s  We would like to acknowledge Ms. Yi -Li Liu and  Ms.,Non-OADS,/arxiv_data1/oa_pdf/11/c7/ijbsv08p0606.PMC3341602.pdf
"2012, 8      http://www.biolsci.org  620  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2012; 8(5):620-629. doi: 10.7150/ ijbs.4329   Research Paper   Real -time Investigation of Measles Epidemics with Estimate of Vaccine     Efficacy    Keisuke Ejima1, Ryosuke Omori2, Kazuyuki Aihara1,3, Hiroshi Nishiura2,4   1.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  621  believed to be high (e.g.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  622  discharge and congestion of conjunctiva) with (cond i- tion ii) laboratory diagnosis based either on (a)  isola- tion of the virus, (b) isolation of the virus RNA, or (c)  serological diagnosis  (i.e.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  623  Assuming that the past vaccination history is ind e- penden t of possessing a memory of vaccination hi s- tory, the probability of knowing vaccination status, q,  is assumed to be governed by a binomial sampling  process of the cumulative number of cases with  known vaccination history among the cumulative  total of cases .",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  624  that the above mentioned coverage denotes the fra c- tion immune or seropositive based on serological  survey [ 19].",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  625  both years  with assumed common  vaccination co v- erage , the maximum likelihood estimates of the va c- cine efficacy, , was estimated a t 96.7% (95% CI: 95.8,  97.4) .",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  626    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  627  teristics [ 24] or clarification of the kinetics of measles  transmission  using mathematical model [25].",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  628  However, the following three r emarks  should be  noted as technical limitations.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"Aichi Prefecture: Aichi, Japan, 2012.  http://www.pref.aichi.jp/0000048063.html   15.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
"2012, 8    http://www.biolsci.org  629  patterns relevant to the spread of infectious diseases.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/ijbsv08p0620.PMC3341603.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/28/6c/ijbsv08p0630.PMC3341604.pdf
http://www.biolsci.org/v0 8p0630s1.pdf   Acknowledgements   The authors are deeply grateful to Dr. Wu for the  image  captures.,Non-OADS,/arxiv_data1/oa_pdf/28/6c/ijbsv08p0630.PMC3341604.pdf
"2012, 8      http://www.biolsci.org  640  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2012; 8(5):640-649. doi: 10.7150/ ijbs.4096   Research Paper   Characterization of the Complete M itochondrial Genom e Sequence of   Spirometra erinaceieuropaei  (Cestoda : Diphyllobothriidae ) from China    Guo-Hua Liu1,2, Chun Li2,3, Jia-Yuan Li2,4, Dong -Hui Zhou2, Rong -Chuan  Xiong5, Rui-Qing Lin4, Feng -Cai  Zou6,2 , Xing -Quan Zhu2,1,6   1.",Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
This is an open -acce ss article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  641  ceieuropaei  and S. mansonoides are responsible for  sparganosis  in Asia and Americas, respectively  [3].",Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  642  Table 1.",OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  643  Gene/region    Positions and nt size (bp ) Ini/Ter codon  Anticodons   SEC SEJ SEC SEJ     tRNA -Lys (K)  8584 -8646 (63)  8586 -8648 (63)    CTT   nad3 8650 -8995 (346) 8652 -8997 (346)  ATG/T  ATG/T    tRNA -SerAGN (S1)  8996 -9054 (59)  8998 -9056 (59)    GCT   tRNA -Trp (W)  9057 -9122 (66)  9059 -9124 (66)    TCA   cox1 9130 -10695 (1566)  9132 -10697 (1566)  ATG/TAG  ATG/TAG    tRNA -Thr (T)  10686 -10755 (70)  10688-10757 (70)    TGT   rrnL  10756 -11728 (973)  10758 -11730 (973)      tRNA -Cys (C)  11729 -11793 (65)  11731 -11795 (65)    GCA   rrnS 11794 -12523 (730)  11796 -12525 (730)      cox2 12524 -13093 (570)  12526 -13095 (570)  ATG/TAA  ATG/TAA    tRNA -Glu (E)  13099 -13163 (65)  13101 -13165 (65)    TTC   nad6 13168 -13635 (468)  13170 -13637 (468)  ATG/TAA  ATG/TAA    SEC: S. erinaceieuropaei  (China isolate ), SEJ: S. erinaceieuropaei  (Japan isolate ).",Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  644  using DnaSP v5  [23].",OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"Each gene  was translated into amino acid   sequence using the invertebrate mitochondrial genetic  code in  MEGA  5.0 [24] , and aligned on the basis of its  amino acid sequence, using default  settings , and am- biguously aligned regions were excluded using the  Gblocks online server [25] ( http://molevol.cmima.",OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  645  The mt genome sequence of S. erinaceieuropaei   (China isolate) has high T content and low C content  (T=45.9%, A=20.4%, G=22.6%, C=11.1%), and its  A+T   content was 66.3 %, in accordance with mt genomes of  other Pseudophyllidea  species sequenced to date  [4].",Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  646  all cestode taxa although it has commonly been op- tioned  as molecular markers.",OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  647    Fig.",Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8      http://www.biolsci.org  648  Acknowledgements   This work was supported , in part, by the Pro- gram  for Outstanding Scientists in Agricultural R e- search, the Open Funds of the State Key Laboratory of  Veterinary Etiological Biology, Lanzhou Veterinary  Research Institute , Chinese Academy of Agricultural  Sciences (Grant Nos.",Non-OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"2012, 8    http://www.biolsci.org  649  asis and c ysticercosis by multiplex PCR.",OADS,/arxiv_data1/oa_pdf/3d/89/ijbsv08p0640.PMC3341605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2012) 33, 1105–1111 doi:10.1093/eurheartj/ehr419",Non-OADS,/arxiv_data1/oa_pdf/4a/81/ehr419.PMC3341630.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2012) 33, 1067–1075 doi:10.1093/eurheartj/ehs043",Non-OADS,/arxiv_data1/oa_pdf/0c/76/ehs043.PMC3341631.pdf
"(Accessed May 10, 2010, at      http://www.solutionsight.com/GNSNewsletter_Octob er2009.pdf)  28.",Non-OADS,/arxiv_data1/oa_pdf/07/84/NAJMS-2-301.PMC3341636.pdf
"(Accessed June 15, 2010 at  http://www.who.int/social_de terminants/resources/pp hc_scoping_paper.pdf)  9.",Non-OADS,/arxiv_data1/oa_pdf/89/a5/NAJMS-2-311.PMC3341638.pdf
"(Accessed August 22, 2006, at  http://www.spc.uchicago.edu/prc/pdfs/becker05.pdf# search=%22preston%20quality%20of%20life%22)   32.",Non-OADS,/arxiv_data1/oa_pdf/89/a5/NAJMS-2-311.PMC3341638.pdf
"(Accessed June 29, 2006,  at http://melbourneinstitute.com/wp/wp2004n03.pdf  )  36.",Non-OADS,/arxiv_data1/oa_pdf/89/a5/NAJMS-2-311.PMC3341638.pdf
"(Accessed November 15, 2009,  at http://who.int/cardiovascular_diseases/resources  /index.html )  14.",Non-OADS,/arxiv_data1/oa_pdf/a5/94/NAJMS-2-320.PMC3341639.pdf
"(Accessed November 15, 2009 at  http://www.genepi.qimr.edu.au/contents/p/.../Webbin k_JnrlHealthEcon_Feb2010.pdf)   21.",Non-OADS,/arxiv_data1/oa_pdf/a5/94/NAJMS-2-320.PMC3341639.pdf
Available at: http://www.uspto.gov/inven- tors/patents.jsp.,OADS,/arxiv_data1/oa_pdf/22/db/DialoguesClinNeurosci-14-100.PMC3341645.pdf
"(Immediate Communication); August 9,2011:1-10. http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201185a.html.",OADS,/arxiv_data1/oa_pdf/6e/40/DialoguesClinNeurosci-14-19.PMC3341646.pdf
These documents and additional infor- mation regarding RDoC (including the proceedings  of past workshops) can be viewed at http://www.nimh.nih.gov/research-funding/rdoc/ index.shtml.,Non-OADS,/arxiv_data1/oa_pdf/b1/f7/DialoguesClinNeurosci-14-29.PMC3341647.pdf
REFERENCES 1.http://www.nimh.nih.gov/about/strategic-planning- reports/index.shtml#strategic-objective1.,Non-OADS,/arxiv_data1/oa_pdf/b1/f7/DialoguesClinNeurosci-14-29.PMC3341647.pdf
Available at: http://plato.stanford.edu/entries/consciousness/.,Non-OADS,/arxiv_data1/oa_pdf/89/82/DialoguesClinNeurosci-14-55.PMC3341650.pdf
Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1692320 Accessed February 2012.,Non-OADS,/arxiv_data1/oa_pdf/8f/a9/DialoguesClinNeurosci-14-77.PMC3341653.pdf
Available at: http://www.ethikrat.org/dateien/pdf/Stellungnahme_Organmangel.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8f/a9/DialoguesClinNeurosci-14-77.PMC3341653.pdf
Available at: http://www.aerzteblatt.de/v4/ news/news.asp?id=44490.,Non-OADS,/arxiv_data1/oa_pdf/8f/a9/DialoguesClinNeurosci-14-77.PMC3341653.pdf
"It is estimated that less than 15% of the world’s population speaks  English, with just 5% being native speakers (http://en.wikipedia.org/ wiki/English_language).",Non-OADS,/arxiv_data1/oa_pdf/90/51/1399.PMC3341706.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/51/1399.PMC3341706.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Adipose tissue phenotypes and insulin resistance SJ Bigornia et al 6 Nutrition and Diabetes (2012) 1 - - 6 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9e/d2/nutd20123a.PMC3341707.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Weight loss and ectopic fat AP Rossi et al 7 Nutrition and Diabetes &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/11/fa/nutd20125a.PMC3341708.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Increasing atmospheric CO 2and obesity L-G Hersoug et al 3 Nutrition and Diabetes &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/be/11/nutd20122a.PMC3341709.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Apolipoprotein A-I mimetic L-4F actions in female obmice JS Marino et al 9 Nutrition and Diabetes &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/0f/ce/nutd20124a.PMC3341710.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/TGF-b/Smad3 signaling in obesity and diabetes CK Tan et al 13 Nutrition and Diabetes &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/af/4c/nutd20121a.PMC3341711.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8d/1b/srep00391.PMC3341739.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Tempel, D.G.",Non-OADS,/arxiv_data1/oa_pdf/8d/1b/srep00391.PMC3341739.pdf
Available from: http://www.orpha.net/data/patho/ GB/ukneuroblastoma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/b2/CCD-3-108.PMC3341745.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/63/72/CCD-3-2.PMC3341753.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/26/96/CCD-3-38.PMC3341757.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/26/96/CCD-3-38.PMC3341757.pdf
Available from: http://emedicine.medscape.com/article/1599374-overview#a0101.,Non-OADS,/arxiv_data1/oa_pdf/e6/7a/CCD-3-86.PMC3341767.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/e9/51/CCD-3-9.PMC3341768.pdf
http://www.spyglass-consulting.com/press_releases/ SpyglassPR_Mobile_Computing_Nursing.v1.2.pdf 2004.,Non-OADS,/arxiv_data1/oa_pdf/7b/fa/amiajnl-2010-000020.PMC3341772.pdf
1998. http://www.wfmc.org/standards/docs/ if19807r3.pdf (accessed 2008).,Non-OADS,/arxiv_data1/oa_pdf/7b/fa/amiajnl-2010-000020.PMC3341772.pdf
1997. http://lap.umd.edu/quis/ (accessed 2008).52.,Non-OADS,/arxiv_data1/oa_pdf/7b/fa/amiajnl-2010-000020.PMC3341772.pdf
"British Geriatrics Society, 2010. http://www.bgs.org.uk/index.php?option ¼com_content&view ¼article&id ¼359% 3Amanaginglongtermconditions&catid ¼12%3Agoodpractice&Itemid ¼106&showall ¼1 (accessed Aug 2011).",Non-OADS,/arxiv_data1/oa_pdf/90/bc/amiajnl-2011-000319.PMC3341784.pdf
http://bioinfo.amc.uva.nl/human-genetics/pubreminer/ (accessed Aug 2011).,Non-OADS,/arxiv_data1/oa_pdf/90/bc/amiajnl-2011-000319.PMC3341784.pdf
Analyses were conducted by using the R 2.10.1 statisticalpackage (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/91/4f/amiajnl-2011-000394.PMC3341788.pdf
"Topic Series: HIE Technical Models , November, 2009. http://www.himss.org/content/ﬁles/2009HIETechnicalModels.pdf (accessed23 Oct 2011).Table 4 Study population societal savings over the 2-year study period Characteristic Cost (US$)Direct access group (n [5019) Mixed access group (n [10 779) Total (n [15 798) Increase (decrease) in occurrenceSavings (US$)Increase (decrease) in occurrenceSavings (US$)Increase (decrease) in occurrenceSavings (US$) Hospitalized 4999 (191) 954 809 (221) 1 104 779 (412) 2 059 588 Head CT 416 74 (30 784) (103) 42 848 (29) 12 064 Body CT 485 NS (196) 95 060 (196) 95 060 Chest x-ray 77 800 (61 600) NS 800 ($61 600) Laboratory tests 18 NS (258) 4644 (258) 4644Study societal savings over 13 months* 862 425 1 247 331 2 109 756 Approximate annual savings 796 085 1 151 382 1 947 467 *The month preceding and the month following the 13-month period contained 17 records (0.11%) of the total set.",Non-OADS,/arxiv_data1/oa_pdf/91/4f/amiajnl-2011-000394.PMC3341788.pdf
2011. http://directproject.org/ (accessed 1 Jul 2011).,Non-OADS,/arxiv_data1/oa_pdf/91/4f/amiajnl-2011-000394.PMC3341788.pdf
2006. http://www.connectingforhealth.org/ (accessed 23 Feb 2007).,Non-OADS,/arxiv_data1/oa_pdf/91/4f/amiajnl-2011-000394.PMC3341788.pdf
2007. http://www.chcf.org/documents/hospitals/ EDOveruse.pdf (accessed 1 Jul 2011).,Non-OADS,/arxiv_data1/oa_pdf/91/4f/amiajnl-2011-000394.PMC3341788.pdf
"George Washington University School of Public Health and Health Serivces, Department of Health Policy, 2004. http://urgentmatters.org/media/ ﬁle/aboutProject_reports_Final_Memphis.pdf (accessed 1 Jul 2011).",Non-OADS,/arxiv_data1/oa_pdf/91/4f/amiajnl-2011-000394.PMC3341788.pdf
2009. http://www.cdc.gov/hiv/surveillance/resources/reports/ 2009report 2.,Non-OADS,/arxiv_data1/oa_pdf/47/46/amiajnl-2011-000412.PMC3341789.pdf
http://www.dhh.state.la.us/ofﬁces/publications/pubs-264/ FINAL_2009_AR_PDF.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/47/46/amiajnl-2011-000412.PMC3341789.pdf
2003. http://aspe.hhs.gov/sp/nhii/lhii-lorenzi-12.16.03.pdf (accessed 26 Aug 2011).,Non-OADS,/arxiv_data1/oa_pdf/98/b5/amiajnl-2011-000432.PMC3341790.pdf
http://www.ncbi.nlm.nih.gov/pubmed/15659453/.,Non-OADS,/arxiv_data1/oa_pdf/98/b5/amiajnl-2011-000432.PMC3341790.pdf
https://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/98/b5/amiajnl-2011-000432.PMC3341790.pdf
2011. http://health.state.tn.us/twis/(accessed 25 Oct 2009).,Non-OADS,/arxiv_data1/oa_pdf/98/b5/amiajnl-2011-000432.PMC3341790.pdf
"Rockville, MD: Agency for Healthcare Research and Quality, 2011. http://www.ahrq.gov/clinic/tp/medmgttp.htm (accessed Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"Surescripts LLC, 2010. http://www.surescripts.com/media/515306/ 2009_national-progress-report.pdf (accessed Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"Washington, DC: GAO, 2011. http://www.gao.gov/new.items/d11159.pdf (accessed Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"Washington, DC: US Department of Health and Human Services, Ofﬁce of the National Coordinator for Health Information Technology, 2011. http://healthit.hhs.gov/media/faca/MU_RFC%20_2011-01-12_ﬁnal.pdf (accessed Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"Washington, DC: DHHS, 2009. http://oig.hhs.gov/oei/reports/oei-05-08-00320.pdf (accessed Oct 2011).18.",Non-OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
2010. http://www.ncpanet.org/pdf/leg/eprescribing012510.pdf (accessed Oct 2011).,OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
2011. http://www.hschange.org/index.cgi?data ¼06 (accessed Oct 2011).,OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"Surescripts LLC, 2010. http://www.surescripts.com/about-e-prescribing/progress-reports/state-progress- reports.aspx (accessed Oct 2011).",OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"224, 19 Nov 2008; 42 CFR Parts 405, 409, 410,411, 413, 414, 415, 423, 424, 485, 486, and 489. http://edocket.access.gpo.gov/ 2008/E8-26213.htm (accessed Oct 2011).",OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
http://www.ncpdp.org/pdf/Eprescribing_fact_sheet.pdf (accessed Oct 2011).,OADS,/arxiv_data1/oa_pdf/47/2b/amiajnl-2011-000515.PMC3341793.pdf
"The objectives of this study were to evaluate the incidence of meniscal tears in patients with chronic ACL-defi  cient knees and  to determine the infl  uence of PTS on secondary medial meniscal  tears in ACL-defi  cient knees.Medial Meniscal Tears in Anterior Cruciate Ligament- Defi cient Knees: Eff  ects of Posterior Tibial Slope on  Medial Meniscal Tear Jae-Jeong Lee, MD, Yun-Jin Choi, MD, Keun-Y oung Shin, MD and Chong-Hyuk Choi, MD, PhD Department of Orthopedic Surgery, Gangnam Severance Hospital, Y onsei University College of Medicine, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/6d/ksrr-23-227.PMC3341801.pdf
"KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):227-230http://dx.doi.org/10.5792/ksrr.2011.23.4.227pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  To evaluate the incidence of meniscal tears in patients with chronic anterior cruciate ligament (ACL) -defi  cient knees, and to determine the  infl uence of posterior tibial slope (PTS) on medial meniscal tears in ACL-defi  cient knees.",Non-OADS,/arxiv_data1/oa_pdf/b8/6d/ksrr-23-227.PMC3341801.pdf
"In this study, we analyzed the clinical and radiological outcomes of separate vertical wiring 12) for the treatment of extra-articular  fractures of the distal pole of the patella.Separate Vertical Wirings for the Extra-articular  Fractures of the Distal Pole of the Patella Y oung Mo Kim, MD, PhD, Jun Y oung Y ang, MD, PhD, Kyung Cheon Kim, MD, PhD, Chan Kang, MD,  Y ong Bum Joo, MD, Woo Y ong Lee, MD and  Jung Mo Hwang, MD Department of Orthopedic Surgery, Chungnam National University School of Medicine, Daejeon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/5a/ksrr-23-220.PMC3341802.pdf
KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):220-226http://dx.doi.org/10.5792/ksrr.2011.23.4.220pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  To evaluate the usefulness of separate vertical wirings for extra-articular fracture of distal pole of patella.,Non-OADS,/arxiv_data1/oa_pdf/0d/5a/ksrr-23-220.PMC3341802.pdf
"Th  e treatment decision should  be based on the patient’s activity level, age, cause, size and depth Management of Focal Chondral Lesion in the Knee  Joint Seung-Suk Seo, MD, PhD, Chang-Wan Kim, MD, PhD and Dae-Won Jung, MD Department of Orthopaedics, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ksrr-23-185.PMC3341803.pdf
"KOREAN KNEE SOCIETY www.jksrr.orgReview Article Knee Surg Relat Res 2011;23(4):185-196http://dx.doi.org/10.5792/ksrr.2011.23.4.185pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Articular cartilage does not contain vascular, nervous and lymphatic tissue and chondrocytes hardly participate in the healing or repair process  of chondral tissue because of being surrounded by plenty of extracellular matrix.",Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ksrr-23-185.PMC3341803.pdf
"If the wire is removed, the Delayed Knee Locking aft  er Complicated Anterior  Cruciate Ligament Reconstruction Despite Good Stability Using A Bio-Transfi  x  Y ong Seuk Lee, MD, PhD, Beom Koo Lee, MD, PhD, Jae Ang Sim, MD, PhD, Ji Hoon Kwak, MD and  Shin Woo Nam, MD Department of Orthopaedic Surgery, Gachon University Gil Hospital, Gachon University School of Medicine, Incheon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/6b/ksrr-23-236.PMC3341804.pdf
KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2011;23(4):236-239http://dx.doi.org/10.5792/ksrr.2011.23.4.236pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research We describe a case of delayed cyst formation that presented as intermittent knee locking after complicated anterior cruciate li gament (ACL)  reconstruction using a Bio-TransFix implant in a 21-year-old male patient.,Non-OADS,/arxiv_data1/oa_pdf/5f/6b/ksrr-23-236.PMC3341804.pdf
"Materials and Methods   A survey was performed in the ambulatory of 82 hospitals (62 university and 20 general hospitals) where 111 physicians, members of the Korean Knee Society, had prescribed NSAIDs to Th e Pattern of Use of Oral NSAIDs with or without Co- prescription of Gastroprotective Agent for Arthritic Knee by Korean Practitioners Hee-Chun Kim, MD1, Myung Chul Lee, MD2, Y oung-Wan Moon, MD3, Seung Suk Seo, MD4,  Kwang Won Lee, MD5, Ju Hong Lee, MD6 and Choong-Hyeok Choi, MD7 Department of Orthopedic Surgery, 1CHA Bundang Medical Center, CHA University, Seongnam; 2Seoul National University College of Medicine; 3Sungkyunkwan  University School of Medicine; 4Inje University College of Medicine; 5Eulji University College of Medicine, Seoul; 6Chonbuk National University College of Medicine,  Jeonju; 7Hanyang University College of Medicine, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/f5/ksrr-23-203.PMC3341805.pdf
"KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):203-207http://dx.doi.org/10.5792/ksrr.2011.23.4.203pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  Th e aim of this study was to describe the patterns of use of non-steroidal anti-infl  ammatory drugs (NSAIDs) for arthritic knees in clinical  practice, particularly focusing on the co-prescription of gastroprotective agents for patients with risk factors for adverse ga strointestinal (GI) events.",Non-OADS,/arxiv_data1/oa_pdf/37/f5/ksrr-23-203.PMC3341805.pdf
"In this study, we compared ≥1-year short-term clinical results of ACL Reconstruction with Autologous Hamstring  Tendon: Comparison of Short Term Clinical Results between Rigid-fi  x and PINN-ACL Cross Pin Seung-Suk Seo, MD1, Chang-Wan Kim, MD1, Tae-Seok Nam, MD2 and Sang-Y eong Choi, MD1 Department of Orthopedic Surgery, 1Busan Paik Hospital, University of Inje College of Medicine, Busan; 2Nanoori Hospital, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/81/ksrr-23-208.PMC3341806.pdf
KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):208-212http://dx.doi.org/10.5792/ksrr.2011.23.4.208pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  To compare the short term clinical results of anterior cruciate ligament (ACL) reconstruction with autologous hamstring tendon  between  Rigid-fi  x and PINN-ACL Cross Pin for femoral side fi  xation.,Non-OADS,/arxiv_data1/oa_pdf/10/81/ksrr-23-208.PMC3341806.pdf
"Using this material, we designed a Ti-Ni SMA ring  shaped bone fixator (SMA-rBF, Bio-Smart, Ulsan, Korea) Th e Use of a Ti-Ni Shape Memory Alloy Ring Bone  Fixator During the Retrograde Nailing of Supracondylar Femoral Fractures Hyuk-Soo Han, MD, PhD, Dae-Ha Kim, MD and Seung-Baik Kang, MD, PhD Department of Orthopaedic Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/b2/ksrr-23-231.PMC3341807.pdf
KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):231-235http://dx.doi.org/10.5792/ksrr.2011.23.4.231pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  To identify the effects of using a Ti-Ni shape memory alloy ring shaped bone fixator (SMA-rBF) during the retrograde nailing o f  supracondylar femoral fractures.,Non-OADS,/arxiv_data1/oa_pdf/4d/b2/ksrr-23-231.PMC3341807.pdf
"1A).Skin-capsular Mismatch According to Knee Positions  for Instrument Insertion via Arthroscopic Portals Jung-Ro Y oon, MD, Venkatesh KP , MD, Taik-Sun Kim, MD, Deuk-Soo Lim, MD and Jae-Hyuk Y ang, MD Department of Orthopedic Surgery, Seoul Veterans Hospital, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/83/ksrr-23-248.PMC3341808.pdf
"KOREAN KNEE SOCIETY www.jksrr.orgTechnical Note Knee Surg Relat Res 2011;23(4):248-250http://dx.doi.org/10.5792/ksrr.2011.23.4.248pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Damage to soft   tissues, chondral surfaces, and the menisci may result from impris e or overly aggressive establ ishment of portals in arthrosc opic knee  surgeries.",Non-OADS,/arxiv_data1/oa_pdf/26/83/ksrr-23-248.PMC3341808.pdf
"Anatomic Single Bundle Anterior Cruciate Ligament  Reconstruction by the Two Anteromedial Portal Method: Th  e Comparison of Transportal and  Transtibial Techniques Myung-Ku Kim, MD, PhD, Byung-Cheol Lee, MD and Joo-Hyun Park, MD Department of Orthopaedic Surgery, Inha University Hospital, Inha University College of Medicine, Incheon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/7a/ksrr-23-213.PMC3341809.pdf
KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):213-219http://dx.doi.org/10.5792/ksrr.2011.23.4.213pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  Th e purpose of this study was to report the results of anatomic single bundle anterior cruciate ligament (ACL) reconstruction by  the two  anteromedial portal method.,Non-OADS,/arxiv_data1/oa_pdf/e9/7a/ksrr-23-213.PMC3341809.pdf
"On plain radiographs, there was no fracture around patella upper pole, but irregular calcifi  c deposits in the supra-patella area Simultaneous Bilateral Quadriceps Tendon Rupture in  Patient with Chronic Renal Failure Yunseok Lee, MD1, Byounggook Kim, MD, PhD1, Ju-Hwan Chung, MD2 and Jinmyoung Dan, MD1 Department of Orthopaedic Surgery, 1CHA Gumi Medical Center, CHA University, Gumi; 2Seoul Nanoori Hospital, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/ab/ksrr-23-244.PMC3341810.pdf
KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2011;23(4):244-247http://dx.doi.org/10.5792/ksrr.2011.23.4.244pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Simultaneous bilateral spontaneous rupture of the quadriceps tendon is a very rare condition and only a few cases have been rep orted in the literature.,Non-OADS,/arxiv_data1/oa_pdf/db/ab/ksrr-23-244.PMC3341810.pdf
"Th  e medial femoral condyle appeared comparatively  smaller, the intercondylar notch was decreased in height and Ligament Reconstruction in Congenital Absence of the  Anterior Cruciate Ligament: A Case Report Jae Jeong Lee, MD, Won Taek Oh, MD, Keun Y oung Shin, MD, Min Seok Ko, MD and  Chong-Hyuk Choi, MD, PhD Department of Orthopedic Surgery, Gangnam Severance Hospital, Y onsei University College of Medicine, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/1b/ksrr-23-240.PMC3341811.pdf
KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2011;23(4):240-243http://dx.doi.org/10.5792/ksrr.2011.23.4.240pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Congenital absence of the cruciate ligament is an extremely rare condition that was fi  rst reported in Giorgi’s radiographic study in 1956.,Non-OADS,/arxiv_data1/oa_pdf/4d/1b/ksrr-23-240.PMC3341811.pdf
"Our hypothesis was that radiological and clinical results of TKA would be more satisfying in the experimental group where the lateral eminence was used as a re ference for tibial osteotomy  compared to that in the control group where the center of the Th e Position of Proximal Reference Point of Tibia  Plateau for Correct Tibial Osteotomy in Total Knee Replacement: Prospective Randomized and 6 Y ears Follow-up Study Kye Y oung Han, MD and Woo Y oung Chae, MD Department of Orthopaedic Surgery, Kangwon National University College of Medicine, Chuncheon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/c3/ksrr-23-197.PMC3341812.pdf
"KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(4):197-202http://dx.doi.org/10.5792/ksrr.2011.23.4.197pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  When there is a varus deformity in proximal tibia, the extensio n of a tibial shaft axis tends to pass through the lateral inte rcondylar  eminence.",Non-OADS,/arxiv_data1/oa_pdf/a5/c3/ksrr-23-197.PMC3341812.pdf
"Of them, A Comparison of the Clinical and Radiographic Results  of Press Fit Condylar Rotating-Platform High-Flexion  and Low Contact Stress Mobile Bearing Prosthesis in  T otal Knee Arthroplasty: Short term Results Shin W oo Nam, MD, Y ong Seuk Lee, MD, PhD, Ji Hoon Kwak, MD, Nam Ki Kim, MD and Beom Koo Lee,  MD, PhD Department of Orthopedic Surgery, Gil Medical Center, Gachon University of Medicine and Science, Inchon, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/0a/ksrr-24-7.PMC3341813.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):7-13 http://dx.doi.org/10.5792/ksrr.2012.24.1.7 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  This study compared the results of rotating-platform high-flexion (RP-F) total knee arthroplasty with low contact stress (LCS) for clinical  and radiographical assessment after a short-term period.,Non-OADS,/arxiv_data1/oa_pdf/b5/0a/ksrr-24-7.PMC3341813.pdf
"Incidence of V enous Thromboembolism Using 64  Channel Multidetector Row Computed T omography- Indirect V enography and Anti-Coagulation Therapy  after T otal Knee Arthroplasty in Korea Kyung-Hyun Park, MD, Sang-Ho Cheon, MD, Ji-Ho Lee, MD and Hee-Soo Kyung, MD Department of Orthopedic Surgery, Kyungpook National University School of Medicine, Daegu, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/51/ksrr-24-19.PMC3341814.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):19-24 http://dx.doi.org/10.5792/ksrr.2012.24.1.19 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  This study evaluated the incidence of a venous thromboembolism (VTE) after total knee arthroplasty (TKA) using multidetector row  computed tomography-indirect venography (MDCT-indirect venography) and assessed the efficacy of anti-coagulation therapy.,Non-OADS,/arxiv_data1/oa_pdf/98/51/ksrr-24-19.PMC3341814.pdf
"However, there is a  certain elasticity in the graft-implant complex, and the fixation  point of the Endobutton system is relatively far from the joint  line, resulting in graft-tunnel motion of up to 3 mm under a Cross Pins versus Endobutton Femoral Fixation in  Hamstring Anterior Cruciate Ligament Reconstruction:  Minimum 4-Y ear Follow-Up Chae-Gwan Kong, MD1, Y ong In, MD2, Geon-Hyeong Kim, MD1 and Chi-Y oung Ahn, MD1 Department of Orthopaedic Surgery, 1Uijongbu St. Mary’ s Hospital, 2Seoul St. Mary’ s Hospital, The Catholic University of Korea, Seoul, K orea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/ba/ksrr-24-34.PMC3341815.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):34-39 http://dx.doi.org/10.5792/ksrr.2012.24.1.34 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  W e aimed to compare cross-pin fixation and Endobutton femoral fixation for hamstring anterior cruciate ligament (ACL) reconstruction  with respect to clinical and radiographic results, including tunnel widening and the progression of knee osteoarthritis (OA).",Non-OADS,/arxiv_data1/oa_pdf/2c/ba/ksrr-24-34.PMC3341815.pdf
"T otal Knee Arthroplasty in Rheumatoid Arthritis Jin Kyu Lee, MD and Choong-Hyeok Choi, MD, PhD Department of Orthopaedic Surgery, Hanyang University College of Medicine, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/48/ksrr-24-1.PMC3341816.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgReview Article Knee Surg Relat Res 2012;24(1):1-6 http://dx.doi.org/10.5792/ksrr.2012.24.1.1 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research The course of rheumatoid arthritis varies from mild disease to severe joint destructive variant that progresses rapidly, eventually leading to  unremitting pain and joint deformity.",Non-OADS,/arxiv_data1/oa_pdf/e7/48/ksrr-24-1.PMC3341816.pdf
"The mean age of group A and B patients was 72.9 (range, 54 The Efficacy and Safety of Postoperative Autologous  Transfusion of Filtered Shed Blood and Anticoagulant  Prophylaxis in T otal Knee Arthroplasty Patients Kwon-Hee Park, MD, Sung-Rak Lee, MD, Jong-Mun Jin, MD and Myung-Sang Moon, MD Department of Orthopaedic Surgery, Cheju Halla General Hospital, Jeju, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/ac/ksrr-24-14.PMC3341817.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):14-18 http://dx.doi.org/10.5792/ksrr.2012.24.1.14 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  T o assess the efficacy and safety of autologous transfusion of filtered shed blood in total knee arthroplasty (TKA).,Non-OADS,/arxiv_data1/oa_pdf/0e/ac/ksrr-24-14.PMC3341817.pdf
"Plain Simultaneous Bilateral Quadriceps T endon Rupture in a  Patient with Chronic Renal Failure Byung Soo Kim, MD1, Y ong W ook Kim, MD1, Eun Kyoo Song, MD2, Jong Keun Seon, MD2, Kyung Do Kang,  MD2 and Hyung Nam Kim, MD2 1Department of Orthopedic Surgery, Gwangju City Hospital, Gwangju; 2Center for Joint Disease, Chonnam National University Hwasun Hospital, Hwasun, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/60/ksrr-24-56.PMC3341818.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2012;24(1):56-59 http://dx.doi.org/10.5792/ksrr.2012.24.1.56 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Bilateral quadriceps tendon rupture is an unusual injury, but may be encountered in patients with various chronic diseases after minor trauma.",Non-OADS,/arxiv_data1/oa_pdf/bf/60/ksrr-24-56.PMC3341818.pdf
"Comparison of Mobile-Bearing and Fixed-Bearing  Designs in High Flexion T otal Knee Arthroplasty: Using  a Navigation System Tae W an Kim, MD, Shi Hwan Park, MD and Jeung Tak Suh, MD, PhD  Department of Orthopaedic Surgery, Pusan National University School of Medicine, Busan, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/49/ksrr-24-25.PMC3341819.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):25-33 http://dx.doi.org/10.5792/ksrr.2012.24.1.25 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  We compared and analyzed the short term results of high flexion total knee arthroplasty (TKA) with mobile-bearing and fixed bearing  designs.,Non-OADS,/arxiv_data1/oa_pdf/3d/49/ksrr-24-25.PMC3341819.pdf
"In all patients, an absorbable Clinical Presentation of Staphylococcus epidermidis   Septic Arthritis Following Anterior Cruciate Ligament  Reconstruction Y oung Mo Kim, MD, PhD and Y ong Bum Joo, MD Department of Orthopaedic Surgery, Chungnam National University School of Medicine, Daejeon, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/36/ksrr-24-46.PMC3341820.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):46-51 http://dx.doi.org/10.5792/ksrr.2012.24.1.46 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  This study evaluated the clinical presentations of Staphylococcus epidermidis  (S. epidermidis ) septic arthritis after arthroscopic anterior  cruciate ligament reconstruction (ACLR).,Non-OADS,/arxiv_data1/oa_pdf/50/36/ksrr-24-46.PMC3341820.pdf
"In this study, we investigated the validity of the three FPTs and V alidation of Functional Performance T ests after  Anterior Cruciate Ligament Reconstruction Doo Hwan Kong, MS1, Sang Jin Y ang, MS1, Jeong Ku Ha, MD2, Seok Hwan Jang, MD2, Jung Gook Seo, MD2 and  Jin Goo Kim, MD1,2 1Sports Medicine Research Institute, 2Department of Orthopedic Surgery, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/93/ksrr-24-40.PMC3341821.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2012;24(1):40-45 http://dx.doi.org/10.5792/ksrr.2012.24.1.40 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  T o validate the functional performance tests (FPT s) after anterior cruciate ligament (ACL) reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/cd/93/ksrr-24-40.PMC3341821.pdf
"The cystic lesion was seen originating  from the deep recess between the posterior root of the MM and  the PCL that bulged into the posteromedial joint space with a  signal change in the posterior root of MM and the PCL adjacent Symptomatic Posterior Cruciate Ganglion Cyst Causing  Impingement between Posterior Root of the Medial  Meniscus and Anterior to the Posterior Cruciate  Ligament Y ong Bum Joo, MD and Y oung Mo Kim, MD, P hD Department of Orthopedic Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/6f/ksrr-24-52.PMC3341822.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2012;24(1):52-55 http://dx.doi.org/10.5792/ksrr.2012.24.1.52 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research There are several reports of symptomatic ganglion cysts near the posterior cruciate ligament (PCL), but no reports of a symptomatic ganglion  originating from the anterior aspect of the PCL in the deep recess between the posterior root of the medial meniscus and the PCL, bulging into  the posteromedial joint space.",Non-OADS,/arxiv_data1/oa_pdf/0b/6f/ksrr-24-52.PMC3341822.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, andreproduction in any medium, provided the original work is properly cited.Open Access Mol.",Non-OADS,/arxiv_data1/oa_pdf/b3/ea/msr296.PMC3341825.pdf
"2008 ) at the CIPRES portal ( http://www.phylo.org/sub_sections/ portal/ ), using the rapid bootstrap heuristics (100 boot- strap replicates) and ﬁnal thorough tree search underthe WAG þFþC4þI substitution model.",OADS,/arxiv_data1/oa_pdf/b3/ea/msr296.PMC3341825.pdf
An additional ML bootstrap analysis (100 replicates) was run at the ATCGserver ( http://www.atgc-montpellier.fr/phyml/ ) employing PhyML 3.0 ( Guindon and Gascuel 2003 ) and the LG þC4þI substitution model.,OADS,/arxiv_data1/oa_pdf/b3/ea/msr296.PMC3341825.pdf
"Available from: http://evolution.genetics.washington.edu/phylip.html Flajnik MF, Kasahara M. 2010.",OADS,/arxiv_data1/oa_pdf/b3/ea/msr296.PMC3341825.pdf
"Available from: http://www.nrbsc.org/gfx/genedoc/Padmanabhan M, Cournoyer P, Dinesh-Kumar SP.",Non-OADS,/arxiv_data1/oa_pdf/b3/ea/msr296.PMC3341825.pdf
ALF is available as a stand-alone application or via a web interface at http://www.cbrg.ethz.ch/alf .,OADS,/arxiv_data1/oa_pdf/63/d6/msr268.PMC3341827.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/d6/msr268.PMC3341827.pdf
Web Interface and Stand-Alone Version A web interface for ALF is available at http://www.cbrg.,OADS,/arxiv_data1/oa_pdf/63/d6/msr268.PMC3341827.pdf
Supplementary Material Supplementary table S1 and figures S1–S4 are available at Molecular Biology and Evolution online (http://www.mbe.,OADS,/arxiv_data1/oa_pdf/63/d6/msr268.PMC3341827.pdf
"Y oon-Seok Y oum, MD, Sung-Do Cho, MD, Jin Eo, MD, Ki-Bong Park, MD and Sun-Ho Lee, MD Department of Orthopedic Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/19/ksrr-23-149.PMC3341828.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(3):149-152http://dx.doi.org/10.5792/ksrr.2011.23.3.149pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  We tried to demonstrate whether the posterior condylar offset (PCO, the distance from the femoral diaphysis posterior cortex t o the  posterior condylar margin) and ratio (PCOR, dividing PCO by the maximum antero-posterior diameter of the distal femur) could be  used as  predictive factors for overhang of the implants or using gender implants in total knee arthroplasty (TKA).",Non-OADS,/arxiv_data1/oa_pdf/d9/19/ksrr-23-149.PMC3341828.pdf
"Surgical Technique   Anteromedial, anterolateral, and superomedial portals were Fibrin Clot Delivery System for Meniscal Repair Suk Hwan Jang, MD, Jeong Ku Ha, MD, Dong Won Lee, MD and Jin Goo Kim, MD, PhD Department of Orthopedic Surgery, Inje University College of Medicine, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/7b/ksrr-23-180.PMC3341829.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgTechnical Note Knee Surg Relat Res 2011;23(3):180-183http://dx.doi.org/10.5792/ksrr.2011.23.3.180pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research As meniscal preservation particularly in younger active individu als with a symptomatic meniscal tear remains the preferred trea tment option, various  methods have been suggested to increase healing and success rates aft  er meniscal repair.",Non-OADS,/arxiv_data1/oa_pdf/7c/7b/ksrr-23-180.PMC3341829.pdf
"Letter Knee Surg Relat Res 2011;23(3):133 http://dx.doi.org/10.5792/ksrr.2011.23.3.133pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Editorial Knee Surgery and Related Surgery makes its debut on September 1st, 2011,  replacing Th  e Journal of Korean Knee Society (pISSN 1225-1623, www.koreaknee.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/ksrr-23-133.PMC3341830.pdf
"Complete flexion was obtained at the Surgical Treatment of Habitual Patella Dislocation with  Genu Valgum Ji Hoon Kwak, MD, Jae Ang Sim, MD, Nam Ki Kim, MD and Beom Koo Lee, MD Department of Orthopedics, Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/6e/ksrr-23-177.PMC3341831.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2011;23(3):177-179http://dx.doi.org/10.5792/ksrr.2011.23.3.177pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Habitual dislocation of patella is a rare disorder.,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/ksrr-23-177.PMC3341831.pdf
"Prolonged intravenous antibiotic treatment had been administrated for two months due to persistent fever, signs of infections in the right A Case of Adult Onset Still’s Disease Misdiagnosed as  Septic Arthritis Sang Jun Song, MD, PhD1, Dae Kyung Bae, MD, PhD1, Jung Ho Noh, MD, PhD2, Geon Wook Seo, MD1 and  Dong Cheol Nam, MD1 Department of Orthopaedic Surgery, 1Kyung Hee University College of Medicine,  2National Police Hospital, Seoul, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ksrr-23-171.PMC3341832.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgCase Report Knee Surg Relat Res 2011;23(3):171-176http://dx.doi.org/10.5792/ksrr.2011.23.3.171pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research We present a case of adult onset Still’s disease (AOSD) that wa s misdiagnosed as septic arthritis of the shoulder and knee.,Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ksrr-23-171.PMC3341832.pdf
"The purpose of this study was to evaluate dual fixations with different fixation mechanisms, determine the advantages, and compare the outcomes between single and dual femoral fi  xation.Comparison between Single and Dual Femoral Fixation  for Anterior Cruciate Ligament Reconstruction with a Hamstring Autograft   Jin Goo Kim, MD, PhD1, Y ong Seuk Lee, MD, PhD2 and Nam Ki Kim, MD2 Department of Orthopedic Surgery, 1Seoul Paik Hospital, Inje University College of Medicine, Seoul; 2Gil Hospital, Gachon University School of Medicine, Incheon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/70/ksrr-23-159.PMC3341833.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(3):159-163http://dx.doi.org/10.5792/ksrr.2011.23.3.159pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  Th e purpose of this study was to evaluate dual fi  xation with diff  erent fi  xation mechanisms, determine the advantages, and compare the  outcomes between single and dual femoral fi  xation.",Non-OADS,/arxiv_data1/oa_pdf/a7/70/ksrr-23-159.PMC3341833.pdf
"Burnett and Bourne9) reported that age, weight, gender,  anatomical factors including the condition of the patellar cartilage, radiographic fi  ndings, and the presence of preoperative  anterior knee pain and systemic diseases such as rheumatoid arthritis should be accounted for in determining whether A Comparison of Patella Retention versus Resurfacing  for Moderate or Severe Patellar Articular Defects in Total Knee Arthroplasty: Minimum 5-year Follow-up Results Seung Suk Seo, MD, Chang Wan Kim, MD and Sang Won Moon, MD Department of Orthopaedics, Inje University Pusan Paik Hospital, Inje University College of Medicine, Busan, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/04/ksrr-23-142.PMC3341834.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(3):142-148http://dx.doi.org/10.5792/ksrr.2011.23.3.142pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  Th e purpose of this study is to assess the clinical and radiologic al results of patients who underwent patellar retention or res urfacing for  moderate or severe patellar articular defects during total knee arthroplasty and evaluate the clinical effi   cacy of patellar resurfacing according to the  articular defect of the patella.,Non-OADS,/arxiv_data1/oa_pdf/89/04/ksrr-23-142.PMC3341834.pdf
"The purpose of this study was to Rotational Alignment of Femoral Component for  Minimal Medial Collateral Ligament Release in Total Knee Arthroplasty Je Gyun Chon, MD, Doo Hoon Sun, MD, Jae Y ong Jung, MD, Tae In Kim, MD and Seong Won Jang, MD Department of Orthopedic Surgery, Sun General Hospital, Daejeon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ksrr-23-153.PMC3341835.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(3):153-158http://dx.doi.org/10.5792/ksrr.2011.23.3.153pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  We attempted to determine the degree of rotation of the femoral component to achieve an ideal rectangular fl  exion gap with minimal  medial collateral ligament (MCL) release using a modifi  ed measured technique.,Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ksrr-23-153.PMC3341835.pdf
"Repair of the Complete Radial Tear of the Anterior  Horn of the Medial Meniscus in Rabbits: A Comparison between Simple Pullout Repair and Pullout Repair with Human Bone Marrow Stem Cell Implantation Jang-Hee Hong, MD, PhD1, Jong-Il Park, MD2, Kyung-Hee Kim, MD3, Y oung-Mo Kim, MD, PhD4,  Y ong-Bum Joo, MD4 and Y oo-Sun Jeon, MD4 Departments of 1Pharmacology, 2Biochemistry, Chungnam National University School of Medicine; 3Department of Pathology, Cancer Research Institute; 4Department  of Orthopedic Surgery, Chungnam National University School of Medicine, Daejeon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/30/ksrr-23-164.PMC3341836.pdf
THE KOREAN KNEE SOCIETY www.jksrr.orgOriginal Article Knee Surg Relat Res 2011;23(3):164-170http://dx.doi.org/10.5792/ksrr.2011.23.3.164pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Purpose:  To evaluate the degree of biological healing response that oc curs between the anterior horn of the medial meniscus (MM) and th e tibial  plateau and investigate the biological healing response aft  er injection of human bone marrow stem cells (hBMSCs) in a rabbit model.,Non-OADS,/arxiv_data1/oa_pdf/02/30/ksrr-23-164.PMC3341836.pdf
"If the pulses are weak or the ankle-brachial index Rupture of Posterior Cruciate Ligament: Diagnosis and  Treatment Principles Beom Koo Lee, MC and Shin Woo Nam, MC Department of Orthopedic Surgery, Gil Medical Center, Gachon University, Incheon, Korea Th is is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/d9/ksrr-23-135.PMC3341837.pdf
"THE KOREAN KNEE SOCIETY www.jksrr.orgReview Article Knee Surg Relat Res 2011;23(3):135-141http://dx.doi.org/10.5792/ksrr.2011.23.3.135pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Posterior cruciate ligament (PCL) injuries associated with multiple ligament injuries can be easily diagnosed, but isolated PCL  tears are less  symptomatic, very diffi   cult to diagnose, and frequently misdiagnosed.",Non-OADS,/arxiv_data1/oa_pdf/ad/d9/ksrr-23-135.PMC3341837.pdf
"Letter from  the President of Korean Knee SocietyLetter Knee Surg Relat Res 2011;23(3):134 http://dx.doi.org/10.5792/ksrr.2011.23.3.134pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Dear Korean Knee Society members, The Korean Knee Society has grown to be one of the largest societies in the  Korean Orthopedic Association since the foundation of in 1983.",Non-OADS,/arxiv_data1/oa_pdf/de/e2/ksrr-23-134.PMC3341838.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/89/sfs019.PMC3341841.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/f9/sfs011.PMC3341842.pdf
"Northjersey.com, 2011. http://www.legacy.com/obituaries/northjersey/obituary.aspx?n=ed-strudwick&pid=154528912 (18 November 2011, date last accessed) 11.",Non-OADS,/arxiv_data1/oa_pdf/b5/f9/sfs011.PMC3341842.pdf
"The Guardian 2011. http://www.guardian.co.uk/lifeandstyle/ 2006/sep/21/healthandwellbeing.health1/print (18 November 2011, date last accessed) 13.",Non-OADS,/arxiv_data1/oa_pdf/b5/f9/sfs011.PMC3341842.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial us e, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/1e/sfs008.PMC3341843.pdf
Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) Proportion of CD133+ subpopulation (%) SW620 CD133– 102104103101100104103102101100Vimentin E-cadherin TGF-/afii9826.fcsSB431542.fcs TGF-/afii9826.fcsSB431542.fcsControl.fcs Control.fcsIsotype control.fcs Isotype control.fcsSample name Sample name020406080 TGF-/afii9826 ***SB431542Control C BA Figure 5 TGF- b1 might have important roles in the inter-conversion and homoeostasis between NSCCs and CSCs via activating EMT.,Non-OADS,/arxiv_data1/oa_pdf/ad/32/bjc2012126a.PMC3341854.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website http://www.nature.com/bjc REFERENCES Arango D, Wilson AJ, Shi Q, Corner GA, Aranes MJ, Nicholas C, Lesser M, Mariadason JM, Augenlicht LH (2004) Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells Br J Cancer 91(11): 1931–1946 Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ (1995) Inhibition of Apoptosisduring Development of Colorectal Cancer.",Non-OADS,/arxiv_data1/oa_pdf/80/20/bjc2012133a.PMC3341858.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW,Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF(2005) Pegylated arginine deiminase treatment of patients with meta-static melanoma: results from phase I and II studies.",Non-OADS,/arxiv_data1/oa_pdf/ed/2c/bjc2012106a.PMC3341859.pdf
"In Denmark, the incidence of oropharyngeal cancers has doubled from 1999 to 2008, in both men and women (the Danish Cancer Registry http://www.sst.dk).Human papilloma virus þHNSCC is distinct from HPV-negative (HPV/C0) HNSCC in a number of ways.",Non-OADS,/arxiv_data1/oa_pdf/ac/aa/bjc2012109a.PMC3341860.pdf
"The heatmap and PCA visualisation was performed using the Qlucore Gene Expression Explorer (http://www.qlucore.com) .The role of miRNAs in HPV-associated cancers CB Lajer et al 1530 British Journal of Cancer (2012) 106(9), 1526 – 1534 &2012 Cancer Research UK Molecular Diagnostics",Non-OADS,/arxiv_data1/oa_pdf/ac/aa/bjc2012109a.PMC3341860.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T (2007a) Down- regulation of microRNAs-143 and -145 in B-cell malignancies.",Non-OADS,/arxiv_data1/oa_pdf/ac/aa/bjc2012109a.PMC3341860.pdf
Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Aas E (2009) Pecuniary compensation increases participation in screening for colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.kreftregisteret.no/Global/Publikasjoner%20og%20rapporter/Special%20Issue/Special_Issue_Cancer_in_Norway_2009.pdf (accessed 6January 2011) Cancer Registry of Norway (2011) Cancer in Norway 2009.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.kreftregisteret.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.federalreserve.gov/RELEASES/H10/Hist/dat00_no.htm (accessed 13 June 2011) Franco EL (2003) Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.helsedirektoratet.no/vp/multimedia/archive/00020/IS-1435_20969a.pdf (accessed on 6 January 2011) Norwegian Directorate of Health (2010) Activity-based funding 2010/2011.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.helsedirektoratet.no/finansieringsordninger/ regelverk_innsatsstyrt_finansiering__isf__2011_78057 (accessed 10December 2010)Norwegian Finance Department (2005) Guideline for Economic Analysis.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.regjeringen.no/upload/kilde/fin/reg/2005/0029/ddd/pdfv/266324-veileder_i_samfunnsok_analyse_trykket.pdf (accessed 6 January 2011) Norwegian Medical Association (2010a) Guidelines for Cervical Cancer.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
Available at: http://www.legeforeningen.no/id/153817.0 (accessed 11November 2010) Norwegian Medical Association (2010b) Normal tariff for private general practice 2010–2011.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
"Available at: http://www.legemiddelverket.no/upload/144901/ 09-16212-8%20RAPPORT%201622714_underskrevet.pdf (accessed 1May 2011) Nygard JF, Nygard M, Skare GB, Thoresen SO (2006) Pap smear screening in women under 30 in the Norwegian Coordinated CervicalCancer Screening Program, with a comparison of immediate biopsyvs Pap smear triage of moderate dysplasia.",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
"J Natl Cancer Inst Monogr 2003 (31):97–101 Statistics Norway (2011) Available at: http://www.ssb.no/english/ (accessed 10 January 2011) Stinnett AA, Paltiel AD (1997) Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.",OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
"Available at: http://www.ssb.no/whs_en/ (accessed 5 January 2011) Wright TC, Massad S, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/bjc201294a.PMC3341862.pdf
http://ctep.cancer.gov/reporting/ctc_v30.html accessed on 24 October 2011 National Comprehensive Cancer Network (2012) NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer.,Non-OADS,/arxiv_data1/oa_pdf/1e/48/bjc201289a.PMC3341863.pdf
"http://www.nccn.org accessed on 2February 2012 Oudard S, Elaidi RT (2012) Sequential therapy with targeted agents in patients with advanced renal cell carcinoma: optimizing patient benefit.Cancer Treat Rev , http://dx.doi.org/10.1016/j.ctrv.2011.12.009 Porta C, Ostanto S, Ravaud A, Climent MA, Vaishampayan U, White DA, Creel P, Dickow B, Fischer P, Gornell SS, Meloni F, Motzer RJ (2011b)Management of adverse events associated with the use of everolimus inpatients with advanced renal cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/1e/48/bjc201289a.PMC3341863.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Bakolitsa C, Cohen DM, Bankston LA, Bobkov AA, Cadwell GW, Jennings L, Critchley DR, Craig SW, Liddington RC (2004) Structural basis for vinculin activation at sites of cell adhesion.",Non-OADS,/arxiv_data1/oa_pdf/57/7d/bjc2012107a.PMC3341864.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participantdata from randomised trials.",Non-OADS,/arxiv_data1/oa_pdf/a1/b6/bjc2012101a.PMC3341868.pdf
Matched binding sites were selected withcore and matrix similarity of 40.8 (http://www.genomatix.de/ online_help/help_matinspector/matinspector_help.html).,OADS,/arxiv_data1/oa_pdf/58/6c/bjc2012130a.PMC3341869.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/PPARgamma inhibits liver cancer metastasis B Shen et al 1494 British Journal of Cancer (2012) 106(9), 1486 – 1494 &2012 Cancer Research UK Translational Therapeutics",Non-OADS,/arxiv_data1/oa_pdf/58/6c/bjc2012130a.PMC3341869.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG (2001) Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion.",Non-OADS,/arxiv_data1/oa_pdf/ac/c7/bjc201274a.PMC3341870.pdf
The sequence logo wasgenerated using WebLogo (http://weblogo.berkeley.edu/).,OADS,/arxiv_data1/oa_pdf/3d/c7/fimmu-02-00069.PMC3341948.pdf
"Peptides Reference Experimental HLAPredicted afﬁnity (nM)Predicted HLABlock position Pan-DENV peptide frequencyProtein A MLLALIAVL 16493038 A*02:01 10 A*02:01 2151 24.86 NS4ALLLTLLATV 16493038 A*02:01 9 A*02:01 2151 24.79 NS4ALLLGLMILL 16493038 A*02:01 14 A*02:01 2151 23.29 NS4AML VALLGAM 16493038 A*02:01 300 A*02:01 2151 25.23 NS4A Accumulated frequency: 98.17 TPEGIIPSM 7529799 B*35:01 49 B*35:01 1977 25.78 NS3TPEGIIPTL 7529799 B*35:01 345 B*35:01 1977 25.73 NS3TPEGIIPAL 7544398 B*35 108 B*35:01 1977 48.19 NS3TPEGIIPSL 7544398 B*35 836 B*35:01 1977 0.15 NS Accumulated frequency: 99.85 KYTDRKWCF 16517753 A*24 21 A*24:02 2033 23.18 NS3NYADRKWCF 16517753 A*24 32 A*24:02 2033 7 .67 NS3QYSDRRWCF 16517753 A*24 17 A*24:02 2033 24.89 NS3SYKDREWCF 16517753 A*24 18 A*24:02 2033 24.99 NS3NYADRRWCF 1 1709777 A*24 23 A*24:02 2033 17 .62 NS3 Accumulated frequency: 98.35 KPWDIIPMV 17626101 B*55:02 149 B*55:02 2828 0.04 NS5KPWDVIPMV 17626101 B*55:02 192 B*55:02 2828 51 .09 NS5KPWDVLPMV 17626101 B*55:02 158 B*55:02 2828 0.30 NS5KPWDVLPTV 17626101 B*55:02 107 B*55:02 2828 7 .53 NS5KPWDVVPMV 17626101 B*55:02 139 B*55:02 2828 38.73 NS5KPWDVVPTV 17626101 B*55:02 1 12 B*55:02 2828 1 .65 NS5 Accumulated frequency: 99.34 B FLDLPLPWT 16493038 A*02 64 A*02:01 493 50.13 EFLDLPLPWL 16493038 A*02 1 1 A*02:01 493 22.7 EFFDLPLPWT 16493038 A*02:01 13995 A*02:01 493 23.83 E Accumulated frequency: 96.66 GTSGSPIIDKK 12808447 A*1 1 17 A*1 1:01 161 1 9.36 NS3GTSGSPIVDRK 12808447 A*1 1 20 A*1 1:01 161 1 14.2 NS3GTSGSPIVDKK 12808447 A*1 1 18 A*1 1:01 161 1 2.26 NS3GTSGSPIADKK 12808447 A*1 1 22 A*1 1:01 161 1 0.04 NS3GTSGSPIVNRE 12808447 A*1 1 18023 A*1 1:01 161 1 24.97 NS3GTSGSPIINRE 12808447 A*1 1 18156 A*1 1:01 161 1 23.26 NS3GTSGSPIINRK 12808447 A*1 1 16 A*1 1:01 161 1 21 .53 NS3 Accumulated frequency: 95.62 Damm’s; Rebild National Park Society, Inc.; Inge and Jørgen Larsen’s Memorial Scholarship; Mayor Niels Albrechtsen’s Schol-arship; Danish Society of Engineers Scholarship; and OticonFoundation).SUPPLEMENTARY MATERIAL The Supplementary Material for this article can be found online athttp://www.frontiersin.org/t_cell_biology/10.3389/ﬁmmu.2011.00069/abstract REFERENCES Appay, V .",Non-OADS,/arxiv_data1/oa_pdf/3d/c7/fimmu-02-00069.PMC3341948.pdf
Encyclopedia of Life Sciences .Available at: http://www.els.net (accessed September 2009).,OADS,/arxiv_data1/oa_pdf/47/58/fimmu-02-00063.PMC3341996.pdf
Available at: http://www.oed.com/ view/Entry/95531?redirectedFrom=inﬂuenza#eid (2011).,Non-OADS,/arxiv_data1/oa_pdf/62/da/fimmu-02-00076.PMC3342000.pdf
"Available at: http://clinicaltrials.gov/ct2/show/NCT012 08506?term =IL-21&rank =11 Ident iﬁer: NCT01208506 Ozaki, K., Kikly, K., Michalovich, D., Y oung, P .",Non-OADS,/arxiv_data1/oa_pdf/c1/49/fimmu-03-00002.PMC3342005.pdf
"Available at: http://clinicaltrials.gov/ct2/show/NCT01162889?term =A TR-107&rank =1 Identiﬁer: NCT01162889 Qian, Y ., Qin, J., Cui, G., Naramura, M., Snow, E. C., W are, C. F ., Fairchild, R.L., Omori, S. A., Rickert, R. C., Scott,M., Kotzin, B. L., and Li, X.",Non-OADS,/arxiv_data1/oa_pdf/c1/49/fimmu-03-00002.PMC3342005.pdf
See: http://ebooks.adelaide.edu.au/a/aristotle/generation/.,Non-OADS,/arxiv_data1/oa_pdf/62/22/fimmu-03-00068.PMC3342039.pdf
The vaccine was developed in the 1950s and1960s for use in humans and was licensed by the FDA in 1970(http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4915a1.htm).,Non-OADS,/arxiv_data1/oa_pdf/62/22/fimmu-03-00068.PMC3342039.pdf
The structure was downloaded from database of protein structures maintained at NCBI site (http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid =68072).,OADS,/arxiv_data1/oa_pdf/38/c5/fimmu-02-00093.PMC3342094.pdf
"The yellow bar highlights the solvent exposed position of the unstructured segment T yr927–Gly945(D)the X-ray structure of type VIII collagen gC1q, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/38/c5/fimmu-02-00093.PMC3342094.pdf
"S.Prahl,“Tabulatedmolarextinctioncoefﬁcientforhemoglobininwater”(OregonMedicalLaserCenter,2007), http://omlc.ogi.edu/spectra/hemoglobin/summary.html.",OADS,/arxiv_data1/oa_pdf/45/45/1006.PMC3342179.pdf
"of Ophthalmology, University MedicalCenter ofSchleswig-Holstein, CampusKiel, Arnold-Heller-Straße 3, Kiel, Germany ∗huettmann@bmo.uni-luebeck.de http://www.bmo.uni-luebeck.de, http://www.mll.uni-luebeck.de Abstract: Visualizing retinal photocoagulation by real-time OCT measurements may considerably improve the understanding of thermally induced tissue changes and might enable a better reproducibility of the ocular laser treatment.",Non-OADS,/arxiv_data1/oa_pdf/a9/3b/1025.PMC3342180.pdf
All 23 images used in the study and their corresponding manual and automatic  segmentation data are available at http://www.duke.edu/~sf59/Chiu_BOE_2012_dataset.htm.,OADS,/arxiv_data1/oa_pdf/1b/bc/1127.PMC3342188.pdf
"“Age -Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study  (A2ASDOCT)” (2008 –2013), http://clinicaltrials.gov/ct2/show/NCT00734487   23.",Non-OADS,/arxiv_data1/oa_pdf/ac/79/927.PMC3342198.pdf
"W. Dong, “Sparsity -based Image Denoising via Dictionary Learning and Structural Clustering,”  http://www4.comp.polyu.edu.hk/~cslzhang/code.htm .",Non-OADS,/arxiv_data1/oa_pdf/ac/79/927.PMC3342198.pdf
"To encourage further  research in this area, we have made the data set and the software that we have developed for this project pu blically available at http://www.duke.edu/~sf59/Fang_BOE_2012.htm .",Non-OADS,/arxiv_data1/oa_pdf/ac/79/927.PMC3342198.pdf
"“L1-ls Toolbox,” http://www.stanford.edu/~boyd/l1_ls/ .",Non-OADS,/arxiv_data1/oa_pdf/63/1f/943.PMC3342199.pdf
"The latter was downloaded from the website “Simple Matlab  Solver for l1 - regularized Least Squares Problems,” http://www.stanford.edu/~boyd/l1_ls/, and utilized in  this study.",Non-OADS,/arxiv_data1/oa_pdf/63/1f/943.PMC3342199.pdf
"Life Technologies , “Fl uoSpheres®,” http://probes.invitrogen.com/media/spectra/data/8809h2o.txt.",OADS,/arxiv_data1/oa_pdf/a0/f2/958.PMC3342200.pdf
All operators were trained by the UC Irvine team to teach proper  measurement technique (see http://acrin.bli.uci.edu/ for training manuals and videos).,OADS,/arxiv_data1/oa_pdf/9a/75/966.PMC3342201.pdf
"References and links   1. WHO , ed., “World Malaria Report: 2010 ,” in WHO Library Cataloguing in Publication Data,   http://www.who.int/malaria/world_malaria_report_2010/en/index.html .",Non-OADS,/arxiv_data1/oa_pdf/64/88/991.PMC3342204.pdf
"2. WHO , “Microscopy Quality Assurance Manual” ( 2009 ),  http://www.searo.who.int/LinkFiles/Malaria_MalariaMicroscopyManual .",Non-OADS,/arxiv_data1/oa_pdf/64/88/991.PMC3342204.pdf
"The 14-bp Ins/Del polymorphism (rs 66554220) in the 1http://www.ebi.ac.uk/imgt/hla/T a b l e1|P atients, disease, and transplant characteristics.",Non-OADS,/arxiv_data1/oa_pdf/4f/24/fimmu-02-00074.PMC3342264.pdf
A typical example 2http://www.ncbi.nlm.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/4f/24/fimmu-02-00074.PMC3342264.pdf
"RESULTS PATIENT POPULATION AND OVERALL ASSESSMENT STRATEGY Biopsies of HPV-16 positive cervical cancer were obtained fromHLA-A ∗02 positive patients either prior to or following neoadju- vant chemotherapy with cisplatin and etoposide ( Bae et al., 2008 ), 1http://ca.expasy.org/tools/dna.html 2http://mafft.cbrc.jp/alignment/software/.",OADS,/arxiv_data1/oa_pdf/aa/e5/fimmu-02-00075.PMC3342284.pdf
"In Egypt and Aztec cul- tures urine was used to disinfect wounds and was rubbed into theskin to treat cuts and burns (Aztecs at Mixicoloro by Bernard Ortiz de Montellano, W ayne State University, USA; Available at: http://www.mexicolore.co.uk/index.php?one=azt&two=hea).In medical papyri (1550 BCE) of ancient Egypt hematuria wasdescribed using hieroglyphic symbols.",Non-OADS,/arxiv_data1/oa_pdf/e2/05/fimmu-03-00045.PMC3342332.pdf
The color of urine turns brownish due 1www.cdc.gov/parasites/schistosomiasis/gen_info/faqs.html 2http://www.who.int/mediacentre/fa ctsheets/fs115/en/index.html 3http://www.who.int/mediacent re/factsheets/fs117/en/ www.frontiersin.org March 2012 | Volume 3 | Article 45 | 1,Non-OADS,/arxiv_data1/oa_pdf/e2/05/fimmu-03-00045.PMC3342332.pdf
"Fluorescent confocal and tissue images were generatedin the University of New Mexico and Cancer Center Fluo-rescence Microscopy Shared Resource, funded as detailed onhttp://hsc.unm.edu/crtc/microscopy/Facility.html.",OADS,/arxiv_data1/oa_pdf/90/e8/fimmu-03-00046.PMC3342342.pdf
"Adenylate cyclase has been utilized to deliver Ag and induces strong CTL responses that inhibited tumor growth in animalmodels ( Fayolle et al., 1999 ) and is now being trialed in a phase I/II study in melanoma patients for its ability to induceimmunity against an A2 epitope of the melanoma-Ag tyrosinase(http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/2f/7f/fimmu-03-00013.PMC3342351.pdf
One of 1http://www.txcell.com T able 3 | Clinical trials with T reg-based cell therapy.,Non-OADS,/arxiv_data1/oa_pdf/e9/84/fimmu-03-00030.PMC3342353.pdf
"T rial Disease Methods of generation Ag-speciﬁcity In vitro induction In vitro expansion Ex vivo isolation TR1 CELLS Allo-speciﬁc ( Bacchetta et al., 2009 ) Allo-HSCT Y es No No Y es OVA-speciﬁc (http://www.txcell.com) Crohn’s disease No Y es No Y es TREG CELLS CD25highcells ( Di Ianni et al., 201 1 ) Allo-HSCT No No Y es No CD25highcells ( Brunstein et al., 2010 ) Allo-HSCT No Y es Y es No CD25highcells ( T rzonkowski et al., 2009 ) Allo-HSCT No Y es Y es No CD25highcells ( Edinger and Hoffmann, 201 1 ) Allo-HSCT No No Y es No CD25+CD127low/−cells (ClinicalT rials.gov Identiﬁer: NCT01210664)T1D No Y es Y es No www.frontiersin.org February 2012 | Volume 3 | Article 30 | 7",Non-OADS,/arxiv_data1/oa_pdf/e9/84/fimmu-03-00030.PMC3342353.pdf
"Future clinical trials planning to test the safety and efﬁcacy of T reg-based therapy in patients after allogeneic organ trans- plant (THE ONE study)2as well as in patients with autoim- mune diseases, such as type 1 diabetes (ClinicalT rials.gov Iden-tiﬁer: NCT01210664) and rheumatoid arthritis (see text footnote1) will deﬁne if T reg can suppress allograft rejection under the umbrella of immune suppression, and whether T regcan suppress self-Ag speciﬁc T cell responses, and can regulate an ongoing 2http://www.onestudy.org/immune response.",Non-OADS,/arxiv_data1/oa_pdf/e9/84/fimmu-03-00030.PMC3342353.pdf
"Available at:http://www.who.int/leishmaniasis/resources/documents/en/TDR_PRD_LEISH_V AC_01.1.pdf Dunan, S., Frommel, D., Monjour, L., Ogunkolade, B. W ., and Cruz, A, and Quilici, M. (1989).",OADS,/arxiv_data1/oa_pdf/96/b4/fimmu-03-00069.PMC3342354.pdf
"Available at:http://www.portal.saude.gov.br/portal/arquivos/pdf/manual_leish_visceral2006.pdf Miret, J., Nascimento, E., Sampaio, W ., França, J. C., Fujiwara, R. T ., V ale, A., Dias, E. S., Vieira, E., da Costa, R. T ., Mayrink, W ., CamposNeto, A., and Reed, S. (2008).",Non-OADS,/arxiv_data1/oa_pdf/96/b4/fimmu-03-00069.PMC3342354.pdf
Available at:http://www.pt.scribd.com/doc/56634570/Canileish-revista[accessed February 2011].,Non-OADS,/arxiv_data1/oa_pdf/96/b4/fimmu-03-00069.PMC3342354.pdf
Available at: http://www.who.int/leishmaniasis/en/ [accessed February 2011].,Non-OADS,/arxiv_data1/oa_pdf/96/b4/fimmu-03-00069.PMC3342354.pdf
"Avail-able at: http://clinicaltrials.gov/ct2/show/NCT01127464 Osmani, N., Peglion, F., Chavrier, P ., and Etienne-Manneville, S. (2010).Cdc42 localization and cell polaritydepend on membrane trafﬁc.",OADS,/arxiv_data1/oa_pdf/71/3f/fimmu-03-00037.PMC3342355.pdf
"The need for a broadly pro- tective inﬂuenza vaccine is clearly demonstrated by the failureof seasonal inﬂuenza vaccines to control the annual epidemicsof inﬂuenza viruses, which result in about three to ﬁve mil-lion cases of severe illness, and up to 500,000 deaths worldwide(http://www.who.int/mediacentre/fa ctsheets/fs211/en/).",Non-OADS,/arxiv_data1/oa_pdf/52/91/fimmu-03-00053.PMC3342361.pdf
References 1.http://www.cancer.gov/cancertopics/types/prostate .,Non-OADS,/arxiv_data1/oa_pdf/82/cb/520_2011_Article_1213.PMC3342489.pdf
Available at: http://www.cebm.net/index.aspx?,Non-OADS,/arxiv_data1/oa_pdf/f6/f8/520_2011_Article_1378.PMC3342492.pdf
"To view a copy of this license, visit http://creati-vecommons.org/licenses/by-nc-nd/3.0 The Supplementary Information that accompanies this paper is available on the Immunology and Cell Biology webs ite (http://www.nature.com/icb)IL-7 response heterogeneity in naı ¨ve CD8+Tc e l l s MJ Palmer et al 594 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/ce/7d/icb20115a.PMC3342499.pdf
Database URL: http://flybase.org/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction One of the key sources of data within Model Organism Databases (MODs) is the primary research literature.,OADS,/arxiv_data1/oa_pdf/66/6c/bas024.PMC3342516.pdf
"Therefore, it is essential to have a strat-egy to prioritize papers so that the fraction of papers that can be curated includes those with the data of most value to the community.At FlyBase (http://flybase.org), the MOD for Drosophila genetic and genomic information ( 2), the data types that we prioritize include genetic data (e.g.",Non-OADS,/arxiv_data1/oa_pdf/66/6c/bas024.PMC3342516.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creative-commons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/6c/bas024.PMC3342516.pdf
"six steps, which guide the user through the complete skim curation process ( Figure 2 ; http://flybase.org/submission/ publication/).",Non-OADS,/arxiv_data1/oa_pdf/66/6c/bas024.PMC3342516.pdf
"Furthermore, ORs sequences have long been 1http://www.cbs.dtu.dk/services/TMHMM/ 2http://www.enzim.hu/hmmtop 3http://salilab.org/modeller/ FIGUR E 2 | hOR17-209 TM prediction results from TMHMM.",OADS,/arxiv_data1/oa_pdf/d1/ef/fgene-03-00061.PMC3342527.pdf
5http://bioinfo.genetics.uab.edu/hydro-eff.pl 6http://www.ks.uiuc.edu/Research/vmd www.frontiersin.org May 2012 | Volume 3 | Article 61 | 3,Non-OADS,/arxiv_data1/oa_pdf/d1/ef/fgene-03-00061.PMC3342527.pdf
7http://www.gromacs.org/Downloads/Use r_contributions/Force_ﬁelds 8http://www.bevanlab.biochem.vt.edu/GridMA T-MD/ 9http://www.arguslab.com/arguslab.com/ArgusLab.html2.2.,OADS,/arxiv_data1/oa_pdf/d1/ef/fgene-03-00061.PMC3342527.pdf
The addition of ligands may require that 10http://vakser.bioinformatics.ku.edu/main/resources_gramm1.03.php Frontiers in Genetics | Bioinformatics and Computational Biology May 2012 | Volume 3 | Article 61 | 4,Non-OADS,/arxiv_data1/oa_pdf/d1/ef/fgene-03-00061.PMC3342527.pdf
"Theresults of the dynamic simulations presented in Ta b l e 1 identify 11http://vakser.bioinformatics.ku.edu/main/resources_gramm1.03.download.phpnot only the residues that are likely to bind isoamyl acetate over the course of the simulation, but also quantify these interactionsby determining the time spent in a 6-Å radius around the odorant.The residues in Ta b l e 1 are listed in decreasing order of the time spent in the vicinity of the odorant and form a more complete pic-ture of the residues participating in binding and ligand interaction.",OADS,/arxiv_data1/oa_pdf/d1/ef/fgene-03-00061.PMC3342527.pdf
"For details, we refer to the yeast cell cycle project of the Stanford Genome database(http://genome-www.stanford.edu).",OADS,/arxiv_data1/oa_pdf/71/5b/fgene-03-00071.PMC3342528.pdf
"Available at: http://bioinfogp.cnb.csic.es/tools/FIESTA Opitz, J. M. (1987).",OADS,/arxiv_data1/oa_pdf/a6/6c/fnmol-05-00058.PMC3342529.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Much Concern but Little Research on Semiconductor Occupational  Health Issues Chungsik Yoon Institute of Health and Environment, School of Public Health, Seoul National University, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2012.27.5.461  •  J Korean Med Sci 2012; 27: 461-464EDITORIAL Occupation & Environmental Medicine Emerging occupational and environmental issues in the  semiconductor industryWe humans have experienced historical lessons on the dangers of introducing new techniques and chemicals expecting bene - fits, while ignoring unexpected harmful side effects.",Non-OADS,/arxiv_data1/oa_pdf/cf/1f/jkms-27-461.PMC3342533.pdf
Yoon C  • Occupational Health Issues in the Semiconductor Industry  462  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.461cesses replace old ones before sufficient information is obtained  on health hazards (1).,Non-OADS,/arxiv_data1/oa_pdf/cf/1f/jkms-27-461.PMC3342533.pdf
"Yoon C  • Occupational Health Issues in the Semiconductor Industry  http://jkms.org   463  http://dx.doi.org/10.3346/jkms.2012.27.5.461ers and cancer of all lymphatic and hematopoietic tissues in fe - male workers was significantly elevated, but lack of individual  exposure information made it difficult to associate the cancer with particular agents (7).",Non-OADS,/arxiv_data1/oa_pdf/cf/1f/jkms-27-461.PMC3342533.pdf
"Yoon C  • Occupational Health Issues in the Semiconductor Industry  464  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.461SUGGESTION The semiconductor industry is a new industry that developed in  the late twentieth century, and the paucity of scientific evidence on occupational health and environmental issues exists in part because of the short history.",Non-OADS,/arxiv_data1/oa_pdf/cf/1f/jkms-27-461.PMC3342533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Depletion of Mitochondrial DNA Stabilizes C1qTNF-Related Protein 6 mRNA in Muscle Cells Mutation and reduction of mitochondrial DNA (mtDNA) have been suggested as factors in the pathogenesis of several metabolic diseases.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
"Received: 3 October 201 1 Accepted: 26 January 2012 Address for Correspondence: Seung-Yoon Park, MD Department of Biochemistry, Dongguk University School of  Medicine, 87 Dongdae-ro, Gyeongju 780-714, Korea Tel: +82.54-770-2421, Fax: +82.54-770-2447 E-mail: psyoon@dongguk.ac.kr This study was supported by the Basic Science Research Program  through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (201 1- 0016102) and by a grant from 21C Frontier Functional Proteomics  Project from Ministry of Education, Science and Technology  (M108KM010008-08K1301-00810).http://dx.doi.org/10.3346/jkms.2012.27.5.465  •  J Korean Med Sci 2012; 27: 465-470ORIGINAL ARTICLE Basic Medical Sciences  INTRODUCTION C1qTNF-related protein 6 (CTRP6) was initially identified as a  member of adiponectin paralogs (1).",Non-OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
"• Effect on mtDNA Depletion in CTRP6 Expression  466  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.465gen, Carlsbad, CA, USA) and appropriate antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
• Effect on mtDNA Depletion in CTRP6 Expression  http://jkms.org   467  http://dx.doi.org/10.3346/jkms.2012.27.5.465bated with 12.5 μg/mL actinomycin D to inhibit transcription.,OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
• Effect on mtDNA Depletion in CTRP6 Expression  468  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.465pared to control and reverted C2C12 cells (Fig.,OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
"• Effect on mtDNA Depletion in CTRP6 Expression  http://jkms.org   469  http://dx.doi.org/10.3346/jkms.2012.27.5.465ful tool for the investigation of various cellular changes in re - sponse to mtDNA depletion (12, 17, 18).",OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
• Effect on mtDNA Depletion in CTRP6 Expression  470  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.465ic and metabolic stress: a novel mode of inter-organelle crosstalk.,OADS,/arxiv_data1/oa_pdf/86/e8/jkms-27-465.PMC3342534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii  Bacteremia: Impact of Appropriate  Antimicrobial Therapy This study investigated predictors associated with 14-day mortality, and focused especially on the impact of appropriate antimicrobial treatment among patients with carbapenem-resistant  Acinetobacter baumannii (CRAB) bacteremia.",Non-OADS,/arxiv_data1/oa_pdf/74/2e/jkms-27-471.PMC3342535.pdf
"Key Words:  Acinetobacter baumannii ; Risk Factors; Carbapenem-Resistance; MortalityYoun Jeong Kim1, Sang Il Kim1,  Kyung-Wook Hong1, Yang Ree Kim1,  Yeon Joon Park2, and Moon-Won Kang1 Departments of 1Internal Medicine and 2Laboratory  Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea Received: 1 August 201 1 Accepted: 27 January 2012 Address for Correspondence: Yang Ree Kim, MD Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea College of Medicine,   271 Cheonbo-ro, Uijeongbu 480-717, KoreaTel: +82.31-820-3798, Fax: +82.31-847-2719E-mail: yrkim@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.471  •  J Korean Med Sci 2012; 27: 471-475ORIGINAL ARTICLE Infectious Diseases, Microbiology & Parasitology INTRODUCTION Acinetobacter baumannii is an important nosocomial pathogen  (1-6).",Non-OADS,/arxiv_data1/oa_pdf/74/2e/jkms-27-471.PMC3342535.pdf
• Carbapenem-Resistant Acinetobacter baumannii  Bacteremia 472  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.471age was adequate according to the current guidelines.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/jkms-27-471.PMC3342535.pdf
• Carbapenem-Resistant Acinetobacter baumannii  Bacteremia http://jkms.org   473  http://dx.doi.org/10.3346/jkms.2012.27.5.471tients are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/jkms-27-471.PMC3342535.pdf
"• Carbapenem-Resistant Acinetobacter baumannii  Bacteremia 474  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.471(OR 7.29, 95% CI 1.57-33.8; P= 0.01), pneumonia as a source of  bacteremia (OR 5.29, 95% CI 1.07-26.1; P= 0.04), and inappro - priate antimicrobial therapy (OR 8.05, 95% CI 1.65-39.2; P= 0.009)  were the independent risk factors for 14-day mortality (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/74/2e/jkms-27-471.PMC3342535.pdf
• Carbapenem-Resistant Acinetobacter baumannii  Bacteremia http://jkms.org   475  http://dx.doi.org/10.3346/jkms.2012.27.5.471 Results from the present study also showed that factors for  acquisition of CRAB included diabetes mellitus as an underlying  disease and a prior exposure to carbapenem.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/jkms-27-471.PMC3342535.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Comparison of Ertapenem and Ceftriaxone Therapy for Acute Pyelonephritis and Other Complicated Urinary Tract Infections in Korean Adults: A Randomized, Double-Blind, Multicenter Trial The efficacy and safety of ertapenem, 1 g once daily, were compared with that of ceftriaxone, 2 g once daily, for the treatment of adults with acute pyelonephritis (APN) and complicated urinary tract infections (cUTIs) in a prospective, multicenter, double-blinded, randomized study.",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"http://dx.doi.org/10.3346/jkms.2012.27.5.476  •  J Korean Med Sci 2012; 27: 476-483ORIGINAL ARTICLE Infectious Diseases, Microbiology & Parasitology INTRODUCTION Urinary tract infections (UTIs) are considered the most common  bacterial infections with an estimated annual global incidence of at least 250 million cases and are costly to both patients and healthcare funding systems (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  http://jkms.org   477  http://dx.doi.org/10.3346/jkms.2012.27.5.476infections, a sequential approach with initial parenteral therapy  and subsequent adequate oral agent with a more prolonged course could be considered an option as a standard therapy (9).",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  478  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.476pathogen), or new infection (urine culture after completion of  therapy grew ≥ 105 CFU/mL of a pathogen other than baseline  pathogen).",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  http://jkms.org   479  http://dx.doi.org/10.3346/jkms.2012.27.5.47651 (77.3%) and 14 (19.7%) in the ertapenem group and 62 (87.3%)  and eight (11.3%) in the ceftriaxone group were switched to cip - rofloxacin and cefixime, respectively.",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  480  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.476etiologic agent in 83 (91.2%) of these patients.,Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  http://jkms.org   481  http://dx.doi.org/10.3346/jkms.2012.27.5.476sponse rates of other complicated UTIs were lower than that of  APN in both groups.,Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  482  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.476tions, has a high degree of in vitro activity against antibiotic-re - sistant urinary isolates of Enterobacteriaceae, including ESBL- producing K. pneumoniae  and E. coli strains (27, 28), and would  be considered as the first empirical drug of choice for those sit - uations.",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
Available at http://www.fda.gov/down - loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070981.pdf [accessed on 17 September 2010].,Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"• Comparing Ertapenem and Ceftriaxone for Complicated Urinary Tract Infections  http://jkms.org   483  http://dx.doi.org/10.3346/jkms.2012.27.5.476double-blind, multicentre trials comparing ertapenem and ceftriaxone  followed by appropriate oral therapy.",Non-OADS,/arxiv_data1/oa_pdf/58/87/jkms-27-476.PMC3342536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Serum Elastin-Derived Peptides and Anti-Elastin Antibody   in Patients with Systemic Sclerosis The elastin metabolism in systemic sclerosis (SSc) has been known to be abnormal.",Non-OADS,/arxiv_data1/oa_pdf/7f/43/jkms-27-484.PMC3342537.pdf
"R31-2008-000-10103-0 from the WCU  project of the Ministry of Education, Science and Technology  and the National Research Foundation, Republic of Korea.http://dx.doi.org/10.3346/jkms.2012.27.5.484  •  J Korean Med Sci 2012; 27: 484-488ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Systemic sclerosis (SSc) is a chronic multisystem autoimmune  disease with a complex, multifactorial pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/7f/43/jkms-27-484.PMC3342537.pdf
"• S-EDP and Anti-Elastin Antibody in Systemic Sclerosis http://jkms.org   485  http://dx.doi.org/10.3346/jkms.2012.27.5.484lowing clinical information was collected: age at enrollment and  at disease onset, gender, cutaneous subset, autoantibody status (anti-centromere antibody and anti-Scl-70 antibody), modified Rodnan skin score, and major organ involvement, including the kidneys, heart, lungs, and pulmonary artery.",OADS,/arxiv_data1/oa_pdf/7f/43/jkms-27-484.PMC3342537.pdf
"• S-EDP and Anti-Elastin Antibody in Systemic Sclerosis 486  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.484RESULTS Of the 79 patients, 75 (95%) were females; 37 patients had the  limited cutaneous subtype and 42 patients the diffuse cutane - ous subtype.",Non-OADS,/arxiv_data1/oa_pdf/7f/43/jkms-27-484.PMC3342537.pdf
"• S-EDP and Anti-Elastin Antibody in Systemic Sclerosis http://jkms.org   487  http://dx.doi.org/10.3346/jkms.2012.27.5.484correlated with anti-elastin antibody in SSc patients (age, P=   0.267; disease duration, P= 0.363, by Spearman’s correlation  analysis).",OADS,/arxiv_data1/oa_pdf/7f/43/jkms-27-484.PMC3342537.pdf
• S-EDP and Anti-Elastin Antibody in Systemic Sclerosis 488  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.484files in each subtype.,Non-OADS,/arxiv_data1/oa_pdf/7f/43/jkms-27-484.PMC3342537.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Completeness of Cancer Case Ascertainment in Korea Radiation Effect and Epidemiology Cohort Study The aim of this study was to evaluate whether the completeness of case ascertainment during the follow-up of a cohort differed between the exposed and the nonexposed groups in Korea Radiation Effect and Epidemiology Cohort (KREEC).",Non-OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
"Key Words:  Cohort Studies; Data Collection; Neoplasms; ValidityMinkyo Song1, In-Seong Cho1,  Zhong Min Li2, and Yoon-Ok Ahn1,2 1Department of Preventive Medicine, Seoul National  University College of Medicine, Seoul; 2Institute of  Radiation Effect & Epidemiology, Seoul National  University Medical Research Centre, Seoul, Korea Received: 26 July 201 1 Accepted: 23 February 2012 Address for Correspondence: Yoon-Ok Ahn, MD Department of Preventive Medicine, Seoul National University  College of Medicine, 103 Daehank-ro, Jongno-gu, Seoul   1 10-799, Korea Tel: +82.2-740-8322, Fax: +82.2-747-4830 E-mail: yoahn@plaza.snu.ac.kr http://dx.doi.org/10.3346/jkms.2012.27.5.489  •  J Korean Med Sci 2012; 27: 489-494ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION In a cohort study, it is essential to balance the following up of  the selected exposed group and nonexposed group.",Non-OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
"• Completeness of Cancer Case Ascertainment 490  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.489power plants and residents living within 5 km radius, and the  nonexposed group was set at two different levels - intermediate-distance group of residents living 5-30 km away from the power plants, and far-distance group of residents living more than 30 km away from the power plants.",Non-OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
• Completeness of Cancer Case Ascertainment http://jkms.org   491  http://dx.doi.org/10.3346/jkms.2012.27.5.489 Fig.,Non-OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
• Completeness of Cancer Case Ascertainment 492  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.489Model fitting using log-linear models Table 4 illustrates the results of statistical significance of each data sources in three-source log-linear models.,OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
"• Completeness of Cancer Case Ascertainment http://jkms.org   493  http://dx.doi.org/10.3346/jkms.2012.27.5.489population (11, 13-15).",Non-OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
"• Completeness of Cancer Case Ascertainment 494  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.489Kim DS, Lee SI.",Non-OADS,/arxiv_data1/oa_pdf/17/96/jkms-27-489.PMC3342538.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prognostic Significance of Angiogenesis by Chalkley Counting   in Node Negative Cancer of the Ampulla of Vater  Angiogenesis is essential for tumor growth and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/fb/3d/jkms-27-495.PMC3342539.pdf
"Key Words:  Ampulla of Vater; Carinoma; Prognosis; Angiogenesis; Chalkley CountJoon Seong Park1, Hyun Ki Kim2,  Soon Won Hong2, Jae Keun Kim1,  and Dong Sup Yoon1 Pancreatobiliary Cancer Clinic, Departments of  1Surgery and 2Pathology, Gangnam Severance  Hospital, Yonsei University Health System, Seoul,  Korea Received: 1 September 201 1 Accepted: 1 February 2012 Address for Correspondence: Dong Sup Yoon, MD Pancreatobiliary Cancer Clinic, Department of Surgery,   Gangnam Severance Hospital, Yonsei University Health System,   612 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea Tel: +82.2-2019-2444, Fax: +82.2-3462-5994 E-mail: yds61 10@yuhs.ac This study was supported by Pharmbio Korea co., Ltd.http://dx.doi.org/10.3346/jkms.2012.27.5.495  •  J Korean Med Sci 2012; 27: 495-499ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION Carcinomas of the ampulla of Vater have a higher resection rate,  lower recurrence rate and more favorable prognosis than other malignant tumors of the periampullary region (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/fb/3d/jkms-27-495.PMC3342539.pdf
"• Angiogenesis in Ampulla of Vater Cancer 496  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.495Immunohistochemical staining The 5 μm serial sections of each block were adhered to poly-L- lysin covered slides, and incubated at 62°C for 60 min.",Non-OADS,/arxiv_data1/oa_pdf/fb/3d/jkms-27-495.PMC3342539.pdf
"• Angiogenesis in Ampulla of Vater Cancer http://jkms.org   497  http://dx.doi.org/10.3346/jkms.2012.27.5.495Survival and disease free survival analysis  For the 56 node negative patients who received radical resec - tion for ampulla of Vater cancer, the 3- and 5-yr overall survival rate were 47.2 % and 44.1%, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fb/3d/jkms-27-495.PMC3342539.pdf
"• Angiogenesis in Ampulla of Vater Cancer 498  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.495vessels, taken as the average from the assessment of three hot  spots.",OADS,/arxiv_data1/oa_pdf/fb/3d/jkms-27-495.PMC3342539.pdf
• Angiogenesis in Ampulla of Vater Cancer http://jkms.org   499  http://dx.doi.org/10.3346/jkms.2012.27.5.4955.,Non-OADS,/arxiv_data1/oa_pdf/fb/3d/jkms-27-495.PMC3342539.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Use of Serum Homocysteine to Predict Cardiovascular Disease   in Korean Men with or without Metabolic Syndrome The aim of this study was to examine whether serum homocysteine (Hcy) levels correlated with cardiovascular disease (CVD) depending on the presence or absence of metabolic syndrome (MetS) in Korean men.",Non-OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
"http://dx.doi.org/10.3346/jkms.2012.27.5.500  •  J Korean Med Sci 2012; 27: 500-505ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Traditional risk factors for cardiovascular disease (CVD), such  as diabetes mellitus, dyslipidemia, hypertension, smoking and low physical activity have been used to assess the risk of CVD (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
"• Homocysteine to Predict CVD with or without Mets http://jkms.org   501  http://dx.doi.org/10.3346/jkms.2012.27.5.500 MATERIALS AND METHODS Subjects and study design  This was a retrospective case-control study, in which 4,043 indi - viduals without pre-existing CVD between the ages of 40 to 59 yr participated in annual regular health check-ups in 2008.",Non-OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
• Homocysteine to Predict CVD with or without Mets 502  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.500 RESULTS Table 1 shows the general and clinical characteristics of the 428 study subjects (290 CVD and 138 non-CVD).,Non-OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
• Homocysteine to Predict CVD with or without Mets http://jkms.org   503  http://dx.doi.org/10.3346/jkms.2012.27.5.500 based on the presence of MetS.,OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
• Homocysteine to Predict CVD with or without Mets 504  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.500 disappeared after adjustment for other determinants of Hcy con - centrations (32).,Non-OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
• Homocysteine to Predict CVD with or without Mets http://jkms.org   505  http://dx.doi.org/10.3346/jkms.2012.27.5.500 nese: 12-year prospective cohort study.,Non-OADS,/arxiv_data1/oa_pdf/c1/71/jkms-27-500.PMC3342540.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Erythropoietin Improves Long-Term Outcomes in Patients with Acute Kidney Injury after Coronary Artery Bypass Grafting Previous studies reported the beneficial effect of erythropoietin (EPO) in acute injuries.",Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
"Key Words:  Erythropoietin; Neutrophil Gelatinase-Associated Lipocalin Protein; Mortality Se Won Oh1, Ho Jun Chin1,2,  Dong Wan Chae1,2, and Ki Young Na1,2 1Division of Nephrology, Seoul National University  Bundang Hospital, Seongnam; 2Department of  Internal Medicine, Seoul National University College  of Medicine, Seoul, Korea Received: 26 September 201 1 Accepted: 26 January 2012 Address for Correspondence: Ki Young Na, MD Department of Internal Medicine, Seoul National University  Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam   463-707, Korea Tel: +82.31-787-7014, Fax: +82.31-787-4051 E-mail: kyna@snubh.orghttp://dx.doi.org/10.3346/jkms.2012.27.5.506  •  J Korean Med Sci 2012; 27: 506-511ORIGINAL ARTICLE Nephrology INTRODUCTION Erythropoietin (EPO) is the hormone that regulates blood cell  production and is mainly produced by peritubular fibroblasts of the renal cortex and outer medulla (1).",Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
"• Erythropoietin and Mortality in Acute Kidney Injury  http://jkms.org   507  http://dx.doi.org/10.3346/jkms.2012.27.5.506randomization, chronic renal replacement therapy, uncontrolled  hypertension, known allergy or hypersensitivity to EPO, use of nephrotoxic drugs within 3 days of the planned operation or use of EPO prior to CABG were criteria for exclusion.",Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
• Erythropoietin and Mortality in Acute Kidney Injury  508  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.506higher baseline urine NGAL (4.7 [1.8-10.7] ng/mL vs 13.0 [7.9- 10.7] ng/mL) and lower eGFR (66.5 [56.5-77.9] mL/min/1.73 m2  vs 57.1 [44.7-62.2] mL/min/1.73 m2) than those without AKI  had.,Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
"• Erythropoietin and Mortality in Acute Kidney Injury  http://jkms.org   509  http://dx.doi.org/10.3346/jkms.2012.27.5.506AKI and the administration of EPO: group A, AKI in EPO group;  group B, no AKI in placebo group; group C, no AKI in EPO group; group D, AKI in placebo group.",Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
• Erythropoietin and Mortality in Acute Kidney Injury  510  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.506ing the efficacy of EPO.,Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
• Erythropoietin and Mortality in Acute Kidney Injury  http://jkms.org   51 1  http://dx.doi.org/10.3346/jkms.2012.27.5.506Med Sci 2008; 23: 484-91.,Non-OADS,/arxiv_data1/oa_pdf/d4/4a/jkms-27-506.PMC3342541.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prevalence of Dietary Supplement Use in Korean Children and Adolescents: Insights from Korea National Health and Nutrition Examination Survey 2007-2009 The purpose of this study was to estimate the prevalence of dietary supplement (DS) use in Korean children and adolescents and to examine the related factors associated with DS use from the 4th Korea National Health and Nutrition Examination Survey.",Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
"Key Words:  Dietary Supplements; Child; Adolescent; KoreanJi Ye Yoon1, Hyun Ah Park1,  Jae Heon Kang1, Kyung Woo Kim1,  Yang Im Hur1, Jin Joo Park2, Ran Lee3,  and Hyun Hye Lee1 1Department of Family Medicine, Inje University  College of Medicine, Seoul; 2Department of Internal  Medicine and Cardiovascular Center, Seoul National  University Hospital, Seoul; 3Department of  Pediatrics, Konkuk University School of Medicine, Seoul, Korea Received: 1 September 201 1 Accepted: 23 February 2012 Address for Correspondence: Hyun Ah Park, MD  Department of Family Medicine, Seoul Paik Hospital,   Inje University College of Medicine, 5 Mareunnae-gil, Jung-gu, Seoul 100-032, Korea  Tel: +82.2-2270-0952, Fax: +82.2-2267-2030 E-mail: drparkhyunah@gmail.comhttp://dx.doi.org/10.3346/jkms.2012.27.5.512  •  J Korean Med Sci 2012; 27: 512-517ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism INTRODUCTION With improvement of economic state, there are increasing inter - ests on “well-being” and how diet might influence the personal  health.",Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
• Prevalence of Dietary Supplement Use in Korean Children http://jkms.org   513  http://dx.doi.org/10.3346/jkms.2012.27.5.512descriptions of the plan and operation of the survey have been  described on the KNHANES website (http://knhanes.cdc.go.kr/).,Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
"• Prevalence of Dietary Supplement Use in Korean Children 514  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.512normal BMI rather than lean ( P= 0.43) or overweight ( P= 0.10),  obesity ( P= 0.03) after adjustment for related factors.",Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
• Prevalence of Dietary Supplement Use in Korean Children http://jkms.org   515  http://dx.doi.org/10.3346/jkms.2012.27.5.512behaviors.,Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
• Prevalence of Dietary Supplement Use in Korean Children 516  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.512eases were more likely to take DS.,Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
• Prevalence of Dietary Supplement Use in Korean Children http://jkms.org   517  http://dx.doi.org/10.3346/jkms.2012.27.5.512DS use was subjected to recall bias.,Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
Available at http://www.cdc.go.kr/ [accessed on 3 Feburary 2012].,Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
Available at http://hfoodi.kfda.go.kr/laws [accessed on 17 March 2012].,Non-OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
Available at http://www.mw.go.kr/front/mw_sch/index.jsp [accessed on 3 Feburary 2012].,OADS,/arxiv_data1/oa_pdf/1f/4f/jkms-27-512.PMC3342542.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Body Mass Index and Waist Circumference According to Glucose Tolerance Status in Korea: The 2005 Korean Health and Nutrition Examination Survey The purpose of this study was to investigate the stage of glucose intolerance in which persons showed a maximum obesity in Korea.",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"Key Words:  Body Mass Index; Waist Circumference; Diabetes Mellitus; KoreaHye Mi Kang and Dong-Jun Kim Department of Internal Medicine, Inje University  College of Medicine, Goyang, Korea  Received: 2 September 201 1 Accepted: 2 February 2012 Address for Correspondence: Dong-Jun Kim, MD Department of Internal Medicine, Ilsan-Paik Hospital   170 Juhwa-ro, Ilsanseo-gu, Goyang 41 1-706, Korea Tel: +82.31-910-7205, Fax: +82.31-913-5095 E-mail: djkim@paik.ac.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.518  •  J Korean Med Sci 2012; 27: 518-524ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism  INTRODUCTION Obesity and weight gain are associated with an increased risk of  developing diabetes (1-3).",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"• Body Mass Index, Waist Circumference, and Glucose Tolerance Status http://jkms.org   519  http://dx.doi.org/10.3346/jkms.2012.27.5.518MATERIALS AND METHODS Study population This study was based on the data obtained from the third Korea National Health and Nutrition Examination Survey (KNHANES 2005) among non-institutionalized civilians in the Republic of Korea, which was conducted by the Korean Ministry of Health  and Welfare in 2005.",OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"• Body Mass Index, Waist Circumference, and Glucose Tolerance Status 520  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.518sex.",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"• Body Mass Index, Waist Circumference, and Glucose Tolerance Status http://jkms.org   521  http://dx.doi.org/10.3346/jkms.2012.27.5.518according to an increase of FPG (WC; NFG1, 77.1 ±0.2; NFG2,  79.4±0.3; IFG1, 81.8 ±0.6; IFG2, 83.3 ±1.0; DM, 83.7 ±0.7 cm  [P for trend < 0.001]).",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"• Body Mass Index, Waist Circumference, and Glucose Tolerance Status 522  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.518tion on the diagnosis and classification of diabetes mellitus (29).",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"• Body Mass Index, Waist Circumference, and Glucose Tolerance Status http://jkms.org   523  http://dx.doi.org/10.3346/jkms.2012.27.5.518REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"• Body Mass Index, Waist Circumference, and Glucose Tolerance Status 524  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.51832.",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jkms-27-518.PMC3342543.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Diagnostic Accuracy of Notified Cases as Pulmonary Tuberculosis in Private Sectors of Korea  The diagnostic accuracy of the data reported in the Korean tuberculosis surveillance system (KTBS) has not been adequately investigated.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
"Key Words:  Tuberculosis; Diagnosis; Electronic Notification; Private Sector; KoreaIna Jeong1, Hee-Jin Kim2, Juyong Kim3,  Soo-Yeon Oh2, Jin-Beom Lee2,  Jeong Ym Bai2, and Chang-Hoon Lee4 1Department of Internal Medicine, National Medical  Center, Seoul; 2Korean Institute of Tuberculosis,  Seoul; 3Department of Rehabilitation Medicine,  Seoul National University College of Medicine,  Seoul; 4Department of Internal Medicine, Seoul  Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea  Received: 6 August 201 1 Accepted: 23 February 2012 Address for Correspondence: Chang-Hoon Lee, MD Department of Internal Medicine, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 1 10-744, Korea Tel: +82.2-2072-4743, Fax: +82.2-762-9662 E-mail: kauri670@empal.comhttp://dx.doi.org/10.3346/jkms.2012.27.5.525  •  J Korean Med Sci 2012; 27: 525-531ORIGINAL ARTICLE Respiratory Diseases INTRODUCTION Tuberculosis (TB) still remains a huge health burden worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
• Diagnostic Accuracy of Notified Pulmonary Tuberculosis 526  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.525ease due to the Mycobacterium tuberculosis  complex.,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
• Diagnostic Accuracy of Notified Pulmonary Tuberculosis http://jkms.org   527  http://dx.doi.org/10.3346/jkms.2012.27.5.525of the total patients were  M. tuberculosis  culture positive.,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
• Diagnostic Accuracy of Notified Pulmonary Tuberculosis 528  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.525of the notified new PTB patients did not have TB’.,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
"• Diagnostic Accuracy of Notified Pulmonary Tuberculosis http://jkms.org   529  http://dx.doi.org/10.3346/jkms.2012.27.5.525that patients suspected of having TB should have appropriate  specimens collected for smear and culture for M. tuberculosis  (19), smear-positive patients were 42.5% among the new PTB cases in our study, which is lower to some degree than that of global epidemiology data that showed smear-positive rate of ap - proximately 57% in 2008 (1).",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
• Diagnostic Accuracy of Notified Pulmonary Tuberculosis 530  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.525for sputum tests.,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
• Diagnostic Accuracy of Notified Pulmonary Tuberculosis http://jkms.org   531  http://dx.doi.org/10.3346/jkms.2012.27.5.525Project.,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/jkms-27-525.PMC3342544.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Longitudinal Study on Trace Mineral Compositions (Selenium, Zinc, Copper, Manganese) in Korean Human Preterm Milk  We measured selenium, zinc, copper and manganese concentrations in the human milk of Korean mothers who gave birth to preterm infants, and compared these measurements with the recommended daily intakes.",Non-OADS,/arxiv_data1/oa_pdf/c4/c2/jkms-27-532.PMC3342545.pdf
"Key Words:  Preterm; Milk, Human; Selenium; Zinc; Copper; ManganeseSeung-Yeon Kim1, Jung Hwa Park2,  Ellen Ai-Rhan Kim3,  and Yang Cha Lee-Kim4 1Department of Pediatrics, Eulji University College  of Medicine, Daejeon; 2Research Institute of Food &  Nutritional Sciences, Yonsei University, Seoul;  3Department of Pediatrics, University of Ulsan  College of Medicine, Seoul; 4Department of Food &  Nutrition, Yonsei University, Seoul, KoreaReceived: 26 October 201 1 Accepted: 13 February 2012 Address for Correspondence: Ellen Ai-Rhan Kim, MD Department of Pediatrics, Division of Neonatology, Asan Medical Center Children’s Hospital, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  KoreaTel:+82.2-3010-3382, Fax: +82.2-3010-6978E-mail: arkim@amc.seoul.kr This study was supported by a grant (2004-2005) from the Asan  Institute for Life Sciences, Seoul, Korea.http://dx.doi.org/10.3346/jkms.2012.27.5.532  •  J Korean Med Sci 2012; 27: 532-536ORIGINAL ARTICLE Pediatrics INTRODUCTION Human milk is the most appropriate nutrition for newborn in - fants, and breast feeding provides many well-known benefits to  infants and mothers (1-5).",Non-OADS,/arxiv_data1/oa_pdf/c4/c2/jkms-27-532.PMC3342545.pdf
"• Trace Mineral Compositions in Korean Human Preterm Milk http://jkms.org   533  http://dx.doi.org/10.3346/jkms.2012.27.5.532 Samples were diluted 10-fold, diluted 100-fold, and diluted  1,000-fold for the measurement of the selenium (Se) and cop - per (Cu), the manganese (Mn), and zinc (Zn), respectively.",Non-OADS,/arxiv_data1/oa_pdf/c4/c2/jkms-27-532.PMC3342545.pdf
• Trace Mineral Compositions in Korean Human Preterm Milk 534  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.532tion of 0.9-4.1 μg/100 kcal (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/c2/jkms-27-532.PMC3342545.pdf
• Trace Mineral Compositions in Korean Human Preterm Milk http://jkms.org   535  http://dx.doi.org/10.3346/jkms.2012.27.5.532these minerals due to the lower volume of milk intake in their  early life (26).,Non-OADS,/arxiv_data1/oa_pdf/c4/c2/jkms-27-532.PMC3342545.pdf
• Trace Mineral Compositions in Korean Human Preterm Milk 536  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.53217.,Non-OADS,/arxiv_data1/oa_pdf/c4/c2/jkms-27-532.PMC3342545.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prevalence and Risk Factors of Early-Stage Age-Related Macular Degeneration in Patients Examined at a Health Promotion Center in Korea We evaluated the prevalence and risk factors for early age-related macular degeneration (AMD) in Koreans 50 yr of age or older who were examined at a single health promotion center.",Non-OADS,/arxiv_data1/oa_pdf/14/0b/jkms-27-537.PMC3342546.pdf
"Key Words:  Age-Related Macular Degeneration; Gealth Screening Examination; Risk FactorsByung Gil Moon1, Soo Geun Joe1,  Jong-uk Hwang1, Hong Kyu Kim2,  Jaewon Choe2, and Young Hee Yoon1 1Department of Ophthalmology, 2Health Promotion  Center, University of Ulsan College of Medicine,  Asan Medical Center, Seoul, Korea Received: 6 July 201 1 Accepted: 9 February 2012 Address for Correspondence: Young Hee Yoon, MD Department of Ophthalmology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil,   Songpa-gu, Seoul 138-736, KoreaTel: +82.2-3010-3680, Fax: +82.2-640-4770E-mail: yhyoon@amc.seoul.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.537  •  J Korean Med Sci 2012; 27: 537-541ORIGINAL ARTICLE Ophthalmology INTRODUCTION Age-related macular degeneration (AMD) is the main cause of  blindness in elderly patients in the USA and Asia (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/14/0b/jkms-27-537.PMC3342546.pdf
"• Risk Factors for Age-Related Macular Degeneration 538  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.537the health promotion facility of the Asan Medical Center (Uni - versity of Ulsan College of Medicine, Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/14/0b/jkms-27-537.PMC3342546.pdf
• Risk Factors for Age-Related Macular Degeneration http://jkms.org   539  http://dx.doi.org/10.3346/jkms.2012.27.5.537 The mean uncorrected distant visual acuity (LogMAR value)  was 0.19 ±0.23/0.19 ±0.24 (right/left eye) in the early AMD group  and 0.15 ±0.22/0.16 ±0.21 in the control group.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/jkms-27-537.PMC3342546.pdf
"• Risk Factors for Age-Related Macular Degeneration 540  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.537DISCUSSION  In the present retrospective population-based study, we evalu - ated the prevalence and type of, and risk factors for, develop - ment of early AMD in a relatively healthy, middle-aged, middle- class urban population of Koreans.",Non-OADS,/arxiv_data1/oa_pdf/14/0b/jkms-27-537.PMC3342546.pdf
• Risk Factors for Age-Related Macular Degeneration http://jkms.org   541  http://dx.doi.org/10.3346/jkms.2012.27.5.537this is a limitation of our risk factor analysis.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/jkms-27-537.PMC3342546.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Ocular Manifestations of Acquired Immunodeficiency Syndrome in Korea The clinical features of HIV/AIDS-related ocular manifestations in Korean patients were investigated in this study.",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
"Key Words:  Acquired Immunodeficiency Syndrome; HIV; Cytomegalovirus RetinitisSang Jin Kim1*, Sang Jun Park1,  Hyeong Gon Yu1,3, Nam Joong Kim2,  Hee-Chang Jang2, and Myoung-don Oh2 Departments of 1Ophthalmology and 2Internal  Medicine, Seoul National University College of  Medicine, Seoul; 3Sensory Organ Research Institute,  Seoul National University Medical Research Center, Seoul, Korea *Present address: Department of Ophthalmology,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Received: 22 October 201 1 Accepted: 26 January 2012 Address for Correspondence: Hyeong Gon Yu, MD Department of Ophthalmology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul   1 10-744, KoreaTel: +82.2-2072-2438, Fax: +82.2-741-3187 E-mail: hgonyu@snu.ac.kr http://dx.doi.org/10.3346/jkms.2012.27.5.542  •  J Korean Med Sci 2012; 27: 542-546ORIGINAL ARTICLE Ophthalmology INTRODUCTION The number of patients with the human immunodeficiency    virus (HIV) has been steadily increasing in Korea since the first reported case in 1985 (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
"• Ocular Manifestations of AIDS in Korea http://jkms.org   543  http://dx.doi.org/10.3346/jkms.2012.27.5.542tients presented with cotton-wool spots located in the posterior  pole, retinal hemorrhages, microanerurysms, and telengiectatic vessels (6).",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
• Ocular Manifestations of AIDS in Korea 544  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.542sented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
"• Ocular Manifestations of AIDS in Korea http://jkms.org   545  http://dx.doi.org/10.3346/jkms.2012.27.5.542affected between 20% and 40% of patients with AIDS (3, 7, 18,  19).",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
Available at http://www.cdc.go.kr/phwr [accessed on 1 June 2011].,Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
• Ocular Manifestations of AIDS in Korea 546  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.542system for HIV infection and expanded surveillance case definition for  AIDS among adolescents and adults.,Non-OADS,/arxiv_data1/oa_pdf/2b/d7/jkms-27-542.PMC3342547.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Hepatic Ischemic Preconditioning Provides Protection Against Distant Renal Ischemia and Reperfusion Injury in Mice We previously demonstrated that there are acute and delayed phases of renal protection against renal ischemia and reperfusion (IR) injury with renal ischemic preconditioning (IPC).",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
"Key Words:  Cytoprotective Proteins; Ischemic Preconditioning (IPC); Ischemia and  Reperfusion (IR) Injury; Proinflammatory Cytokines Jung Ah Lee, Jin Woo Choi,   Jang Hyeok In, Hong Soo Jung,   Yong Shin Kim, Yeon Soo Jeon,   Yoo Jin Kang, Dae Woo Kim,   Yong Gul Lim, Jae Hee Park,   and Jin Deok Joo   Department of Anesthesiology and Pain Medicine,  Saint Vincent Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea Received: 6 May 201 1 Accepted: 17 October 201 1 Address for Correspondence: Jin-Deok Joo, MD  Department of Anesthesiology and Pain Medicine, Saint Vincent Hospital, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, KoreaTel: +82.31-249-7212, Fax: +82.31-258-4212 E-mail: joojd@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.547  •  J Korean Med Sci 2012; 27: 547-552ORIGINAL ARTICLE Anesthesiology & Pain INTRODUCTION Renal ischemia and reperfusion (IR) injury is a major cause of  acute kidney injury during the perioperative period, and occurs frequently after aortovascular surgery or kidney transplantation (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
"• Renal Protection by Hepatic Ischemic Preconditioning 548  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.547line laparotomy and intraperitoneal application of 20 U of hep - arin, all mice had a right nephrectomy and dissection of the left  renal and hepatic pedicle.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
• Renal Protection by Hepatic Ischemic Preconditioning http://jkms.org   549  http://dx.doi.org/10.3346/jkms.2012.27.5.547Extended PCR products were quantified using Gel DocTM XR  (BioRad) after 2.0% agarose gel electrophoresis and staining with ethidium bromide dye.,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
"• Renal Protection by Hepatic Ischemic Preconditioning 550  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.547Protective effects against renal IR injury of hepatic IPC As expected, serum creatinine at 24 hr after reperfusion was sig - nificantly elevated in group II (IR, 2.7 ±0.6 mg/dL; n = 8; P<  0.001) and group IV (MPG - IPC + IR, 2.2 ±0.5 mg/dL; n = 8; P<   0.001) compared with group I (sham operation, 0.4 ±0.1 mg/dL;  n = 8) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
• Renal Protection by Hepatic Ischemic Preconditioning http://jkms.org   551  http://dx.doi.org/10.3346/jkms.2012.27.5.547DISCUSSION Acute kidney injury frequently results from renal IR injury and  is a major contributor to morbidity and mortality during the peri - operative period.,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
• Renal Protection by Hepatic Ischemic Preconditioning 552  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.547mice (group IV).,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/jkms-27-547.PMC3342548.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Unusual Primary Peritonitis due to Streptococcus pyogenes   in a Young Healthy Woman We describe the first case of primary peritonitis in Korea of a healthy person due to Streptococcus pyogenes .",Non-OADS,/arxiv_data1/oa_pdf/cb/36/jkms-27-553.PMC3342549.pdf
"Key Words:  Peritonitis, Primary; Streptococcus pyogenesJi Yoon Park1, Soo-youn Moon1,  Jun Seong Son1, Mi Suk Lee1,  and Min-Hyung Jung2 1Division of Infectious Diseases, Department of  Internal Medicine and 2Department of Obstetrics  and Gynecology, Kyung Hee University School of  Medicine, Seoul, Korea  Received: 4 August 201 1 Accepted: 21 January 2012 Address for Correspondence: Mi Suk Lee, MD Division of Infectious Diseases, Department of Internal Medicine,  Kyung Hee University School of Medicine, 45 Kyungheedae-gil, Dongdaemun-gu, Seoul 130-701, Korea Tel: +82.2-958-1634, Fax: +82.2-968-1848 E-mail: mslee@khmc.or.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.553  •  J Korean Med Sci 2012; 27: 553-555CASE REPORT Infectious Diseases, Microbiology & Parasitology INTRODUCTION Primary peritonitis constitutes less than 1% of peritonitis and  spontaneous bacterial peritonitis usually occurs in patients with comorbid conditions.",Non-OADS,/arxiv_data1/oa_pdf/cb/36/jkms-27-553.PMC3342549.pdf
• Primary Peritonitis due to Streptococcus pyogenes 554  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.553(Fig.,Non-OADS,/arxiv_data1/oa_pdf/cb/36/jkms-27-553.PMC3342549.pdf
• Primary Peritonitis due to Streptococcus pyogenes http://jkms.org   555  http://dx.doi.org/10.3346/jkms.2012.27.5.553REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cb/36/jkms-27-553.PMC3342549.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Hyperammonemia in a Patient with Late-Onset Ornithine Carbamoyltransferase Deficiency Ornithine carbamoyltransferase (OTC) deficiency is a urea cycle disorder that causes the accumulation of ammonia, which can lead to encephalopathy.",Non-OADS,/arxiv_data1/oa_pdf/2b/90/jkms-27-556.PMC3342550.pdf
"Key Words:  Ornithine Carbamoyltransferase Deficiency; Urea Cycle Disorder;  Hyperammonemia; HemodialysisDae Eun Choi, Kang Wook Lee,   Young Tai Shin, and Ki Ryang Na Department of Internal Medicine, Chungnam  National University Hospital, Daejeon, Korea Received: 15 September 201 1 Accepted: 26 January 2012 Address for Correspondence: Ki Ryang Na, MD Department of Internal Medicine, Chungnam National  University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon   301-721, KoreaTel: +82.42-280-7142, Fax: +82.42-280-7995 E-mail: drngr@cnu.ac.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.556  •  J Korean Med Sci 2012; 27: 556-559CASE REPORT Nephrology INTRODUCTION The amino acid products of endogenous and exogenous pro - tein digestion are degraded by hepatic transamination and oxi - dative deamination to produce ammonia.",Non-OADS,/arxiv_data1/oa_pdf/2b/90/jkms-27-556.PMC3342550.pdf
"• Hyperammonemia as Late-Onset Ornithine Carbamoyltransferase Deficiency http://jkms.org   557  http://dx.doi.org/10.3346/jkms.2012.27.5.556were 17.7 mg/dL and 1.01 mg/dL, respectively.",Non-OADS,/arxiv_data1/oa_pdf/2b/90/jkms-27-556.PMC3342550.pdf
"• Hyperammonemia as Late-Onset Ornithine Carbamoyltransferase Deficiency 558  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.556tomatic until much later in life were almost always heterozygotes  and symptom onset coincided with a precipitating factor such as infection, trauma, sodium valproate, surgery, childbirth, phys - iological stress or, as in our patient, excess protein intake (8, 9).",Non-OADS,/arxiv_data1/oa_pdf/2b/90/jkms-27-556.PMC3342550.pdf
• Hyperammonemia as Late-Onset Ornithine Carbamoyltransferase Deficiency http://jkms.org   559  http://dx.doi.org/10.3346/jkms.2012.27.5.556correlation with the clinical and biochemical phenotype.,Non-OADS,/arxiv_data1/oa_pdf/2b/90/jkms-27-556.PMC3342550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Rare Case of Primary Hyperparathyroidism Associated with Primary Aldosteronism, Hürthle Cell Thyroid Cancer and Meningioma  Multiple endocrine neoplasia type 1 (MEN1) syndrome includes varying combinations of endocrine and non-endocrine tumors.",Non-OADS,/arxiv_data1/oa_pdf/ae/4f/jkms-27-560.PMC3342551.pdf
"Key Words:  Hyperparathyroidism; Primary Hyperaldosteronism; Thyroid Cancer, Hürthle- cell; MeningiomaYou Lim Kim1, Young Woo Jang1,  Jin Taek Kim1, Su Ah Sung1,  Tae Seok Lee2, Won Mi Lee3,  and Hyo Jeong Kim1 Departments of 1Internal Medicine, 2General  Surgery, and 3Pathology, Eulji University School of  Medicine, Seoul, KoreaReceived: 30 October 201 1 Accepted: 26 January 2012 Address for Correspondence: Hyo Jeong Kim, MD Department of Internal Medicine, Division of Endocrinology and Metabolism, Eulji University School of Medicine, Eulji General Hospital, 14 Hangeulbiseok-gil, Nowon-gu, Seoul 139-872,  Korea Tel: +82.2-970-8558, Fax: +82.2-970-8227 E-mail: kimhj@eulji.ac.krhttp://dx.doi.org/10.3346/jkms.2012.27.5.560  •  J Korean Med Sci 2012; 27: 560-564CASE REPORT Endocrinology, Nutrition & Metabolism INTRODUCTION Multiple endocrine neoplasia type 1 (MEN1) syndrome is an  autosomal dominant inherited disorder, which predisposes pa - tients to the development of varying combinations of endocrine and non-endocrine tumors (1).",Non-OADS,/arxiv_data1/oa_pdf/ae/4f/jkms-27-560.PMC3342551.pdf
"• Atypical Combinations of MEN1-like Phenotype  http://jkms.org   561  http://dx.doi.org/10.3346/jkms.2012.27.5.560 When she visited the Department of Endocrinology due to  hypercalcemia, she had taken spironolactone for 2 yr, maintain - ing a normal potassium level.",Non-OADS,/arxiv_data1/oa_pdf/ae/4f/jkms-27-560.PMC3342551.pdf
• Atypical Combinations of MEN1-like Phenotype  562  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.560MEN1-related tumor (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/4f/jkms-27-560.PMC3342551.pdf
• Atypical Combinations of MEN1-like Phenotype  http://jkms.org   563  http://dx.doi.org/10.3346/jkms.2012.27.5.560tested this using genomic DNA from peripheral blood leuko - cytes.,Non-OADS,/arxiv_data1/oa_pdf/ae/4f/jkms-27-560.PMC3342551.pdf
• Atypical Combinations of MEN1-like Phenotype  564  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.5608.,Non-OADS,/arxiv_data1/oa_pdf/ae/4f/jkms-27-560.PMC3342551.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Two Novel Insulin Receptor Gene Mutations in a Patient with Rabson-Mendenhall Syndrome: The First Korean Case Confirmed by Biochemical, and Molecular Evidence Rabson-Mendenhall syndrome (RMS) is a rare syndrome manifested by extreme insulin resistance with hyperinsulinemia, acanthosis nigricans, tooth dysplasia and growth retardation.",Non-OADS,/arxiv_data1/oa_pdf/ff/7b/jkms-27-565.PMC3342552.pdf
"Received: 6 May 201 1 Accepted: 1 February 2012 Address for Correspondence: Dong-Kyu Jin, MD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-3525, Fax: +82.2-3410-0043 E-mail: jindk@skku.eduhttp://dx.doi.org/10.3346/jkms.2012.27.5.565  •  J Korean Med Sci 2012; 27: 565-568CASE REPORT Pediatrics INTRODUCTION The human insulin receptor is a heterotetramer consisting of  two extracellular α subunits and two transmembranous and in - tracellular β subunits.",Non-OADS,/arxiv_data1/oa_pdf/ff/7b/jkms-27-565.PMC3342552.pdf
"• Insulin Receptor Gene Mutations in a Patient with Rabson-Mendenhall Syndrome 566  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.5658 months due to pigmentations on skin-folded areas, gingival  hyperplasia, and hirsutism, on 28 December 1999.",Non-OADS,/arxiv_data1/oa_pdf/ff/7b/jkms-27-565.PMC3342552.pdf
"• Insulin Receptor Gene Mutations in a Patient with Rabson-Mendenhall Syndrome http://jkms.org   567  http://dx.doi.org/10.3346/jkms.2012.27.5.565authors were used for amplification of all coding exons and their  flanking intronic sequences of the INSR  gene by polymerase  chain reaction using a thermal cycler (Model 9700; Applied Bio - systems, Foster City, CA, USA).",OADS,/arxiv_data1/oa_pdf/ff/7b/jkms-27-565.PMC3342552.pdf
• Insulin Receptor Gene Mutations in a Patient with Rabson-Mendenhall Syndrome 568  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.5655.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/jkms-27-565.PMC3342552.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Pseudotumor of the Omentum Associated with Migration of the Ingested Crab-Leg Foreign body ingestion is not uncommon in clinical practice, and it may occasionally lead to penetration injuries.",Non-OADS,/arxiv_data1/oa_pdf/e0/12/jkms-27-569.PMC3342553.pdf
"Key Words:  Foreign Bodies; Crab; Perforation; Stomach; Pseudotumor Han-Jin Cho, Su-Jin Kim, Sung Woo Lee,  Sung Woo Moon, and Jong Hak Park Department of Emergency Medicine, Korea University College of Medicine, Seoul, Korea Received: 7 July 201 1 Accepted: 13 February 2012 Address for Correspondence: Su-Jin Kim, MD Department of Emergency Medicine, Korea University Anam  Hospital, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82.2-920-5408, Fax: +82.2-920-5629 E-mail: icarusksj@nate.comhttp://dx.doi.org/10.3346/jkms.2012.27.5.569  •  J Korean Med Sci 2012; 27: 569-571CASE REPORT Emergency & Critical Care Medicine INTRODUCTION Most of ingested foreign bodies pass through the gastrointesti - nal tract uneventfully within a week.",Non-OADS,/arxiv_data1/oa_pdf/e0/12/jkms-27-569.PMC3342553.pdf
• Pseudotumorous Omental Lesion with Crab-Leg Ingestion 570  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.569defined infiltration of the surrounding omentum.,Non-OADS,/arxiv_data1/oa_pdf/e0/12/jkms-27-569.PMC3342553.pdf
"• Pseudotumorous Omental Lesion with Crab-Leg Ingestion http://jkms.org   571  http://dx.doi.org/10.3346/jkms.2012.27.5.569ed foreign bodies perforate the gastrointestinal tract, and most  foreign bodies pass through the gastrointestinal tract within one week without any complications.",Non-OADS,/arxiv_data1/oa_pdf/e0/12/jkms-27-569.PMC3342553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Protective Effect of Sauchinone Against Regional Myocardial Ischemia/Reperfusion Injury: Inhibition of p38 MAPK and JNK Death Signaling Pathways  Sauchinone has been known to have anti-inflammatory and antioxidant effects.",Non-OADS,/arxiv_data1/oa_pdf/0b/3f/jkms-27-572.PMC3342554.pdf
http://dx.doi.org/10.3346/jkms.2012.27.5.572  •  J Korean Med Sci 2012; 27: 572-575BRIEF COMMUNICATION Cardiovascular Disorders A myocardial ischemia/reperfusion (I/R) injury is a complex  process involving the generation and release of reactive oxygen  species and inflammatory cytokines (1).,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/jkms-27-572.PMC3342554.pdf
• Sauchinone and Cardioprotection http://jkms.org   573  http://dx.doi.org/10.3346/jkms.2012.27.5.572cally ventilated with an air-oxygen mixture.,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/jkms-27-572.PMC3342554.pdf
"• Sauchinone and Cardioprotection 574  http://jkms.org  http://dx.doi.org/10.3346/jkms.2012.27.5.572been supported by the observations in which an inhibition of  p38 activation reduced the caspase-3 activity and protected car - diac myocytes following I/R insult in vitro (13), and improved postischemic cardiac function in vivo (14).",Non-OADS,/arxiv_data1/oa_pdf/0b/3f/jkms-27-572.PMC3342554.pdf
• Sauchinone and Cardioprotection http://jkms.org   575  http://dx.doi.org/10.3346/jkms.2012.27.5.5722.,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/jkms-27-572.PMC3342554.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 http://dx.doi.org/10.3346/jkms.2012.27.5.576  •  J Korean Med Sci 2012; 27: 576-577CORRESPONDENCE Letter to the Editor Detection of EML4-ALK  and Other  ALK Fusion Genes in Lung  Cancer: A Lesson from the Leukemia Fusion Gene Analysis and Future Application Tae Sung Park1, You La Jeon1, Hee Joo Lee1, Jae-Heon Jeong2, Si Young Kim2, Eun Hae Cho3, Rolf Marschalek4, and Claus Meyer4  1Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul; 2Department of Hematology-Oncology, School of Medicine, Kyung Hee University,  Seoul; 3Green Cross Reference Laboratory, Yongin, Korea; 4Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia, Goethe-University of  Frankfurt, Biocenter, Max-von-Laue-Str.",Non-OADS,/arxiv_data1/oa_pdf/03/72/jkms-27-576.PMC3342555.pdf
"Correspondence: To the Editor http://jkms.org   577  http://dx.doi.org/10.3346/jkms.2012.27.5.576kemia patients but has turned out to be informative also on solid  tumors, like e.g.",Non-OADS,/arxiv_data1/oa_pdf/03/72/jkms-27-576.PMC3342555.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 http://dx.doi.org/10.3346/jkms.2012.27.5.578  •  J Korean Med Sci 2012; 27: 578CORRESPONDENCE The Author Response EML4-ALK  Fusion Gene in Korean Non-Small Cell Lung Cancer Jae Yong Park Department of Biochemistry and Cell Biology, and Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea I would like to thank the interest and comments on our paper  entitled “ EML4-ALK fusion gene in Korean non-small cell lung  cancer” (1).",Non-OADS,/arxiv_data1/oa_pdf/e0/12/jkms-27-578.PMC3342556.pdf
Available at: http://www.mbl.edu/ html/BB/MMER/CIR/CirTit.,Non-OADS,/arxiv_data1/oa_pdf/54/80/fimmu-03-00096.PMC3342567.pdf
See http://icub.org/.,Non-OADS,/arxiv_data1/oa_pdf/20/8e/fnbot-06-00003.PMC3342577.pdf
"HHI TECHNICAL SETUP During the interaction we recorded: (i) both subjects’ headmotions with an HD video camera (both subjects simultane-ously by using a mirror), and by a motion capture system,(ii) the subjects’ speech, by head mounted microphones, and(iii) the gaze of the referent subject and a video of what shesees by a head mounted eye tracker (Pertech eye tracker; seehttp://www.pertech.fr; Figure 1B inset).",Non-OADS,/arxiv_data1/oa_pdf/20/8e/fnbot-06-00003.PMC3342577.pdf
"Available at: http://www.praat.org/ [retrievedJune 28, 2009].",Non-OADS,/arxiv_data1/oa_pdf/20/8e/fnbot-06-00003.PMC3342577.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/a5/srep00394.PMC3342585.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Tsutsui, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/14/a5/srep00394.PMC3342585.pdf
"URL http://www.R-project.org/ Rousseeuw, P .",Non-OADS,/arxiv_data1/oa_pdf/ce/b9/fnhum-06-00119.PMC3342588.pdf
"Parpura and A. Verkhratsky 202 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/an004e087.PMC3342593.pdf
"As a consequence we haveguest edited a special online collection for ASN NEUROentitled ‘Neuroglia–more than a nervenkitt’, which encompasses a collection of review articles along with original research papers(http://www.asnneuro.org/an/online_collection.htm).",Non-OADS,/arxiv_data1/oa_pdf/ac/85/an004e087.PMC3342593.pdf
"The emphasis has been placed on the effects thatthe two major signalling molecules, ATP and glutamate (alongwith this amino acid homoeostasis), as well as adrenergicreceptor activation have on astrocytic metabolism with anNeuroglia overview E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.203",Non-OADS,/arxiv_data1/oa_pdf/ac/85/an004e087.PMC3342593.pdf
"Parpura and A. Verkhratsky 204 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/an004e087.PMC3342593.pdf
"ASN NEURO 4(2):art:e00080.doi:10.1042/AN20110061 Received 23 March 2012/28 March 2012; accepted 29 March 2012 Published as Immediate Publication 29 March 2012, doi 10.1042/AN20120019Neuroglia overview E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.205",Non-OADS,/arxiv_data1/oa_pdf/ac/85/an004e087.PMC3342593.pdf
"Esen and others 208 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"The next day, microglia were stimulated for 24 heither with NSV or a known TLR ligand in a total volumeof 200 ml as follows: 1 610 6pfu NSV (infectious virusAlphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.209",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Esen and others 210 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Type-I IFN levels and viral titres in these experiments were measured in triplicate CNS samples collected at each time point from a single cohort of mice.Alphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.211",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Esen and others 212 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Data are representative of two separate experiments performed under identical conditions.Alphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.213",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Esen and others 214 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"The production of these mediators without or with Baf A1 treatment was measured using primary cells prepared on two separate occasions.Alphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.215",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Esen and others 216 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Table 1 NSV triggers the production of inflammatory mediators in primary microglia via multiple non-overlapping signalling pathways Mediator UNC93b1-dependent MyD88-dependent IRF7-dependentIL-12p40 ++ 2 CCL2 2 +/22 CXCL13 +++ * IFNa 22 + * Inhibitory.Alphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.217",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Esen and others 218 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"J Neurosci 24:7566–7575.Alphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.219",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Esen and others 220 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"Received 2 March 2012/30 March 2012; accepted 3 April 2012 Published as Immediate Publication 3 April 2012, doi 10.1042/AN20120016Alphavirus-induced microglial activation E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.221",Non-OADS,/arxiv_data1/oa_pdf/fc/da/an004e088.PMC3342594.pdf
"MATERIALS AND METHODS Image Dataset In this paper, we used the  PIDER Breast MRI dataset  (https://imaging.nci.nih.gov/ncia).",OADS,/arxiv_data1/oa_pdf/16/5d/JMSS-1-138.PMC3342621.pdf
"In  this section, as mentioned before, the performance of this  method is investigated by using PIDER Breast MRI dataset  (https://imaging.nci.nih.gov/ncia).",Non-OADS,/arxiv_data1/oa_pdf/16/5d/JMSS-1-138.PMC3342621.pdf
"Version 2.10: Aug 12, 2004 3:58 pm GMT-5, available  from: http://cnx.org/content/m10055/2.10/.",Non-OADS,/arxiv_data1/oa_pdf/54/9f/JMSS-1-130.PMC3342623.pdf
Available from: http://www.sleepapnea.org/assets/files/pdf/ESS%20 PDF%201990-97.pdf [Last accessed on 2011 Sept 26].,Non-OADS,/arxiv_data1/oa_pdf/54/9f/JMSS-1-130.PMC3342623.pdf
Available from: http://www.nihroadmap.nih.gov/ interdisciplinary/index.asp.,OADS,/arxiv_data1/oa_pdf/c2/aa/JMSS-1-89.PMC3342625.pdf
Author reply: (JMSS_1_11R4) It’s OK. Thanks.Javanmard and Rabbani: Interdisciplinary researches in Iran Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/c2/aa/JMSS-1-89.PMC3342625.pdf
Apparatus and procedure The stimuli were presented on a color VGA monitor driven by a Pentium-class microcomputer running DirectRT software (http://www.empirisoft.com/DirectRT.aspx).,OADS,/arxiv_data1/oa_pdf/3f/8b/fnhum-06-00113.PMC3342677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"2 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"hEkata (Gabon) and Mbomo (RoC).Dead or alive: animal sampling Ebola outbreaks Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"4 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"bStudy counted both Mops condylurus and Hiposideros gigas .Dead or alive: animal sampling Ebola outbreaks Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"6 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"Similarly only carcasses of a few species have been tested.Dead or alive: animal sampling Ebola outbreaks Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9988180.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.bucknell.edu/msw3.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/16319873.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"8 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9988178.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9988154.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18176937.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19649327.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15757552.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21571728.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
Available from: http://digitalcommons.unl.edu/usgsnpwrc/225.,Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"*Damien O. Joly Wildlife Health Program Wildlife Conservation Society 900 Fifth Street, Building 373Nanaimo, BC V9R 5S5Canada Tel:/C271 917 512 2890 Fax:/C271 250 483 6475 Email: djoly@wcs.orgDead or alive: animal sampling Ebola outbreaks Citation: Emerg Health Threats J 2012, 5: 9134 - http://dx.doi.org/10.3402/ehtj.v5i0.9134 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/96/af/EHTJ-5-9134.PMC3342678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
"2 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
"There are a number of filters that were used asArsenic mitigation and Bangladesh Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
"4 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
"Arsenic mitigation efforts should be con- sidered as an ongoing priority issue in Bangladesh.Arsenic mitigation and Bangladesh Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
"6 (page number not for citation purpose)Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
"*Mahfuzar Rahman Department of EpidemiologyMailman School of Public HealthColumbia University, NY 10032 USA Email: mr2640@columbia.eduArsenic mitigation and Bangladesh Citation: Emerg Health Threats J 2012, 5: 7269 - http://dx.doi.org/10.3402/ehtj.v5i0.7269 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f2/29/EHTJ-5-7269.PMC3342680.pdf
Available  form: http://www.moffitt.org/moffittapps/ccj/v2n6/article3.html [ l ast accessed on 2011 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/61/0e/IJMPO-32-125.PMC3342717.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/61/0e/IJMPO-32-125.PMC3342717.pdf
5. common terminology criteria for Adverse events (ctcAe)  v4.0 available from: https://cabig.nci.nih.gov/workspaces/VcDe/workspaces/VcDe/ctcAe [last accessed on 2010  Dec 05].,Non-OADS,/arxiv_data1/oa_pdf/2c/97/IJMPO-32-139.PMC3342719.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/34/5a/IJMPO-32-143.PMC3342720.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/71/8d/IJMPO-32-165.PMC3342726.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/d8/4c/IJMPO-32-183.PMC3342732.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/d8/4c/IJMPO-32-183.PMC3342732.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b0/20/IJMPO-32-184.PMC3342733.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/b0/20/IJMPO-32-184.PMC3342733.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/PC-2-15.PMC3342743.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/PC-2-15.PMC3342743.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/58/16/PC-2-21.PMC3342744.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/db/7d/PC-2-28.PMC3342745.pdf
"Predicted GM and other parameters by county in the U.S. http://eande.lbl.gov/IEP/high- radon/files.html Date last accessed: May 20, 2010.",OADS,/arxiv_data1/oa_pdf/00/5a/erj-39-05-1113.PMC3342765.pdf
"This is an Open  Access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/78/111536.PMC3342783.pdf
Information for commercial entities is available online ( http://www.chestpubs.org/site/misc/reprints.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1c/78/111536.PMC3342783.pdf
http://www.goldcopd.org.,Non-OADS,/arxiv_data1/oa_pdf/1c/78/111536.PMC3342783.pdf
Additional information:  The e-Figures and e-Table can be found  in the Online Supplement at http://chestjournal.chestpubs.org/content/141/5/1233/suppl/DC1.,Non-OADS,/arxiv_data1/oa_pdf/1c/78/111536.PMC3342783.pdf
"LSE Research Online, http://eprints.lse.ac.uk/ 523/1/Audit-SocialWork_05.pdf.",Non-OADS,/arxiv_data1/oa_pdf/75/3c/biosoc201026a.PMC3342788.pdf
"1, http://www.york.ac.uk/res/sci/projects/res340250001salter.htm.",Non-OADS,/arxiv_data1/oa_pdf/75/3c/biosoc201026a.PMC3342788.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Creating the ‘ethics industry’ 141 r2011 The London School of Economics and Political Science 1745-8552 BioSocieties Vol.",Non-OADS,/arxiv_data1/oa_pdf/75/3c/biosoc201026a.PMC3342788.pdf
"Development of feedstocks for cellulosic biofuels Heather Youngs* and Chris Somerville Address: Energy Biosciences Institute, University of California Berkeley, Berkeley CA 94720, USA * Corresponding author: Heather Youngs (hlyoungs@berkeley.edu) F1000 Biology Reports 2012, 4:10 (doi:10.3410/B4-10) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/4/10 Abstract The inclusion of cellulosic ethanol in the Energy Independence and Security Act (EISA) of 2007 and the revised Renewable Fuel Standard (RFS2) has spurred development of the first commercial scale cellulosic ethanol biorefineries.,Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Page 2 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"and others, Page 3 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Improving biomass yield In order to minimize the amount of land diverted fromother purposes to energy production it is essential tomaximize the “yield ”–the amount of biomass produced Page 4 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Altering root architecture may Page 5 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Conventional con-trolled crossing and screening of switchgrass has allowed identification of self-compatible and dihaploid stocks, Page 6 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Page 7 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Dohleman FG, Heaton EA, Leakey ADB, Long SP: Does greater leaf-level photosynthesis explain the larger solar energy Page 8 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Page 9 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Rae AM, Pinel MPC, Bastien C, Sabatti M, Street NR, Tucker J, Dixon C, Marron N, Dillen SY, Taylor G: QTL for yield in Page 10 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"Page 11 of 11 (page number not for citation purposes)F1000 Biology Reports 2012, 4:10 http://f1000.com/reports/b/4/10",Non-OADS,/arxiv_data1/oa_pdf/53/bd/biolrep-04-10.PMC3342825.pdf
"The immune diet: meeting the metabolic demands of lymphocyte activation Ruoning Wang and Douglas R. Green* Address: Department of Immunology, St. Jude Children ‘s Research Institute, Memphis, TN, USA * Corresponding author: Douglas R. Green (douglas.green@stjude.org) F1000 Biology Reports 2012, 4:9 (doi:10.3410/B4-9) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/b5/biolrep-04-09.PMC3342832.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/4/9 Abstract During the adaptive immune response, lymphocytes undergo dramatic changes in metabolism that accompany the proliferative burst and differentiation into functional subsets.",Non-OADS,/arxiv_data1/oa_pdf/f0/b5/biolrep-04-09.PMC3342832.pdf
"Page 2 of 5 (page number not for citation purposes)F1000 Biology Reports 2012, 4:9 http://f1000.com/reports/b/4/9",Non-OADS,/arxiv_data1/oa_pdf/f0/b5/biolrep-04-09.PMC3342832.pdf
"Page 3 of 5 (page number not for citation purposes)F1000 Biology Reports 2012, 4:9 http://f1000.com/reports/b/4/9",Non-OADS,/arxiv_data1/oa_pdf/f0/b5/biolrep-04-09.PMC3342832.pdf
"Bunpo P, Cundiff JK, Reinert RB, Wek RC, Aldrich CJ, Anthony TG: The eIF2 kinase GCN2 is essential for the murine immune Page 4 of 5 (page number not for citation purposes)F1000 Biology Reports 2012, 4:9 http://f1000.com/reports/b/4/9",Non-OADS,/arxiv_data1/oa_pdf/f0/b5/biolrep-04-09.PMC3342832.pdf
"F1000 Factor 6 Evaluated by Douglas Green 16 Apr 2012 Page 5 of 5 (page number not for citation purposes)F1000 Biology Reports 2012, 4:9 http://f1000.com/reports/b/4/9",Non-OADS,/arxiv_data1/oa_pdf/f0/b5/biolrep-04-09.PMC3342832.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/b8/evr113.PMC3342867.pdf
Supplementary Material Supplementary tables 1 and 2and ﬁgure 1 are available at Genome Biology and Evolution online ( http://www.gbe .oxfordjournals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b8/evr113.PMC3342867.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/3d/evs008.PMC3342868.pdf
"(There is, however, a small problem in retrieving some of the infor- mation: the bibliographic system in the printed text simplylists references in order of appearance, making it difﬁcultto check whether a particular author or article has been cited.This problem is partly corrected by the online referencing sys-tem, which can be found at http://shapiro.bsd.uchicago.edu/ evolution21.shtml .)",Non-OADS,/arxiv_data1/oa_pdf/8e/3d/evs008.PMC3342868.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/af/evs016.PMC3342869.pdf
"For the simulation of frequency spectra, we use the soft- ware IMaGe (see http://omnibus.uni-freiburg.de/ ;fb6/).",Non-OADS,/arxiv_data1/oa_pdf/a0/af/evs016.PMC3342869.pdf
"Available from: http://arxiv.org/abs/1105.5014 , 1–8 Borodovsky M, McIninch J.",Non-OADS,/arxiv_data1/oa_pdf/a0/af/evs016.PMC3342869.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/1e/evs018.PMC3342870.pdf
"Additional proteomes were retrieved from the JGI database ( http://www.jgi.doe.gov/ ):Populus trichocarpa (v1.1), Ostreococcus tauri andChlamydomonas reinhardtii (v3.1).",OADS,/arxiv_data1/oa_pdf/6b/1e/evs018.PMC3342870.pdf
Theremaining protein families were manually classiﬁed by se-quence similarity to known KOGs using the KOGnitor tool(http://www.ncbi.nlm.nih.gov/COG/grace/kognitor.html ).,OADS,/arxiv_data1/oa_pdf/6b/1e/evs018.PMC3342870.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/d5/evs020.PMC3342871.pdf
"Materials and Methods Data Source RNA-seq reads, generated from the modENCODE project (http://www.modencode.org/ ) from 30 developmental time points ( Graveley et al.",OADS,/arxiv_data1/oa_pdf/c5/d5/evs020.PMC3342871.pdf
"2011 ), were acquired from the NCBI Short Read Archive ( http://www.ncbi.nlm.nih.gov/sra?- term5srp001065 ).",Non-OADS,/arxiv_data1/oa_pdf/c5/d5/evs020.PMC3342871.pdf
Oligonu-cleotides for ampliﬁcation of lincRNA cDNAs were designed using E-RNAi ( http://www.dkfz.de/signaling/e-rnai3/ ).,OADS,/arxiv_data1/oa_pdf/c5/d5/evs020.PMC3342871.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/99/evs022.PMC3342872.pdf
The results ofcomparison are available online at http://esper.lab.nig.ac.jp/genome-composition-database/ .,OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
Materials and Methods Available complete genomes were collected from NCBI(http://www.ncbi.nlm.nih.gov/ ;Wheeler et al.,OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
"2007 ), Ensembl ( http://uswest.ensembl.org/ ;Flicek et al.",Non-OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
"2012 ), Uni- versity of California–Santa Cruz ( http://genome.ucsc.edu/ ; Fujita et al.",OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
"2012 ), and WormBase ( http://www.wormbase.org/ ; Harris 2010 ).",OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
Supplementary Material Supplementary ﬁgure 1 and table 1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/22/2f/evs026.PMC3342873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/fc/evs028.PMC3342874.pdf
Supplementary Material Supplementary ﬁgures S1–S4 and table S1 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/c4/fc/evs028.PMC3342874.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/b1/evs029.PMC3342875.pdf
"The strainswere mixed prior to the isolation of vRNA in the followingratios: 1:19, 1:4, 1:2, and 1:1 General Linear Models General linear models analysis of variance (ANOVA) wasconducted in Minitab version 15.0 ( http://www.minitab.",OADS,/arxiv_data1/oa_pdf/fe/b1/evs029.PMC3342875.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/70/evs030.PMC3342876.pdf
Materials and Methods Genome Sequences We retrieved all publicly available prokaryotic genomesequences and associated annotations from the Integrated Microbial Genomes (IMG) system ( http://genome.jgi-psf.,OADS,/arxiv_data1/oa_pdf/17/70/evs030.PMC3342876.pdf
Supplementary Material Supplementary ﬁgure S1 and table S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/17/70/evs030.PMC3342876.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This article also appears with doi: 10.1093/molbev/mss098, in Molecular Biology and Evolution by permission of both Editors-in-Chief.",Non-OADS,/arxiv_data1/oa_pdf/85/18/evs031.PMC3342877.pdf
The CHAP 2 package is freelyavailable from http://www.bx.psu.edu/miller_lab .,Non-OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
The new software pack- age that includes our previous CHAP tools plus this neworthology-identifying pipeline is called CHAP 2 (freely avail-able from http://www.bx.psu.edu/miller_lab ).,Non-OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
"Whereas the output of our previous CHAP package is primarily conversioncalls, the output of the CHAP 2 orthology pipeline is a set of pairwise alignments in MAF format (see http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
The DNA sequence data for these clusters are available at the ENSEMBL ( http://www.ensembl.org ) and GenBank (http://www.ncbi.nlm.nih.gov/genbank ) Web sites.,OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
Supplementary Material Supplementary material and tables S1 –S7are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
"[cited 2012 Mar 22] Available from: http://www.repeatmasker.org Song G, Hsu C, Riemer C, Miller W. 2011.",Non-OADS,/arxiv_data1/oa_pdf/bb/cc/evs032.PMC3342878.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/2c/evs033.PMC3342879.pdf
We obtained the sequences of piwiRNAs (piRNAs) forhuman from RNAdb ( http://jsm-research.imb.uq.edu.au/ rnadb/ ).,OADS,/arxiv_data1/oa_pdf/0f/2c/evs033.PMC3342879.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/58/evs034.PMC3342880.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/c5/evs038.PMC3342881.pdf
"Thus, all raw data were parsed locally using 454 Replicate Filter(http://microbiomes.msu.edu/replicates/ ) to remove these ar- tifacts.",OADS,/arxiv_data1/oa_pdf/af/c5/evs038.PMC3342881.pdf
Large contigs ( .1000 bp) were submitted to open reading frame (ORF) Finder ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/af/c5/evs038.PMC3342881.pdf
The raw data are available from the Dryad Repository: http://dx.doi.org/10.5061/dryad.83164r7v .,OADS,/arxiv_data1/oa_pdf/af/c5/evs038.PMC3342881.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/6e/evs041.PMC3342882.pdf
Recent development of Roche GS FLX Titanium DNA sequencing technology enables one to se-quence numerous DNA fragments of more than 400 bpin average size ( ;1 kbp with the latest speciﬁcation in Feb- ruary 2012) without the vector-based cloning that tends tointroduce a bias in cloned sequences ( http://454.com/ products-solutions/454-seque ncing-system- portfolio.asp ).,Non-OADS,/arxiv_data1/oa_pdf/cb/6e/evs041.PMC3342882.pdf
"Materials and Methods Identiﬁcation of OR Genes from the Anole Lizard and the Python Genome Assembly We examined the draft genomic sequences of the green anole lizard (AnoCar2.0, May 2010; http://www.ensembl.",OADS,/arxiv_data1/oa_pdf/cb/6e/evs041.PMC3342882.pdf
"2004 ,http://genome.weizmann.ac.il/ horde/ ) using the FASTA search and classiﬁed into the same family as the best-hit human OR sequence.",Non-OADS,/arxiv_data1/oa_pdf/cb/6e/evs041.PMC3342882.pdf
"Available from: http://www.issg.org/ database Katoh K, Misawa K, Kuma K, Miyata T. 2002.",OADS,/arxiv_data1/oa_pdf/cb/6e/evs041.PMC3342882.pdf
"Keywords: HIV, Rev, RRE, export, scaffold, oligomer, assembly, RNA, virus Submitted: 07/28/11 Revised: 09/20/11Accepted: 09/22/11http://dx.doi.org/10.4161/rna.9.1.18178 *Correspondence to: Alan D. Frankel; Email: frankel@cgl.ucsf.eduThe HIV-1 Rev response element (RRE) is a ~350 nucleotide, highly structured, cis-acting RNA element essen- tial for viral replication.",OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Proc Natl Acad Sci USA 1991;88:683-7; PMID:1992459; http://dx.doi.org/10.1073/ pnas.88.3.683 2.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Nature 1989; 338:254-7; PMID:2784194; http://dx.doi.org/10.1038/338254a0 6.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1989; 57: 1155-65; PMID:2736624; http://dx.doi.org/10.1016/0092-8674(89)90053-6 7.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1989;59:789-95; PMID:2686839; http://dx.doi.org/10.1016/0092-8674(89)90602-8 8.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
J Mol Biol 1994; 241:193- 207; PMID:8057359; http://dx.doi.org/10.1006/jmbi.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Science 1989; 246:1625-9; PMID: 2688093; http://dx.doi.org/10.1126/science.2688093 11.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
J Mol Biol 1997; 266:950-62; PMID:9086273; http://dx.doi.org/ 10.1006/jmbi.1996.0858 12.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Nature 1989; 342: 714-6; PMID:2556643; http://dx.doi.org/10.1038/ 342714a0 13.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Nature 1989; 342: 816-9; PMID:2481237; http://dx.doi.org/10.1038/ 342816a0 14.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Science 1990; 247:845-8; PMID:2406903; http://dx.doi.org/ 10.1126/science.2406903 15.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1990; 60:685-93; PMID:1689218; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1991; 65:241-8; PMID:2015625; http://dx.doi.org/10.1016/0092-8674(91)90158-U 18.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Characterization of HIV-1 REV protein:binding stoichiometry and minimal RNA substrate.Nucleic Acids Res 1991; 19:1577-83; PMID:2027765; http://dx.doi.org/10.1093/nar/19.7.1577 19.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1990; 60:675-83; PMID:2406030; http://dx.doi.org/10.1016/0092-8674(90)90670-A 21.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1993; 73:1031-40; PMID:7684657; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Mol Cell 2008; 31:824-34; PMID:18922466;http://dx.doi.org/10.1016/j.molcel.2008.07.016 27.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Protein Sci2008; 17:420-30; PMID:18218716; http://dx.doi.org/ 10.1110/ps.073246608 29.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Nat Struct Mol Biol 2010; 17:1337-42; PMID:20953181; http://dx.doi.org/10.1038/nsmb.1902 30.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Proc Natl Acad Sci USA 2010; 107:12481-6; PMID:20616058; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
J Virol 2001; 75: 2957-71; PMID:11222721; http://dx.doi.org/10.1128/ JVI.75.6.2957-2971.2001 36.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell2009; 136:701-18; PMID:19239890; http://dx.doi.org/10.1016/j.cell.2009.02.009 41.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Cell 1989; 58:205-14; PMID:2752419;http://dx.doi.org/10.1016/0092-8674(89)90416-9 44.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Med Res Rev 2002; 22:617- 36; PMID:12369091; http://dx.doi.org/10.1002/med.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
J Virol 2011; 85:2333-41; PMID: 21159877; http://dx.doi.org/10.1128/JVI.01518-10 47.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Genes Dev 1990; 4:1014-22; PMID:2116986; http://dx.doi.org/10.1101/ gad.4.6.1014 48.,OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
EMBO J 1999; 18:1953-65; PMID:10202158; http://dx.doi.org/10.1093/emboj/18.7.1953 50.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
Annu Rev Microbiol 1998; 52:491-532; PMID: 9891806; http://dx.doi.org/10.1146/annurev.micro.,Non-OADS,/arxiv_data1/oa_pdf/67/26/rna-9-6.PMC3342944.pdf
"One auspicious example *Correspondence to: Ulrich Hahn; Email: uli.hahn@uni-hamburg.de Submitted: 08/02/11; Revised: 09/12/11; Accepted: 09/13/11 http://dx.doi.org/10.4161/rna.9.1.18062RESEARCH PAPER RNA Biology 9:1, 67 –80; January 2012; G2012 Landes Bioscience www.landesbioscience.com RNA Biology 67",Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Expert Opin Investig Drugs 1997; 6: 237-66; PMID:15989626; http://dx.doi.org/10.1517/ 13543784.6.3.237 2.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
J Leukoc Biol 2006; 80:227-36; PMID:16707558; http://dx.doi.org/10.1189/jlb.1105674 3.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Eur J Immunol 1993; 23:473-80; PMID:8436181; http://dx.doi.org/ 10.1002/eji.1830230226 5.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Clin Pharmacol Ther 2010; 87:396-8; PMID: 20305672; http://dx.doi.org/10.1038/clpt.2010.1 6.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Science 1990; 249:505-10; PMID: 2200121; http://dx.doi.org/10.1126/science.2200121 7.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nature 1990; 346: 818-22; PMID:1697402; http://dx.doi.org/10.1038/ 346818a0 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
AnalBioanal Chem 2008; 390:1067-75; PMID:18049815;http://dx.doi.org/10.1007/s00216-007-1735-8 9.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Fold Des 1998; 3:423-31; PMID:9889155; http://dx.doi.org/10.1016/S1359-0278(98) 00059-510.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Aptamers that bind to the antibioticmoenomycin A. Bioorg Med Chem 2001; 9:2557-63; PMID:11557343; http://dx.doi.org/10.1016/S0968- 0896(01)00030-X 11.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
NucleicAcids Res 2009; 37:3094-109; PMID:19304999; http://dx.doi.org/10.1093/nar/gkp185 13.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
J Biochem 2006; 139:837-46; PMID: 16751591; http://dx.doi.org/10.1093/jb/mvj095 14.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Angew Chem Int Ed Engl 2008; 47:5190-3; PMID:18512861; http://dx.doi.org/10.1002/anie.200800216 15.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
PLoS One 2010; 5:pii: e13050; PMID:20927342; http://dx.doi.org/10.1371/journal.pone.0013050 17.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Cancer Res 2006; 66:5989-92; PMID:16778167; http://dx.doi.org/10.1158/0008-5472.CAN-05-4583 19.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nat Biotechnol 2006; 24:1005-15; PMID:16823371; http://dx.doi.org/10.1038/nbt1223 20.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nat Biotechnol 2009; 27: 839-49; PMID:19701187; http://dx.doi.org/10.1038/ nbt.1560 22.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
J Clin Invest 2011; 121:1692-708; PMID:21519141; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Cancer Cell 2011; 19:456-69; PMID:21481788; http://dx.doi.org/10.1016/j.ccr.2011.03.009 24.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nat Biotechnol 1997; 15:142-5; PMID:9035138; http://dx.doi.org/10.1038/nbt0297-142 25.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nucleic Acids Res 1992; 20:4061-7; PMID:1508691; http://dx.doi.org/ 10.1093/nar/20.15.4061 27.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
FEBS Lett 1998; 435:74-8; PMID:9755862; http://dx.doi.org/10.1016/ S0014-5793(98)01043-6 29.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Biochim Biophys Acta 2010; 1803:234-45; PMID:20026129; http://dx.doi.org/10.1016/j.bbamcr.2009.12.001 30.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
J Chromatogr B Biomed Sci Appl 1999; 731:275-84; PMID:10510781; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Anal Chem 2004; 76: 4066-75; PMID:15253644; http://dx.doi.org/10.1021/ac049858n 32.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
JThromb Haemost 2008; 6:2105-12; PMID:18826387; http://dx.doi.org/10.1111/j.1538-7836.2008.03162.x 34.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Chem Biol 1997; 4:809-16; PMID: 9384527; http://dx.doi.org/10.1016/S1074-5521(97)90114-9 35.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Osteoarthritis Cartilage 2011; 19: 711-8; PMID:21310253; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nature 2006; 441: 111-4; PMID:16565705; http://dx.doi.org/10.1038/ nature04688 37.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Nature 2004; 432:173-8; PMID: 15538359; http://dx.doi.org/10.1038/nature03121 38.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Proc Natl Acad Sci USA 2008; 105:17356-61; PMID:18978032; http://dx.doi.org/10.1073/ pnas.0809154105 39.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
ACS Nano 2010; 4:3689-96; PMID:20550178; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
J Exp Med 1987; 166:967-81; PMID: 2821154; http://dx.doi.org/10.1084/jem.166.4.967 44.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
"Ann N Y AcadSci 1989; 557:388-93, discussion 94-5; PMID:2786701;http://dx.doi.org/10.1111/j.1749-6632.1989.tb24031.x 45.",Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Cancer Res 2010; 70:8617-29; PMID:20861190; http://dx.doi.org/10.1158/0008- 5472.CAN-10-092046.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
FEBS Lett 1992; 306:219- 22; PMID:1321736; http://dx.doi.org/10.1016/0014- 5793(92)81004-6 47.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
BiullEksp Biol Med 1997; 124:527-9; PMID:9471247; http://dx.doi.org/10.1007/BF02445668 48.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Annu Rev Biochem 2009; 78:857-902; PMID: 19317650; http://dx.doi.org/10.1146/annurev.biochem.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
"Ther Deliv 2010; 1:849-61; PMID:21643487; http://dx.doi.org/ 10.4155/tde.10.61 50. van Dam M, Mullberg J, Schooltink H, Stoyan T, Brakenhoff JP, Graeve L, et al.",OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Eur J Biochem 2001; 268:160-7; PMID:11121117; http://dx.doi.org/10.1046/j.1432-1327.2001.01867.x 53.,OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Biochemistry 2008; 47:689-97; PMID: 18092816; http://dx.doi.org/10.1021/bi701873c 55.,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
Biopolymers 1987; 26:1601-20; PMID: 3663875; http://dx.doi.org/10.1002/bip.360260911 80 RNA Biology Volume 9 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/d2/eb/rna-9-67.PMC3342945.pdf
"8Today, it is still challenging to predict off-target effects based on computational algorithms since the exact moleculardeterminants that direct on- and off-target recognition of *Correspondence to: Ulrich Certa; Email: ulrich.certa@roche.com Submitted: 07/05/11; Revised: 08/31/11; Accepted: 09/16/11 http://dx.doi.org/10.4161/rna.9.1.18121RESEARCH PAPER RNA Biology 9:1, 87 –97; January 2012; G2012 Landes Bioscience www.landesbioscience.com RNA Biology 87",Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Cell 2009; 136:642-55; PMID: 19239886; http://dx.doi.org/10.1016/j.cell.2009.01.035 2.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nature 1998; 391:806-11; PMID:9486653; http://dx.doi.org/10.1038/35888 3.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Pharm Res 2009; 26:1-18; PMID:18841450; http://dx.doi.org/10.1007/s11095-008-9646-8 5.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
"Nature 2009; 457:426-33; PMID:19158789; http://dx.doi.org/10.1038/ nature07758 6. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J.",Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Rev Drug Discov 2007; 6:443-53; PMID:17541417; http://dx.doi.org/10.1038/nrd2310 7.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nature 2006; 441:111-4; PMID:16565705; http://dx.doi.org/10.1038/ nature04688 8.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Biotechnol 2003; 21:635-7; PMID:12754523; http://dx.doi.org/ 10.1038/nbt831 10.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Trends Genet 2004; 20:521-4; PMID:15475108; http://dx.doi.org/10.1016/j.tig.2004.08.006 11.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
BMC Mol Biol 2008; 9:60; PMID:18577207; http://dx.doi.org/10.1186/1471-2199-9-60 12.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
RNA 2008; 14:853-61; PMID: 18367722; http://dx.doi.org/10.1261/rna.704708 13.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Methods 2006; 3:199-204; PMID:16489337; http://dx.doi.org/10.1038/nmeth854 14.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Biotechnol 2009; 27:549-55; PMID:19465925; http://dx.doi.org/10.1038/nbt0709-671a16.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
RNA 2009; 15:308-15; PMID:19144911; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Methods 2008; 5:1023-5; PMID:18978784; http://dx.doi.org/10.1038/nmeth.1267 18.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
J Biol Chem 2003; 278:44312-9; PMID:12952966; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Mol Cell 2009; 33:204-14; PMID:19187762; http://dx.doi.org/10.1016/j.molcel.2008.12.012 20.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
RNA 2006; 12:1179-87; PMID:16682560; http://dx.doi.org/10.1261/rna.25706 21.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Genet 2007; 39:1278-84; PMID:17893677; http://dx.doi.org/10.1038/ng2135 22.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nat Struct Mol Biol 2005; 12:469-70; PMID:15852021; http://dx.doi.org/ 10.1038/nsmb931 96 RNA Biology Volume 9 Issue 1,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Mol Ther 2010; 18:466-76; PMID:20087319; http://dx.doi.org/ 10.1038/mt.2009.306 24.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Improving performance of mammalian microrna target prediction.BMC Bioinformatics 2010; 11:476; PMID:20860840;http://dx.doi.org/10.1186/1471-2105-11-476 25.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
NatBiotechnol 2008; 26:1379-82; PMID:19029911;http://dx.doi.org/10.1038/nbt.151226.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nucleic Acids Res 2008; 36:2136-51; PMID:18267968; http://dx.doi.org/10.1093/nar/gkn042 27.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Annu Rev Pharmacol Toxicol2010; 50:259-93; PMID:20055705; http://dx.doi.org/ 10.1146/annurev.pharmtox.010909.10565428.,Non-OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
Nucleic Acids Res 2008; 36: W119-27; PMID:18495751; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e8/0e/rna-9-87.PMC3342946.pdf
"Cell Cycle 2012; 11:953–62; PMID:22333590;  http://dx.doi.org/10.4161/cc.11.5.19445 Masha V. Poyurovsky; Kadmon Research Institute; New York, NY USA; Email: masha@kadmon.com; http://dx.doi.org/10.4161/cc.20047 a p53-dependent embryonic lethality.",Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Proc  n atl Acad  sci U s A 2003;  100:12009-14; PM i D:14507994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
F e B s  Lett 2009; 583:2710-4;  PM i D:19619542; http://dx.doi.org/10.1016/j.febs- let.2009.07.021.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cancer Res 2007; 67:6026-30;  PMi D:17616658; http://dx.doi.org/10.1158/0008- 5472.CA n -07-1313.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
J Biol Chem 2011; 286:23725-34;  PM i D:21572037; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Proc  n atl Acad  sci U s A 2011;  108:12001-6; PM iD :21730163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Proc  n atl Acad  sci U s A 2011; 108:11995- 2000; PM i D:21730132; http://dx.doi.org/10.1073/ pnas.1102241108.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
J Mol Biol 2006; 363:433-50;  PM i D:16965791; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell Death Differ 2008; 15:841-8;  PM i D:18219319; http://dx.doi.org/10.1038/ sj.cdd.4402309.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
PM i D:22333590; http://dx.doi.org/10.4161/ cc.11.5.19445.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cancer Lett 2003; 194:199-208;  PM i D:12757978; http://dx.doi.org/10.1016/ s 0304- 3835(02)00707-3.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Mol Cell Biol 2003; 23:389-401;  PM i D:12482990; http://dx.doi.org/10.1128/ MCB.23.1.389-401.2003.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell Cycle 2012; 11:1008-13;  PM i D:22333593; http://dx.doi.org/10.4161/ cc.11.5.19492.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cancer Cell 2010; 17:376-87;  PM i D:20385362; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
n at Rev Cancer 2002; 2:910-7;  PM i D:12459729; http://dx.doi.org/10.1038/nrc950.pRb or its cousins: Who controls the family business?,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell Cycle 2012; 11:1008–13; PMID:22333593;  http://dx.doi.org/10.4161/cc.11.5.19492 Koji Itahana1 and Goberdhan P .,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
"Dimri2,*; 1Duke-NUS Graduate Medical School; Singapore; 2George Washington University Medical Center; Washington, DC USA;  *Email: gdimri@gwu.edu; http://dx.doi.org/10.4161/cc.20048 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
"Cell Cycle 2012; 11: 1108–1117; PMID:22313602;   http://dx.doi.org/10.4161/cc.11.6.19530 Alastair M. Thompson1,* and Timothy J. Newman2; 1Dundee Cancer Centre; 2College of Life Sciences; University of Dundee; Dundee, UK;   *Email: a.m.thompson@dundee.ac.uk; http://dx.doi.org/10.4161/cc.20049 in vestment in the post-genomic molecular  dissection of breast cancer has resulted in an emphasis on prognostic and predictive mark - ers, signatures derived to stratify the disease and the drive to generate targeted therapies.",Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Breast Cancer Res 2011; 13:227; http//  breast-cancer-research.com/content/13/6/227;  PM i D:22078026; http://dx.doi.org/10.1186/ bcr2912.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell Cycle 2012; 11:1108 - 17;  PM i D:22313602; http://dx.doi.org/10.4161/ cc.11.6.19530.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
n at Rev Cancer 2011; 11:237- 8; PM i D:21548400; http://dx.doi.org/10.1038/ nrc3036.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Phys Biol 2011; 8:010302;  PM iD :21368346; http://dx.doi.org/10.1088/1478- 3975/8/1/010302.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
n at Med 2008; 14:518-27;  PM i D:18438415; http://dx.doi.org/10.1038/nm1764 7.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Br J Cancer 2012; 106:1117- 22; PM i D:22361631; http://dx.doi.org/10.1038/ bjc.2012.56.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell Cycle 2012; 1142–50; PMID: 22370482;  http://dx.doi.org/10.4161/cc.11.6.19559 David P .,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
"Lane; p53 Laboratory; A*STAR; Singapore; Email: dplane@p53lab.a-star.edu.sg; http://dx.doi.org/10.4161/cc.20073 in an exciting and surprising paper in a recent  issue of  Cell Cycle, Leidecker et al.",OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell Cycle 2012; 11:1142 - 50;  PM i D:22370482; http://dx.doi.org/10.4161/ cc.11.6.19559.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
n ature 2009; 458:732-6;  PM i D:19360080; http://dx.doi.org/10.1038/ nature07884.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Annu Rev Cell Dev Biol 2006; 22:159- 80; PM i D:16753028; http://dx.doi.org/10.1146/ annurev.cellbio.22.010605.093503.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cancer Cell 2011; 19:168-76;  PM i D:21316600; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Curr Opin  s truct Biol 2011; 21:257- 64; PM i D:21288713; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
Cell 2004; 118:83-97;   PM i D:15242646; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
e MBO Rep 2008; 9:280- 6; PM i D:18274552; http://dx.doi.org/10.1038/ embor.2008.10.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
e MBO Rep 2009; 10:1132- 9; PM i D:19713960; http://dx.doi.org/10.1038/ embor.2009.178.,Non-OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
.J Biol Chem 1998; 273:34983- 91; PM i D:9857030; http://dx.doi.org/10.1074/ jbc.273.52.34983.,OADS,/arxiv_data1/oa_pdf/5c/6b/cc-11-1485.PMC3342954.pdf
"Cell Cycle 2012; 11:953–62; PMID:22333590;  http://dx.doi.org/10.4161/cc.11.5.19445 Masha V. Poyurovsky; Kadmon Research Institute; New York, NY USA; Email: masha@kadmon.com; http://dx.doi.org/10.4161/cc.20047 a p53-dependent embryonic lethality.",Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Proc  n atl Acad  sci U s A 2003;  100:12009-14; PM i D:14507994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
F e B s  Lett 2009; 583:2710-4;  PM i D:19619542; http://dx.doi.org/10.1016/j.febs- let.2009.07.021.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cancer Res 2007; 67:6026-30;  PMi D:17616658; http://dx.doi.org/10.1158/0008- 5472.CA n -07-1313.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
J Biol Chem 2011; 286:23725-34;  PM i D:21572037; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Proc  n atl Acad  sci U s A 2011;  108:12001-6; PM iD :21730163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Proc  n atl Acad  sci U s A 2011; 108:11995- 2000; PM i D:21730132; http://dx.doi.org/10.1073/ pnas.1102241108.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
J Mol Biol 2006; 363:433-50;  PM i D:16965791; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell Death Differ 2008; 15:841-8;  PM i D:18219319; http://dx.doi.org/10.1038/ sj.cdd.4402309.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
PM i D:22333590; http://dx.doi.org/10.4161/ cc.11.5.19445.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cancer Lett 2003; 194:199-208;  PM i D:12757978; http://dx.doi.org/10.1016/ s 0304- 3835(02)00707-3.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Mol Cell Biol 2003; 23:389-401;  PM i D:12482990; http://dx.doi.org/10.1128/ MCB.23.1.389-401.2003.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell Cycle 2012; 11:1008-13;  PM i D:22333593; http://dx.doi.org/10.4161/ cc.11.5.19492.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cancer Cell 2010; 17:376-87;  PM i D:20385362; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
n at Rev Cancer 2002; 2:910-7;  PM i D:12459729; http://dx.doi.org/10.1038/nrc950.pRb or its cousins: Who controls the family business?,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell Cycle 2012; 11:1008–13; PMID:22333593;  http://dx.doi.org/10.4161/cc.11.5.19492 Koji Itahana1 and Goberdhan P .,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
"Dimri2,*; 1Duke-NUS Graduate Medical School; Singapore; 2George Washington University Medical Center; Washington, DC USA;  *Email: gdimri@gwu.edu; http://dx.doi.org/10.4161/cc.20048 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
"Cell Cycle 2012; 11: 1108–1117; PMID:22313602;   http://dx.doi.org/10.4161/cc.11.6.19530 Alastair M. Thompson1,* and Timothy J. Newman2; 1Dundee Cancer Centre; 2College of Life Sciences; University of Dundee; Dundee, UK;   *Email: a.m.thompson@dundee.ac.uk; http://dx.doi.org/10.4161/cc.20049 in vestment in the post-genomic molecular  dissection of breast cancer has resulted in an emphasis on prognostic and predictive mark - ers, signatures derived to stratify the disease and the drive to generate targeted therapies.",Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Breast Cancer Res 2011; 13:227; http//  breast-cancer-research.com/content/13/6/227;  PM i D:22078026; http://dx.doi.org/10.1186/ bcr2912.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell Cycle 2012; 11:1108 - 17;  PM i D:22313602; http://dx.doi.org/10.4161/ cc.11.6.19530.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
n at Rev Cancer 2011; 11:237- 8; PM i D:21548400; http://dx.doi.org/10.1038/ nrc3036.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Phys Biol 2011; 8:010302;  PM iD :21368346; http://dx.doi.org/10.1088/1478- 3975/8/1/010302.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
n at Med 2008; 14:518-27;  PM i D:18438415; http://dx.doi.org/10.1038/nm1764 7.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Br J Cancer 2012; 106:1117- 22; PM i D:22361631; http://dx.doi.org/10.1038/ bjc.2012.56.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell Cycle 2012; 1142–50; PMID: 22370482;  http://dx.doi.org/10.4161/cc.11.6.19559 David P .,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
"Lane; p53 Laboratory; A*STAR; Singapore; Email: dplane@p53lab.a-star.edu.sg; http://dx.doi.org/10.4161/cc.20073 in an exciting and surprising paper in a recent  issue of  Cell Cycle, Leidecker et al.",OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell Cycle 2012; 11:1142 - 50;  PM i D:22370482; http://dx.doi.org/10.4161/ cc.11.6.19559.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
n ature 2009; 458:732-6;  PM i D:19360080; http://dx.doi.org/10.1038/ nature07884.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Annu Rev Cell Dev Biol 2006; 22:159- 80; PM i D:16753028; http://dx.doi.org/10.1146/ annurev.cellbio.22.010605.093503.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cancer Cell 2011; 19:168-76;  PM i D:21316600; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Curr Opin  s truct Biol 2011; 21:257- 64; PM i D:21288713; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
Cell 2004; 118:83-97;   PM i D:15242646; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
e MBO Rep 2008; 9:280- 6; PM i D:18274552; http://dx.doi.org/10.1038/ embor.2008.10.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
e MBO Rep 2009; 10:1132- 9; PM i D:19713960; http://dx.doi.org/10.1038/ embor.2009.178.,Non-OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
.J Biol Chem 1998; 273:34983- 91; PM i D:9857030; http://dx.doi.org/10.1074/ jbc.273.52.34983.,OADS,/arxiv_data1/oa_pdf/ab/67/cc-11-1486.PMC3342955.pdf
"Cell Cycle 2012; 11:953–62; PMID:22333590;  http://dx.doi.org/10.4161/cc.11.5.19445 Masha V. Poyurovsky; Kadmon Research Institute; New York, NY USA; Email: masha@kadmon.com; http://dx.doi.org/10.4161/cc.20047 a p53-dependent embryonic lethality.",Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Proc  n atl Acad  sci U s A 2003;  100:12009-14; PM i D:14507994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
F e B s  Lett 2009; 583:2710-4;  PM i D:19619542; http://dx.doi.org/10.1016/j.febs- let.2009.07.021.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cancer Res 2007; 67:6026-30;  PMi D:17616658; http://dx.doi.org/10.1158/0008- 5472.CA n -07-1313.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
J Biol Chem 2011; 286:23725-34;  PM i D:21572037; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Proc  n atl Acad  sci U s A 2011;  108:12001-6; PM iD :21730163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Proc  n atl Acad  sci U s A 2011; 108:11995- 2000; PM i D:21730132; http://dx.doi.org/10.1073/ pnas.1102241108.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
J Mol Biol 2006; 363:433-50;  PM i D:16965791; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell Death Differ 2008; 15:841-8;  PM i D:18219319; http://dx.doi.org/10.1038/ sj.cdd.4402309.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
PM i D:22333590; http://dx.doi.org/10.4161/ cc.11.5.19445.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cancer Lett 2003; 194:199-208;  PM i D:12757978; http://dx.doi.org/10.1016/ s 0304- 3835(02)00707-3.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Mol Cell Biol 2003; 23:389-401;  PM i D:12482990; http://dx.doi.org/10.1128/ MCB.23.1.389-401.2003.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell Cycle 2012; 11:1008-13;  PM i D:22333593; http://dx.doi.org/10.4161/ cc.11.5.19492.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cancer Cell 2010; 17:376-87;  PM i D:20385362; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
n at Rev Cancer 2002; 2:910-7;  PM i D:12459729; http://dx.doi.org/10.1038/nrc950.pRb or its cousins: Who controls the family business?,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell Cycle 2012; 11:1008–13; PMID:22333593;  http://dx.doi.org/10.4161/cc.11.5.19492 Koji Itahana1 and Goberdhan P .,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
"Dimri2,*; 1Duke-NUS Graduate Medical School; Singapore; 2George Washington University Medical Center; Washington, DC USA;  *Email: gdimri@gwu.edu; http://dx.doi.org/10.4161/cc.20048 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
"Cell Cycle 2012; 11: 1108–1117; PMID:22313602;   http://dx.doi.org/10.4161/cc.11.6.19530 Alastair M. Thompson1,* and Timothy J. Newman2; 1Dundee Cancer Centre; 2College of Life Sciences; University of Dundee; Dundee, UK;   *Email: a.m.thompson@dundee.ac.uk; http://dx.doi.org/10.4161/cc.20049 in vestment in the post-genomic molecular  dissection of breast cancer has resulted in an emphasis on prognostic and predictive mark - ers, signatures derived to stratify the disease and the drive to generate targeted therapies.",Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Breast Cancer Res 2011; 13:227; http//  breast-cancer-research.com/content/13/6/227;  PM i D:22078026; http://dx.doi.org/10.1186/ bcr2912.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell Cycle 2012; 11:1108 - 17;  PM i D:22313602; http://dx.doi.org/10.4161/ cc.11.6.19530.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
n at Rev Cancer 2011; 11:237- 8; PM i D:21548400; http://dx.doi.org/10.1038/ nrc3036.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Phys Biol 2011; 8:010302;  PM iD :21368346; http://dx.doi.org/10.1088/1478- 3975/8/1/010302.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
n at Med 2008; 14:518-27;  PM i D:18438415; http://dx.doi.org/10.1038/nm1764 7.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Br J Cancer 2012; 106:1117- 22; PM i D:22361631; http://dx.doi.org/10.1038/ bjc.2012.56.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell Cycle 2012; 1142–50; PMID: 22370482;  http://dx.doi.org/10.4161/cc.11.6.19559 David P .,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
"Lane; p53 Laboratory; A*STAR; Singapore; Email: dplane@p53lab.a-star.edu.sg; http://dx.doi.org/10.4161/cc.20073 in an exciting and surprising paper in a recent  issue of  Cell Cycle, Leidecker et al.",OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell Cycle 2012; 11:1142 - 50;  PM i D:22370482; http://dx.doi.org/10.4161/ cc.11.6.19559.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
n ature 2009; 458:732-6;  PM i D:19360080; http://dx.doi.org/10.1038/ nature07884.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Annu Rev Cell Dev Biol 2006; 22:159- 80; PM i D:16753028; http://dx.doi.org/10.1146/ annurev.cellbio.22.010605.093503.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cancer Cell 2011; 19:168-76;  PM i D:21316600; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Curr Opin  s truct Biol 2011; 21:257- 64; PM i D:21288713; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
Cell 2004; 118:83-97;   PM i D:15242646; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
e MBO Rep 2008; 9:280- 6; PM i D:18274552; http://dx.doi.org/10.1038/ embor.2008.10.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
e MBO Rep 2009; 10:1132- 9; PM i D:19713960; http://dx.doi.org/10.1038/ embor.2009.178.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
.J Biol Chem 1998; 273:34983- 91; PM i D:9857030; http://dx.doi.org/10.1074/ jbc.273.52.34983.,OADS,/arxiv_data1/oa_pdf/be/b4/cc-11-1487.PMC3342956.pdf
"Cell Cycle 2012; 11:953–62; PMID:22333590;  http://dx.doi.org/10.4161/cc.11.5.19445 Masha V. Poyurovsky; Kadmon Research Institute; New York, NY USA; Email: masha@kadmon.com; http://dx.doi.org/10.4161/cc.20047 a p53-dependent embryonic lethality.",Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Proc  n atl Acad  sci U s A 2003;  100:12009-14; PM i D:14507994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
F e B s  Lett 2009; 583:2710-4;  PM i D:19619542; http://dx.doi.org/10.1016/j.febs- let.2009.07.021.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cancer Res 2007; 67:6026-30;  PMi D:17616658; http://dx.doi.org/10.1158/0008- 5472.CA n -07-1313.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
J Biol Chem 2011; 286:23725-34;  PM i D:21572037; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Proc  n atl Acad  sci U s A 2011;  108:12001-6; PM iD :21730163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Proc  n atl Acad  sci U s A 2011; 108:11995- 2000; PM i D:21730132; http://dx.doi.org/10.1073/ pnas.1102241108.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
J Mol Biol 2006; 363:433-50;  PM i D:16965791; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell Death Differ 2008; 15:841-8;  PM i D:18219319; http://dx.doi.org/10.1038/ sj.cdd.4402309.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
PM i D:22333590; http://dx.doi.org/10.4161/ cc.11.5.19445.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cancer Lett 2003; 194:199-208;  PM i D:12757978; http://dx.doi.org/10.1016/ s 0304- 3835(02)00707-3.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Mol Cell Biol 2003; 23:389-401;  PM i D:12482990; http://dx.doi.org/10.1128/ MCB.23.1.389-401.2003.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell Cycle 2012; 11:1008-13;  PM i D:22333593; http://dx.doi.org/10.4161/ cc.11.5.19492.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cancer Cell 2010; 17:376-87;  PM i D:20385362; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
n at Rev Cancer 2002; 2:910-7;  PM i D:12459729; http://dx.doi.org/10.1038/nrc950.pRb or its cousins: Who controls the family business?,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell Cycle 2012; 11:1008–13; PMID:22333593;  http://dx.doi.org/10.4161/cc.11.5.19492 Koji Itahana1 and Goberdhan P .,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
"Dimri2,*; 1Duke-NUS Graduate Medical School; Singapore; 2George Washington University Medical Center; Washington, DC USA;  *Email: gdimri@gwu.edu; http://dx.doi.org/10.4161/cc.20048 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
"Cell Cycle 2012; 11: 1108–1117; PMID:22313602;   http://dx.doi.org/10.4161/cc.11.6.19530 Alastair M. Thompson1,* and Timothy J. Newman2; 1Dundee Cancer Centre; 2College of Life Sciences; University of Dundee; Dundee, UK;   *Email: a.m.thompson@dundee.ac.uk; http://dx.doi.org/10.4161/cc.20049 in vestment in the post-genomic molecular  dissection of breast cancer has resulted in an emphasis on prognostic and predictive mark - ers, signatures derived to stratify the disease and the drive to generate targeted therapies.",Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Breast Cancer Res 2011; 13:227; http//  breast-cancer-research.com/content/13/6/227;  PM i D:22078026; http://dx.doi.org/10.1186/ bcr2912.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell Cycle 2012; 11:1108 - 17;  PM i D:22313602; http://dx.doi.org/10.4161/ cc.11.6.19530.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
n at Rev Cancer 2011; 11:237- 8; PM i D:21548400; http://dx.doi.org/10.1038/ nrc3036.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Phys Biol 2011; 8:010302;  PM iD :21368346; http://dx.doi.org/10.1088/1478- 3975/8/1/010302.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
n at Med 2008; 14:518-27;  PM i D:18438415; http://dx.doi.org/10.1038/nm1764 7.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Br J Cancer 2012; 106:1117- 22; PM i D:22361631; http://dx.doi.org/10.1038/ bjc.2012.56.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell Cycle 2012; 1142–50; PMID: 22370482;  http://dx.doi.org/10.4161/cc.11.6.19559 David P .,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
"Lane; p53 Laboratory; A*STAR; Singapore; Email: dplane@p53lab.a-star.edu.sg; http://dx.doi.org/10.4161/cc.20073 in an exciting and surprising paper in a recent  issue of  Cell Cycle, Leidecker et al.",OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell Cycle 2012; 11:1142 - 50;  PM i D:22370482; http://dx.doi.org/10.4161/ cc.11.6.19559.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
n ature 2009; 458:732-6;  PM i D:19360080; http://dx.doi.org/10.1038/ nature07884.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Annu Rev Cell Dev Biol 2006; 22:159- 80; PM i D:16753028; http://dx.doi.org/10.1146/ annurev.cellbio.22.010605.093503.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cancer Cell 2011; 19:168-76;  PM i D:21316600; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Curr Opin  s truct Biol 2011; 21:257- 64; PM i D:21288713; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
Cell 2004; 118:83-97;   PM i D:15242646; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
e MBO Rep 2008; 9:280- 6; PM i D:18274552; http://dx.doi.org/10.1038/ embor.2008.10.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
e MBO Rep 2009; 10:1132- 9; PM i D:19713960; http://dx.doi.org/10.1038/ embor.2009.178.,Non-OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
.J Biol Chem 1998; 273:34983- 91; PM i D:9857030; http://dx.doi.org/10.1074/ jbc.273.52.34983.,OADS,/arxiv_data1/oa_pdf/43/85/cc-11-1488.PMC3342957.pdf
"Accepted on July 18, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.139  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.those stages.2 Another 20% of patients with terminal stage HCC  receive recommendations for the best supportive treatment.",Non-OADS,/arxiv_data1/oa_pdf/18/4c/gnl-6-139.PMC3343153.pdf
"Accepted on January 18, 2012.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.149  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.Key Words:  Non-alcoholic fatty liver disease; Hepatic ﬁ brosis;  Non-alcoholic steatohepatitis INTRODUCTION Non-alcoholic fatty liver disease (NAFLD) is the commonest  form of liver disease in all regions of the world with modern industrialised economies, including Korea and many other Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/fd/77/gnl-6-149.PMC3343154.pdf
DOI: http://dx.doi.org/10.1053/j.gastro.2012.02.003.,OADS,/arxiv_data1/oa_pdf/fd/77/gnl-6-149.PMC3343154.pdf
"Accepted on October 20, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.172  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.databases carry biases by their implicit nature: being postmor- tem or requiring biliary symptoms/complications, respectively.1-3  Another potential measure of disease burden, the frequency of cholecystectomy, is a limited marker for the prevalence of gall-stones, as the perceived threshold for surgery and patient access to care differ greatly.",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/gnl-6-172.PMC3343155.pdf
"Surveillance, Epidemiology and End Results (SEER) Program [http://seer.cancer.gov/]).",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/gnl-6-172.PMC3343155.pdf
Available from http://seer.cancer.gov/).,Non-OADS,/arxiv_data1/oa_pdf/7c/f2/gnl-6-172.PMC3343155.pdf
"Accepted on July 24, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.188So-Young Joo and Young-A Song contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/64/68/gnl-6-188.PMC3343156.pdf
"Accepted on August 30, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.197  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.INTRODUCTION Gastroesophageal reflux disease (GERD) has a high prevalence  and an increasing incidence.",Non-OADS,/arxiv_data1/oa_pdf/82/04/gnl-6-197.PMC3343157.pdf
"Accepted on September 2, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.203  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.INTRODUCTION Colorectal cancer is the third most frequently diagnosed  cancer in Korea1 and it has been continuously increasing over  the past two decades with similar trends in the West.2 In locally  advanced rectal cancer, curative surgery with neoadjuvant or adjuvant chemoradiotherapy (CRT) became standard treatment in most clinical institutes.",Non-OADS,/arxiv_data1/oa_pdf/7a/c5/gnl-6-203.PMC3343158.pdf
"Accepted on October 10, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.210  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.agents, and are commonly prescribed by physicians.",Non-OADS,/arxiv_data1/oa_pdf/8a/f0/gnl-6-210.PMC3343159.pdf
"Accepted on October 25, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.218  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.INTRODUCTION Video capsule endoscopy (VCE) was first reported by Iddan  et al.1 in 2000.",Non-OADS,/arxiv_data1/oa_pdf/7d/f4/gnl-6-218.PMC3343160.pdf
"Accepted on October 18, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.223  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.by structural and biochemical dysfunctions and has various and  repetitive gastrointestinal symptoms without definite patho-physiology.",Non-OADS,/arxiv_data1/oa_pdf/16/73/gnl-6-223.PMC3343161.pdf
"Accepted on October 28, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.229Hye Sung Won and Lee So Maeng contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/1e/48/gnl-6-229.PMC3343162.pdf
"Accepted on October 26, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.235  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.Ghana is lower than that of other areas in the same country.",Non-OADS,/arxiv_data1/oa_pdf/fd/81/gnl-6-235.PMC3343163.pdf
Available from: http://www.globalhealthfacts.org/.,Non-OADS,/arxiv_data1/oa_pdf/fd/81/gnl-6-235.PMC3343163.pdf
Available from: http://apps.who.int/ghodata/?theme=country#.,Non-OADS,/arxiv_data1/oa_pdf/fd/81/gnl-6-235.PMC3343163.pdf
Available from: http://www.ghanadistricts.com/home/.,Non-OADS,/arxiv_data1/oa_pdf/fd/81/gnl-6-235.PMC3343163.pdf
Available from: http://accubiotech.en.ecplaza.net/.,Non-OADS,/arxiv_data1/oa_pdf/fd/81/gnl-6-235.PMC3343163.pdf
"Accepted on November 7, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.241Moon Seok Choi and Dong Hyun Sinn contributed equally to this study as first authors.",Non-OADS,/arxiv_data1/oa_pdf/bd/5d/gnl-6-241.PMC3343164.pdf
"Accepted on November 21, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.249  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.interstitial collagens (gelatins), type V collagen, and type IV col- lagen.1 These MMPs can cleave noncollagenous ECM including  elastin, fibronectin, and laminin.1 The collagen, elastin, fibronectin, and laminin support the  cellular components of blood vessels.2 These ECMs are impor- tant for the maintenance of the structure of blood vessels.",Non-OADS,/arxiv_data1/oa_pdf/5f/1c/gnl-6-249.PMC3343165.pdf
"Accepted on September 16, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.256  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.INTRODUCTION Acute pancreatitis is the most common complication of endo- scopic retrograde cholangiopancreatography (ERCP), it is most often clinically mild or moderate in severity but in about 10% of cases it is severe and potentially fatal.",Non-OADS,/arxiv_data1/oa_pdf/5b/7a/gnl-6-256.PMC3343166.pdf
"Accepted on October 13, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.262  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.Key Words:  HMG-CoA reductase inhibitor; PPAR γ agonist;  Pancreatic stellate cells; Synergism INTRODUCTION Chronic pancreatitis is characterized by irreversible fibrosis  from sustained inflammation, pain and loss of exocrine and en-docrine functions.",Non-OADS,/arxiv_data1/oa_pdf/8f/31/gnl-6-262.PMC3343167.pdf
"Accepted on October 11, 2010.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.270  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.CASE REPORT A 66-year-old female presented with a 1-month history of  dyspepsia.",Non-OADS,/arxiv_data1/oa_pdf/04/69/gnl-6-270.PMC3343168.pdf
"Accepted on November 11, 2010.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.275  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.Esophageal manometric and radiographic findings showed fea- tures of achalasia.",Non-OADS,/arxiv_data1/oa_pdf/9c/23/gnl-6-275.PMC3343169.pdf
"Accepted on November 15, 2010.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.280  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.mutation is one of the early genetic events in the initiation of  this serrated pathway.4-6 BRAF  mutations have recently been  found in 5% to 15% of CRCs.7-9 We present a case of a 34-year- old young woman with HPS who had a BRAF  mutation.",Non-OADS,/arxiv_data1/oa_pdf/f5/43/gnl-6-280.PMC3343170.pdf
"Accepted on October 10, 2011.pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2012.6.2.284  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.tion, there was smooth muscle proliferation and some endome- trial glands and stroma in these areas (Fig.",Non-OADS,/arxiv_data1/oa_pdf/02/ec/gnl-6-284.PMC3343171.pdf
Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4c/d1/41467_2012_Article_BFncomms1796.PMC3343228.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Drexler, J.F.",Non-OADS,/arxiv_data1/oa_pdf/4c/d1/41467_2012_Article_BFncomms1796.PMC3343228.pdf
"Re- trieved on April 15, 2011, from http://www.fabriquedesens.net/ Faut-il-craindre-la-technoscience32 Nanoethics (2012) 6:29 –37",Non-OADS,/arxiv_data1/oa_pdf/71/ff/11569_2011_Article_137.PMC3343232.pdf
http://www.ahrq.gov/clinic/tp/comhworktp.htm .,Non-OADS,/arxiv_data1/oa_pdf/32/ce/10900_2011_Article_9484.PMC3343233.pdf
http://hdl.handle.net/1928/10875 .,Non-OADS,/arxiv_data1/oa_pdf/32/ce/10900_2011_Article_9484.PMC3343233.pdf
"Since the empirical analysis is based on data for 2008, we will not elaborate on the new regulation and refer to the website of theTPP for more information ( http://www.inami.be/drug/fr/drugs/ general-information/refunding/index.htm#nature ).316 F. Vrijens et al.",Non-OADS,/arxiv_data1/oa_pdf/60/36/10198_2011_Article_367.PMC3343241.pdf
All molecules available on the 2The authorization can be accessed at http://www.ksz-bcss.fgov.,Non-OADS,/arxiv_data1/oa_pdf/60/36/10198_2011_Article_367.PMC3343241.pdf
http://www.inami.be/care/fr/ doctors/promotion-quality/feedbacks/feedback-generica/feedback2009.htm (2010) 9.,Non-OADS,/arxiv_data1/oa_pdf/60/36/10198_2011_Article_367.PMC3343241.pdf
http://www.gkv-spitzenverband.,Non-OADS,/arxiv_data1/oa_pdf/60/36/10198_2011_Article_367.PMC3343241.pdf
http://www.who.int/whosis/mort/proﬁles/mort_euro_ deu_germany.pdf (2006).,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
http://www.heartstats.org/temp/ ESspTabsp12.2spweb08.xls (2006).,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
http://www.rxabbott.com/pdf/ niaspan.pdf (2005).,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
http://www.gbe-bund.de/ (2007).,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
http://www.destatis.de/ jetspeed/portal/cms/ (2007).,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
http://www.lauer-ﬁscher.,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
http://www.guidance.nice.org.uk/CG67/ Guidance/pdf/English (2008).,Non-OADS,/arxiv_data1/oa_pdf/43/bd/10198_2011_Article_309.PMC3343242.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ba/f7/IJMPO-32-187.PMC3343243.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/64/9f/IJMPO-32-197.PMC3343245.pdf
available  from: http://www.phoindia.org/pdf/all-abstracts-PHOcOn-2009-chandigarh.pdf [last accessed on 2010 Dec 26].,Non-OADS,/arxiv_data1/oa_pdf/1c/f2/IJMPO-32-211.PMC3343248.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/e8/96/IJMPO-32-217.PMC3343250.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/IJMPO-32-242.PMC3343256.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/IJMPO-32-242.PMC3343256.pdf
"However, given the unique design of the platform (for detailed annotations for the 450K array including probe sequences: http://www.illu-mina.com/), some cautions might need to be  exerted when analyzing the 450K array data,  in addition to some general challenges for analyzing the whole-genome DNA methyla-tion data ( Laird, 2010 ).",Non-OADS,/arxiv_data1/oa_pdf/09/2d/fgene-03-00073.PMC3343275.pdf
"It has been estimated that the development of diabetes to a large extent is preventable by adopting a healthy diet and increasingphysical activity (International Diabetes Federation, http://www.idf.",Non-OADS,/arxiv_data1/oa_pdf/a7/db/ejcn2011203a.PMC3343291.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Metabolic effects of rose hip U Andersson et al 590 European Journal of Clinical Nutrition (2012) 585 - - 590 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/a7/db/ejcn2011203a.PMC3343291.pdf
Data were acquired using a 128-channel Biosemi system (http://www.biosemi.com/).,OADS,/arxiv_data1/oa_pdf/2f/ae/fpsyg-03-00131.PMC3343304.pdf
"Butterworth filter I repeated the same analyses as above on data filtered with a fourth order Butterworth filter as implemented in the pop_basicfilter function in ERPLAB (http://erpinfo.org/erplab),  which calls Matlab Signal Processing T oolbox functions but-ter and filtfilt.",OADS,/arxiv_data1/oa_pdf/2f/ae/fpsyg-03-00131.PMC3343304.pdf
Hierarchical framework of visual attention SUPPLEMENTARY MATERIAL The Supplementary Material for this article can be found online at http://www.frontiersin.org/Neural_Circuits/10.3389/ fncir.2012.00022/abstract Movie S1 | Time-lapse simulation of phase map and activity map progression with uniform initial phase maps.,Non-OADS,/arxiv_data1/oa_pdf/48/ae/fncir-06-00022.PMC3343306.pdf
"However, all groupshttp://www.kidney-international.org original article &2012 International Society of Nephrology Received 14 February 2011; revised 5 October 2011; accepted 25 October 2011; published online 25 January 2012Correspondence: Hector F. DeLuca, Department of Biochemistry, University of Wisconsin, Madison, Wisconsin, USA.",Non-OADS,/arxiv_data1/oa_pdf/6f/39/ki2011463a.PMC3343313.pdf
"Using geneticapproaches, we validated SR-A as a critical modulator oftransforming growth factor (TGF)- b1/Smad signaling and monocyte chemoattractant protein-1 (MCP-1) in HK-2 cellsoriginal article http://www.kidney-international.org &2012 International Society of Nephrology Received 19 May 2011; revised 19 September 2011; accepted 25 October 2011; published online 29 February 2012Correspondence: Wei Shi, Division of Nephrology, Guangdong General Hospital, Guangzhou, 510080, China.",Non-OADS,/arxiv_data1/oa_pdf/07/5c/ki2011457a.PMC3343314.pdf
Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/07/5c/ki2011457a.PMC3343314.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ 1014 Kidney International (2012) 81, 1002– 1014original article W Wang et al.",Non-OADS,/arxiv_data1/oa_pdf/07/5c/ki2011457a.PMC3343314.pdf
"; 2009 [cited 2012 2012/Jan/17];  Available from: http://www.bu.edu/drrk/research-syntheses/psy- chiatric-disabilities/peer-delivered-services/   [5]  Pistrang N, Barker C, Humphreys K. Mutual help groups for  mental health problems: a review of effectiveness studies.",Non-OADS,/arxiv_data1/oa_pdf/0f/b6/CPEMH-8-22.PMC3343315.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/b6/CPEMH-8-22.PMC3343315.pdf
"Available at: http://www.who.int/mediacentre/factsheets/fs 317/en/  index.html [Accessed on July 2, 2010].",Non-OADS,/arxiv_data1/oa_pdf/50/1b/TOAIDJ-6-29.PMC3343316.pdf
"Available at: http://www.americanhe  art.org/downloadable/heart/1260725431950FS01AF10.pdf  [Accessed on June 15, 2010].",Non-OADS,/arxiv_data1/oa_pdf/50/1b/TOAIDJ-6-29.PMC3343316.pdf
Available at: http://www.census.,OADS,/arxiv_data1/oa_pdf/50/1b/TOAIDJ-6-29.PMC3343316.pdf
youthinmind;  Available from: http://www.dawba.info [Accessed 17 Nov. 2011].,Non-OADS,/arxiv_data1/oa_pdf/6a/61/CPEMH-8-16.PMC3343321.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/61/CPEMH-8-16.PMC3343321.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/2d/srep00397.PMC3343322.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Karsai, M., Kaski, K., Baraba ´si, A.",Non-OADS,/arxiv_data1/oa_pdf/67/2d/srep00397.PMC3343322.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/90/srep00395.PMC3343323.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Li, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/79/90/srep00395.PMC3343323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Gutie´rrez, R., Sendin ˜a-Nadal, I., Zanin, M., Papo, D. & Boccaletti, S. Targeting the dynamics of complex networks.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/srep00396.PMC3343324.pdf
Isolated RNA (100 ng) was usedfor generation of cDNA and terminal labelling using the 3 0IVT Express Kit (Affymetrix) and labelled probes were hybridized toGeneChip C. elegans Genome Arrays (http://www.affymetrix.com/ estore/browse/products.jsp?productId ¼131405&categoryId ¼35878 &productName ¼GeneChip-C.-elegans-Genome-Array) representing 22 500 transcripts.,OADS,/arxiv_data1/oa_pdf/20/45/emboj201261a.PMC3343340.pdf
Enriched GO groups were deﬁnedusing the Generanker tool in the Genomatix Genome Analyzersoftware (http://www.genomatix.de /en/produkte/genomatix-genome- analyzer.html).Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/20/45/emboj201261a.PMC3343340.pdf
[http://creativecommons.org/licenses/by-nc-sa/3.0/]A nematode ALT strain DH Lackner et al &2012 European Molecular Biology Organization The EMBO Journal VOL 31 |NO 8 |2012 2033,Non-OADS,/arxiv_data1/oa_pdf/20/45/emboj201261a.PMC3343340.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: An, Z., Liu, F.Q., Lin, Y.",Non-OADS,/arxiv_data1/oa_pdf/3d/19/srep00388.PMC3343344.pdf
Available in: http://www.sciencedaily.com/releases/2007/10/071022124744.htm.,Non-OADS,/arxiv_data1/oa_pdf/ce/6d/jp2011106a.PMC3343345.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/3.0/Prevention of postpartum smoking relapse RM Phillips et al 380 Journal of Perinatology",Non-OADS,/arxiv_data1/oa_pdf/ce/6d/jp2011106a.PMC3343345.pdf
Supplementary information is available at EMBO reports online (http://www.emboreports.org).,Non-OADS,/arxiv_data1/oa_pdf/f6/32/embor201242a.PMC3343353.pdf
This article is licensed under a Creative Commons Attribution Noncommercial No Derivative Works 3.0 Unported License [http://creativecommons.org/licenses/by-nc-nd/3.0]Asymmetric division in neural tube R.M.,Non-OADS,/arxiv_data1/oa_pdf/f6/32/embor201242a.PMC3343353.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1007/ s10895-008-0315-4 Basso, E., V. Petronilli, M.A.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1074/jbc .C800132200 Bernardi, P., S. Vassanelli, P. Veronese, R. Colonna, I. Szabó, and  M. Zoratti.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"273:2077– 2099. http://dx.doi.org/10.1111/j.1742-4658.2006.05213.x Bradford, M.M.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1016/0003-2697(76)90527-3 Camara, A.K., M. Bienengraeber, and D.F.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"2:13. http://dx.doi.org/10.3389/ fphys.2011.00013 Castuma, C.E., R. Huang, A. Kornberg, and R.N.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1074/jbc.270.22.12980 Cowling, R.T., and H.C. Birnboim.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1016/j.cell.2009.11.001 Müller, W.E., X. Wang, B. Diehl-Seifert, K. Kropf, U. Schlossmacher,  I. Lieberwirth, G. Glasser, M. Wiens, and H.C. Schröder.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/j.actbio.2011.03.007 Negoda, A., E. Negoda, and R.N.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1039/ c0mb00092b Nicolli, A., V. Petronilli, and P. Bernardi.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1021/bi00067a039 Omelon, S.J., and M.D.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1021/cr0782527 Omelon, S., J. Georgiou, Z.J.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1371/journal .pone.0005634 Pavlov, E., C. Grimbly, C.T.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/j .febslet.2005.08.032 Pavlov, E., E. Zakharian, C. Bladen, C.T.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1074/jbc.M109.013011 Petronilli, V., G. Miotto, M. Canton, M. Brini, R. Colonna, P.  Bernardi, and F. Di Lisa.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(99)77239-5 Piot, C., P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton,  R. Elbelghiti, T.T.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1056/NEJMoa071142 Rasola, A., and P. Bernardi.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/j.ceca.2011.04.007Dedkova, E.N., and L.A. Blatter.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1152/ajpcell.00011.2005 Dedkova, E.N., and L.A. Blatter.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"587:851– 872. http://dx.doi.org/10.1113/jphysiol.2008.165423 Dedkova, E.N., and L.A. Blatter.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2011.08.030 Di Lisa, F., and P. Bernardi.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2009.03.006 Docampo, R., W. de Souza, K. Miranda, P. Rohloff, and S.N.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1038/ nrmicro1097 Ferreira, R. 2010a.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1093/cvr/cvp063 Halestrap, A.P.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1007/s10863-009-9206-x Halestrap, A.P.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1016/j.yjmcc.2009.02.021 Huang, R., and R.N.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.7150/ijbs.4.37 Kornberg, A., N.N.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1146/annurev.biochem.68.1.89 Krasnikov, B.F., N.S.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1152/ajpcell.00519.2009 Kulaev, I., V. Vagabov, and T. Kulakovskaya.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/S1389-1723(99)80189-3 Kumble, K.D., and A. Kornberg.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1074/jbc.270.11.5818 Leung, A.W., P. Varanyuwatana, and A.P.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1074/jbc.M805235200 Marsh, D. 1996.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1146/annurev.bi.57.070188.001315 Zakharian, E., and R.N.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi .org/10.1529/biophysj.106.095273 Zakharian, E., B. Thyagarajan, R.J. French, E. Pavlov, and T.  Rohacs.",Non-OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1371/journal .pone.0005404Reusch, R.N., and H.L.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/S0006-3495 (95)79958-1 Ricchelli, F., J. Sileikyte ˙, and P. Bernardi.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1016/j.bbabio.2011 .02.012 Schwerzmann, K., L.M.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
"http://dx.doi.org/10.1083/ jcb.102.1.97 Sedova, M., E.N.",OADS,/arxiv_data1/oa_pdf/92/dc/JGP_201210788.PMC3343371.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
S1–S4 are available at http://www.jgp.org/cgi/content/full/jgp .201210789/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/ jgp.200409076 Csanády, L., A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp.200609558 Csanády, L., P. Vergani, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/ 10.1038/nature05155 Dawson, R.J., and K.P.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi .org/10.1016/j.febslet.2007.01.073 Gunderson, K.L., and R.R.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1016/ 0092-8674(95)90310-0 Hollenstein, K., D.C. Frei, and K.P.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1038/nature05626 Hwang, T.C., G. Nagel, A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi .org/10.1073/pnas.91.11.4698 Ivetac, A., J.D.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1021/bi0622571 Khare, D., M.L.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/ 10.1016/j.molcel.2009.01.035 Kopeikin, Z., Y. Sohma, M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp.201010518 Lewis, H.A., S.G. Buchanan, S.K.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"23:282– 293. http://dx.doi.org/10.1038/sj.emboj.7600040 Mense, M., P. Vergani, D.M.",Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601373 Powe, A.C., Jr., L. Al-Nakkash, M. Li, and T.C.",Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1126/science.1168750 Bai, Y., M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10 .1085/jgp.201010480 Bai, Y., M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp.201110705 Bear, C.E., C.H.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/ 10.1016/0092-8674(92)90155-6 Bompadre, S.G., T. Ai, J.H.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/ 10.1085/jgp.200409227 Bompadre, S.G., J.H.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1074/jbc.M510576200 Carson, M.R., S.M.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1074/jbc .270.4.1711 Chakrapani, S., and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"78:785– 799. http://dx.doi.org/10.1016/S0006-3495(00)76636-7 Csanády, L. 2010.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"114:49– 53. http://dx.doi.org/10.1085/jgp.114.1.49 Csanády, L., K.W.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
125:43– 55. http://dx.doi.org/10.1085/jgp.200409174,Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/ 10.1073/pnas.0709388104 Winter, M.C., D.N.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp .113.4.541 Zhou, Z., S. Hu, and T.C.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1113/ jphysiol.2005.095083 Zhou, Z., X. Wang, H.Y.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
http://dx.doi .org/10.1085/jgp.200609622Identification of the cystic fibrosis gene: cloning and character-ization of complementary DNA.,Non-OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"137:549– 562. http://dx.doi.org/10.1085/jgp.201110608 Tsai, M.F., H. Shimizu, Y. Sohma, M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp.200810186 Tsai, M.F., K.Y.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1074/jbc.M110.172817 Tsai, M.F., M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp.201010399 Vergani, P., A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi.org/10.1085/jgp.20028673 Vergani, P., S.W.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
"http://dx.doi .org/10.1038/nature03313 Ward, A., C.L.",OADS,/arxiv_data1/oa_pdf/a0/f8/JGP_201210789.PMC3343372.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
The online supplemental material is available at  http://www.jgp.org/cgi/content/full/jgp.201110716/DC1.,Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1074/jbc .M411324200 Khakh, B.S., X.R.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10 .1038/7233 Koshimizu, T., M. Tomic ´, M. Koshimizu, and S.S. Stojilkovic.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1074/jbc.273.21.12853 Koshimizu, T., M. Tomic ´, F. Van Goor, and S.S. Stojilkovic.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1210/me.12.7.901 Koshimizu, T., M. Koshimizu, and S.S. Stojilkovic.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1074/ jbc.274.53.37651 Koshimizu, T.A., K. Kretschmannova, M.L.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1124/mol.105.019802 Lynch, K.J., E. Touma, W. Niforatos, K.L.",Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi .org/10.1016/S0378-5955(98)00065-3 Simon, J., E.J.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi .org/10.1126/science.272.5262.735 Tyson, J.J., K.C.",Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1016/ S0955-0674(03)00017-6 Virginio, C., A. MacKenzie, F.A.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1038/7225 Yan, Z., Z. Liang, T. Obsil, and S.S. Stojilkovic.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1074/jbc.M512791200 Yan, Z., S. Li, Z. Liang, M. Tomic ´, and S.S. Stojilkovic.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1085/ jgp.200810059 Yan, Z., A. Khadra, S. Li, M. Tomic, A. Sherman, and S.S. Stojilkovic.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2390-10.2010desensitization determine the total conductivity, result- ing in generation of monophasic P2X2R currents.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi .org/10.1073/pnas.0803008105 Chaumont, S., L.H.",Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi .org/10.1124/pr.110.003129 Ding, S., and F. Sachs.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi .org/10.1111/j.1469-7793.2000.t01-1-00199.x Egan, T.M., D.S.",Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1007/ s00424-006-0078-1 Eickhorst, A.N., A. Berson, D. Cockayne, H.A.",Non-OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3250-04.2004 He, M.L., H. Zemkova, T.A.",OADS,/arxiv_data1/oa_pdf/93/41/JGP_201110716.PMC3343373.pdf
The online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201210770/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/ 10.1016/j.ymeth.2010.10.005 Bailey, M.F., L.M.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.ab.2009.03.045suggesting unexpectedly slow reaction kinetics, the  dimer s-value estimated by either the sw isotherm or the  dimer c(s) peak was too low.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1006/meth.1999.0853 Jensen, M.H., M. Sukumaran, C.M.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi .org/10.1016/j.jmb.2011.09.037 Jin, R., S.K.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"28:1812– 1823. http://dx.doi.org/10.1038/emboj.2009.140 Johnson, M.L.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/ 10.1016/0003-2697(92)90356-C Josephs, R., and W.F.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1021/ bi00848a020 Karakas, E., N. Simorowski, and H. Furukawa.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/ nature10180 Kingsbury, J.S., and T.M.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/B978-0-12- 381268-1.00021-5 Kingsbury, J.S., T.M.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.ab.2008.11.033 Kumar, J., P. Schuck, R. Jin, and M.L.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/nsmb .1613 Kumar, J., P. Schuck, and M.L.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"71:319– 331. http://dx.doi.org/10.1016/j.neuron.2011.05.038 Lakowicz, J.R. 1999.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.bpc.2003.10.018 Marcum, J.M., and G.G.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.conb.2011.02.001 Melikishvili, M., D.W. Rodgers, and M.G.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.dnarep .2011.09.007Balbo, A., P.H.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1021/bm070193j Brown, P.H., A. Balbo, and P. Schuck.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/emboj.2009.86 Clayton, A., C. Siebold, R.J.C.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/ j.jmb.2009.07.082 Crispin, M., V.T.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1074/jbc.M109.006254 Dam, J., C.A.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"278:221– 257. http://dx.doi.org/10.1016/S0076-6879(97)78013-3 Emsley, P., B. Lohkamp, W.G.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1107/S0907444910007493 Furukawa, H., S.K.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/nature04089 García De La Torre, J., M.L.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi .org/10.1016/j.ymeth.2010.12.005 Gilbert, G.A.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/186882a0 Greger, I.H., and J.A.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
http://dx.doi .org/10.1016/j.conb.2007.04.007,OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/S0003-2697 (03)00289-6 Schuck, P. 2010.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.03.004 Schuck, P., A. Balbo, P.H.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/417245a Traynelis, S.F., L.P. Wollmuth, C.J.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1124/ pr.109.002451 Vistica, J., J. Dam, A. Balbo, E. Yikilmaz, R.A. Mariuzza, T.A.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.ab.2003.12.014 Weston, M.C., P. Schuck, A. Ghosal, C. Rosenmund, and M.L.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/ 10.1038/nsmb1178 Yphantis, D.A., J.J. Correia, M.L.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.03.004Mok, Y.-F., T.M.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1016/j.ymeth.2010.10.004 Nayeem, N., Y. Zhang, D.K.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1124/mol.109.056598 Philo, J.S.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10 .1016/S0076-6879(00)21189-0 Philo, J.S., J. Wen, J. Wypych, M.G.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1074/ jbc.271.12.6895 Reeves, P.J., N. Callewaert, R. Contreras, and H.G.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1038/emboj.2011.16 Ryan, T.M., M.D.W.",OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1021/bi201192r Sackett, D.L., and R.E.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
"http://dx.doi.org/10.1021/bi00228a023 Schuck, P. 2000.",Non-OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
http://dx.doi.org/10.1016/ S0006-3495(00)76713-0,OADS,/arxiv_data1/oa_pdf/d3/a3/JGP_201210770.PMC3343374.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after the   publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
Kinetic modeling and determination of rate constants Kinetic analyses of single-channel currents were done by using the QuB software suite (http://www.qub.buffalo.edu).,OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
The online supplemental material is available  at http://www.jgp.org/cgi/content/full/jgp.201110752/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1113/jphysiol.2002.034173 Jackson, M.B.",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/ S0006-3495(86)83693-1 Jackson, M.B., K. Imoto, M. Mishina, T. Konno, S. Numa, and B.  Sakmann.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.01.025 Jha, A., D.J.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1085/jgp.200709856 Jha, A., S. Gupta, S.N.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/0022-5193(67)90011-2 Mitra, A., T.D.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/ j.str.2004.08.004 Monod, J., J. Wyman, and J.P. Changeux.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/S0022-2836(65)80285-6 Mukhtasimova, N., W.Y.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi .org/10.1038/nature07923 Neubig, R.R., and J.B. Cohen.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1021/ bi00553a036 Purohit, P., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1085/jgp.200910384 Purohit, P., A. Mitra, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1038/nature05721 Qin, F., A. Auerbach, and F. Sachs.",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/ S0006-3495(96)79568-1 Qin, F., A. Auerbach, and F. Sachs.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"264:375– 383. http://dx.doi.org/10.1098/rspb.1997.0054 Salamone, F.N., M. Zhou, and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(96)79834-X Akk, G., S. Sine, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi .org/10.1113/jphysiol.2009.182774 Cadugan, D.J., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.05.008 Chakrapani, S., T.D.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1085/jgp.200309004 Colquhoun, D., and B. Sakmann.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi .org/10.1021/bi011864f Grosman, C., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1085/jgp.115.5.637 Grosman, C., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/ 10.1085/jgp.115.5.621 Grosman, C., M. Zhou, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1038/35001586 Gupta, S., and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1016/j.bpj .2010.12.3727 Hatton, C.J., C. Shelley, M. Brydson, D. Beeson, and D. Colquhoun.",OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
http://dx.doi .org/10.1529/biophysj.105.067215kinetics.,Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1111/j .1469-7793.1999.0315v.x Spitzmaul, G., J. Corradi, and C. Bouzat.",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"http://dx.doi.org/10.1080/09687680310001607341 Wang, H.L., K. Ohno, M. Milone, J.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
http://dx.doi .org/10.1085/jgp.116.3.449,OADS,/arxiv_data1/oa_pdf/5a/9f/JGP_201110752.PMC3343375.pdf
"Images were processed using the ImageJ freeware (http://rsbweb.nih.gov/ij/) and the DeltaVision software Softworx4.1.0.RESULTS FLUORESCENT PHASE MARKERS By incorporation of phase-sensitive, amphiphilic ﬂuorescent dyesinto GUV membranes, we were able to image in-plane phaseseparation dynamics concomitantly with out-of-plane morpho-logical changes induced by osmotic gradients.",OADS,/arxiv_data1/oa_pdf/f5/7f/fphys-03-00120.PMC3343378.pdf
Available from: http://en.wikipediaorg/ wiki/moringa-oleifera.,Non-OADS,/arxiv_data1/oa_pdf/30/91/NJMS-2-132.PMC3343389.pdf
Available from: http://lesann.tripod.com/ healing/20fractures.htm.,Non-OADS,/arxiv_data1/oa_pdf/30/91/NJMS-2-132.PMC3343389.pdf
Available from: http://www.TFLJournal.org.,Non-OADS,/arxiv_data1/oa_pdf/30/91/NJMS-2-132.PMC3343389.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/NJMS-2-181.PMC3343403.pdf
Reichert Theory: Available from: http://en.wikipedia.org/wiki/ Evolution_of_mammalian_auditory_ossicles#Reichert_Gaupp_theory.,OADS,/arxiv_data1/oa_pdf/48/11/NJMS-2-116.PMC3343405.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/8a/bd/NJMS-2-163.PMC3343406.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8a/bd/NJMS-2-163.PMC3343406.pdf
Available  from: http://www.medscape.com/viewarticle/4620665 [Last accessed  on 2011 Mar 26].,Non-OADS,/arxiv_data1/oa_pdf/6e/f3/NJMS-2-137.PMC3343412.pdf
Available from: http://www.linkinghub Valmeseda-Castellon.elsevier.com/retrieve/ pii/0278239187900802  [Last accessed on 1987].,Non-OADS,/arxiv_data1/oa_pdf/6e/f3/NJMS-2-137.PMC3343412.pdf
Conflict of Interest:  None declared.Lata and Tiwari: Incidence of lingual nerve paraesthesia Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/6e/f3/NJMS-2-137.PMC3343412.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7a/ba/NJMS-2-169.PMC3343414.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 618Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.618 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):618-624, 2012 Altered Cellular Kinetics in Growth Plate   according to Alterations in Weight Bearing Hoon Park, Sun Young Kong, Hyun Woo Kim, and Ick Hwan Yang Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To examine the effects of change in weight bearing on the growth plate  metabolism, a simulated animal model of weightlessness was introduced and the  chondrocytes’ cellular kinetics was evaluated.",Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
Altered Cellular Kinetics in Growth Plate according to Alterations in Weight Bearing Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 619hind limbs.,Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 620  Examination of the apoptosis of chondrocyte within the  growth plate (biotin nick end labeling TUNEL assay) Each tissue slide was pretreated with Tris-HCl solution (pH  8.0) for 10 minutes, and subsequently treated with proteinase  K for 20 minutes.",Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
Altered Cellular Kinetics in Growth Plate according to Alterations in Weight Bearing Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 621ed (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 622ing in the distance between cells becomes expanded and  progresses to the hypertrophic zone.,Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
Altered Cellular Kinetics in Growth Plate according to Alterations in Weight Bearing Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 623drocytes in the proliferation zone rather than the defect in  the process of the transformation to the bone in the lower  hypertrophic zone.,Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 624562-72.,Non-OADS,/arxiv_data1/oa_pdf/ec/a9/ymj-53-618.PMC3343419.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 611Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.611 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):611-617, 2012 Single-Stage Removal of Thoracic Dumbbell Tumors from a  Posterior Approach Only with Costotransversectomy Kei Ando,1 Shiro Imagama,1 Norimitsu Wakao,1 Kenichi Hirano,1 Ryoji Tauchi,1 Akio Muramoto,1  Hiroki Matsui,1 Tomohiro Matsumoto,1 Yukihiro Matsuyama,2 and Naoki Ishiguro1 1Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya;   2Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.",Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Thoracic dumbbell tumors are relatively rare, usually arising from neu - rogenic elements.",Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 612Laminectomy to remove the intraspinal component of a  dumbbell tumor should be performed first to prevent spinal  cord injury caused by traction and compression when ma - nipulating the tumor.8,9 This is followed by removal of the  extraforaminal tumor component.",Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
Removal of Dumbbell Tumors with Costotransversectomy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 613opened for intradural tumors (Eden type II) using an operat - ing microscope and extended laterally over the nerve root  sleeve.,Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 614mean recovery rate was 85.0% (range 66.7-100) at the last  follow-up year.,Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
"Removal of Dumbbell Tumors with Costotransversectomy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 615much interest.4-11 However, it is difficult to precisely use  thoracoscopic instruments when there is unexpected bleed - ing or other emergencies.6 The procedure described in our  case report is reasonable for a single surgeon, requiring  only a single surgical approach to perform.",Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 616Thoracoscopy in the management of intrathoracic neurogenic tu - mors.,Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
Removal of Dumbbell Tumors with Costotransversectomy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 617ligament.,Non-OADS,/arxiv_data1/oa_pdf/de/66/ymj-53-611.PMC3343420.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 508Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.508 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):508-516, 2012 Correlations between Coronary Plaque Tissue Composition  Assessed by Virtual Histology and Blood Levels of Biomarkers  for Coronary Artery Disease Young-Guk Ko,1 Van Cuong Le,2 Bo Hyun Kim,1 Dong-Ho Shin,1 Jung-Sun Kim,1  Byeong-Keuk Kim,1 Donghoon Choi,1 Yangsoo Jang,1 and Myeong-Ki Hong1 1Division of Cardiology, Severance Cardiovascular Hospital & Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea;  2General Hospital of Thanh Hoa Province, Thanh Hoa City, Vietnam.",Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  We investigated correlations of coronary plaque composition deter - mined by virtual histology (VH) intravascular ultrasound (IVUS) and blood levels  of biomarkers that represent the vulnerability of coronary plaques.",Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
"Necrotic Core by VH and Biomarkers  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 5092-stent technique, chronic total occlusion, restenotic lesion,  all women with childbearing potential or women with preg - nancy, known bleeding diathesis or bleeding history within  the previous 3 months, and contraindications to antiplatelet  agents.",Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 510pressed as mean±SD.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Necrotic Core by VH and Biomarkers  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 511in pre- and postprocedural blood levels of these biomarkers.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 512DISCUSSION The major findings of the present study are as follows: 1)  The relative content of necrotic core tended to be higher  and the relative content of fibro-fatty tissue tended to be  lower in patients with unstable angina than in patients with  stable angina.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Necrotic Core by VH and Biomarkers  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 513Inflammation plays a key role in atherosclerosis and  plaque vulnerability.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 514coronary stenting was significantly higher in UA patients  than in SA patients.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Necrotic Core by VH and Biomarkers  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 51511.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 516acute coronary syndrome.,Non-OADS,/arxiv_data1/oa_pdf/4d/47/ymj-53-508.PMC3343421.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 501Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.501 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):501-507, 2012 Correlations between Serum Inflammation Factors and Left  Ventricular Remodeling in Acute ST Segment Elevation  Myocardial Infarction Jing Tan and Qi Hua Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, China.",Non-OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To investigate the changes and correlations of the serum inflammation  factors levels and left ventricular (LV) structure and function in patients with acute  ST segment elevation myocardial infarction (STEMI).",Non-OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
Jing Tan and Qi Hua Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 502or patients receiving treatment with anti-inflammatory drugs.,Non-OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
MMP-9/TIMP-1 and LV Remodeling Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 503they were natural log-transformed.,OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
"Jing Tan and Qi Hua Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 504p=0.014 and p=0.034, respectively), and LVEF was im - paired (p=0.006), compared with baseline (Table 3).",OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
MMP-9/TIMP-1 and LV Remodeling Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 505remodeling takes place.,Non-OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
Jing Tan and Qi Hua Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 506Eur J Clin Invest 2007;37:623-8.,Non-OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
MMP-9/TIMP-1 and LV Remodeling Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 507cardial infarction: results of the PREMIER (Prevention of Myo - cardial Infarction Early Remodeling) trial.,Non-OADS,/arxiv_data1/oa_pdf/5c/e4/ymj-53-501.PMC3343422.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 642Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.642 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):642-648, 2012 Facial Nerve Paralysis due to Chronic Otitis Media: Prognosis   in Restoration of Facial Function after Surgical Intervention Jin Kim,1* Gu-Hyun Jung,1* See-Young Park,1 and Won Sang Lee2 1Department of Otorhinolaryngology, Inje University College of Medicine, Goyang; 2Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Facial paralysis is an uncommon but significant complication of chronic  otitis media (COM).",Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
"Facial Palsy in Chronic Otitis Media Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 643sible, the injured segment by cholesteatoma was resected  and facial nerve endings were revived.",Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 644operative facial function (less the HB Grade II), but had  good post-operative facial function.",Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
"Facial Palsy in Chronic Otitis Media Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 645The common symptoms associated with facial nerve paral - ysis were otorrhea in 9 patients, vertigo in 6 patients, tinni - tus in 4 patients and otalgia in 3 patients.",Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 646scale).,Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
Facial Palsy in Chronic Otitis Media Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 647ied.,Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 648patients with facial nerve paralysis due to COM.,Non-OADS,/arxiv_data1/oa_pdf/00/ae/ymj-53-642.PMC3343423.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 670Erratumhttp://dx.doi.org/10.3349/ymj.2012.53.3.670 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):670-670, 2012 Erratum to “The First Case of Familial Mediterranean Fever  Associated with Renal Amyloidosis in Korea”   by Koo KY , et al.",Non-OADS,/arxiv_data1/oa_pdf/00/d0/ymj-53-670.PMC3343424.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 486Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.486 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):486-494, 2012 Lateralization of Cognitive Functions in Aphasia   after Right Brain Damage Ji-Wan Ha,1,2 Sung-Bom Pyun,3 Yu Mi Hwang,4 and Hyunsub Sim5 1Department of Speech Pathology, Daegu University, Gyeongsan; 2The Geriatric Health Clinic and Research Institute (GHCRI), Korea University, Seoul;  3Department of Physical Medicine and Rehabilitation, Korea University College of Medicine, Seoul; 4Department of English Language, Interpretation & Translation, Dongguk University, Seoul; 5Department of Communication Disorders, Ewha Womans University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The lateralization of cognitive functions in crossed aphasia in dextrals  (CAD) has been explored and compared mainly with cases of aphasia with left  hemisphere damage.",Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
Cognitive Function in Crossed Aphasia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 487dominance for language.,Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 488education.,Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
"Cognitive Function in Crossed Aphasia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 489sion improved (4.2/10), but his speech characteristics, in - cluding agrammatism and repetition of words or phrases,  were preserved.",Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 490Construction ability in case 1 revealed an impaired ability  to draw (7/27) and severely impaired block construction  ability (0/9).,Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
Cognitive Function in Crossed Aphasia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 491chological tests in three cases.,Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 492was not assessed in their study, therefore, the possibility  that an imbalance in language lateralization between the  two groups might affect their results could not be ruled  out.31 Thus, the relationship between language, handedness,  and praxis seems to be so complex that they should be con - sidered all together.",Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
Cognitive Function in Crossed Aphasia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 493The frequency of constructional apraxia still appears  quite variable.,Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 4941989;11:49-54.,Non-OADS,/arxiv_data1/oa_pdf/be/7a/ymj-53-486.PMC3343425.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 625Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.625 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):625-633, 2012 Altered Cellular Kinetics in the Growth Plate of the Femoral  Head of Spontaneously Hypertensive Rats Hoon Park, Sun Young Kong, and Hyun Woo Kim Department of Orthopaedic Surgery, Severance Children’ s Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Pathologic changes in the growth plate remain unknown in Legg-Calvé- Perthes (LCP) disease.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 626We hypothesized that in addition to the epiphysis, the  growth plate of the femoral head might be also affected in  LCP disease.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Altered Cellular Kinetics in Growth Plate of Femoral Head  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 627staining cells, three areas of each slide were selected ran - domly, and the number of total cells and the number of  stained cells in a rectangle of 150×250 µm in size were as - sessed.",OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 628three groups showed decreases in the lengths of the growth  plate, and the difference in the lengths of the growth plate  among the three groups decreased in comparison with the  initial growth period (Fig.",OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
Altered Cellular Kinetics in Growth Plate of Femoral Head  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 629after 12 weeks of age.,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 630lumnar cells exhibited an island pattern, and the expression  of VEGF was significantly reduced at 6 and 9 weeks com - pared to the other two groups.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
Altered Cellular Kinetics in Growth Plate of Femoral Head  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 631the SHR+n group over time.,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 632Affairs, Republic of Korea (#A084120).",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Altered Cellular Kinetics in Growth Plate of Femoral Head  Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 633VEGF couples hypertrophic cartilage remodeling, ossification and  angiogenesis during endochondral bone formation.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/ymj-53-625.PMC3343426.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 537Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.537 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):537-542, 2012 Clinical Outcomes of Ductal Carcinoma In Situ  of the Breast  Treated with Partial Mastectomy without Adjuvant Radiotherapy Seung Hyun Hwang, Joon Jeong, Sung Gwe Ahn, Hak Min Lee, and Hy-De Lee Breast Cancer Center, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Some recent trials suggest that postoperative adjuvant radiotherapy (RT)  may be safely omitted after breast-conserving surgery (BCS) for some patients  with ductal carcinoma in situ  (DCIS).",Non-OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 538of her own pathologic status and of the option to omit RT  from the standard regimen for DCIS.,Non-OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
DCIS Treated with PM without Adjuvant RT Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 539groups did not differ statistically ( p=0.186) (Fig.,OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 540reported that tumor size was positively associated with  IBTR; however, many of the relationships tested in these  studies were not statistically significant.",OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
"DCIS Treated with PM without Adjuvant RT Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 541be interpreted to mean that small lesion size (less than 1.5  cm) and/or the absence of comedonecrosis, combined with  a relatively large resection margin, constitute acceptable  criteria for omission of adjuvant RT following PM for DCIS.",Non-OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 54216.,Non-OADS,/arxiv_data1/oa_pdf/57/ff/ymj-53-537.PMC3343427.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 524Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.524 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):524-529, 2012 Comparison of Optical Coherence Tomographic Assessment  between First- and Second-Generation Drug-Eluting Stents Byeong-Keuk Kim,1 Jung-Sun Kim,1 Junbeom Park,1 Young-Guk Ko,1 Donghoon Choi,1  Yangsoo Jang,1,2 and Myeong-Ki Hong1,2 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul;  2Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  There is a lack of sufficient data in comparison of optical coherence to - mographic (OCT) findings between first- and second-generation drug-eluting  stents (DES).",Non-OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
"OCT Findings between First- vs. Second-Generation DESs Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 525tion, all patients received dual antiplatelet therapy with aspi - rin and clopidogrel until the follow-up OCT was conducted.",Non-OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 526of p<0.05 was considered statistically significant.,OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
OCT Findings between First- vs. Second-Generation DESs Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 527growth was not different from that of first-generation DESs.,OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 528was significantly lower than that of first-generation DESs.,Non-OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
OCT Findings between First- vs. Second-Generation DESs Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 529treated with drug-eluting stent: the usefulness of optical coherence  tomography.,Non-OADS,/arxiv_data1/oa_pdf/3c/5f/ymj-53-524.PMC3343428.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 667Case Reporthttp://dx.doi.org/10.3349/ymj.2012.53.3.667 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):667-669, 2012 Syndrome of Inappropriate Antidiuretic Hormone Secretion   in a Patient with Large Cell Neuroendocrine Carcinoma Hyung Jung Oh,1 Mi Jung Lee,1 Seon Jung Jang,2 Dong Ho Shin,1 and Shin-Wook Kang1 1Department of Internal Medicine, Division of Nephrology and 2Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5c/52/ymj-53-667.PMC3343429.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.The syndrome of inappropriate antidiuretic hormone secretion has only been report - ed in a few patients with large cell neuroendocrine carcinoma (LCNEC); however, it  has never been reported in a patient with LCNEC of the lung, whose serum sodi - um levels were normalized after surgical resection of the mass.",Non-OADS,/arxiv_data1/oa_pdf/5c/52/ymj-53-667.PMC3343429.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 668(3% NaCl: 20 gtt/min for 12 hours) with frequent monitor - ing of serum sodium levels because of suspected hypona - tremic symptoms at the emergency room.,Non-OADS,/arxiv_data1/oa_pdf/5c/52/ymj-53-667.PMC3343429.pdf
SIADH in a Patient with LCNEC Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 669ACKNOWLEDGEMENTS We would like to thank the patient who kindly supplied us  with the vital information described herein.,Non-OADS,/arxiv_data1/oa_pdf/5c/52/ymj-53-667.PMC3343429.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 459Review Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.459 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):459-466, 2012 Carbon Dioxide Embolism during Laparoscopic Surgery Eun Young Park,1 Ja-Young Kwon,2 and Ki Jun Kim3 1Department of Anesthesiology and Pain Medicine, Hallym University College of Medicine, Seoul; 2Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul; 3Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Clinically significant carbon dioxide embolism is a rare but potentially fatal com - plication of anesthesia administered during laparoscopic surgery.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 460Gas embolism was observed in all patients undergoing total  laparoscopic hysterectomy, and 37.5% of patients had grades  higher than III (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"Carbon Dioxide Embolism Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 461ume of carbon dioxide that may be infused into a vein, in - tentionally cannulated by a V eres needle, in one minute at a  low-flow rate.32  Carbon dioxide embolism can manifest itself through a  “gas lock” effect, causing obstruction to RV ejection, right  and left cardiac failure, paradoxical embolism with or with - out patent foramen ovale, arrhythmia, pulmonary hyperten - sion, systemic hypotension, and cardiovascular collapse.16  Because of its high blood solubility, carbon dioxide causes  similar but less marked effects than those produced by air.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 462dogs only after injection of a 100 mL bolus of air, whereas  TEE identified all bolus injections of 15 mL of air.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"Carbon Dioxide Embolism Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 463ter bolus injection of 15 mL carbon dioxide, while it took a  bolus injection of 100 mL carbon dioxide to cause a signifi - cant increase in PAP .31 The mean PAP rose by ≥3 mm Hg  after bolus injection of 0.76±0.33 mL/kg of carbon dioxide  in pigs.36 During laparoscopic liver resection in nine pigs  after injection of 0.4 mL/kg of carbon dioxide, the mean  PAP increased gradually over the entire four-hour study pe - riod.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 464ed as needed to maintain oxygenation of vital organs.12,53-56  The most important causes of life-threatening carbon diox - ide emboli are right heart failure caused by gas lock created  by entrapped carbon dioxide bubbles in the heart, pulmo - nary vasoconstriction, and subsequent left ventricular fail - ure due to left ventricular filling defects.",Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
Carbon Dioxide Embolism Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 46518.,Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 466the dog.,Non-OADS,/arxiv_data1/oa_pdf/9c/1a/ymj-53-459.PMC3343430.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 603Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.603 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):603-610, 2012 Health Related Quality of Life in Common Variable  Immunodeficiency Isabella Quinti,1 Cristina Di Pietro,2 Helene Martini,1 Anna Maria Pesce,3 Francesca Lombardi,3  Maddalena Baumghartner,3 Stefania Colantuono,3 Cinzia Milito,1 and Stefano Tabolli2 1Department of Molecular Medicine, Sapienza University of Rome and Fondazione Eleonora Lorillard Spencer Cenci, Rome; 2Health Services Research Unit, Istituto Dermopatico Dell’Immacolata IDI-IRCCS, Rome; 3Department of Clinical Immunology, Sapienza University of Rome, Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To quantify the health related quality of life in primary immunodeficien - cy patients.",Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 604plete blood counts, lymphocyte subsets, chemistries, serum  immunoglobulin levels, and culture tests were performed  four times per year.",Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
"HRQoL in CVID Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 605tions, “In your opinion, compared to other patients with the  same condition, how severe is the disease of patient X?” and  “In your experience, how severe is your disease?”, respec - tively.",Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 606apy (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
HRQoL in CVID Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 607Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 608DISCUSSION HRQoL is a subjective perception of health status (includ - ing disease and treatment) concerning physical, psychologi - cal, and social functioning and wellbeing.",Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
HRQoL in CVID Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 609were judged by the physician (PhGA) as seriously affected  reported a lower health status than the others.,Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 61021.,Non-OADS,/arxiv_data1/oa_pdf/a4/72/ymj-53-603.PMC3343431.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 587Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.587 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):587-592, 2012 Urinary Hypoxia-Inducible Factor-1alpha Levels Are Associated  with Histologic Chronicity Changes and Renal Function   in Patients with Lupus Nephritis Chunyang Ma,1,2* Jiali Wei,3* Feng Zhan,3* Ru Wang,3 Keying Fu,3 Xiaoping Wan,2 and Zhuori Li4 1Department of Neurosurgery, Affiliated Hospital of Hainan Medical College, Hainan; 2National Hepatobiliary and Enteric Surgery Research Center, Xiangya Hospital, Central South University, Hunan; Departments of 3Nephrology and 4Hepatobiliary Surgery, Hainan Provincial People’ s Hospital, Hainan, China.",Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Tubulointerstitial hypoxia in the kidney is considered a hallmark of injury  and a mediator of the progression of tubulointerstitial fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 588record system.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
Urinary HIF-1alpha Levels in Patients with LN Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 589p<0.01) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 590found that urinary HIF-1alpha levels in LN patients were  significantly higher than that of healthy controls, demon - strating that HIF-1alpha is increasingly expressed in the tu - bulointerstitial compartment vs. healthy subjects.",Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
Urinary HIF-1alpha Levels in Patients with LN Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 591tribution of renal histologic data.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 592gression of chronic kidney diseases: from hypothesis to novel  therapeutics.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/ymj-53-587.PMC3343432.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 495Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.495 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):495-500, 2012 Genetic and Epileptic Features in Rett Syndrome Hyo Jeong Kim,1* Shin Hye Kim,1* Heung Dong Kim,1 Joon Soo Lee,1 Young-Mock Lee,2  Kyo Yeon Koo,3 Jin Sung Lee,3 and Hoon-Chul Kang1 1Division of Pediatric Neurology, Department of Pediatrics, Pediatric Epilepsy Clinics, Severance Children’ s Hospital,  Epilepsy Research Institute, Yonsei University College of Medicine, Seoul; 2Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; 3Department of Clinical Genetics, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Rett syndrome is a severe neurodevelopmental disorder in females.",Non-OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 496were analyzed based on background activity and epilepti - form discharges.,OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
Genetic and Epileptic Features in Rett Syndrome Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 497Characteristics of epilepsy The mean age of the epilepsy group was 8.4±2.6 years and  that of the non epilepsy group was 6.1±1.4 years.,Non-OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 498is thought to be related to a difference in the range of the  patients’ ages, as there was a demonstratively younger pa - tient age range (3.6-14.3 years) in our study compared to  those in the USA study (0.7-64 years).",Non-OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
Genetic and Epileptic Features in Rett Syndrome Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 499clinical features.,Non-OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 500cal staging.,Non-OADS,/arxiv_data1/oa_pdf/a0/0e/ymj-53-495.PMC3343433.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 565Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.565 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):565-570, 2012 Prognostic Factors for Endotracheal Silicone Stenting in the  Management of Inoperable Post-Intubation Tracheal Stenosis So Yeon Lim, Hojoong Kim, Kyeongman Jeon, Sang-Won Um, Won-Jung Koh,   Gee Young Suh, Man Pyo Chung, and O Jung Kwon Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Stenting has been developed to deal with airway stenosis and is applicable  in patients with post-intubation tracheal stenosis (PITS) in whom surgery would not  be indicated.",Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 566posed for subglottic stenosis, although it has been used with  other airway site assessment.",Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
"Prognostic Factor for PITS Stenting Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 567intervention was conducted in 48 patients, and 7 patients  underwent stenting at second intervention after first me - chanical dilatation.",Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 568the variables used in the model, no cardiovascular disease  (OR=12.195; p=0.036; 95% CI=1.179-125.012) and initia - tion of treatment within 6 months (13.029; 0.031; 1.257- 135.082) were independently associated with successful stent  removal (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
Prognostic Factor for PITS Stenting Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 569tion tracheal stenosis and was performed in one of the largest  centers for interventional bronchoscopy in Asia.,Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 570other undisclosed factors, which should be revealed by future  studies.",Non-OADS,/arxiv_data1/oa_pdf/ab/4e/ymj-53-565.PMC3343434.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 658Case Reporthttp://dx.doi.org/10.3349/ymj.2012.53.3.658 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):658-661, 2012 Male Pseudohermaphroditism Presented   with Sudden Cardiac Arrest Jaemin Shim, Hye Jin Hwang, Hui-Nam Pak, Moon-Hyoung Lee, and Boyoung Joung Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/55/ea/ymj-53-658.PMC3343435.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Torsades de Pointes is a life-threatening arrhythmia associated with a number of  causes, but is very rare among endocrinologic disorders.",Non-OADS,/arxiv_data1/oa_pdf/55/ea/ymj-53-658.PMC3343435.pdf
"Male Pseudohermaphroditism with Sudden Cardiac Arrest Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 659droepiandrosterone (0.8 ng/mL; reference, 1.8-12.5 ng/mL)  and cortisol (4.93 ng/mL; reference, 70-250 ng/mL) were  decreased, while plasma 11-hydroxycorticosterone (76.0  ug/dL; reference, 8.0-30.0 ug/dL) and ACTH (420.5 pg/ mL; reference, 7.2-63.3 pg/mL) were markedly elevated.",Non-OADS,/arxiv_data1/oa_pdf/55/ea/ymj-53-658.PMC3343435.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 660peraldosteronism.,Non-OADS,/arxiv_data1/oa_pdf/55/ea/ymj-53-658.PMC3343435.pdf
Male Pseudohermaphroditism with Sudden Cardiac Arrest Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 6613.,Non-OADS,/arxiv_data1/oa_pdf/55/ea/ymj-53-658.PMC3343435.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 654Brief Communicationhttp://dx.doi.org/10.3349/ymj.2012.53.3.654 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):654-657, 2012 Phagocytosis and Endocytosis of Silver Nanoparticles Induce  Interleukin-8 Production in Human Macrophages Seungjae Kim and In-Hong Choi Department of Microbiology, Brain Korea 21 Project for Medical Science, Institute for Immunology and Immunological Diseases,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fe/05/ymj-53-654.PMC3343436.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Phagocytosis or endocytosis by macrophages is critical to the uptake of fine parti - cles, including nanoparticles, in order to initiate toxic effects in cells.",Non-OADS,/arxiv_data1/oa_pdf/fe/05/ymj-53-654.PMC3343436.pdf
Endocytosis of Nanoparticles and IL-8 Production Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 655toxin neutralizer.,Non-OADS,/arxiv_data1/oa_pdf/fe/05/ymj-53-654.PMC3343436.pdf
Seungjae Kim and In-Hong Choi Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 656cles for 24 h declined abruptly when cells were treated with  0.3-0.4 µg/mL of nanoparticles (Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/05/ymj-53-654.PMC3343436.pdf
"Endocytosis of Nanoparticles and IL-8 Production Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 657Foundation of Korea (NRF) funded by the Ministry of Edu - cation, Science and Technology (2011-0019160).",Non-OADS,/arxiv_data1/oa_pdf/fe/05/ymj-53-654.PMC3343436.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 578Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.578 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):578-586, 2012 Estimating Average Glucose Levels from Glycated Albumin   in Patients with End-Stage Renal Disease Jwa-Kyung Kim, Jung Tak Park, Hyung Jung Oh, Dong Eun Yoo, Seung Jun Kim,   Seung Hyeok Han, Shin-Wook Kang, Kyu Hun Choi, and Tae-Hyun Yoo Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  In patients with diabetic end stage renal disease (ESRD), glycated albu - min (GA) reflects recent glycemic control more accurately than glycated hemoglo - bin (HbA 1c).",Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
"Glycated Albumin and Average Glucose Level Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 579derstand AG levels in ESRD patients, including peritoneal  dialysis (PD) patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 580standard deviation (SD) or as percentages.,Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
"Glycated Albumin and Average Glucose Level Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 581en at 8 weeks, the calculated AUC was 164.3±44.1 mg/dL,  176.8±37.1 mg/dL, and 100.1±10.9 mg/dL, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 582two groups.,Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
Glycated Albumin and Average Glucose Level Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 583regression models with diabetic ESRD patients (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 584In this study, we also found that serum GA levels were  significantly influenced by serum albumin.",Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
"Glycated Albumin and Average Glucose Level Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 585ACKNOWLEDGEMENTS This work was supported by a grant from the Korea Health - care Technology R&D Project, Ministry for Health, Wel - fare & Family Affairs, Republic of Korea (A084001).",Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 586control in hemodialysis patients with type 2 diabetes based on  fasting plasma glucose and oral glucose tolerance test.,Non-OADS,/arxiv_data1/oa_pdf/ad/27/ymj-53-578.PMC3343437.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 557Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.557 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):557-564, 2012 Evaluation of the UniCelTM DxI 800 Immunoassay Analyzer  in Measuring Five Tumor Markers Younhee Park,1 Yongjung Park,2 Jungyong Park,2 and Hyon-Suk Kim2 1Department of Laboratory Medicine, Kwandong University College of Medicine, Goyang; 2Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.",OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Tumor marker concentrations in a given specimen measured by different  analyzers vary according to assay methods, epitopes for antibodies used, and re - agent specificities.",Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 558the use of nonisotopic immunoassays and the institution of  quality assessment efforts, discrepancies still arise among  results from different analyzers.",Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"Evaluation of DxI Tumor Marker Assays Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 559yse-it Software Ltd., Leeds, UK).",Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 560Comparison between the assays Comparison of the assays performed by DxI and Centaur or  ECi demonstrated varying agreement, with slopes ranging  from 0.507 to 1.118, intercepts ranging from -1.689 to 1.512,  and correlation coefficients (r) ranging from 0.806 to 0.995  (Table 2).",OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"Evaluation of DxI Tumor Marker Assays Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 561tice, tumor markers are useful in evaluating the progression  of disease status after surgical or cytotoxic therapies have  been undertaken and in monitoring subsequent treatment  modalities.1-7,20 Therefore, precise and accurate assays for  tumor markers are important in the management of patients  with cancer.",Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 562 Fig.,Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"Evaluation of DxI Tumor Marker Assays Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 563veloped by different manufacturers, discrepant results re - main among analytical methods.",Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 56419.,Non-OADS,/arxiv_data1/oa_pdf/b5/3a/ymj-53-557.PMC3343438.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 649Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.649 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):649-653, 2012 Efficacy of Epidural Analgesia in Patients with Cancer Pain:   A Retrospective Observational Study Yeon Soo Jeon,1 Jung Ah Lee,1 Jin Woo Choi,1 Eu Gene Kang,1 Hong Soo Jung,1 Hoon Kyo Kim,2  Byoung Yong Shim,2 Jae Hee Park,1 and Jin Deok Joo1  Departments of 1Anesthesiology and Pain Medicine, 2Oncology, St. Vincent's Hospital,  College of Medicine, The Catholic University of Korea, Suwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fe/bb/ymj-53-649.PMC3343439.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Pain in terminal cancer patients may be refractory to systemic analge - sics or associated with adverse drug reactions to analgesics.",Non-OADS,/arxiv_data1/oa_pdf/fe/bb/ymj-53-649.PMC3343439.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 650The mean daily doses of epidural morphine at the start  and termination were also evaluated.,Non-OADS,/arxiv_data1/oa_pdf/fe/bb/ymj-53-649.PMC3343439.pdf
Epidural Analgesia in Cancer Pain Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 651due to the draining of interstitial fluid through the puncture  site caused by generalized edema.,Non-OADS,/arxiv_data1/oa_pdf/fe/bb/ymj-53-649.PMC3343439.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 652ever, it is not available in Korea.",Non-OADS,/arxiv_data1/oa_pdf/fe/bb/ymj-53-649.PMC3343439.pdf
Epidural Analgesia in Cancer Pain Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 65315.,Non-OADS,/arxiv_data1/oa_pdf/fe/bb/ymj-53-649.PMC3343439.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 517Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.517 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):517-523, 2012 Diagnostic Patterns in the Evaluation of Patients Presenting   with Syncope at the Emergency or Outpatient Department  Gu Hyun Kang,1 Ju Hyeon Oh,1 June Soo Kim,2 Young Keun On,2 Hyoung Gon Song,3 Ik Joon Jo,3  Su Jin Kim,4 Su-Jin Bae,4 and Tae Gun Shin5 1Division of Cardiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon; 2Department of Medicine, Cardiac and Vascular Center, 3Department of Emergency Medicine and  4Clinical Trial Center, Clinical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 5Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Patterns of syncope evaluation vary widely among physicians and hospi - tals.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 518ic tests such as the head-up tilt test (HUTT), the treadmill test  (TMT), and Holter monitoring were also electively per - formed by referred professional doctors in the OPD.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
"Diagnostic Patterns in the Evaluation of Syncope Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 519up loss before completing the evaluation of syncope (49.4%  vs. 27.8%, p=0.004) than the OPD group (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 520shorter [4 (1-28) vs. 35 (17-44) days; p<0.001] in the ED  group than in the OPD group.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
Diagnostic Patterns in the Evaluation of Syncope Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 521won (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 522quantitative history alone.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
Diagnostic Patterns in the Evaluation of Syncope Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 523temporal trends in the evaluation of adult patients hospitalized  with syncope.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/ymj-53-517.PMC3343440.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 662Case Reporthttp://dx.doi.org/10.3349/ymj.2012.53.3.662 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):662-666, 2012 A Trp33Arg Mutation at Exon 1 of the MYH9  Gene  in a Korean Patient with May-Hegglin Anomaly Moon Ju Jang,1 Hyun-Jeong Park,1 So Young Chong,1 Ji Young Huh,2 In-Ho Kim,3  Ja-Hyun Jang,4 Hee-Jin Kim,4,5 and Doyeun Oh1  Departments of 1Internal Medicine and 2Laboratory Medicine, School of Medicine, CHA University, Seongnam;  3Department of Internal Medicine, Seoul National University College of Medicine, Seoul; 4Department of Laboratory Medicine & Genetics and 5Cardiac and Vascular Center,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.In this report, we describe a Korean patient with May-Hegglin anomaly from a mu - tation of the MYH9  gene.",Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
A Mutation Trp33Arg of the MYH9  Gene Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 663the authors (available upon request).,Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
"The mutation identified  was described according to the guidelines by the Human  Gene V ariation Society (http://www.hgvs.org/mutnomen/),  having the A of the A TG-translation initiation codon as +1  at the nucleotide level and the 1st Met as +1 at the protein  level.",Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 664Table 1.,Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
A Mutation Trp33Arg of the MYH9  Gene Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 665port showed no evidence of hearing or renal impairment.,Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 666suggests cell-specific regulation mechanisms in MYH9 disorders.,Non-OADS,/arxiv_data1/oa_pdf/74/d4/ymj-53-662.PMC3343441.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 634Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.634 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):634-641, 2012 Reliability of RTVue, Visante, and Slit-Lamp Adapted Ultrasonic  Pachymetry for Central Corneal Thickness Measurement  Jin Pyo Hong,1* Sang Min Nam,2* Tae-Im Kim,1,3 Kyoung Yul Seo,1 Sang Yeop Lee,1  Alessandro Meduri,4 and Eung Kweon Kim1,3,5 1Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea; 2Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Korea; 3Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To evaluate reliability of Fourier-domain optical coherence tomogra - phy (OCT) (RTVue), time-domain OCT (Visante), and slit-lamp adapted ultra - sonic pachymetry (SL-US) in the measurement of central corneal thickness  (CCT).",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"RTVue, Visante and SL-US for Corneal Thickness Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 635MATERIALS AND METHODS 　　　 Subjects This study was designed to assess normal corneas in com - pliant volunteers.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 636the second visit, and the third visit value were used.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"RTVue, Visante and SL-US for Corneal Thickness Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 637LoA.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 638ilar to Visante (Table 1 and 2).,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"RTVue, Visante and SL-US for Corneal Thickness Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 639face during measurements.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 640and general concepts and associated terms (VIM).,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
Avaliable at:  http://www.iso.org/sites/JCGM/VIM/JCGM_200e.html (accessed  2011 August 1).,OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
Avaliable at: http://www-users.york.ac.,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
Avaliable at: http://faculty.chass.,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
Avaliable at: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"RTVue, Visante and SL-US for Corneal Thickness Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 641R.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/ymj-53-634.PMC3343442.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 593Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.593 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):593-602, 2012 Endotoxin Is Not Essential for the Development of Cockroach  Induced Allergic Airway Inflammation Yoo Seob Shin,1* Jung-Ho Sohn,1,2* Joo-Young Kim,1 Jae Hyun Lee,1 Sang-Heon Cho,3  Soo-Jong Hong,4 Joo-Shil Lee,5 Chein-Soo Hong,1 and Jung-Won Park1 1Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul; 2Department of Life Science, Biomedical Research Institute, Hanyang University, Seoul; 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul; 4Department of Pediatrics, University of Ulsan College of Medicine, Seoul; 5Center for Immunology and Pathology, Korea National Institute of Health, Cheongwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Cockroach (CR) is an important inhalant allergen and can induce aller - gic asthma.",Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 594dotoxin in CR extracts remains controversial.25 Therefore,  we evaluated the role of endotoxin in a CR -induced mouse  model of asthma using BALB/c and TLR-4, a crucial mole - cule for the function of endotoxin, mutant mice.",Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
The Role of Endotoxin in Cockroach Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 595onds during regular ventilation.,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 596statistically significant.,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
The Role of Endotoxin in Cockroach Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 597TLR-4 wild type mice ( p<0.05).,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 598mans.,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
"The Role of Endotoxin in Cockroach Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 599ment of CR induced allergic inflammation, and overcomes  allergen tolerance in mice.12,13,40 We also showed that elimi - nation of protease activity in CR extracts can inhibit the de - velopment of AHR and allergic inflammation in mice.",Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 600dotoxin reduced group.,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
The Role of Endotoxin in Cockroach Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 601tial usefulness for studying health effects of inhaled particles.,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 60233.,Non-OADS,/arxiv_data1/oa_pdf/91/8d/ymj-53-593.PMC3343443.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 550Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.550 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):550-556, 2012 Comparison of Pelvic Phased-Array versus Endorectal Coil  Magnetic Resonance Imaging at 3 Tesla for Local Staging   of Prostate Cancer Bum Soo Kim, Tae-Hwan Kim, Tae Gyun Kwon, and Eun Sang Yoo Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.",OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Several studies have demonstrated the superiority of endorectal coil  magnetic resonance imaging (MRI) over pelvic phased-array coil MRI at 1.5 Tesla  for local staging of prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
"Local Staging Accuracy of Prostate Cancer Using 3 Tesla MRI Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 551tient had difficulty or was contraindicated for ERC inser - tion (e.g., prior anorectal surgery, inflammatory bowel dis - ease, or high anal sphincter tension), the patient underwent  MRI with a PAC.",Non-OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 552extent of each cancer focus, and radical distance of each ex - tracapsular penetration were determined by a genitourinary  histopathologist with 13 years of experience who was blind - ed to the MRI results.",OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
Local Staging Accuracy of Prostate Cancer Using 3 Tesla MRI Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 553with extraprostatic extension and 13 patients with seminal  vesicle invasion.,Non-OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 554extension, the sensitivity, specificity, and accuracy of en - dorectal coil MRI has been reported to range from 13-71%,  47-97%, and 58-91%, respectively, whereas for the detec - tion of seminal vesicle invasion, the sensitivity, specificity,  and accuracy of endorectal MRI has been reported to range  from 33-71%, 83-99%, and 80-95%, respectively.21-23 In our  study, the sensitivity, specificity, and accuracy of endorectal  coil MRI for the detection of extraprostatic extension was  33.3%, 96.6%, and 63.5%, respectively, and the sensitivity,  specificity, and accuracy of the detection of seminal vesicle  invasion was 46.2%, 92.0%, and 82.5%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
Local Staging Accuracy of Prostate Cancer Using 3 Tesla MRI Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 555the local staging of prostate cancer.,Non-OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 556calised prostate cancer prior to radical prostatectomy.,Non-OADS,/arxiv_data1/oa_pdf/b5/67/ymj-53-550.PMC3343444.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 571Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.571 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):571-577, 2012 Hereditary Thrombophilia in Korean Patients   with Idiopathic Pulmonary Embolism Mirae Lee,1 Hye Jin No,1 Shin Yi Jang,2 Nari Kim,3 Seung Hyuk Choi,1 Hojoong Kim,4  Sun-Hee Kim,5 Hee-Jin Kim,5 and Duk-Kyung Kim1 1Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, 2Cardiaovascular Imaging Center,  3Cardiac and Vascular Center, 4Division of Pulmonary and Critical Care Medicine, Department of Medicine,  5Department of Laboratory Medicine & Genetics, Cardiac and Vascular Center, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Hereditary thrombophilia (HT) is a major risk factor for idiopathic pul - monary embolism (iPE) and shows different prevalence among ethnic groups.",Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 572This study was conducted to assess the prevalence of HT  and its clinical implications in Korean patients with iPE.,Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
Hereditary Thrombophilia in Pulmonary Embolism Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 573proportion of males to females was highest in the iPE/HT+  group (71.4%) and lowest in the pPE group (29.9%) ( p<  0.001).,Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 574pPE group (20.4%) ( p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
"Hereditary Thrombophilia in Pulmonary Embolism Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 575recurrent DVT showed similar results with our study, pre - senting that a decrease of at least one of PC, PS, and A T  levels was observed in almost 50% (15/34) of patients.18 We compared the clinical features of the iPE/HT+ group  with those of the iPE/HT- and pPE groups.",Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 576previously reported in Korean male patients with VTE, and  Met406Ile was described as a novel mutation.25 Given the  findings from the present study, we speculate that Arg - 211Trp and Met406Ile are frequent mutations causing PC  deficiency in Koreans.",Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
Hereditary Thrombophilia in Pulmonary Embolism Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 577Soc Hematol Educ Program 2009:233-9.,Non-OADS,/arxiv_data1/oa_pdf/53/56/ymj-53-571.PMC3343445.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 467Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.467 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):467-476, 2012 Cerebrovascular Disease and Stroke in Korean Male Adolescent  Chang Hyun Oh,1 Joonho Chung,2 Dongkeun Hyun,2 Eunyoung Kim,2 and Hyeonseon Park2 1Seoul Regional Military Manpower Administration, Seoul; 2Department of Neurosurgery, Inha University School of Medicine, Incheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  This study aimed to estimate the prevalence and incidence of cerebro - vascular disease (CVD) and stroke in Korean male adolescents.",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 468cause the data were derived from the military conscription.,OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
"CVD and Stroke in Korean Male Adolescent Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 469with unruptured A VMs (headache, seizure, syncope, and  memory impairment).",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 470Moyamoya disease Finally, we found 16 cases of MMD, giving a prevalence  of 15.82 cases per 100000 adolescents and an incidence of  0.83 cases per 100000 adolescents per year.",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
"CVD and Stroke in Korean Male Adolescent Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 471DISCUSSION Cerebrovascular disease and stroke have been important  causes of morbidity and mortality in adolescents; they are  already among the top ten causes of death in adolescents.1-4  Hemorrhagic stroke has been reported to be more common  than ischemic stroke in children and young adults in the  United States,3,14,15 however, more recent studies have found  different results.",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 472ally, the incidence of multiple aneurysms appears low, and  we observed no such cases in this study.31,32  Cerebral dural arteriovenous fistula The DA VF prevalence is unknown, as some DA VFs re - main asymptomatic for years.",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
CVD and Stroke in Korean Male Adolescent Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 473inclusion criteria.,Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 474tion study would be needed; also it is very difficult.,Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
CVD and Stroke in Korean Male Adolescent Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 475hemorrhage due to anterior communicating artery aneurysms.,Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 47650.,Non-OADS,/arxiv_data1/oa_pdf/c6/a6/ymj-53-467.PMC3343446.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 477Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.477 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):477-485, 2012 The Localizing and Lateralizing Value of Auras   in Lesional Partial Epilepsy Patients Byoung Seok Ye, Yang-Je Cho, Sang Hyun Jang, Moon Kyu Lee, Byung In Lee, and Kyoung Heo Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  We investigated the localizing and lateralizing values of auras in patients  with lesional partial epilepsy on an outpatient basis.",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 478ered as having mesial temporal lobe epilepsy (MTLE), lat - eral temporal lobe epilepsy (LTLE), frontal lobe epilepsy  (FLE), parietal lobe epilepsy (PLE), or occipital lobe epi - lepsy (OLE).",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"Auras in Lesional Partial Epilepsy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 479using the MRI were as follows: HS was the most common  etiology and was found in 111 (40.2%) of the subjects; atro - phic lesions, which were related to trauma, cerebrovascular  accidents, central nervous system infections, or were of un - known origin, occurred in 84 (30.4%) subjects; vascular  malformations were identified in 26 (9.4%) subjects; for - eign tissue in 20 (7.2%) subjects; and malformations of the  cortical development in 23 (8.3%) of the subjects.",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 480the 134 subjects with MTLE had autonomic auras, while  only 2 (3.6%) of the 55 subjects with LTLE had these au - ras.",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
Auras in Lesional Partial Epilepsy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 481ras were not different between the subjects with right-sided  epilepsy and those with left-sided epilepsy.,Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 482Emotional auras were subdivided into either good feel - ings or bad feelings.,Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"Auras in Lesional Partial Epilepsy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 483agreement with our findings that epigastric auras were also  observed in three FLE subjects, but not in any of the PLE  or OLE subjects.",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 484lobar epilepsies, which is consistent with the findings of an - other previously published study.2 V ertigo is thought to be  caused by the mismatch between visuospatial and vestibular  information,24 which could explain the significant correla - tion between vestibular and visual auras in our study.",Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
Auras in Lesional Partial Epilepsy Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 485tory auras in patients with temporal lobe epilepsy.,Non-OADS,/arxiv_data1/oa_pdf/89/bf/ymj-53-477.PMC3343447.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 530Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.530 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):530-536, 2012 Myeloperoxidase Expression in Acute Myeloid Leukemia Helps  Identifying Patients to Benefit from Transplant Yundeok Kim, Sulhee Yoon, Soo Jeong Kim, Jin Seok Kim, Jun-Won Cheong, and Yoo Hong Min Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Despite extensive study, the use of allogeneic hematopoietic stem cell  transplantation in acute myeloid leukemia (AML) vary considerably.",Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
Myeloperoxidase Expression in Acute Myeloid Leukemia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 531currently in use in the different center.,Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 532cytogenetic analysis reveals an abnormal karyotype.,Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
"Myeloperoxidase Expression in Acute Myeloid Leukemia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 53395% confidence interval (CI), 0.06 to 0.997].",Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 534other study of 46 patients with FAB M2 AML reported op - posite results that a high proportion of MPO+ blasts before  treatment may have constituted a significantly unfavorable  prognostic factor.8 So far, the clinical prognostic value of  MPO expression in AML has been controversial.",Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
"Myeloperoxidase Expression in Acute Myeloid Leukemia Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 535In conclusion, despite its retrospective study including  heterogenous patients with AML and small number of pa - tients, MPO expression was associated with DFS and trans - plant was beneficial to overcome a negative prognostic ef - fect of MPO- at diagnosis based upon the result that the  DFS in patients received transplants are not significant be - tween the MPO+ group and MPO- group although DFS in  all patients was different according to MPO expression.",Non-OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 536the distribution picture of peroxidase activity and cell size.,OADS,/arxiv_data1/oa_pdf/c9/20/ymj-53-530.PMC3343448.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 543Original Articlehttp://dx.doi.org/10.3349/ymj.2012.53.3.543 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 53(3):543-549, 2012 Recent Changes in the Clinicopathologic Features of Korean Men  with Prostate Cancer: A Comparison with Western Populations Seok-Soo Byun,1 Sangchul Lee,1 Sang Eun Lee,1 Eunsik Lee,2 Seong Il Seo,3 Hyun Moo Lee,3  Han Yong Choi,3 Cheryn Song,4 Hanjong Ahn,4 Young Deuk Choi,5 and Jin Seon Cho6 1Department of Urology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam; 2Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul; 3Department of Urology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul; 4Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul;  5Department of Urology, Yonsei University College of Medicine, Seoul; 6Department of Urology, Hallym University School of Medicine, Chuncheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
"© Copyright: Yonsei University College of Medicine 2012 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to evaluate the recent changes in the clinico - pathologic features of prostate cancer in Korea and to compare these features with  those of Western populations.",Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
"Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 544tem, with histologic grading determined in accordance with  the Gleason grading system.9 Beginning 6-8 weeks after  radical prostatectomy, the prostate-specific antigen (PSA)  level was measured every 3-6 months.",Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
"Recent Changes of Korean Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 545Group 2 than in Group 1 and the proportion of low Gleason  scores (≤6) was correspondingly higher in Group 2 ( p=  0.003 and p<0.001, respectively).",Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 546ed better characteristics in terms of pathologic stage and  histologic differentiation compared to Group 1 (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
Recent Changes of Korean Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 547three ethnic groups demonstrated no statistical differences  in disease-free survival.,Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 548rectal examination in Korean men: a nationwide multicenter study.,Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
Available at: http://www.kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
5. http://www.ncc.re.kr.,Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
Recent Changes of Korean Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 54926.,Non-OADS,/arxiv_data1/oa_pdf/fa/23/ymj-53-543.PMC3343449.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/80/81/srep00393.PMC3343458.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kumatani, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/80/81/srep00393.PMC3343458.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society www.biochemj.org Biochemical Journal © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Compounds and reagents The study used ZSTK474 (pan-PI3K inhibitor) [25], PI-103(pan-PI3K/mTOR inhibitor) [26], BEZ235 (pan-PI3K inhibitor/ c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"All c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"In the present paper we report pharmacokineticdata for PI-103, TGX221 and IC87114 following oral or intraperitoneal injection (Supplementary Figure S1 at http://www.BiochemJ.org/bj/442/bj4420161add.htm).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Effect of inhibitors on whole-body glucose metabolism The results of the present study show that the pan-PI3K/mTOR inhibitors PI-103 and BEZ235, and the pan-PI3K inhibitor c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Furthermore, we ﬁnd PI-103, BEZ235 and ZSTK474 (Supplementary Table S1 at http://www.BiochemJ.org/bj/442/bj4420161add.htm) and A66[28] have very low levels of off-target activity.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Two previous studies have c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"98, 1638–1642 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"425, 53–54 Received 26 October 2011/21 November 2011; accepted 5 December 2011 Published as BJ Immediate Publication 5 December 2011, doi:10.1042/BJ20111913 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Enzyme PI-103 (10 μM) AS252424 (10 μM) BEZ235 (10 μM) ZSTK474 (10 μM) MKK1 105 70 116 83 MKK2 115 77 86 95 MKK6 107 99 93 83 ERK1 112 85 106 106ERK2 106 104 114 105JNK1 102 99 105 93 JNK2 100 85 89 87 JNK3 101 90 93 88p38αMAPK 109 86 111 89 p38βMAPK 100 74 96 95 p38γMAPK 76 65 101 92 p38δMAPK 84 38 100 107 ERK8 87 10 94 92 RSK1 101 88 97 95 RSK2 96 40 81 83PDK1 107 97 98 92PKBα 78 97 126 123 PKBβ 114 40 106 84 SGK1 92 59 98 98S6K1 90 43 109 98PKA 100 66 82 76 ROCK2 91 70 84 85 PRK2 71 88 74 82PKCα 93 102 87 86 PKCζ 98 96 123 87 PKD1 120 55 107 96 MSK1 105 54 102 89MNK1 97 48 101 96 MNK2 90 62 94 101 MAPKAP-K2 90 80 99 91MAPKAP-K3 100 63 110 97PRAK 77 64 93 82 CAMKKb 114 51 61 87 CAMK1 99 46 100 114SmMLCK 48 37 109 91PHK 84 61 95 94 DAPK1 30 8 107 75 CHK1 115 87 146 90CHK2 85 53 80 88GSK3b 48 10 76 79 CDK2-Cyclin A 94 89 74 77 PLK1 93 90 95 75Aurora A 92 95 104 99 Aurora B 95 71 101 94 LKB1 62 52 105 103AMPK 99 39 99 92MARK1 91 88 97 106 MARK2 107 90 86 87 MARK3 88 67 100 94MARK4 108 63 81 89BRSK1 109 56 85 161 BRSK2 99 44 89 88 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Class-IA PI3K inhibitors affect glucose metabolism Table S1 Continued Enzyme PI-103 (10 μM) AS-252424 (10 μM) BEZ235 (10 μM) ZSTK474 (10 μM) MELK 104 91 35 91 NUAK1 98 73 44 90CK1 100 85 96 76CK2 102 25 79 54 DYRK1A 59 3 93 78 DYRK2 83 20 79 93DYRK3 64 18 56 87NEK2a 86 136 145 106 NEK6 87 94 95 83 IKKb 74 73 92 94IKKe 85 40 86 84TBK1 91 70 107 102 PIM1 72 7 92 97 PIM2 90 7 94 92PIM3 41 7 87 76 SRPK1 116 39 106 92 EF2K 99 91 110 96HIPK1 63 29 89 100HIPK2 18 3 101 63 HIPK3 82 23 102 98 CLK2 25 16 53 85PAK2 106 89 87 100PAK4 70 65 87 92 PAK5 112 49 90 84 PAK6 108 71 105 93MST2 115 60 89 92MST4 114 45 100 88 GCK 91 53 12 104 MINK1 116 24 75 102MEKK1 97 56 67 92MLK1 65 53 67 86 MLK3 57 32 62 97 TAO1 84 18 81 93ASK1 101 110 106 90 TAK1 79 48 67 97 IRAK4 119 114 78 102RIPK2 72 19 28 89TTK 66 56 91 88 Src 99 96 121 104 Lck 85 110 54 89CSK 101 100 100 84YES1 92 36 69 72 BTK 82 45 20 98 JAK2 93 60 24 79SYK 69 55 72 85EPH-A2 113 51 110 106 EPH-A4 103 74 105 87 EPH-B1 131 94 133 96EPH-B2 105 100 77 106EPH-B3 127 52 117 113 EPH-B4 86 89 99 105 FGF-R1 118 42 106 102HER4 114 68 117 103 IGF-1R 54 75 72 87 IR 80 94 99 104IRR 89 36 80 88TrkA 93 79 59 83 VEGFR 92 22 80 87 Received 26 October 2011/21 November 2011; accepted 5 December 2011 Published as BJ Immediate Publication 5 December 2011, doi:10.1042/BJ20111913 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/bj4420161.PMC3343648.pdf
"Available Online at http://www.theassc.org/vol_14_2008Bartolomeo, P. (2011).",Non-OADS,/arxiv_data1/oa_pdf/3b/d0/fnhum-06-00110.PMC3343690.pdf
12 Iconico Screen Calipers (http://www.iconico.com/caliper/).,Non-OADS,/arxiv_data1/oa_pdf/61/f9/cee-0001-0036.PMC3343749.pdf
"M e t h o d s    Literature Search Strategy      On March 2, 2011, we searched MEDLINE (http://www.ncbi.nlm.nih.gov/pubmed)  from 1966 and EMBASE (http://ovidsp.ovid.com) from 1980 for studies that investigated the association between lipid profiles and HT in patients with acute cerebral ischemia.",OADS,/arxiv_data1/oa_pdf/b2/02/cee-0001-0130.PMC3343754.pdf
"http://www.co- chrane-handbook.org, 2009.",Non-OADS,/arxiv_data1/oa_pdf/b2/02/cee-0001-0130.PMC3343754.pdf
"The NINDS is in the midst of proposing a library of CDEs or ‘com-mon data elements’ (http://www.commondataelements.ninds.nih.gov/) for use in stroke studies; however, while these elements include factors such as hypertension and diabetes, the NINDS standards currently do not offer definitions for the elements but rather only specify classification for these factors as ‘yes’, ‘no’ or ‘unknown’  [3, 4] .",Non-OADS,/arxiv_data1/oa_pdf/a7/9c/cee-0001-0084.PMC3343760.pdf
"3 NINDS: NINDS common data elements, 2010 (http://www.commondataelements.ninds.nih.gov/).",OADS,/arxiv_data1/oa_pdf/a7/9c/cee-0001-0084.PMC3343760.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Glob Health Action 2012, 5: 17288 - http://dx.doi.org/10.3402/gha.v5i0.17288",Non-OADS,/arxiv_data1/oa_pdf/7a/f9/GHA-5-17288.PMC3343878.pdf
"Geographical distribution of clinical research studies in cancer (10).Raghib Ali and Alexander Finlayson 2 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 17288 - http://dx.doi.org/10.3402/gha.v5i0.17288",Non-OADS,/arxiv_data1/oa_pdf/7a/f9/GHA-5-17288.PMC3343878.pdf
"Organisation of INDOX network and development of clinical trial protocols.The INDOX cancer research network experience Citation: Glob Health Action 2012, 5: 17288 - http://dx.doi.org/10.3402/gha.v5i0.17288 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7a/f9/GHA-5-17288.PMC3343878.pdf
"Significant delays in gaining regulatory approval from Ministry of health Regulatory system, particularly for early phase trials.Worked closely with Drugs Controller General of India to improve understanding of, and need for Phase 1 trials inIndia.Successful in gaining regulatory approval for one of the first multinational Phase 1 trials in India.Raghib Ali and Alexander Finlayson 4 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 17288 - http://dx.doi.org/10.3402/gha.v5i0.17288",Non-OADS,/arxiv_data1/oa_pdf/7a/f9/GHA-5-17288.PMC3343878.pdf
"Professor Vinod Raina, All India Institute of Medical Sciences (AIIMS) New Delhi.The INDOX cancer research network experience Citation: Glob Health Action 2012, 5: 17288 - http://dx.doi.org/10.3402/gha.v5i0.17288 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7a/f9/GHA-5-17288.PMC3343878.pdf
"*Raghib Ali INDOX Cancer Research Network University of OxfordRichard Doll Building Oxford, OX37LF , UK Email: raghib.ali@ndm.ox.ac.ukRaghib Ali and Alexander Finlayson 6 (page number not for citation purpose)Citation: Glob Health Action 2012, 5: 17288 - http://dx.doi.org/10.3402/gha.v5i0.17288",Non-OADS,/arxiv_data1/oa_pdf/7a/f9/GHA-5-17288.PMC3343878.pdf
from http://www.abc.net.au/ra/innovations/stories/s1343400.htm 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/10916_2010_Article_9626.PMC3345114.pdf
"People ’s Daily Online, from http://english.peopledaily.",Non-OADS,/arxiv_data1/oa_pdf/e1/05/10916_2010_Article_9626.PMC3345114.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2012 : pls009; doi:10.1093/aobpla/pls009, available online at www.aobplants.oxfordjournals.org &The Authors 2012 1",Non-OADS,/arxiv_data1/oa_pdf/82/b4/pls009.PMC3345123.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/uk/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2012 : pls010; doi:10.1093/aobpla/pls010, available online at www.aobplants.oxfordjournals.org &The Authors 2012 1",Non-OADS,/arxiv_data1/oa_pdf/78/f8/pls010.PMC3345124.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Current Review http://dx.doi.org/10.5415/apallergy.2012.2.2.101 Asia Pac Allergy 2012;2:101-108 Asthma in the elderly Andrew Gillman1,* and Jo A Douglass2,3 1Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne 3004, Australia 2Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, Melbourne 3050, Australia 3Central Clinical School, Monash University, Melbourne 3004, Australia As the population increases in age, the diseases of older age will have increasing prevalence and place a greater burden on the  health system.",Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
"apallergy.orggillman a, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.101 102affecting greater than 10% of the population [1, 2].",OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
apallergy.orgasthma in the elderly http://dx.doi.org/10.5415/apallergy.2012.2.2.101  103that the prevalence of current asthma peaks in the 10 to 24 year  old age-group with a reported prevalence of between 3 and 18% [18].,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
"apallergy.orggillman a, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.101 104Asthma is a chronic inflammatory condition that has been  shown to be correlated with a slow but progressive loss of lung  function over time.",Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
apallergy.orgasthma in the elderly http://dx.doi.org/10.5415/apallergy.2012.2.2.101  105is often fixed.,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
"apallergy.orggillman a, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.101 106the pharmacy [51].",OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
apallergy.orgasthma in the elderly http://dx.doi.org/10.5415/apallergy.2012.2.2.101  1071998;114:1704-33.,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
Available from: http://www.ginasthma.org.,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
"apallergy.orggillman a, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.101 1081995;24:190-2.",OADS,/arxiv_data1/oa_pdf/ee/f6/apa-2-101.PMC3345322.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Current Review http://dx.doi.org/10.5415/apallergy.2012.2.2.109 Asia Pac Allergy 2012;2:109-114 The role of tiotropium in the management of  asthma Heung-Woo Park Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea Asthma is a chronic respiratory disease characterized by reversible airway obstruction that is secondary to an allergic inflammation  and excessive smooth muscle contraction.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
"apallergy.orgPark HWAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.109 110Anti-cholinergic agents had been left orphan in the field of  asthma pharmacology until tiotropium bromide, a long-acting  inhaled anti-cholinergic agent was introduced.",Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
apallergy.orgTiotropium for the management of asthma http://dx.doi.org/10.5415/apallergy.2012.2.2.109  111the reduction of TGF- β1 production might one of the underlying  mechanism for their observations.,Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
apallergy.orgPark HWAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.109 112gene [56].,OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
Available from:  http://www.ginasthma.org/guidelines-pocket-guide-for-asthma- management.html.,Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
Available from:  http://www.goldcopd.org/guidelines-global- strategy-for-diagnosis-management.html.,Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
apallergy.orgTiotropium for the management of asthma http://dx.doi.org/10.5415/apallergy.2012.2.2.109  1132009;64:778-83.,Non-OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
apallergy.orgPark HWAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.109 11446.,OADS,/arxiv_data1/oa_pdf/61/7d/apa-2-109.PMC3345323.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.2.115 Asia Pac Allergy 2012;2:115-121 Olopatadine ophthalmic solution suppresses  substance P release in the conjunctivitis models Tadafumi Tamura* Marketing Department Sales & Marketing Division and Pharmacological Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd.,  Tokyo 100-8185, Japan Background: Olopatadine hydrochloride ophthalmic solutions are treated for allergic conjunctival diseases that are a selective  histamine H1 receptor antagonist and an inhibitor of the release of mediators including histamine from the human mast cells.",Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
apallergy.orgTamura T Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.115 116including histamine and cytokines.,Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
apallergy.orgOlopatadine drop suppresses substance P release http://dx.doi.org/10.5415/apallergy.2012.2.2.115 117above.,Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
"apallergy.orgTamura T Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.115 118and 0.2% significantly inhibited the increased conjunctival dye  leaked by 75.7% and 89.2% inhibition ( p < 0.0001, p < 0.0001).",Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
"apallergy.orgOlopatadine drop suppresses substance P release http://dx.doi.org/10.5415/apallergy.2012.2.2.115 119DISCUSSION In this study, a rat model of conjunctivitis was used to examine  the ocular anti-histamine and anti-allergic efficacies of olopatadine  ophthalmic solution compared with other anti-allergic ophthalmic solutions.",Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
apallergy.orgTamura T Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.115 120anti-allergic ophthalmic solutions.,Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
apallergy.orgOlopatadine drop suppresses substance P release http://dx.doi.org/10.5415/apallergy.2012.2.2.115 1211997;27:372-8.,Non-OADS,/arxiv_data1/oa_pdf/6f/c3/apa-2-115.PMC3345324.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.2.122 Asia Pac Allergy 2012;2:122-128 Impact of helminth infection on childhood    allergic diseases in an area in transition from high  to low infection burden  Manori Amarasekera1,*, Nipul Kithsiri Gunawardena2, Nilanthi Renuka de Silva2, Jo Anne Douglass3,     Robyn Elizabeth O’Hehir3, and Anura Weerasinghe1 Departments of 1Physiology, and 2Parasitology, Faculty of Medicine, University of Kelaniya, Ragama 11010, Sri Lanka 3Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne VIC 3004, Australia Background: The effect of helminth infections on allergic diseases is still inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"apallergy.orgHelminth infections and childhood allergic diseases http://dx.doi.org/10.5415/apallergy.2012.2.2.122 123 INTRODUCTION Among the various theories proposed to explain the alarming  rise in allergic diseases around the world, the ‘hygiene hypothesis’  has gained much attraction [1].",Non-OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"apallergy.orgamarasekera m, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.122 124for the variables known to affect the outcome of the association.",OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"apallergy.orgHelminth infections and childhood allergic diseases http://dx.doi.org/10.5415/apallergy.2012.2.2.122 125tIgE levels than those who had monoinfection (2462.6 kU/L  vs.  780.2 kU/L, p = 0.01).",Non-OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"apallergy.orgamarasekera m, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.122 126DISCUSSION In this randomly selected population of schoolchildren in the  Western Province of Sri Lanka, 15.5% were infected with one or  more helminth species, while 33.7% evidence of allergic disease.",OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
apallergy.orgHelminth infections and childhood allergic diseases http://dx.doi.org/10.5415/apallergy.2012.2.2.122 127molecules of the parasite that exert the immunomodulatory effect  in the host and be used to avert or control the allergy epidemic while keeping the population free of parasite infections.,Non-OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"apallergy.orgamarasekera m, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.122 12812.",OADS,/arxiv_data1/oa_pdf/b4/71/apa-2-122.PMC3345325.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.2.129 Asia Pac Allergy 2012;2:129-135 Prevalence of allergic rhinitis in Filipino adults  based on the National Nutrition and Health    Survey 2008 Jovilia M. Abong1,2,3,*, Shirley L. Kwong4,5, Hilda Diana A. Alava6,7, Mary Anne R. Castor1,2, and Julia C. De Leon1,2 1College of Medicine, University of the Philippines, Manila 1000, Philippines 2Section of Allergy and Immunology, Department of Internal Medicine, Philippine General Hospital, Manila 1000, Philippines 3De La Salle Health Sciences Institute, College of Medicine, Dasmariñas City 4114, Philippines 4Section of Allergy and Immunology, Department of Pediatrics, Dr. Fe Del Mundo Medical Center, Quezon City, Metro Manila 1100, Philippines 5Department of Pediatrics, Chinese General Hospital, Manila 1014, Philippines 6Department of Pediatrics, College of Medicine, Manila Central University FDTMF, Caloocan City, Metro Manila 1400, Philippines 7Department of Pediatrics, Manila Doctors Hospital, Manila 1000, Philippines Background: There has been no documented data on the prevalence of allergic rhinitis among Filipino adults.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"apallergy.orgamarasekera m, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.129 130INTRODUCTION Allergic rhinitis is characterized by one or more of the following  symptoms: nasal itching, sneezing, watery nasal discharge and/ or nasal congestion.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"apallergy.orgPrevalence of allergic rhinitis in Filipinos, 2008 http://dx.doi.org/10.5415/apallergy.2012.2.2.129 131agricultural, mountainous agricultural) 2.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"apallergy.orgamarasekera m, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.129 132RESULTS In the 7th NNS Clinical and Health Component, a total of 3,744  eligible households were covered from 79 provinces and 3,377  EAs.",OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"apallergy.orgPrevalence of allergic rhinitis in Filipinos, 2008 http://dx.doi.org/10.5415/apallergy.2012.2.2.129 133Improvement in identification of risk factors and triggers, health  care delivery, public awareness, appropriate management and implementation of preventive measures are needed to improve the quality of life of allergic patients.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"apallergy.orgamarasekera m, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.129 134and chemosis associated with symptoms of itchy eyes and tearing.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"apallergy.orgPrevalence of allergic rhinitis in Filipinos, 2008 http://dx.doi.org/10.5415/apallergy.2012.2.2.129 135DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph  CC, Schuller D, Spector SL, Tilles SA.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/apa-2-129.PMC3345326.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.2.136 Asia Pac Allergy 2012;2:136-143 Immunoglobulin E-binding reactivities of natural  pollen grain extracts from selected grass species  in the Philippines Clarissa R. Cabauatan1,2 and John Donnie A. Ramos2,3,4,* 1Center for Natural Sciences, School of Arts and Sciences, Saint Mary’s University, Bayombong, Nueva Vizcaya 3700, Philippines 2The Graduate School, 3Research Center for the Natural and Applied Sciences, Thomas Aquinas Research Complex, and 4Department of    Biological Sciences, College of Science, University of Santo Tomas, Manila 1015, Philippines Background: Pollen grains have been reported to be present in the Philippine atmosphere but studies regarding their allergenicity are  limited.",Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
"apallergy.orgIgE reactivity of grass pollens http://dx.doi.org/10.5415/apallergy.2012.2.2.136 137 individuals with pollen allergy [3, 4].",OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
"apallergy.orgcabauatan cr, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.136 138Total and specific-IgE level determination Enzyme-linked Immunosorbent Assay (ELISA) was performed  to quantify the total and specific-IgE levels of each serum using  anti-human IgE biotin-conjugate antibody (Pharmingen, USA) and 4-Nitrophenyl phosphate disodium salt hexahydrate (Sigma- Aldrich, USA) substrate based on the protocols described [25].",OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
apallergy.orgIgE reactivity of grass pollens http://dx.doi.org/10.5415/apallergy.2012.2.2.136 139shows that the level within and among species are highly  associated.,OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
"apallergy.orgcabauatan cr, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.136 140S.",OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
apallergy.orgIgE reactivity of grass pollens http://dx.doi.org/10.5415/apallergy.2012.2.2.136 141initially selected.,Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
"apallergy.orgcabauatan cr, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.136 142pollen and its components, Lol p I and Lol p II (rye I and rye II).",OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
apallergy.orgIgE reactivity of grass pollens http://dx.doi.org/10.5415/apallergy.2012.2.2.136 14339.,Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
Available from: http://natureserve.org/explorer.,Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
Available from:  http://www.plantatlas.usf.edu/.,Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
Available from: http://www.hear.org/pier/index.html.,Non-OADS,/arxiv_data1/oa_pdf/50/a4/apa-2-136.PMC3345327.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Hypothesis & Experience Original Article http://dx.doi.org/10.5415/apallergy.2012.2.2.144 Asia Pac Allergy 2012;2:144-148 The methodology of the GUSTO cohort study:    a novel approach in studying pediatric allergy Shu E Soh1, Samuel Shang Ming Lee2, Sarah Wenli Hoon2, Mae Yun Tan2, Anne Goh3, Bee Wah Lee2,    Lynette Pei-Chi Shek2, Oon Hoe Teoh3, Kenneth Kwek3, Seang Mei Saw1, Keith Godfrey4, Yap Seng Chong5,   Peter Gluckman6, and Hugo PS van  Bever2,* 1Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117597, Singapore 2Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore  3KK Women’s and Children’s Hospital, Singapore 229899, Singapore 4University of Southampton, Southampton SO16 5YA, UK 5Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore 6Singapore Institute for Clinical Sciences, A*Star, Singapore 117609, Singapore Growing Up in Singapore Towards healthy Outcomes (GUSTO) is Singapore’s largest birth cohort study to date.",Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
"apallergy.orgStudying pediatric allergy in the GUSTO cohort study http://dx.doi.org/10.5415/apallergy.2012.2.2.144  145 INTRODUCTION Allergic diseases such as asthma, rhinitis, and atopic eczema are  considered the most common group of diseases in children and  are an important cause of somatic and psychosocial morbidity,  affecting quality of life of patients and their families [1].",Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.144 146permanent residents aged 18 years and above who are Chinese,  Malay or Indian with homogenous parental ethnic background and have the intention to eventually deliver in the 2 major public maternity units (National University Hospital and KK Women’s and Children’s Hospital) and to reside in Singapore for the next 5 years.",Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
"apallergy.orgStudying pediatric allergy in the GUSTO cohort study http://dx.doi.org/10.5415/apallergy.2012.2.2.144  147with 1,163 pregnant women recruited into the main GUSTO cohort  (current drop-out rate = 12.1%).",Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.144 148REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
Available from: http://www.gusto.sg/.,Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
Available from: http://isaac.auckland.ac.nz/story/methods/resources/phaseonemanual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/2d/apa-2-144.PMC3345328.pdf
Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.2.149 Asia Pac Allergy 2012;2:149-160Educational & Teaching Material Review Management of chronic urticaria in Asia: 2010  AADV consensus guidelines Steven K.W.,Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"apallergy.orgChow SKAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.149 150suppress symptoms by inhibiting the release and/or the effect of  mast cell mediators and possibly other inflammatory mediators [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
apallergy.orgManagement of chronic urticaria in Asia: 2010 AADV consensus guideline http://dx.doi.org/10.5415/apallergy.2012.2.2.149  151[6].,Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"apallergy.orgChow SKAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.149 152Infections and infestations  Among the causal factors associated with chronic urticaria, the  following fit into this particular category.",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
apallergy.orgManagement of chronic urticaria in Asia: 2010 AADV consensus guideline http://dx.doi.org/10.5415/apallergy.2012.2.2.149  153release are corticosteroids.,Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
apallergy.orgChow SKAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.149 154Fig.,OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"apallergy.orgManagement of chronic urticaria in Asia: 2010 AADV consensus guideline http://dx.doi.org/10.5415/apallergy.2012.2.2.149  155Third line therapy  If symptoms persist after a further 1-4 weeks, the treatment  regimen of the nsAH dosage can be changed to a 1st generation  sedating antihistamine or an alternative 2nd generation non- sedating antihistamine with the option of adding a leukotriene  antagonist.",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"apallergy.orgChow SKAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.149 156task force [31], their findings reveal that these drugs pose a  considerable level of risk to the self-medicating general public and to special patient groups that are purchased over-the-counter in the absence of appropriate medical supervision.",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
apallergy.orgManagement of chronic urticaria in Asia: 2010 AADV consensus guideline http://dx.doi.org/10.5415/apallergy.2012.2.2.149  157It is in the opinion of the Asian Academy of Dermatology and  Venereology Study Group that second generation non-sedating  antihistamines should be prescribed as first-line treatment.,Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"apallergy.orgChow SKAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.149 158chronic idiopathic urticaria has seen an abundance of fad  therapies, including ayurvedic and homeopathic medications and naturopathy.",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"apallergy.orgManagement of chronic urticaria in Asia: 2010 AADV consensus guideline http://dx.doi.org/10.5415/apallergy.2012.2.2.149  159Limitations  Data regarding the racial differences of chronic urticaria in  Asia, its epidemiology, socio-economic impact and outcomes of  management was not covered as part of this consensus.",Non-OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
apallergy.orgChow SKAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.149 160pylori.,OADS,/arxiv_data1/oa_pdf/1d/29/apa-2-149.PMC3345329.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Case Report http://dx.doi.org/10.5415/apallergy.2012.2.2.161 Asia Pac Allergy 2012;2:161-164 Food-dependent exercise-induced anaphylaxis  occurred only in a warm but not in a cold    environment Eun-Jung Jo1,2,3, Min-Suk Yang1,2,3, Yoon-Jeong Kim1,2,3, Hyun-Suk Kim1,2, Mi-Yeong Kim1,2, Sae-Hoon Kim1,2,3, Sang-Heon Cho1,2,  Kyung-Up Min1,2, and Yoon-Seok Chang1,2,3,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-799, Korea  3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-802, Korea Food-dependent exercise-induced anaphylaxis (FDEIA) is a type of exercise-induced anaphylaxis associated with postprandial  exercise.",Non-OADS,/arxiv_data1/oa_pdf/e9/8d/apa-2-161.PMC3345330.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/8d/apa-2-161.PMC3345330.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/e9/8d/apa-2-161.PMC3345330.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.161 162a sensitized individual ingests food allergens and proceeds to  exercise within 2 to 6 h [5].,Non-OADS,/arxiv_data1/oa_pdf/e9/8d/apa-2-161.PMC3345330.pdf
"apallergy.orgFDEIA only in a warm environment http://dx.doi.org/10.5415/apallergy.2012.2.2.161  163hydrocortisone, he was recovered.",Non-OADS,/arxiv_data1/oa_pdf/e9/8d/apa-2-161.PMC3345330.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.161 164REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/8d/apa-2-161.PMC3345330.pdf
"EditorialAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.2.91 Asia Pac Allergy 2012;2:91-92 Asia Pacific Allergy: a successful first year and the  future Yoon-Seok Chang Department of Internal Medicine, Seoul National University College of Medicine, and Institute of Allergy and Clinical Immunology, Seoul National  University Medical Research Center, Seoul 110-799, KoreaDivision of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-802, Korea Let’s celebrate the first anniversary of Asia Pacific Allergy ( AP  Allergy ), the official journal of the Asia Pacific Association of  Allergy, Asthma and Clinical Immunology (APAAACI)!",Non-OADS,/arxiv_data1/oa_pdf/d4/15/apa-2-91.PMC3345331.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/15/apa-2-91.PMC3345331.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d4/15/apa-2-91.PMC3345331.pdf
"apallergy.orgChang ysAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.91 92professor Frank Thien from Australia, professor Pakit Vichyanond,  Thailand, professor Donald Leung, USA, professor Jiu-Yao Wang, Taiwan, professor Akihiro Morikawa, professor Hirohisa Saito, professor Naoki Shimojo, professor Ruby Pawankar from Japan, professor Zakiudin Munasir, Indonesia, professor Shahd Abbas, Pakistan, professor Hee-Bom Moon, professor Kyu-Earn Kim, professor Sang-Heon Cho and professor Kangmo Ahn from Korea.",Non-OADS,/arxiv_data1/oa_pdf/d4/15/apa-2-91.PMC3345331.pdf
"Asia Pacific allergy  pISSN 2233-8276 · eISSN 2233-8268 Current Review http://dx.doi.org/10.5415/apallergy.2012.2.2.93 Asia Pac Allergy 2012;2:93-100 Impact of allergic rhinitis in school going children Elias Mir, Chandramani Panjabi†, and Ashok Shah* Department of Respiratory Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110 007, India Allergic rhinitis (AR) is the most common chronic pediatric disorder.",Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
"Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.93 94which significantly affect the learning process and thus impacts  on school performance and all these aspects upset the family [2].,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
apallergy.org Impact of AR in school going children http://dx.doi.org/10.5415/apallergy.2012.2.2.93  95clinical profile of the patients and classification The ARIA update 2008 [1] classifies AR on the basis of frequency  and severity.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.93 96ragweed pollen season [18].,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
apallergy.org Impact of AR in school going children http://dx.doi.org/10.5415/apallergy.2012.2.2.93  97AR rarely occurs in isolation and is associated with multiple  co-morbidities.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.93 98anti-cholinergic side effects [42], they are best avoided lest they  lead to impairment in performance and learning at school.",Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
apallergy.org Impact of AR in school going children http://dx.doi.org/10.5415/apallergy.2012.2.2.93  99productivity in school going children with allergic rhinitis and/ or asthma.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.2.93 100improve sleep and daytime somnolence in allergic rhinitis?,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/apa-2-93.PMC3345332.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution,and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/fa/pcs038.PMC3345369.pdf
"TheStudent’s t-test was performed using Microsoft Excel software, and the calculation of the FDR of the P-values for the t-test was performed using the software R v2.13.0 with the q value pack- age, which is available free from the web site (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/d5/fa/pcs038.PMC3345369.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution,and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/6b/pcs044.PMC3345370.pdf
"Therefore, other, ‘faster’ mechanismsfor long-term adaptation have been postulated and oftenrelated to the idea of Lamarckian inheritance, assuming that‘an organism can pass on characteristics or potential that itacquired during its lifetime to its offspring’ (http://en.wikipedia.org/wiki/Inheritance_of_acquired_characteristics).",Non-OADS,/arxiv_data1/oa_pdf/af/6b/pcs044.PMC3345370.pdf
"If so, join our MASH unit: simply go to  http://blog.openmedicine.ca/mash .",Non-OADS,/arxiv_data1/oa_pdf/f8/3c/OpenMed-05-e175.PMC3345373.pdf
"For more information, please see  http://creativecommons.org/licenses/ by-sa/2.5/ca/",Non-OADS,/arxiv_data1/oa_pdf/f8/3c/OpenMed-05-e175.PMC3345373.pdf
"For  more information, please see  http://creativecommons.org/licenses/ by-sa/2.5/ca/",Non-OADS,/arxiv_data1/oa_pdf/8f/53/OpenMed-05-e173.PMC3345374.pdf
"For  more information, please see  http://creativecommons.org/licenses/ by-sa/2.5/ca/   Appendix A: Stress scale to measure global perceptions  of stress Response set: 0 = never, 1 = almost never, 2 = sometimes, 3 = often, 4 = very often, 5 = always.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/OpenMed-05-e154.PMC3345375.pdf
"For more information, see  http://creativecommons.org/licenses/by-sa/2.5/ca/.On the basis of the results of the VISION Pilot Study  we have initiated the full-scale large international   VISION Study.",Non-OADS,/arxiv_data1/oa_pdf/fb/ad/OpenMed-05-e193.PMC3345376.pdf
2010.  http://www.ombudsman.on.ca/Files/ sitemedia/Documents/Investigations/SORT%20Investigations/ltc-for-web-en-1.pdf .,OADS,/arxiv_data1/oa_pdf/ee/4f/OpenMed-05-e183.PMC3345377.pdf
Available from: http://mchp-appserv.cpe.,Non-OADS,/arxiv_data1/oa_pdf/ee/4f/OpenMed-05-e183.PMC3345377.pdf
"For more information, please see  http://creativecommons.org/licenses/by- sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/OpenMed-05-e183.PMC3345377.pdf
"Available  from: http://academia.wikia.com/wiki/Flexibility_in_wiki_ publishing:_author_desires,_peer_review_and_citation (ac- cessed 2011 April 5).",Non-OADS,/arxiv_data1/oa_pdf/c0/8a/OpenMed-05-e201.PMC3345378.pdf
Available from: http://davidrothman.net/list-of-medical-wikis/ (accessed 2011 Apr 4).,Non-OADS,/arxiv_data1/oa_pdf/c0/8a/OpenMed-05-e201.PMC3345378.pdf
"For more information, please see  http://creativecommons.org/licenses/ by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/c0/8a/OpenMed-05-e201.PMC3345378.pdf
Ottawa:  Canadian Institute for Health Information; [2000–2009] Avail - able: https://secure.cihi.ca/estore/productSeries.htm?pc=PCC34   (accessed 2011 Feb 1).,Non-OADS,/arxiv_data1/oa_pdf/56/9b/OpenMed-05-e166.PMC3345379.pdf
"For  more information, please see  http://creativecommons.org/licenses/ by-sa/2.5/ca/ .",Non-OADS,/arxiv_data1/oa_pdf/56/9b/OpenMed-05-e166.PMC3345379.pdf
"For more information, please see  http://creativecommons.org/licenses/ by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/50/06/OpenMed-05-e177.PMC3345380.pdf
"The current paradigm of H. pylori -induced gastric cancer proposes that chronic and persistent gastritis during a lifetime of infec-tion generates an environment awash with inﬂammatory media-tors and signaling pathways that ultimately lead to tumorigenesis 1http://www.who.int/mediacent re/factsheets/fs297/en 2http://www.cancer.gov/cancertopics/types/stomach(Correa and Piazuelo, 2011 ).",Non-OADS,/arxiv_data1/oa_pdf/3c/b8/fimmu-03-00105.PMC3345449.pdf
Data from the Cardiovascular Health StudyGWAS of MI were accessed through a publicly available database(http://www.ncbi.nlm.nih.gov/gap ).,OADS,/arxiv_data1/oa_pdf/85/33/ehr075.PMC3345557.pdf
27.http://www.screening.nhs.uk/cms.php?folder=2718 .,Non-OADS,/arxiv_data1/oa_pdf/85/33/ehr075.PMC3345557.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/d3/f1/AIAN-15-134.PMC3345592.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/05/d1/AIAN-15-137.PMC3345593.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/bd/ef/AIAN-15-141.PMC3345595.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/73/f3/AIAN-15-145.PMC3345596.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/50/f5/AIAN-15-151.PMC3345598.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ef/09/AIAN-15-158.PMC3345599.pdf
2008 Available  from: http://www.gfmer.ch/Books/Reproductive_health/Cohort_ and_case_control_studies.html [Last accessed on 2011 Nov 24].,Non-OADS,/arxiv_data1/oa_pdf/a3/0b/AIAN-15-76.PMC3345604.pdf
Available from:  http://circ.ahajournals.org/content/115/9/1164.full [Last accessed  on 2011 Nov 24].,Non-OADS,/arxiv_data1/oa_pdf/a3/0b/AIAN-15-76.PMC3345604.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/a3/0b/AIAN-15-76.PMC3345604.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/a3/0b/AIAN-15-76.PMC3345604.pdf
Available from: http://www.sign.,Non-OADS,/arxiv_data1/oa_pdf/37/4d/AIAN-15-81.PMC3345605.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/37/4d/AIAN-15-81.PMC3345605.pdf
Available from: http://www.epilepsyindia.,Non-OADS,/arxiv_data1/oa_pdf/e1/0d/AIAN-15-89.PMC3345606.pdf
"Therefore, statis-tical analysis was completed using the Mann–Whitney U-test (http://elegans.swmed.edu/∼leon/stats/utest.html).",OADS,/arxiv_data1/oa_pdf/7c/d3/fmicb-03-00170.PMC3345613.pdf
"References and links 1.WHO, “Diabetes,” http://www.who.int/mediacentre/factsheets/fs312/en/.",Non-OADS,/arxiv_data1/oa_pdf/9f/e7/667.PMC3345797.pdf
"“Monte Carlo simulations,” Oregon Medical Laser Center, accessed Jan. 1, 2009,  http://omlc.ogi.edu/s oftware/mc/ .",OADS,/arxiv_data1/oa_pdf/bc/72/692.PMC3345799.pdf
"The Gnu Project, “Gnu Scientific Library,” accessed June 15, 2011, http://www.gnu.org/s/gsl/ .",Non-OADS,/arxiv_data1/oa_pdf/bc/72/692.PMC3345799.pdf
"Network for Translational Research , Handbook for NTR Investigators  (Nov. 9, 2010 ),  http://ntroi.wus tl.edu/wiki/ntroi/images/d/d7/Handbook_for_NTR_Investigators_110910_for_upload.pdf .",OADS,/arxiv_data1/oa_pdf/9d/1e/764.PMC3345805.pdf
"S. L.  Jacques , “Melanosome absorption coefficient,” http://omlc.ogi.edu/spectra/melanin/mua.html .",OADS,/arxiv_data1/oa_pdf/a9/c0/792.PMC3345807.pdf
"Hemedex, Inc. , http://www.hemedex.com .",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/800.PMC3345808.pdf
"In the UK, risperidoneis licensed for up to 6 weeks treatment of persistent aggressionin subjects with moderate-to-severe AD, and the recommenda-tions are to be used as a last resort for aggression, when all othermethods have failed to alleviate the most distressing symptomsof dementia, and only when it is in the best interests of the per-son (https://www.alzheimers.org.uk/antipsychotics).",Non-OADS,/arxiv_data1/oa_pdf/b9/83/fneur-03-00073.PMC3345875.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Neuroprotection by DRIPost involves K ATPchannels J Sun et al 859 Journal of Cerebral Blood Flow & Metabolism (2012) 32, 851–859",Non-OADS,/arxiv_data1/oa_pdf/ea/9e/jcbfm2011199a.PMC3345910.pdf
"Theincidence of adverse events was similar between the acotiamide group and placebo group and no signiﬁcant cardiovascular effects due to treatment were seen.Conclusions Over 4 weeks, acotiamide signiﬁcantly improved symptom severity and eliminated meal-related symptoms in patients with FD.Trial registration number http://ClinicalTrials.gov number, NCT00761358.",Non-OADS,/arxiv_data1/oa_pdf/61/dd/gutjnl-2011-301454.PMC3345932.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in an y medium, provided the original work is properly cited.1 Citation: Int J Qualitative Stud Health Well-being 2012, 7: 16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228",Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
2 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228,Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
"Characteristics n/C3010 Men/women 5/5 Age, range (median) 20 /C161 years (41 years) Married, cohab/single 6/4 Occupational status Employed 2 Student 2 Parental leave 1Long-term sick leave or disability pension4 Unemployed 1 Physical illness Recovering from brain tumour 1 Clinical psychiatric diagnoses (ICD-10) Depression (major/NOSa)5 Bipolar mood disorder 3Personality disorder (EIb/NOSa)3 Chronic alcoholism 1 Current prescription of psychotropic drugs9 Previous suicide attempts None 11/C135 5 or more 4 Contact with psychiatric services B1 year 1 4/C110 years 4 /C2110 years 5 aNOS/C30not otherwise specified;bEI/C30emotionally instable (/C30borderline).Being in want of control Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
4 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228,Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
/C1 The road to decidingT o pass the point of noreturn Making sense of the suicide attemptBeing stuck in vicious circlesThe only way out of endless suffering Being exhausted andunable to think straight Opening the door to possible life-linesFinding alternative solutionsSeeking and receiving adequate helpBeing in want of control Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228 5 (page number not for citation purpose),Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
6 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228,Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
"It wasgenerally believed that after the point of no return nothing could have stopped them, except for if someone had discovered them and made themstop, and in accordance with this it was stressedthat the time of seeking and receiving help wascrucial*it has to happen before it is too late.Being in want of control Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
8 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228,Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
It shouldBeing in want of control Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228 9 (page number not for citation purpose),Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
10 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228,Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
"European Psychiatry ,27, 129/C1141.Being in want of control Citation: Int J Qualitative Stud Health Well-being 2012; 7:16228 - http://dx.doi.org/10.3402/qhw.v7i0.16228 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/94/QHW-7-16228.PMC3345936.pdf
"The method thatwe implement here is called Maximum Excluded Mass Burningalgorithm (MEMB), and the algorithm can be downloaded fromhttp://lev.ccny.cuny.edu/hmakse/soft_data.html).",OADS,/arxiv_data1/oa_pdf/71/65/fphys-03-00123.PMC3345943.pdf
"Method Outputs Available Command ARFIMA EML ˆd,ˆφ,ˆθ SAS: IML subroutine FARMAFITFitting ARFIMA (1, d, 1): call farmafit(d, ar, ma, sigma, x, opt=1) p=1 q=1; print d ar ma sigma; CSS ˆd,ˆφ,ˆθ SAS: IML subroutineFARMAFITcall farmafit(d, ar, ma, sigma, x, opt=0) p=1 q=1; print d ar ma sigma; AML ˆd,ˆφ,ˆθ R: library fracdiff summary(fracdiff(x, nar=1, nma=1)) FRACTAL DFA ˆα R: library fractal DFA(x, detrend=""bridge"", sum.order=1) SSC ˆα R-Code SSC.R Download the ﬁle SSC.R from http://www.psychologie.uni-heidelberg.de/projekte/zeitreihen/R_Code_Data_Files.html then click “read R-code” from the data menu and start the test via command SSC(x) PERIODOGRAM lowPSD ˆβ SPSS, SAS, R SPSS-, SAS-, and R-Codes in Appendix lowPSD weˆβ R-Code lowPSDwe.R Download the ﬁle lowPSDwe.R from http://www.psychologie.uni-heidelberg.de/projekte/ zeitreihen/R_Code_Data_Files.html then click “read R-code” from the data menu and start thetest via command PSD(x) hurstSpec ˆα R: library fractal hurstSpec(x) fdGPH ˆd R: library fracdiff fdGPH(x) fdSperio ˆd R: library fracdiff fdSperio(x) FDWhittle ˆd R: library fractal FDWhittle(x) x is the time series name.",Non-OADS,/arxiv_data1/oa_pdf/46/cd/fphys-03-00127.PMC3345945.pdf
"Step “Preparation” •Install R from http://www.r-project.org/ •Install the packages fracdiff ,fractal, tseries [Click install packages under the packages menu, select these packages and conﬁrm with ok].",Non-OADS,/arxiv_data1/oa_pdf/46/cd/fphys-03-00127.PMC3345945.pdf
"•Load SSC andlowPSD we(download the ﬁles SSC.R and lowPSDwe.R from http://www.psychologie.uni-heidelberg.de/projekte/ zeitreihen/R_Code_Data_Files.html, then click read R-code from the data menu).",Non-OADS,/arxiv_data1/oa_pdf/46/cd/fphys-03-00127.PMC3345945.pdf
"The Compseq program, an EMBOSS algorithm29 that calculates nucleotide composition in a sequence, was used http://mobyle.pasteur.fr/cgi-bin/ portal.py#forms::compseq .",OADS,/arxiv_data1/oa_pdf/e5/5f/mt201229a.PMC3345983.pdf
"27 Dinucleotide frequency analy - sis was executed by the Compseq program, an EMBOSS algorithm29 that  calculates nucleotide composition in a given sequence ( http://mobyle.pas- teur.fr/cgi-bin/portal.py#forms::compse q).",OADS,/arxiv_data1/oa_pdf/e5/5f/mt201229a.PMC3345983.pdf
"deMello 3 1DepartmentofChemistry,ImperialCollegeLondon 2DepartmentofBiochemistry,ProteinChipResearchCenter,ChungbukNationalUniversity 3DepartmentofChemistryandAppliedBiosciences,InstituteforChemicalandBioengineering,ETHZurich Correspondenceto:XavierCasadevalliSolvasat x.casadevall-i-solvas@imperial.ac.uk ,XizeNiuat x.niu@imperial.ac.uk URL:http://www.jove.com/video/3437/ DOI:10.3791/3437 Keywords:Bioengineering,Issue58,DropletMicrofluidics,SingleCellAssays,SingleMoleculeAssays,FluorescenceSpectroscopy,Fluorescence LifetimeImaging, DatePublished:12/10/2011 Thisisanopen-accessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense,whichpermits non-commercialuse,distribution,andreproduction,providedtheoriginalworkisproperlycited.",Non-OADS,/arxiv_data1/oa_pdf/2c/05/jove-58-3437.PMC3346046.pdf
VideoLink Thevideocomponentofthisarticlecanbefoundat http://www.jove.com/video/3437/ Protocol 1.Microchipfabrication December2011| 58 |e3437|Page1of7JournalofVisualizedExperiments www.jove.com Copyright©2011 CreativeCommonsAttributionLicense1.,Non-OADS,/arxiv_data1/oa_pdf/2c/05/jove-58-3437.PMC3346046.pdf
5.http://mems.gatech.edu/msmawebsite/members/processes/processes_files/SU8/Data%20Sheet%2050-100.pdf 6.,OADS,/arxiv_data1/oa_pdf/2c/05/jove-58-3437.PMC3346046.pdf
"Lewis 1 1DepartmentofMaterialsScienceandEngineering,UniversityofIllinoisatUrbana-Champaign 2CenterforMicro-andNanotechnology,LawrenceLivermoreNationalLaboratory 3PresentlyattheInterdisciplinaryCenterforWideBand-gapSemiconductors,UniversityOfCaliforniaSantaBarbara URL:http://www.jove.com/video/3189/ DOI:10.3791/3189 Keywords:Bioengineering,Issue58,Direct-writeassembly,silverink,3Dprinting,planar,three-dimensional,microelectrodes,flexibleelectronics, printedelectronics, DatePublished:12/9/2011 Thisisanopen-accessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense,whichpermits non-commercialuse,distribution,andreproduction,providedtheoriginalworkisproperlycited.",Non-OADS,/arxiv_data1/oa_pdf/73/0e/jove-58-3189.PMC3346051.pdf
VideoLink Thevideocomponentofthisarticlecanbefoundat http://www.jove.com/video/3189/ Protocol 1.Introduction 1.,Non-OADS,/arxiv_data1/oa_pdf/73/0e/jove-58-3189.PMC3346051.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2010  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2010 |  43  | e2161 | Page 1 of 5Video Article Assessment of Cerebral Lateralization in Children using Functional Transcranial Doppler Ultrasound (fTCD) Dorothy V. M. Bishop1, Nicholas A. Badcock1, Georgina Holt1 1Department of Experimental Psychology, University of Oxford Correspondence to: Dorothy V. M. Bishop at dorothy.bishop@psy.ox.ac.uk URL: http://www.jove.com/video/2161 DOI: doi:10.3791/2161 Keywords: Neuroscience, Issue 43, functional transcranial Doppler ultrasound, cerebral lateralization, language, child Date Published: 9/27/2010 Citation: Bishop, D.V.M., Badcock, N.A., Holt, G. Assessment of Cerebral Lateralization in Children using Functional Transcranial Doppler Ultrasound (fTCD).",Non-OADS,/arxiv_data1/oa_pdf/50/a1/jove-43-2161.PMC3346060.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/2161/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/50/a1/jove-43-2161.PMC3346060.pdf
"There is a useful computer simulation by Rune Aaslid that can help with training   (http://www.transcranial.com/), but the best way to learn is by practising on friends and colleagues.",Non-OADS,/arxiv_data1/oa_pdf/50/a1/jove-43-2161.PMC3346060.pdf
"(from: http://en.wikipedia.org/wiki/File:Gray517.png )   Figure 2: Schematic outline of experimental trial with 12 second baseline video, 10 second response interval, and 16 second rest phase.",Non-OADS,/arxiv_data1/oa_pdf/50/a1/jove-43-2161.PMC3346060.pdf
"Avi examples: the video sequences to tell the ""Freezefoot"" story can be downloaded from: http://psyweb.psy.ox.ac.uk/oscci/Miscellaneous.htm Discussion As well as studying normal development, we have been using fTCD to study language lateralization in adults and children with developmental disorders of language and literacy 8, 9.",Non-OADS,/arxiv_data1/oa_pdf/50/a1/jove-43-2161.PMC3346060.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in an y medium, provided the original work is properly cited.1 Citation: Int J Qualitative Stud Health Well-being 2012, 7: 17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
2 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318,Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
The time spent with friends is meaningful and often takes place in environments and at times that the womenA project for future life *Swedish women’s thoughts Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318 3 (page number not for citation purpose),Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
4 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318,Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"The woman can either give birth herself in a same sex-relationship oralternatively her partner can become pregnant and give birth, ‘‘I can consider having a child butA project for future life *Swedish women’s thoughts Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
6 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318,Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"The importance of women’ssocial network in relation to women’s childbearing has earlier been described by Bernardi (2003) and Kemkes-Grottenthaler (2003), and according toBernardi (2003) peer relationships affect women’schildbearing plans, which are in line with our results.Living in a culture of choice it is harder to make the decision to start a family (Lundqvist & Roman, 2003; Proudfoot et al., 2009) and most womendo want a family rather than just a child (ProudfootA project for future life *Swedish women’s thoughts Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
8 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318,Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://onlinelibrary.wiley.com/doi/ 10.1111/j.1552-6909.2006.00079.x/pdf Bernardi, L. (2003).",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://dx.doi.org/10.1016/j.ijnurstu.2011.07.013.",OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://dx.doi.org/ 10.1016/j.ejogrb.2004.05.004.",OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://dx.doi.org/10.1016/j.fertnstert.",OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://dx.doi.org/ 10.1016/j.ogrm .2010.12.003.",OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://www.ijqhw.net/ index.php/qhw/article/view/5600/8083 Phipps, S. (2000).",OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved April 4, 2012, from http://dx.doi.org/10.1016/j.contraception.2008.09.005.",OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Retrieved, April 4, 2012, from http://informahealthcare.com/doi/pdf/ 10.1080/17482620601016120 Statistics Sweden.",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"Journal of Comparative Family Studies , 33(2), 191 /C1214.A project for future life *Swedish women’s thoughts Citation: Int J Qualitative Stud Health Well-being 2012; 7:17318 - http://dx.doi.org/10.3402/qhw.v7i0.17318 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/50/05/QHW-7-17318.PMC3346159.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in an y medium, provided the original work is properly cited.1 Citation: Int J Qualitative Stud Health Well-being 2012, 7: 8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187",Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
D. Churchill 2 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187,Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
"It often remains ineffable,Resoundings of the flesh Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
D. Churchill 4 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187,Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
"And, it is when we find ourselves on the receiving side of thisResoundings of the flesh Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
D. Churchill 6 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187,Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
"Either way, when I experience myself as being addressed by the other, when I am pulled into theother’s field, I am simultaneously pulled out of my own solipsism into the resoundings of the flesh.Resoundings of the flesh Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
D. Churchill 8 (page number not for citation purpose)Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187,Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
"Retrieved from http://www.ipjp.org/index.php?option /C30 com_jdownloads&Itemid /C3025&task /C30view.download&cid /C3060 Churchill, S. D. (2007).",OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
"Charlottesville, VA: Imprint Academic.Resoundings of the flesh Citation: Int J Qualitative Stud Health Well-being 2012; 7:8187 - http://dx.doi.org/10.3402/qhw.v7i0.8187 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/77/QHW-7-8187.PMC3346160.pdf
Cross sections of the PAS and Masson’s trichrome stains were semi-quan-tified using NIH ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/42/72/nne-0002-0087.PMC3346163.pdf
"and its leaf mould fungal pathogen Cladosporium fulvum is a model system to study ETI conferred by receptor-likeprotein type R proteins ( Joosten and De Wit, 1999 ;Rivas ª2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/err397.PMC3346213.pdf
The tomato cDNAs and their N. benthamiana homologues corresponding to the differentially expressed proteins were obtained through tBLASTn search againstthe DFCI The Gene Indices database ( http://compbio.dfci.harvard.,OADS,/arxiv_data1/oa_pdf/8f/f9/err397.PMC3346213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/0d/fc/err415.PMC3346214.pdf
"DQ099803) was obtained from an apple expressed sequence tag (EST) database ( http://titan.biotec.uiuc.edu/apple/ ), and a pair of primers (5#-CACGACCAAACCTGTTCCTT-3 #/5#-GTTGCAACCCCTGTC AACTT-3 #) was designed to screen an apple bacterial artiﬁcial Fig.",OADS,/arxiv_data1/oa_pdf/0d/fc/err415.PMC3346214.pdf
Golden Delicious ( http://www.rosaceae.,Non-OADS,/arxiv_data1/oa_pdf/0d/fc/err415.PMC3346214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/ec/53/err416.PMC3346215.pdf
http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/ec/53/err416.PMC3346215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/55/70/err418.PMC3346216.pdf
"In all cases, ethidium bromide-stained DNA bands were visualized under UV light, and the Image J software (National Institutes of Health; http://rsb.info.nih.gov/ij/ ) was employed to quantify DNA strand breaks.",OADS,/arxiv_data1/oa_pdf/55/70/err418.PMC3346216.pdf
"This allowed the characterization of 102 kiwifruit proteins ( Table 1 ;s e ea l s o Supplementary Table S2 ), which is a substantial increase because on 25 August 2011 only 17 reviewed kiwi proteins were listed in the Uniprot/S wiss-prot database, of which only three were from kiwifruit ( http://www.uniprot.org/ uniprot/?query ¼kiwi&sort ¼score ).",OADS,/arxiv_data1/oa_pdf/55/70/err418.PMC3346216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/85/de/err419.PMC3346217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
"Indeed, mass sequencing of new Arabidopsis accessions by the 1001 Genomes Project ( http://1001genomes.org/acces- sions.html ) has dramatically expanded the possibilities for sequence comparisons for mapping.",Non-OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
"Importantly, these markers are also readilyaccessible; either as desig ned and tested PCR markers deposited at The Arabidopsis Information Resource(TAIR; http://www.arabidopsis.org/ )o ra sa ni n d e x e dl i s t of polymorphisms in direct seque nce comparisons (Cereon collection, also available at TAIR).",Non-OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
"Using the Primer3 software (http://frodo.wi.mit.edu/primer3/ ), the primers were designed ac- cordingly to match the characteristics of each INDEL.",OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
", 2011;http://www.1001genomes.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
"Firstly, a selection of the predictedCereon INDELs (http://www.arabidopsis.org/browse/Cereon/index.jsp; Jander et al.",Non-OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
"The Cereon collection as a classical resource for identiﬁcation of INDEL markers In the ﬁrst approach, which yielded about two-thirds of our markers ( Table 1 ), predicted Col-0/L er-0 polymorphisms were taken from the Monsanto Arabidopsis Polymorphismand L erSequence Collections ( http://www.arabidopsis.org/ browse/Cereon/index.jsp ;Jander et al.",OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
", 2011 ;http://www.1001genomes.org/ ) was used to computa- tionally predict INDELs between Col-0 and Ws-0.",OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
",2 0 1 1 ;http://1001genomes.org/ accessions.html ).",OADS,/arxiv_data1/oa_pdf/47/97/err422.PMC3346218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/0b/61/err425.PMC3346219.pdf
"The full open reading frame of PtrLAR3 was ampliﬁed with gene- speciﬁc primers (LAR3-F: 5 #-ACATGAATGGTCATTCTCCA-3 #; LAR3-R: 5 #-TCATGCTGTAATAAATAAAG- 3 #; Joint Genome Institute, http://genome.jgi-psf.org/poplar/poplar.info.html )b yR T - PCR with 2 ll cDNA from roots.",OADS,/arxiv_data1/oa_pdf/0b/61/err425.PMC3346219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/18/15/err428.PMC3346220.pdf
", ª2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/f2/a6/err431.PMC3346221.pdf
"All proc esses for labelling, hybridization, and washing were performed through Affymetrix custom service (Capitalbio) by the protocols give n at http://www.affymetrix.com/ support/technical/man nual/exprssion-mannua l.affx.",OADS,/arxiv_data1/oa_pdf/f2/a6/err431.PMC3346221.pdf
The strong induction of this gene by abiotic stress prompted this study to check its promoter sequence (1500 bp upstream from the transcrip-tion start site) by searching the promoter sequence againstthe PLACE database ( http://www.dna.affrc.go.jp/PLACE/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/a6/err431.PMC3346221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/22/7a/err433.PMC3346222.pdf
"Materials and methods Plant materials and growth conditions Arabidopsis thaliana ecotype Columbia (Col) was used in this study and all transgenic plants were generated in a Col background.Both mutant alleles, aspg1-1 (SALK_045354) and aspg1-2 (SAIL_667_E02), were from the Arabidopsis Biological Resource Center (ABRC; http://www.arabidopsis.org/abrc/ ).",OADS,/arxiv_data1/oa_pdf/22/7a/err433.PMC3346222.pdf
Aspartic protease activity of ASPG1 ASPG1 is predicted to be an aspartic protease (PF00026)of 53 kDa belonging to the MEROPS peptidase familyA1 (pepsin family) ( http://arabidopsis.org/servlets/ TairObject?id ¼40580&type ¼gene).,Non-OADS,/arxiv_data1/oa_pdf/22/7a/err433.PMC3346222.pdf
ASPG1 does not have a signal peptide ( http://smart.embl-heidelberg.de/smart/ show_motifs.pl ).,Non-OADS,/arxiv_data1/oa_pdf/22/7a/err433.PMC3346222.pdf
http://www.aspb.org/ publications/arabidopsis/ .,Non-OADS,/arxiv_data1/oa_pdf/22/7a/err433.PMC3346222.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/44/47/err436.PMC3346223.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/3f/69/err443.PMC3346224.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/6d/6a/err448.PMC3346225.pdf
"sativus were aligned (ClustalW2, http://www.ebi.ac.uk/Tools/msa/clustalw2/ ) and consensus peptide sequences identiﬁed.",OADS,/arxiv_data1/oa_pdf/6d/6a/err448.PMC3346225.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/a3/70/err449.PMC3346226.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/12/29/err450.PMC3346227.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/err451.PMC3346228.pdf
"Sudan IV assay Sudan IV (MP Biomedicals, http://mpbio.com ) stock solution [0.1% (w/v) in isopropyl alcohol] was diluted 3:2 with distilledwater, mixed well, and ﬁltered through a syringe ﬁlter to remove precipitates.",Non-OADS,/arxiv_data1/oa_pdf/4b/23/err451.PMC3346228.pdf
"Photographs were made with a Leica digital camera, and the software package ImageJ ( Rasband, 1997–2008 ; http://rsb.info.nih.gov/ij/ ) was used to analyse the photographs and collect size parameters of a coloured cuticle.",OADS,/arxiv_data1/oa_pdf/4b/23/err451.PMC3346228.pdf
"Digital images of sections were analysed using ImageJ(Rasband, 1997–2008 ,http://rsb.info.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/4b/23/err451.PMC3346228.pdf
"Companyhas, catalogue number 53210 Fruit pressure tester http://www.trsnc.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/4b/23/err451.PMC3346228.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"The results suggest that reduced levels of ABI5 inArabidopsis fy-1 may be linked to this ABA-insensitivity.Materials and methods Plant materials and growth conditions Arabidopsis fy-1 mutant (CS57) seeds and its wild-type back- ground parent (L er) were obtained from the Arabidopsis Biological Resource Centre (ABRC, http://www.arabidopsis.org ).",Non-OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"For the real-time RT- PCR, the extracted total RNA was treated with DNaseI (Qiagen, http://www1.qiagen.com ) for digestion of genomic DNA, and was further puriﬁed using the RNeasy plant mini kit (Qiagen, http:// www1.qiagen.com ) according to the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"Quantitative RT-PCR was performed, in triplicate, with 1 ll of cDNA template in 25 ll reaction using QuantiTect /C210SYBR Green PCR kit (Qiagen, http://www1.qiagen.- com) and run on the Applied Biosystem 7500 Fast real-time PCR system ( http://www.appliedbiosystems.com ) according to the manu- facturer’s instructions.",OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"The 1.33 kb PCR product was ampliﬁed and cloned into pGEM-Teasy vector (Promega, http://www.promega.com ) and conﬁrmed by sequencing.",Non-OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"After staining, tissues were transferred to a solutionof ethanol: acetic acid (3:1 v/v) and photographed using a Leica DC500 dissecting microscope ( http://www.leica-microsystems.",Non-OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"The PCR products were cloned into pGEM- Teasy (Promega, http://www.promega.com ) and sequenced.",Non-OADS,/arxiv_data1/oa_pdf/b3/67/err452.PMC3346229.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/a0/cf/err453.PMC3346230.pdf
(2000) aAccording to BLAST ( http://blast.ncbi.nlm.nih.gov ).,OADS,/arxiv_data1/oa_pdf/a0/cf/err453.PMC3346230.pdf
bAccording to PFAM search ( http://pfam.janelia.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/cf/err453.PMC3346230.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/e8/81/err455.PMC3346231.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/c6/ee/err456.PMC3346232.pdf
Forward and reverse primers were designed using Biotools (http://biotools.umassmed.edu/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/err456.PMC3346232.pdf
"Primers were designed using IDT Scitools, Oligo Analyzer 3.1 (http://eu.idtdna.com ) to divide the AlstroTPS ORF sequence into segments that overlapped each other by ;100 nucleotides ( Supple- mentary Table S2 atJXB online).",OADS,/arxiv_data1/oa_pdf/c6/ee/err456.PMC3346232.pdf
All three of these compounds are also found in thevolatile emissions of a range of taxonomically distinctﬂowers ( http://www.pherobase.com ).,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/err456.PMC3346232.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/29/11/err457.PMC3346233.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/cb/cf/err461.PMC3346234.pdf
The cDNA microarrays used were developed in the framework of the CFGP ( http://bioinfo.ibmcp.,OADS,/arxiv_data1/oa_pdf/cb/cf/err461.PMC3346234.pdf
"FatiGO+ (Babelomics, http://bioinfo.cipf.es/ ), developed by Al-Shahrour et al.",OADS,/arxiv_data1/oa_pdf/cb/cf/err461.PMC3346234.pdf
"Statistical analysis (a pairwise ﬁxed reallocation randomization test) was carried out using the Relative Expression Software Tool (REST: http://rest.gene-quantiﬁcation.info ;Pfafﬂ, 2001 ).",OADS,/arxiv_data1/oa_pdf/cb/cf/err461.PMC3346234.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/26/ef/err463.PMC3346235.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/74/c8/err465.PMC3346236.pdf
"The transgenic p35S::miR156a plants exhibited a much stronger rescue of the hyl1-2 mutant phenotype than was seen in spl9-4 spl15-1 plants .The limited restoration of spl9- 4 spl15-1 alleles to the hyl1-2 phenotype indicated that HYL1 regulates other SPL genes besides SPL9 andSPL15 .Table 2. miRNA-targeted genes upregulated >1.5-fold in 3-week-old hyl1seedlings relative to the wild type Accession no.aGene miRNAs Fold change AT1G72830 HAP2C miR169a, -b, -c, -h, -i, -j, -k, -l, -m, -n 12.197156 AT5G06510 CBF-B /NF-YA miR169b, -c, -d, -e, -f, -g, -h, -i, -j, -k, -l, -m, -n 9.1556805 AT3G15270 SPL5 miR156a, -b, -c, -d, -e, -f, -g; miR157d 7.4200788 AT3G05690 HAP2B miR169b, -c, -d, -e, -f, -g, -h, -i, -j, -k, -l, -m, -n 7.0425992 AT1G53160 SPL4 miR156a, -b, -c, -d, -e, -f, -g, -h; miR157a, -b, -c, -d 6.1503794 AT1g52070 JR/MBP miR846a 5.352703 AT1G63150 PPR miR161.1a, miR161.2a 4.8119594 AT3G57230 AGL16 miR824a 4.7594344 AT2G02850 ARPN miR408a 4.6092139 AT1G01040 DCL1 miR162a, -b 4.462162 AT1g52060 JR/MBP miR846a 4.0534713 AT1G17590 rCBF-B /NF-YA miR169a, -b, -c, -h, -i, -j, -k, -l, -m, -n 3.8572252 AT1G31280 AGO2 miR403a 3.7480951 AT1G63130 PPR miR161.1a; miR400a 3.0100167 AT1G30490 PHV miR165a, -b; miR166a, -b, -c, -d, -e, -f, -g 3.0088157 AT3G11440 ATMYB65 miR159c 2.9420524 AT2G33810 SPL3 miR156a, -b, -c, -d, -e, -f, -g 2.9262585 AT1G63080 PPR miR161.1a; miR400a 2.8489617 AT5G06100 MYB33 miR159c 2.6038222 AT3G09220 LAC7 miR857a 2.5730044 AT1G12290 CC-NBS-LRR miR472a 2.5651874 AT3G15030 TCP4 miR319a, -b, -c 2.4187059 AT1G54160 CBF-B /NF-YA miR169a, -b, -c, -h, -i, -j, -k, -l, -m, -n 2.3524761 AT1G27370 SPL10 miR156a, -b, -c, -d, -e, -f, -g, -h; miR157a, -b, -c, -d 2.2149103 AT3G20910 CBF-B /NF-YA miR169a, -b, -c, -d, -e, -f, -g 2.0370432 AT3G60630 SCARECROW miR170a; miR171a, -b, -c 2.0144381 AT2G42200 SPL9 miR156a, -b, -c, -d, -e, -f, -g, -h; miR157a, -b, -c, -d 1.9632046 AT1G56010 NAC1 miR164a, -b, -c 1.9609002 AT1G52150 ATHB-15 miR165a, -b; miR166a, -b, -c, -d, -e, -f, -g 1.9513054 AT1G77850 ARF17 miR160a, -b, -c 1.8860873 AT5G60690 REV miR165a, -b; miR166a, -b, -c, -d, -e, -f, -g 1.7754512 AT1G53230 TCP3 miR319a, -b, -c 1.7221409 AT4G30080 ARF16 miR160a, -b, -c 1.6402834 AT5G43780 APS4 miR395a, -b, -c, -d, -e, -f 1.5858944 AT1G76810 eIF-2 miR771a 1.5199657 aThe Arabidopsis Information Resource database: http://www.arabidopsis.org/ .HYL1 and the juvenile phase |2793",Non-OADS,/arxiv_data1/oa_pdf/74/c8/err465.PMC3346236.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
"All retrieved sequences were used for gene prediction on the Genscan web server ( http://genes.mit.edu/GENSCAN.html )(Burge and Karlin, 1998).",OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
Sequence feature analysis Intron/exon structures were predicted using the Gene Structure Display Server ( http://gsds.cbi.pku.edu.cn/chinese.php )(Guo et al.,OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
", 1994 )(http://web.expasy.org/compute_pi/ ).",Non-OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
The localizations of deduced proteins were predicted on the TargetP 1.1 server ( http://www.cbs.dtu.dk/services/TargetP/ )(Emanuelsson et al.,OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
Transmembrane domains were analysed on the TRMHMM server v 2.0 ( http://www.cbs.dtu.dk/services/TMHMM- 2.0/)(Krogh et al.,OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
", 2009 )(ftp://ftp.sanger.ac.uk/pub/data bases/Pfam/Tools/README ).",OADS,/arxiv_data1/oa_pdf/d6/4b/err466.PMC3346237.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/69/d7/ers001.PMC3346238.pdf
"The P. trichocarpa genome database ( http://genome.jgi-psf.org/ Poptr1/Poptr1.home.html ) was ﬁrst searched for glycosyltransfer- ase homologues of Arabidopsis thaliana UGT72E1-E3 cDNA, which were already known to glucosylate several phenylpropa- noids ( Lim et al.",OADS,/arxiv_data1/oa_pdf/69/d7/ers001.PMC3346238.pdf
Sequence analysis of PtGT1 The conserved protein domain sequences of poplar PtGT1 and Arabidopsis UGT72E1-E3 were obtained from the Proteomics Server of the Expert Protein Analysis system (ExPASy) of the Swiss Institute of Bioinformatics ( http://cn.expasy.org ;(Gasteiger et al.,OADS,/arxiv_data1/oa_pdf/69/d7/ers001.PMC3346238.pdf
The amino acid sequences of PtGT1 and UGT72E1-E3 were aligned using the ClustalX program and the online website ( http://www.ch.embnet.org/software/BOX_ form.html ).,OADS,/arxiv_data1/oa_pdf/69/d7/ers001.PMC3346238.pdf
The sequences of all the published Arabidopsis family 1 GTs used in the phylogenetic tree were obtained from the Carbohydrate-active enzymes database ( http://www.cazy.org/GT1_eukaryota.html )a n d the NCBI database ( Aspeborg et al.,OADS,/arxiv_data1/oa_pdf/69/d7/ers001.PMC3346238.pdf
The GT sequences were retrieved from the Carbohydrate-active enzymes database ( http://www.cazy.org/G T1_eukaryota.html ) and the NCBI database.,OADS,/arxiv_data1/oa_pdf/69/d7/ers001.PMC3346238.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/ff/e5/ers008.PMC3346239.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2011  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2011 |  53  | e2851 | Page 1 of 5Video Article Mouse Oocyte Microinjection, Maturation and Ploidy Assessment Paula Stein1, Karen Schindler1 1Department of Biology, University of Pennsylvania Correspondence to: Karen Schindler at schindla@sas.upenn.edu URL: http://www.jove.com/video/2851 DOI: doi:10.3791/2851 Keywords: Cell biology, Issue 53, oocyte, microinjection, meiosis, meiotic maturation, aneuploidy Date Published: 7/23/2011 Citation: Stein, P., Schindler, K. Mouse Oocyte Microinjection, Maturation and Ploidy Assessment.",Non-OADS,/arxiv_data1/oa_pdf/d3/05/jove-53-2851.PMC3346305.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/2851/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/05/jove-53-2851.PMC3346305.pdf
"Informatics; Universidad de Granada; Granada, Spain; 3Grupo de Ecología Genética de la Rizosfera; Estación Experimental del Zaidín; Consejo Superior de Investigaciones Científicas; CSIC; Granada, Spa in Keywords: Sinorhizobium meliloti , symbiotic nitrogen fixation, RNome, riboregulation, Hfq, Brucella , rhizobia, suhB, speF Abbreviations: sRNA, bacterial small non- coding RNA; IGR, intergenic region; RACE, rapid amplification of cDNA ends; Smr, S. meliloti sRNA; TAP, tobacco acid pyrophosphatase; TSS, transcription start site; CM, covariance model; RBS, ribosome binding site; aSD, anti Shine- Dalgarno; 5'-UTR, 5' untranslated region; GABA, c-amino butyric acid Submitted: 09/28/11 Revised: 11/03/11 Accepted: 11/03/11 http://dx.doi.org/10.4161/rna.9.2.18643 *Correspondence to: Coral del Val; Email: delval@decsai.ugr.esWe have performed a computational comparative analysis of six small non-coding RNA (sRNA) families in a-proteobacteria.",Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
"Query S. meliloti sRNA sequences Name Alternative namesa59-endb,c39-endbLength (nt) Smr7C Sra03/Sm13/SmelC023 201,679 201,828 150 Smr9C Sra32/Sm10/SmelC289 1398,425 1398,277 149 Smr14C Sm7/SmelC397 1,667,613 1,667,491 123 Smr15C Sra41/Sm3/SmelC411 1,698,731 1,698,617 115 Smr16C Sra41/Sm3 9/SmelC412 1,698,937 1,698,817 121 Smr35B SmB6/SmelC053 577,730 577,868 139 Smr45C SmelC706 3,105,445 3,105,298d148 Smr22C Sra56/Sm1/SmelC667/6S 2,972,251 2,972,091c161 aAlternative reported names for the Smr transcripts;7-9 bCoordinates according to the S. meliloti 1021 genome database at http://iant.toulouse.inra.fr/bacteria/annotation/cgi/rhime.cgi or www.rhizogate.de; cRACE-based mapping_ENREF_32;6dDeep-sequencing data9 2 RNA Biology Volume 9 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Cell 2009; 136:615-28; PMID:19239884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nat Rev Microbiol 2004; 2:933-45; PMID:15550939; http://dx.doi.org/10.1038/nrmicro1044 3.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nat Rev Microbiol 2007; 5:619-33; PMID:17632573; http://dx.doi.org/ 10.1038/nrmicro1705 4.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Science 2001; 293: 668-72; PMID:11474104; http://dx.doi.org/10.1126/ science.1060966 5.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
J Bacteriol 2009; 191:2501-11; PMID:19251847; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Mol Microbiol 2007; 66:1080-91; PMID: 17971083; http://dx.doi.org/10.1111/j.1365-2958.2007.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
BMC Genomics 2008; 9:416; PMID:18793445; http://dx.doi.org/10.1186/1471-2164-9-416 9.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Curr Opin Microbiol 2004; 7:140-4; PMID:15063850; http://dx.doi.org/10.1016/j.mib.2004.02.015 11.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nucleic Acids Res 2011; 39: D141-5; PMID:21062808; http://dx.doi.org/10.1093/ nar/gkq1129 12.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Genome Biol 2005; 6:R70; PMID:16086852; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
EMBO J 2002; 21: 3546-56; PMID:12093755; http://dx.doi.org/10.1093/ emboj/cdf32215.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Proc Natl Acad Sci USA 2011; 108:13059-64; PMID:21788484; http://dx.doi.org/ 10.1073/pnas.1107050108 16.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Proc Natl Acad Sci USA 2011; 108:13065-70; PMID:21737752; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Microbiology 2006; 152: 1751-63; PMID:16735738; http://dx.doi.org/10.1099/ mic.0.28743-0 19.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Mol Microbiol 2007; 65:1425-31; PMID:17714443; http://dx.doi.org/10.1111/j.1365-2958.2007.05894.x 20.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Biochem Biophys Res Commun 2009; 390:331-6; PMID:19800865; http://dx.doi.org/10.1016/j.bbrc.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Mol Microbiol 2011; 80:492-506; PMID:21320185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nucleic Acids Res 2003; 31:6435-43; PMID:14602901; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Cell 2009; 139:770-9; PMID: 19914169; http://dx.doi.org/10.1016/j.cell.2009.08.046 26.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Cell 2004; 118: 69-82; PMID:15242645; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Genes Dev 2007; 21: 221-33; PMID:17234887; http://dx.doi.org/10.1101/ gad.1502407 28.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
PLoS Biol 2008; 6:e64; PMID:18351803; http://dx.doi.org/10.1371/journal.pbio.0060064 29.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Bioinformatics 2009; 25:1335-7; PMID:19307242; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
PLOS Comput Biol 2007; 3:e65; PMID:17432929; http://dx.doi.org/10.1371/journal.pcbi.0030065 31.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Bioinformatics 2005; 21:3674-6; PMID:16081474; http://dx.doi.org/10.1093/bioinformatics/bti61032.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nucleic Acids Res 2009; 37: D211-5; PMID:18940856; http://dx.doi.org/10.1093/ nar/gkn785 35.,Non-OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nucleic Acids Res 2010; 38:D211-22; PMID: 19920124; http://dx.doi.org/10.1093/nar/gkp985 36.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
Nucleic Acids Res 2009; 37:D229-32; PMID:18978020; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/2c/rna-9-119.PMC3346310.pdf
"Do not distribute.Distinct families of cis-acting RNA replication elements epsilon from hepatitis B viruses Augustine Chen and Chris Brown* Biochemistry and Genetics Otago; University of Otago; Dunedin, New Zealand Keywords: pgRNA, epsilon element, encapsidation, hepadnavirus, RNA secondary structure Submitted: 09/28/11 Revised: 11/04/11 Accepted: 10/19/11 http://dx.doi.org/10.4161/rna.9.2.18649 *Correspondence to: Chris Brown; Email: chris.brown@otago.ac.nzThe hepadnavirus encapsidation sig- nal, epsilon ( ε), is an RNA struc- ture located at the 5' end of the viral pregenomic RNA.",Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol 2010; 25:19-25; PMID:20136972; http://dx.doi.org/10.1111/j.1440- 1746.2009.06165.x 2.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Microbiol Mol Biol Rev 2000; 64:51-68; PMID: 10704474; http://dx.doi.org/10.1128/MMBR.64.1.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Intervirology 2010; 53:29-38; PMID:20068338; http://dx.doi.org/10.1159/000252781 6.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Nucleic Acids Res 2005; 33:1169-81; PMID:15731337; http://dx.doi.org/10.1093/nar/gki251 8.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Virology 2010; 406:56-64; PMID: 20667576; http://dx.doi.org/10.1016/j.virol.2010.07.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Cell 1990; 63:1357-63; PMID:2261646; http://dx.doi.org/10.1016/0092- 8674(90)90431-D 15.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Virology 1997; 227:500-4; PMID:9018150; http://dx.doi.org/10.1006/viro.1996.8329 16.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
J Biol Chem 2003; 278:36128-38; PMID: 12851401; http://dx.doi.org/10.1074/jbc.M301069200 18.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Virus Res 2008; 134:235-49; PMID: 18339439; http://dx.doi.org/10.1016/j.virusres.2007.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
EMBO J 1997; 16:59-68; PMID:9009268; http://dx.doi.org/10.1093/emboj/16.1.59 22.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
J Virol 2006; 80:2141-50; PMID: 16474122; http://dx.doi.org/10.1128/JVI.80.5.2141- 2150.2006 25.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
J Hepatol 2010; 52:817-26; PMID:20400195; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
J Virol 2010; 84:12824-31; PMID:20926578; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Virol J 2007; 4:136; PMID:18086305; http://dx.doi.org/10.1186/1743-422X-4-136 29.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Nucleic Acids Res 2002; 30:3497-531; PMID: 12177293; http://dx.doi.org/10.1093/nar/gkf48130.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Biochemistry 2009; 48:10499-508; PMID:19817488; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Bioinformatics 2010; 26: i453-9; PMID:20823307; http://dx.doi.org/10.1093/ bioinformatics/btq370 33.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
RNA 2004; 10: 424-37; PMID:14970388; http://dx.doi.org/10.1261/ rna.5174804 34.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Bioinformatics 2009; 25:1335-7; PMID:19307242; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
J Virol 2008; 82:2305-12; PMID: 18094191; http://dx.doi.org/10.1128/JVI.02147-07 38.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Chin Chem Lett 2009; 20:1263-6; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Nucleic Acids Res 2006; 34: 4449-57; PMID:16945960; http://dx.doi.org/10.1093/ nar/gkl582 40.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Nucleic Acids Res 2007; 35:2800-11; PMID: 17430968; http://dx.doi.org/10.1093/nar/gkm131 41.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Biomol NMR Assign 2008; 2:159-62; PMID:19636894; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
Nucleic Acids Res 2011; 39: D141-5; PMID:21062808; http://dx.doi.org/10.1093/ nar/gkq1129 www.landesbioscience.com RNA Biology 7,OADS,/arxiv_data1/oa_pdf/89/91/rna-9-130.PMC3346311.pdf
"Do not distribute.Liver-specific microRNA-122 Biogenesis and function Catherine L. Jopling Centre for Biomolecular Sciences; University of Nottingham; University Park; Nottingham, UK Keywords: MicroRNA, miR-122, Pri-miRNA, GLD-2, CAT-1, Cholesterol, Hepatitis C virus Abbreviations: miRNA, MicroRNA; miR-122, MicroRNA-122; HCV, Hepatitis C virus; nt, Nucleotide; UTR,Untranslated region; Pol II, RNA polymerase II; HNF-4 a, Hepatocyte nuclear factor 4 a; PPAR β/d, Peroxisome proliferator-activated receptor β/d; CPEB, Cytoplasmic polyadenylation element binding protein; CAT-1, Cationic aminoacid transporter 1; Aldo A, Aldolase A;Ndrg3, N-myc downstream regulatedgene 3; Hfe, Hemochromatosis; Hjv, Hemojuvelin; HCC, Hepatocellular carcinoma; IRES, Internal ribosome entrysite; miRISC, miRNA-induced silencingcomplex; LNA, Locked nucleic acid Submitted: 10/07/11 Revised: 11/18/11Accepted: 11/22/11http://dx.doi.org/ Correspondence to: Catherine L. Jopling; Email: Catherine.jopling@nottingham.ac.ukm icroRNA-122 (miR-122) was one of the first examples of a tissue-specific miRNA.",Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Science 2001; 294:853-8; PMID:11679670; http://dx.doi.org/10.1126/science.1064921 3.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Science 2001; 294:862-4; PMID:11679672; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Science 2001; 294: 858-62; PMID:11679671; http://dx.doi.org/10.1126/ science.1065062 5.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Curr Biol 2002; 12:735-9; PMID:12007417; http://dx.doi.org/10.1016/S0960- 9822(02)00809-6 6.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
RNA Biol 2004; 1:106-13; PMID: 17179747; http://dx.doi.org/10.4161/rna.1.2.1066 7.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nucleic Acids Res 2011; 39:D152-7; PMID: 21037258; http://dx.doi.org/10.1093/nar/gkq1027 8.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Mol Cell 2007; 27:91-105; PMID:17612493; http://dx.doi.org/10.1016/j.molcel.2007.06.017 9.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nat Rev Mol Cell Biol 2009; 10:126-39;PMID:19165215; http://dx.doi.org/10.1038/nrm2632 10.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Science 2005; 309:310-1; PMID:15919954; http://dx.doi.org/10.1126/science.1114519 11.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Genome Res 2004; 14:1902-10;PMID:15364901; http://dx.doi.org/10.1101/gr.2722704 12.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
J Hepatol 2011; 55:602-11; PMID: 21241755; http://dx.doi.org/10.1016/j.jhep.2010.12.023 14.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Genes Dev 2009; 23:1313-26; PMID:19487572; http://dx.doi.org/10.1101/gad.178100915.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Genome Res 2010; 20:1398-410; PMID: 20719920; http://dx.doi.org/10.1101/gr.106054.110 16.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
GenesDev 2009; 23:433-8; PMID:19240131; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nature 2011; 473:105-8; PMID:21478871; http://dx.doi.org/10.1038/ nature09908 18.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Cell 2006; 125:1111-24; PMID:16777601; http://dx.doi.org/10.1016/j.cell.2006.04.031 19.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nature 2005; 438:685-9; PMID: 16258535; http://dx.doi.org/10.1038/nature04303 20.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Cell Metab 2006; 3:87-98; PMID:16459310; http://dx.doi.org/ 10.1016/j.cmet.2006.01.005 21.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nucleic Acids Res 2008; 36:1153-62; PMID:18158304; http://dx.doi.org/10.1093/nar/gkm1113 22.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nature 2008; 452:896-9; PMID:18368051; http://dx.doi.org/10.1038/nature06783 23.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
JClin Invest 2011; 121:1386-96; PMID:21364282; http://dx.doi.org/10.1172/JCI44883 24.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Oncogene 2009; 28:3526-36; PMID:19617899; http://dx.doi.org/10.1038/onc.2009.211 26.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
J Biol Chem 2009; 284:32015-27; PMID:19726678; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Cancer Res 2009; 69:5761-7; PMID:19584283; http://dx.doi.org/10.1158/0008-5472.CAN-08-4797 28.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Hepatology 2009; 49:1571-82;PMID:19296470; http://dx.doi.org/10.1002/hep.22806 29.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nature 2005; 436:930-2; PMID:16107831;http://dx.doi.org/10.1038/nature04076 30.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Science 2005; 309:1577-81; PMID:16141076; http://dx.doi.org/10.1126/science.1113329 31.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Cell Host Microbe 2008; 4:77-85; PMID:18621012; http://dx.doi.org/10.1016/j.chom.2008.05.013 32.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nature2005; 436:933-8; PMID:16107832; http://dx.doi.org/10.1038/nature04077 34.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
EMBO J 2008; 27:3300-10;PMID:19020517; http://dx.doi.org/10.1038/emboj.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nucleic Acids Res 2011; 39:7716-29; PMID:21653556; http://dx.doi.org/10.1093/nar/gkr426 36.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
J Virol 2010; 84:6615-25; PMID:20427538; http://dx.doi.org/10.1128/JVI.00417-10 37.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
J Virol 2010; 84:666-70; PMID: 19846523; http://dx.doi.org/10.1128/JVI.01156-09 38.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Antiviral Res 2010; 88: 119-23; PMID:20637242; http://dx.doi.org/10.1016/ j.antiviral.2010.07.004 39.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
J Virol 2011; 85:2342-50; PMID:21177824; http://dx.doi.org/10.1128/JVI.,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Science 2010; 327:198-201; PMID:19965718; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
Nat Med 2009; 15:31-3; PMID:19122656; http://dx.doi.org/10.1038/nm.1902 6 RNA Biology Volume 9 Issue 2,Non-OADS,/arxiv_data1/oa_pdf/19/f4/rna-9-137.PMC3346312.pdf
"The *Correspondance to: Annie Mougin; Email: mougin@biotoul.fr Submitted: 08/26/11; Revised: 11/15/11; Accepted: 11/19/11 http://dx.doi.org/10.4161/rna.9.2.18810RESEARCH PAPER RNA Biology 9:2, 1 –13; February 2012; G2012 Landes Bioscience www.landesbioscience.com RNA Biology 1",Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Cell 2001; 107:133-6; PMID:11672521; http://dx.doi.org/10.1016/S0092- 8674(01)00531-1 2.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Gene 2003; 313:17- 42; PMID:12957375; http://dx.doi.org/10.1016/S0378- 1119(03)00629-2 3.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
EMBO J 2003; 22:1370-80; PMID: 12628929; http://dx.doi.org/10.1093/emboj/cdg121 4.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Trends Cell Biol 2003; 13:255-63; PMID:12742169; http://dx.doi.org/ 10.1016/S0962-8924(03)00054-0 5.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Nucleic Acids Res 2003; 31:799- 804; PMID:12560474; http://dx.doi.org/10.1093/nar/ gkg165 6.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Trends Biochem Sci 2010; 35:260-6; PMID:20137954; http://dx.doi.org/10.1016/j.tibs.2010.01.001 7.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Curr Opin Cell Biol 2005; 17:281-6; PMID:15901498; http://dx.doi.org/10.1016/j.ceb.2005.04.001 8.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
FEBS Lett 2007; 581:2783-93; PMID:17509569; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
PLoS Biol 2009; 7:e1000213; PMID:19806183; http://dx.doi.org/10.1371/journal.pbio.1000213 10.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Cell Mol Life Sci 2008; 65:2334-59; PMID:18408888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
RNA 2009; 15:2083-104; PMID:19850913; http://dx.doi.org/10.1261/rna.1792109 12.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Mol Cell 2002; 10:105-15; PMID:12150911; http://dx.doi.org/10.1016/S1097-2765(02)00579-8 13.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
EMBO J 2001; 20:4204-13; PMID: 11483523; http://dx.doi.org/10.1093/emboj/20.15.4204 15.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Mol Cell Biol 2003; 23:2083-95; PMID:12612080; http://dx.doi.org/10.1128/MCB.23.6.2083-2095.2003 16.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Genes Dev 1995; 9:2470-81; PMID:7590228; http://dx.doi.org/10.1101/gad.9.20.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Mol Cell Biol 2003; 23:1798-807; PMID:12588997; http://dx.doi.org/10.1128/MCB.23.5.1798-1807.2003 19.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
J Biol Chem 2009; 284:35079-91; PMID:19801658; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
RNA 2004; 10:645-56; PMID:15037774; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
RNA 2008; 14:2061-73; PMID: 18755838; http://dx.doi.org/10.1261/rna.1176708 23.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Genes Dev 2004; 18:196- 209; PMID:14729571; http://dx.doi.org/10.1101/gad.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Nucleic Acids Res 2003; 31:690-9; PMID:12527778; http://dx.doi.org/10.1093/nar/gkg145 25.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Nature 2002; 417:967-70; PMID:12068309; http://dx.doi.org/10.1038/nature00769 26.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Genetics 2004; 168:1877-89; PMID:15611164; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
RNA 2001; 7:1268- 83; PMID:11565749; http://dx.doi.org/10.1017/ S1355838201013073 28.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Mol Cell Biol 2005; 25:10352-64; PMID: 16287850; http://dx.doi.org/10.1128/MCB.25.23.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
EMBO J 2009; 28:3808-19; PMID:19927118; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Nature 2003; 425:686-91; PMID: 14562095; http://dx.doi.org/10.1038/nature02026 32.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Genetics 2006; 174: 679-91; PMID:16888326; http://dx.doi.org/10.1534/ genetics.106.062117 33.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Proc Natl Acad Sci U S A 2009; 106:14259-64; PMID:19706509; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
J Mol Biol 2011; 405:3-17; PMID:20934433; http://dx.doi.org/ 10.1016/j.jmb.2010.09.064 35.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
J Cell Biol 2009; 185:1167-80; PMID: 19564402; http://dx.doi.org/10.1083/jcb.200904048 36.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Nucleic Acids Res 2011; 39:280-91; PMID: 20805244; http://dx.doi.org/10.1093/nar/gkq734 38.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
EMBO J 2005; 24:2862-72; PMID:16037817; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Science 2002; 298:1912-34; PMID: 12471243; http://dx.doi.org/10.1126/science.1075762 40.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Mol Microbiol 2002; 44:309-24; PMID:11972772; http://dx.doi.org/10.1046/j.1365-2958.2002.02881.x 41.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Cell 1996; 85:149-58; PMID:8612268; http://dx.doi.org/ 10.1016/S0092-8674(00)81092-2 43.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Protein Sci 2002; 11:1580-4; PMID: 12021457; http://dx.doi.org/10.1110/ps.3560102 45.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
J Biol Chem 2005; 280:37297- 300; PMID:16183636; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
J Cell Sci 2003; 116:2409-19; PMID:12724356; http://dx.doi.org/10.1242/jcs.00464 48.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Proc Natl Acad Sci U S A 2008; 105: 19372-7; PMID:19050074; http://dx.doi.org/10.1073/ pnas.080996610550.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
BMC Cancer 2010; 10:295; PMID:20553613; http://dx.doi.org/10.1186/1471-2407-10-295 51.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Genes Dev 2011; 25:119-24; PMID:21196494; http://dx.doi.org/10.1101/ gad.1998711 52.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Virology 1973; 54:536-9; PMID:4737663; http://dx.doi.org/10.1016/ 0042-6822(73)90163-354.,Non-OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
RNA 2006; 12:832-40; PMID:16601202; http://dx.doi.org/ 10.1261/rna.2344106 55.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
Structure 2004; 12:1585-94; PMID:15341724; http://dx.doi.org/10.1016/j.str.2004.06.016 56.,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
FEBS J 2005; 272:2800-10; PMID:15943813; http://dx.doi.org/10.1111/j.1742- 4658.2005.04702.x www.landesbioscience.com RNA Biology 13,OADS,/arxiv_data1/oa_pdf/8d/86/rna-9-163.PMC3346313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Letter to the Editor 3 &2012 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/b5/eb/bcj201211a.PMC3346679.pdf
"E-mail: bbilgicer@nd.edu or http://www.nd.edu/ Bbbgroup 6These authors contributed equally to this work.Citation: Blood Cancer Journal (2012) 2, e64; doi:10.1038/bcj.2012.10 &2012 Macmillan Publishers Limited All rights reserved 2044-5385/12 www.nature.com/bcj",Non-OADS,/arxiv_data1/oa_pdf/68/d8/bcj201210a.PMC3346680.pdf
"Availableat http://nano.cancer.gov/about_alliance/cancer_nanotechnology_plan, 2004.",OADS,/arxiv_data1/oa_pdf/68/d8/bcj201210a.PMC3346680.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Blood Cancer Journal website (http://www.nature.com/bcj)Rationally designed nanoparticles target myeloma T Kiziltepe et al 10 Blood Cancer Journal &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/68/d8/bcj201210a.PMC3346680.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/T- and NK-cell lymphomas in children and adolescents NK El-Mallawany et al 17 Blood Cancer Journal &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/29/4a/bcj20128a.PMC3346681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Bevacizumab in a novel lymphoma model F Mori et al 9 &2012 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/fb/13/bcj201212a.PMC3346682.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Apoptosis induction by inhibition of Hsp90 and proteasome T Ishii et al 8 Blood Cancer Journal &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/68/6c/bcj201213a.PMC3346683.pdf
"http://dx.doi.org/10.3345/kjp.2012.55.4.115 Korean J Pediatr 2012;55(4):115-120 eISSN 1738-1061 • pISSN 2092-7258Review article 115Treatment of high-risk neuroblastoma Although high-dose chemotherapy and autologous stem cell trans - plantation (HDCT/autoSCT) have improved the prognosis for pa - tients with high-risk neuroblastoma (NB), event-free survival rates  remain in the range of 30 to 40%, which is unsatisfactory.",Non-OADS,/arxiv_data1/oa_pdf/ec/7b/kjped-55-115.PMC3346833.pdf
"Key words: Neuroblastoma, High-dose chemotherapy, Allogeneic  stem cell transplantation Ki Woong Sung, MD, PhD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul,  Korea Received: 15 January 2012, Accepted: 21 February 2012 Corresponding author: Ki Woong Sung, MD, PhD Department of Pediatrics, Samsung Medical Center, Sung - kyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-3529, Fax: +82-2-3410-0043 E-mail: kwsped@skku.edu Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/7b/kjped-55-115.PMC3346833.pdf
"Korean J Pediatr  2012;55(4):115-120 • http://dx.doi.org/10.3345/kjp.2012.55.4.115     117 TBI, into tandem HDCT/autoSCT to reduce late adverse effects  without jeopardizing the survival rate is under evaluation at our  center.",Non-OADS,/arxiv_data1/oa_pdf/ec/7b/kjped-55-115.PMC3346833.pdf
Korean J Pediatr  2012;55(4):115-120 • http://dx.doi.org/10.3345/kjp.2012.55.4.115     119 References  1.,Non-OADS,/arxiv_data1/oa_pdf/ec/7b/kjped-55-115.PMC3346833.pdf
"121http://dx.doi.org/10.3345/kjp.2012.55.4.121 Korean J Pediatr 2012;55(4):121-127 eISSN 1738-1061 • pISSN 2092-7258Original article Evaluation of changes in random blood glucose and  body mass index during and after completion of  chemotherapy in children with acute lymphoblastic  leukemia Purpose:  Improved survival of patients with childhood acute  lymphoblastic leukemia (ALL) has drawn attention to the potential  for late consequences of previous treatments among survivors,  including metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/d8/45/kjped-55-121.PMC3346834.pdf
"Key words: Acute lymphoblastic leukemia, Random glucose, Body  mass index, ChildKyong-Won Bang, MD, Soo Young Seo, MD,  Jae Wook Lee, MD, Pil-Sang Jang, MD, PhD,  Min Ho Jung, MD, PhD, Nack-Gyun Chung,  MD, PhD, Bin Cho, MD, PhD, Dae-Chul  Jeong, MD, PhD, Byung Kyu Suh, MD, PhD,  Hack-Ki Kim, MD, PhD Department of Pediatrics, The Catholic University of  Korea, School of Medicine, Seoul, Korea Received: 15 September 2011, Revised: 28 October, 2011 Accepted: 22 November 2011 Corresponding author: Bin Cho, MD, PhD Department of Pediatrics, Seoul St. Mary’s Hospital, The  Catholic University of Korea School of Medicine, 222 Ban - po-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-6187 , Fax: +82-2-588-3589 E-mail: chobinkr@catholic.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/45/kjped-55-121.PMC3346834.pdf
"Korean J Pediatr  2012;55(4):121-127 • http://dx.doi.org/10.3345/kjp.2012.55.4.121     123 maintenance, while high and very high risk patients underwent two  phases of interim maintenance and delayed intensification.",Non-OADS,/arxiv_data1/oa_pdf/d8/45/kjped-55-121.PMC3346834.pdf
Korean J Pediatr  2012;55(4):121-127 • http://dx.doi.org/10.3345/kjp.2012.55.4.121     125 before maintenance treatment.,Non-OADS,/arxiv_data1/oa_pdf/d8/45/kjped-55-121.PMC3346834.pdf
"Korean J Pediatr  2012;55(4):121-127 • http://dx.doi.org/10.3345/kjp.2012.55.4.121     127 completed treatment, such as the cohort in this study, may differ  significantly from current estimations.",Non-OADS,/arxiv_data1/oa_pdf/d8/45/kjped-55-121.PMC3346834.pdf
128http://dx.doi.org/10.3345/kjp.2012.55.4.128 Korean J Pediatr 2012;55(4):128-135 eISSN 1738-1061 • pISSN 2092-7258Original article Dietary patterns and metabolic syndrome risk factors  among adolescents Purpose:  Unbalanced diets and decreased physical activity have  contributed to increased prevalence of obesity and metabolic  syndrome in adolescents.,Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
"Key words: Dietary pattern, Adolescent, Metabolic syndrome,  KNHANES, Systematic reviewHyojee Joung, PhD1, Soyoung Hong, MPH2,  Yoonju Song, PhD3, Byung Chul Ahn, PhD4,  Mi Jung Park, MD, PhD5  1Division of Public Health Nutrition, School of Public  Health and Institute of Health and Environment, Seoul  National University, Seoul, 2Research Institute, Seoul  Medical Center, Seoul, 3Major of Food and Nutrition,  The Catholic University of Korea, Bucheon, 4School  of Economics and Finance, Yeungnam University,  Gyeongsan, 5Department of Pediatrics, Inje University  Sanggye Paik Hospital, Seoul, Korea Received: 8 February 2012, Accepted: 21 February 2012 Corresponding author: Mi Jung Park, MD, PhD  Department of Pediatrics, Inje University Sanggye Paik Hos - pital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707 , Korea Tel: +82-2-950-1130, Fax: +82-2-951-1246 E-mail: pmj@paik.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
"Korean J Pediatr  2012;55(4):128-135 • http://dx.doi.org/10.3345/kjp.2012.55.4.128     129 Introduction Adolescence is a period of rapid body growth and cognitive  development, requiring balanced and sufficient nutrient intake1).",Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
"Literature selection for review T o identify articles that evaluated dietary patterns with regard to  metabolic syndrome, we searched PubMed (http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
"nih.gov/pubmed/) and BioMedLib (http://bmlsearch.com/) using  combinations of the following terms: “factor analysis,” “principal  component analysis,” “cluster analysis,” “patterns,” “diet,” “food,”  “obesity,” “metabolic syndrome,” “adolescent,” and “children.”  Potentially relevant papers were selected by screening titles and  abstracts or entire articles (i.e., if abstracts were absent or provided  limited information), and then evaluated to determine whether they  met all the inclusion criteria, which were: 1) published in English  in the last 10 years; 2) included a sample of adolescents; 3) included  a dietary pattern analysis; and 4) analyzed the association between  dietary pattern and metabolic syndrome or its components.",Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
"Korean J Pediatr  2012;55(4):128-135 • http://dx.doi.org/10.3345/kjp.2012.55.4.128     131 pressure21) and elevated total/low density lipoprotein cholesterol22),  respectively.",Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
"Korean J Pediatr  2012;55(4):128-135 • http://dx.doi.org/10.3345/kjp.2012.55.4.128     133 males (70.1% in 1998 to 65.4% in 2007 to 2009), and the proportion  of the “Bread & Meat & Fruit & Milk” pattern increased among  females (17 .7% in 1998 to 30.8% in 2007 to 2009).",Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
Korean J Pediatr  2012;55(4):128-135 • http://dx.doi.org/10.3345/kjp.2012.55.4.128     135 National Health and Nutrition Survey.,Non-OADS,/arxiv_data1/oa_pdf/28/31/kjped-55-128.PMC3346835.pdf
136http://dx.doi.org/10.3345/kjp.2012.55.4.136 Korean J Pediatr 2012;55(4):136-142 eISSN 1738-1061 • pISSN 2092-7258Original article Correlation between glomerular filtration rate and  urinary N acetyl-beta-D glucosaminidase in children  with persistent proteinuria in chronic glomerular  disease Purpose: Urinary excretion of N acetyl-beta-D glucosaminidase (NAG)  and β2-microglobulin ( β2-M) was increased in the presence of proximal  tubular damage.,OADS,/arxiv_data1/oa_pdf/dc/79/kjped-55-136.PMC3346836.pdf
"Key words: Proteinuria, Glomerular filtration rate, N acetyl-beta-D  glucosaminidaseJeong Deok Hong, MD, In Seok Lim, MD,  PhD Department of Pediatrics, Chung-Ang University  College of Medicine, Seoul, Korea Received: 2 November 2010, Revised: 7 June, 2011 Accepted: 25 November 2011 Corresponding author: In Seok Lim, MD, PhD Department of Pediatrics, Chung-Ang University College  of Medicine, 84 Heukseok-ro, Dongjak-gu, Seoul 156-861,  Korea Tel: +82-2-748-9967 , Fax: +82-2-795-4698 E-mail: inseok@cau.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/79/kjped-55-136.PMC3346836.pdf
"Korean J Pediatr  2012;55(4):136-142 • http://dx.doi.org/10.3345/kjp.2012.55.4.136     137 Intruduction Proteinuria is defined as a condition where urinary protein level  is greater than 150 mg/24-hour in adults, and greater than 4 mg/ m2/hr in children.",Non-OADS,/arxiv_data1/oa_pdf/dc/79/kjped-55-136.PMC3346836.pdf
Korean J Pediatr  2012;55(4):136-142 • http://dx.doi.org/10.3345/kjp.2012.55.4.136     139 correlation between the creatinine clearance and the 24-hour urinary  NAG (r=-0.888; P=0.044) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/dc/79/kjped-55-136.PMC3346836.pdf
Korean J Pediatr  2012;55(4):136-142 • http://dx.doi.org/10.3345/kjp.2012.55.4.136     141 basement membrane freely and is reabsorbed in the proximal tubule.,Non-OADS,/arxiv_data1/oa_pdf/dc/79/kjped-55-136.PMC3346836.pdf
"143http://dx.doi.org/10.3345/kjp.2012.55.4.143 Korean J Pediatr 2012;55(4):143-146 eISSN 1738-1061 • pISSN 2092-7258Case report Two cases of female hydrocele of the canal of nuck  The processus vaginalis within the inguinal canal forms the canal  of Nuck, which is a homolog of the processus vaginalis in women.",Non-OADS,/arxiv_data1/oa_pdf/ec/d6/kjped-55-143.PMC3346837.pdf
"Key words: Hydrocele, Canal of Nuck, Ultrasonography, Magnetic  resonance imaging, Inguinal herniaYu Mi Choi, MD1, Gyu Min Lee, MD1, Jung  Bin Yi, MD1, Kyung Lim Yoon, MD1, Kye Shik  Shim, MD1, Chong Woo Bae, MD1, Sung Il  Choi, MD2, Hyun Cheol Kim, MD3  Departments of 1Pediatrics, 2Surgery, and 3Radiology,  Kyung Hee University Hospital at Gangdong, Seoul,  Korea Received: 22 June 2011, Revised: 19 August, 2011 Accepted: 24 September 2011 Corresponding author: Kyung Lim Yoon, MD Department of Pediatrics, Kyung Hee University Hospital at  Gandong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727 ,  Korea Tel: +82-2-440-6132, Fax : +82-2-440-7175 E-mail: ykr3215@hanmail.net Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/d6/kjped-55-143.PMC3346837.pdf
Korean J Pediatr  2012;55(4):143-146 • http://dx.doi.org/10.3345/kjp.2012.55.4.143     145 and standing positions6).,Non-OADS,/arxiv_data1/oa_pdf/ec/d6/kjped-55-143.PMC3346837.pdf
"147http://dx.doi.org/10.3345/kjp.2012.55.4.147 Korean J Pediatr 2012;55(4):147-150 eISSN 1738-1061 • pISSN 2092-7258Case report A case of acute necrotizing encephalopathy  associated with parainfluenza virus infection Acute necrotizing encephalopathy (ANE) may be suspected when  a young child presents with abrupt onset of altered mental status,  seizures, or both.",Non-OADS,/arxiv_data1/oa_pdf/fc/1b/kjped-55-147.PMC3346838.pdf
"Key words :  Acute necrotizing encephalopathy, Parainfluenza virus, ChildYoo-Na Kim, MD, Su Jeong You, MD, PhD Department of Pediatrics, Inje University Sanggye Paik  Hospital, Seoul, Korea Received: 8 August 2011, Revised: 22 September, 2011 Accepted: 14 November 2011 Corresponding author: Su Jeong You, MD, PhD Department of Pediatrics, Inje University Sanggye Paik Hos - pital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707 , Korea Tel: +82-2-950-1944, Fax: +82-2-951-1246 E-mail: sjyou@paik.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/1b/kjped-55-147.PMC3346838.pdf
"Korean J Pediatr  2012;55(4):147-150 • http://dx.doi.org/10.3345/kjp.2012.55.4.147     149 disease entity and proposed the following diagnostic criteria: 1)  acute encephalopathy following viral febrile disease with rapid  deterioration in consciousness and/or convulsion; 2) increased protein  in cerebrospinal fluid (CSF) without CSF pleocytosis; 3) CT or MRI  findings indicating symmetric, multifocal brain lesions involving  bilateral thalami, cerebral periventricular white matter, internal  capsule, putamen, upper brain stem tegmentum, and cerebellar  medulla without involvement of other central nervous system regions;  4) variable amount of serum aminotransferase elevation, but no  hyperammonemia; 5) exclusion of other similar diseases such as  overwhelming bacterial and viral infections, fulminant hepatitis,  Reye syndrome, Leigh encephalopathy and related mitochondrial  cytopathies, acute disseminated encephalomyelitis and other types of  encephalitis, vasculitis, and cerebral infarction1,2).",Non-OADS,/arxiv_data1/oa_pdf/fc/1b/kjped-55-147.PMC3346838.pdf
"151http://dx.doi.org/10.3345/kjp.2012.55.4.151 Korean J Pediatr 2012;55(4):151-151 eISSN 1738-1061 • pISSN 2092-7258Correspondence Erratum: Funding Acknowledgment Park SJ, Shin JI T o the Editor:  We found an error in our published article: Park SJ, Shin JI.",Non-OADS,/arxiv_data1/oa_pdf/41/9d/kjped-55-151.PMC3346839.pdf
Korean J Pediatr 2011;54:322-8.  http://dx.doi.org/10.3345/kjp.2011.54.8.322  The funding acknowledgment in this article was omitted as published.,Non-OADS,/arxiv_data1/oa_pdf/41/9d/kjped-55-151.PMC3346839.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/9d/kjped-55-151.PMC3346839.pdf
http://www.who.int/mediacentre/factsheets/fs317/en/index.,Non-OADS,/arxiv_data1/oa_pdf/8c/d3/12471_2011_Article_237.PMC3346869.pdf
Knezevic A. Overlapping confidence intervals and statistical sig- nificance (http://www.cscu.cornell.edu/news/statnews/stnews73.,OADS,/arxiv_data1/oa_pdf/8c/d3/12471_2011_Article_237.PMC3346869.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.115 REVIEW ARTICLE Role of Keratinocytes in the Development of Vitiligo Ai-Young Lee, M.D., Ph.D. Department of Dermatology, Dongguk University Ilsan Hospital, Dongguk University Graduate School of Medicine, Goyang, Korea Vitiligo is an acquired depigmen tary disorder of the skin that  results from the loss of functioning epidermal melanocytes.",Non-OADS,/arxiv_data1/oa_pdf/40/a0/ad-24-115.PMC3346900.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.126 REVIEW ARTICLE Cathelicidin LL-37: An Antimicrobial Peptide with a  Role in Inflammatory Skin Disease Markus Reinholz, M.D., Thomas Ruzicka, M.D., Jürgen Schauber, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b0/bd/ad-24-126.PMC3346901.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.136 ORIGINAL ARTICLE Paracrine Effects of Adipose-Derived Stem Cells on  Keratinocytes and Dermal Fibroblasts Seung Ho Lee, M.D., Ph.D., Sang Yun Jin, M.D., Jin Seok Song, M.D.1, Kyle K. Seo, M.D., Ph.D.2,  Kwang Hyun Cho, M.D., Ph.D.3 Department of Dermatology, Dongguk University Ilsan Hospital, Goyang, 1Soprano Clinic, 2Modelo Clinic, 3Departement of Dermatology,  Seoul National University College of Medicine, Seoul, Korea Background: Adipose-derived stem cells (ASCs) are  mesenchymal stem cells that ha ve recently been applied to  tissue repair and regeneration.",Non-OADS,/arxiv_data1/oa_pdf/40/8b/ad-24-136.PMC3346902.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.144 ORIGINAL ARTICLE A Randomized, Open-Label, Multicenter Trial of Topical  T acrolimus for the Treatment of Pruritis in Patients with Atopic Dermatitis Satoshi Takeuchi, M.D., Ph.D., Hidehisa Saeki, M.D., Ph.D.2, Shoji Tokunaga, Ph.D., M.Sc.2,  Makoto Sugaya, M.D., Ph.D.1, Hanako Ohmatsu, M.D., Ph.D.1, Yuichiro Tsunemi, M.D., Ph.D.1,  Hideshi Torii, M.D.3, Koichiro Nakamura, M.D.4, Tamihiro Kawakami, M.D., Ph.D.5,  Yoshinao Soma, M.D., Ph.D.5, Eiichi Gyotoku, M.D., Ph.D.6, Michihiro Hide, M.D., Ph.D.6,  Rikako Sasaki, M.D., Ph.D.7, Yukihiro Ohya, M.D., Ph.D.8, Makiko Kido, M.D., Ph.D.,  Masutaka Furue, M.D., Ph.D. Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 1Department of Dermatology, Faculty of  Medicine, University of Tokyo, Bunkyo-ku, 2Department of Medical Informatics, Kyushu University Hospital, Fukuoka, 3Department of  Dermatology, Social Insurance Chuo General Hospital, Shinjuku-ku, 4Department of Dermatology, Saitama Medical University,  Iruma-gun, 5Department of Dermatology, St. Marianna University School of Medicine, Kawasaki, 6Department of Dermatology,  Hiroshima University, Hiroshima, 7Division of Dermatology, 8Division of Allergy, Department of Medicine, National Center for Child  Health and Development, Setagaya-ku, Japan Background:  Pruritis caused by atopic dermatitis (AD) is not  always well controlled by topical corticosteroid therapy, but  use of tacrolimus often helps to soothe such intractable  pruritis in clinical settings.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/ad-24-144.PMC3346903.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.151 ORIGINAL ARTICLE Induction of Melanogenesis by Rapamycin in Human  MNT-1 Melanoma Cells Young-Sool Hah, Ph.D., Hee Young Cho, M.S., Tae-Yeon Lim, B.S.1, Dong Hwa Park, M.D.2,  Hwa Mi Kim, M.D.2, Jimi Yoon, M.D.2, Jin Gu Kim, M.D.2, Chi Yeon Kim, M.D.2,  Tae-Jin Yoon, M.D.2 Clinical Research Institute, Gyeongsang National University Hospital, Jinju, 1Department of Skin Science and Institute of Health Science,  Medical Research Center for Neural Dysfunction, 2Department of Dermatology and Institute of Health Sciences, Gyeongsang National  University School of Medicine, Jinju, Korea Background: Melanogenesis is one of the characteristic  parameters of differentiation in melanocytes and melanoma  cells.",Non-OADS,/arxiv_data1/oa_pdf/7c/1e/ad-24-151.PMC3346904.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.158 ORIGINAL ARTICLE Cardiff Acne Disability Index in Sarawak, Malaysia Felix Boon-Bin Yap, M.D., MRCP., AdvMDerm.",Non-OADS,/arxiv_data1/oa_pdf/e3/37/ad-24-158.PMC3346905.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.162 ORIGINAL ARTICLE Efficacy and Safety of 1,064 nm Q-switched Nd:YAG  Laser Treatment for Removing Melanocytic Nevi Yoon Jee Kim, M.D., Kyu Uang Whang, M.D., Won Bok Choi, M.D.1, Hyun Jo Kim, M.D.1,  Jae Young Hwang, M.D.1, Jung Hoon Lee, M.D.1, Sung Wook Kim, M.D.1  Department of Dermatology, College of Medicine, Soonchunhyang University, Seoul, 1CNP Skin Clinic, Cheoan, Korea Background: Until recently, the removal of melanocytic nevi  has been performed with a CO 2 laser or Er:YAG laser.",Non-OADS,/arxiv_data1/oa_pdf/76/b3/ad-24-162.PMC3346906.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.168 ORIGINAL ARTICLE Changes in Transepidermal Water Loss and Skin  Hydration according to Expression of Aquaporin-3 in Psoriasis Young Lee, M.D., Young-Jin Je, M.S., Sang-Sin Lee, M.D., Zheng Jun Li, M.S., Dae-Kyoung Choi, Ph.D.,  Yoo-Bin Kwon, M.S., Kyung-Cheol Sohn, Ph.D., Myung Im, M.D., Young Joon Seo, M.D., Jeung Hoon Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d4/87/ad-24-168.PMC3346907.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.175 ORIGINAL ARTICLE Onychomycosis Due to Nondermatophytic Molds Sung Min Hwang, M.D., Moo Kyu Suh, M.D., Gyoung Yim Ha, M.D.1 Departments of Dermatology, 1Laboratory Medicine, Dongguk University  College of Medicine, Gyeongju, Korea Background: Although there have be en many studies about  onychomycosis due to nonder matophytic molds (NDM),  few studies about etiologic agents including NDM in onychomycosis have been reported in Korea.",Non-OADS,/arxiv_data1/oa_pdf/0d/5d/ad-24-175.PMC3346908.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.181 ORIGINAL ARTICLE The Effect of Adipose-Derived Stem Cell-Cultured  Media on Oxazolone T reated Atopic Dermatitis-Like Murine Model Hae-Jin Lee, M.D., Minyoung Jung, M.S., Jae-Hong Kim, M.D., Na Young Yoon, M.D.,  Eung Ho Choi, M.D., Ph.D. Department of Dermatology, Yonsei Universi ty Wonju College of Medicine, Wonju, Korea Background: A stem cell is an undifferentiated cell that has  the potential for self-renewal and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/75/e7/ad-24-181.PMC3346909.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.189 ORIGINAL ARTICLE Effect of Probiotics on the Treatment of Children with  Atopic Dermatitis Yavuz Ye şilova, M.D., Ömer Çalka, M.D.1, Necmettin Akdeniz, M.D.1, Mustafa Berkta ş, M.D.2 Department of Dermatology, Harran University Faculty of Medicine, Sanliurfa,  Departments of 1Dermatology, 2Microbiology and Yüzüncü Yil University, Faculty of Medicine, Van, Turkey Background: Atopic dermatitis, a chronic recurrent disease,  is frequently encountered in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/17/9e/ad-24-189.PMC3346910.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.194 ORIGINAL ARTICLE The Diagnostic Accuracy of Dermoscopy for Scabies Ju Hyuk Park, M.D., Chul Woo Kim, M.D., Sang Seok Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/c0/66/ad-24-194.PMC3346911.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.200 CASE REPORT Paroxysmal Supraventricular Tachycardia in an Infant  with Hand, Foot, and Mouth Disease Peng Hu, M.D., Shu Hou, M.D., Peng-Fei Du, M.D., Jia-Bin Li, M.D.1, Ying Ye, M.D.1 Departments of Pediatrics and 1Infectious Disease, The First Affiliated Hospital  of Anhui Medical University, Hefei, P.R.",Non-OADS,/arxiv_data1/oa_pdf/ba/e8/ad-24-200.PMC3346912.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.203 CASE REPORT Granular Parakeratosis of Eccrine Ostia Ji-Hye Yang, M.D., Hyung-Min Lee, M.D., Tai-Kyung Noh, M.D., Chong-Hyun Won, M.D.,  Sungeun Chang, M.D., Mi-Woo Lee, M.D., Jee-Ho Choi, M.D., Kee-Chan Moon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1f/dd/ad-24-203.PMC3346913.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.206 CASE REPORT Unilateral Nevoid T elangiectasia Associated with  Ipsilateral Melorheostosis  Jihyun Kim, M.D., Sung Bin Cho, M.D., Ph.D., Suhyun Cho, M.D., Dongsik Bang, M.D., Ph.D. Department of Dermatology and Cutaneous Biology Research Inst itute, Yonsei University Coll ege of Medicine, Seoul, Korea Melorheostosis is a rare disorder characterized by irregular,  flowing hyperostosis in long bones, commonly described on  radiographs as wax flowing down a candle.",Non-OADS,/arxiv_data1/oa_pdf/d1/9d/ad-24-206.PMC3346914.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.209 CASE REPORT Onychomycosis Caused by Scopulariopsis brevicaulis :  Report of T wo Cases Myung Hoon Lee, M.D., Sung Min Hwang, M.D., Moo Kyu Suh, M.D., Gyoung Yim Ha, M.D.1,  Heesoo Kim, Ph.D.2, Jeong Young Park, M.D.3 Departments of Dermatology, 1Laboratory Medicine, and 2Microbiology, College of Medicine, Dongguk University, Gyeongju,  3Department of Dermatology, College of Medicine, Yeungnam University, Daegu, Korea Onychomycosis is usually cau sed by dermatophytes, but  some nondermatophytic molds and yeasts are also  associated with invasion of nails.",Non-OADS,/arxiv_data1/oa_pdf/46/06/ad-24-209.PMC3346915.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.214 CASE REPORT Erythromelalgia and Livedo Reticularis in a Patient with  Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies Thilo Gambichler, M.D., Rebecca Matip, M.D.",Non-OADS,/arxiv_data1/oa_pdf/66/68/ad-24-214.PMC3346916.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.218 LETTER TO THE EDITOR Fig.",Non-OADS,/arxiv_data1/oa_pdf/5a/79/ad-24-218.PMC3346917.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.220 LETTER TO THE EDITOR Received April 11, 2011, Revised June 30, 2011, Accepted for  publication June 30, 2011 Corresponding author:  Joung Soo Kim, M.D., Ph.D., Department o f  Dermatology, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 471-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a9/ba/ad-24-220.PMC3346918.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.223 LETTER TO THE EDITOR Received March 28, 2011, Revised June 29, 2011, Accepted for  publication July 5, 2011 Corresponding author:  Hyo Jin Lee, M.D., Department of Internal  Medicine, Chungnam National University Hospital, 640 Daesa-dong,  Jung-gu, Daejeon 301-721, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fd/13/ad-24-223.PMC3346919.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.225 LETTER TO THE EDITOR Received May 4, 2011, Revised June 30, 2011, Accepted for  publication July 7, 2011 Corresponding author:  Eun-So Lee, M.D., Ph.D., Department o f  Dermatology, Ajou University School of Medicine, San 5  Woncheon-dong, Yeongtong-gu, Suwon 443-721, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ad-24-225.PMC3346920.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.228 LETTER TO THE EDITOR Received July 18, 2011, Revised August 4, 2011, Accepted for publication August 4, 2011 Corresponding author:  Kee Suck Suh, M.D., Department of Dermatology, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan  602-702,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/2c/b3/ad-24-228.PMC3346921.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.230 LETTER TO THE EDITOR Erythema Multiforme after Radiotherapy with  5-fluorouracil Chemotherapy in a Rectal Cancer Patient Jung Hyun Han, M.D., Sook Jung Yun, M.D., Taek-Keun Nam, M.D.1, Yoo-Duk Choi, M.D.2,  Jee-Bum Lee, M.D., Seong-Jin Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ee/e0/ad-24-230.PMC3346922.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.233 LETTER TO THE EDITOR Fig.",Non-OADS,/arxiv_data1/oa_pdf/39/c1/ad-24-233.PMC3346923.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.235 LETTER TO THE EDITORS A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Teresa Pinto-Almeida, M.D., Iolanda Fern andes, M.D., Madalena Sanches, M.D.,  Catarina Lau, M.D.1, Margarida Lima, Ph.D.1, Rosário Alves, M.D., Manuela Selores, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a5/58/ad-24-235.PMC3346924.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.238 LETTER TO THE EDITOR Received June 20, 2011, Revised August 17, 2011, Accepted for  publication August 23, 2011 Corresponding author:  Kapsok Li, M.D., Department of Dermatology,  Chung-Ang University Hospital, 224-1 Heukseok-dong, Dongjak-gu, Seoul 156-755, Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/e2/ad-24-238.PMC3346925.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.240 LETTER TO THE EDITOR Received April 27, 2011, Revised August 5, 2011, Accepted for  publication August 30, 2011 Corresponding author:  Hyun Jeong Park, M.D., Department o f  Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The  Catholic University of Korea, 62 Yeouido-dong, Yeongdeungpo-gu, Seoul 150-713, Korea.",Non-OADS,/arxiv_data1/oa_pdf/70/73/ad-24-240.PMC3346926.pdf
"2, 2012 http://dx.doi.org/10.5021/ad.2012.24.2.242 RETRACTION Basal Cell Nevus Syndrome Showing Several Histologic  T ypes of Basal Cell Carcinoma On September 30, 2011, Annals of Dermatology in Volume  23, Number Supplementary 1, published a case report by Go JW, et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/3c/ad-24-242.PMC3346927.pdf
Accessed on 23 February  2011 <http://www.ses.wsu.edu/People/TSmith/OECDslides.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/f6/67/oby2011351a.PMC3346928.pdf
Available online at: http://www.influenza.rki.de/Saisonberichte/2006.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/57/10096_2011_Article_1437.PMC3346937.pdf
Available online at: http://www.cdc.gov/flu/professionals/diagnosis/labprocedures.htm .,Non-OADS,/arxiv_data1/oa_pdf/81/57/10096_2011_Article_1437.PMC3346937.pdf
Available online at: http://www1.qiagen.,Non-OADS,/arxiv_data1/oa_pdf/81/57/10096_2011_Article_1437.PMC3346937.pdf
Available online at: http://www.who.int/ mediacentre/factsheets/fs211/en.,Non-OADS,/arxiv_data1/oa_pdf/81/57/10096_2011_Article_1437.PMC3346937.pdf
Availableonline at: http://www.who.int/csr/disease/avian_influenza/ guidelines/RapidTestInfluenza_web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/57/10096_2011_Article_1437.PMC3346937.pdf
Available online at: http://www.who.int/globalatlas/dataQuery/ default.asp .,OADS,/arxiv_data1/oa_pdf/81/57/10096_2011_Article_1437.PMC3346937.pdf
Available at URL: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_- _Product_Information/human/ 000387/WC500049756.pdf .,Non-OADS,/arxiv_data1/oa_pdf/05/2f/10096_2011_Article_1425.PMC3346940.pdf
"Guidance, PET Drugs-Current Good Manufacturing Practice (CGMP) (2009) http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070306.pdf .",Non-OADS,/arxiv_data1/oa_pdf/3b/4a/11307_2011_Article_528.PMC3346941.pdf
2008. http://www.samhsa.gov/data/2k8/pregnantAlc/pregnantAlc.htm (accessed Jan 2012).,OADS,/arxiv_data1/oa_pdf/b9/a8/bmjopen-2012-000968.PMC3346942.pdf
"Centers for Disease Control and Prevention, 2011. http://www.cdc.gov/Features/ dsAlcoholChildbearingAgeWomen/ (accessed Jan 2012).",Non-OADS,/arxiv_data1/oa_pdf/b9/a8/bmjopen-2012-000968.PMC3346942.pdf
http://www.abs.gov.au/ausstats/abs@.nsf/mf/ 4832.0.55.001 (accessed Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/b9/a8/bmjopen-2012-000968.PMC3346942.pdf
http://www.aph.gov.au/house/committee/ spla/fasd/index.htm (accessed Dec 2011).,Non-OADS,/arxiv_data1/oa_pdf/b9/a8/bmjopen-2012-000968.PMC3346942.pdf
http://www.strobe-statement.org/ (accessed Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/b9/a8/bmjopen-2012-000968.PMC3346942.pdf
ISBN:978-82-8082-461-5. http://www.fhi.no/dokumenter/0d04decc0b.pdf (accessed 3 Oct 2011).,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjopen-2011-000709.PMC3346943.pdf
2009. http://www.regjeringen.no/pages/2188713/PDFS/OTP200820090084000DDDPDFS.pdf (accessed 3 Oct 2011).,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjopen-2011-000709.PMC3346943.pdf
"Tampa: University of South Florida, 2005. http://cfs.cbcs.usf.edu/publications/detail.cfm?id ¼137 (accessed 20 Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjopen-2011-000709.PMC3346943.pdf
2011. http://www.copmi.net.au/worked/ﬁles/WFD_Res_Eval_POST_ 100210.pdf (accessed 14 Oct 2011).,OADS,/arxiv_data1/oa_pdf/7d/3f/bmjopen-2011-000709.PMC3346943.pdf
To view these ﬁles pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2011-000431).,Non-OADS,/arxiv_data1/oa_pdf/26/0a/bmjopen-2011-000431.PMC3346944.pdf
"Competing interests All authors have completed the Uniﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on requestfrom the corresponding author) and declare that (1) CS, AK and EM havecontract support from PATH for the submitted work and that PC, BLG and SB have grant support from the Bill & Melinda Gates Foundation for the submitted work; no ﬁnancial relationships with any organisations that might have aninterest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have inﬂuenced the submitted work; (2) CS, AK, PC, EM, BG and SB have no relationships with any companies that mighthave an interest in the submitted work in the previous 3 years; (3) theirspouses, partners or children have no ﬁnancial relationships that may be relevant to the submitted work; and (4) CS, AK, PC, EM, BG and SB have no non-ﬁnancial interests that may be relevant to the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/26/0a/bmjopen-2011-000431.PMC3346944.pdf
"Geneva, 2010. http://www.who.int/medicines/publications/ essentialmedicines/en/index.html 2. WHO.",Non-OADS,/arxiv_data1/oa_pdf/26/0a/bmjopen-2011-000431.PMC3346944.pdf
"Brussels: Centre for Research on the Epidemiology of Disasters, 2011. http://www.cred.be/sites/default/ﬁles/ADSR_2010.pdf (accessed 7 Feb 2012).",Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.sintef.no/upload/teknologi_og_samfunn/sikkerhet%20og%20pa ˚litelighet/rapporter/ STF38%20A02405.pdf (accessed 9 Feb 2012).,OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
1989. http://www.un.org/documents/ga/res/44/a44r236.,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
"United Nations, 1994. http://www.preventionweb.net/ﬁles/ 8241_doc6841contenido1.pdf (accessed 9 Feb 2012).",Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.cosafe.eu/ (accessed 6 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/ (accessed 9 Feb 2012).,OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
2011. http://www.cochrane-handbook.org (accessed 8 Feb 2012).,OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.unisdr.org/we/inform/terminology(accessed 7 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.opengrey.eu/ (accessed 8 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.cabi.org/default.aspx?site ¼170&page ¼1016&pid ¼328 (accessed 14 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.healthnet.org/essential-health-links (accessed 15 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.eurasiahealth.org/ (accessed 15 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://bases.bireme.br/cgi-bin/wxislind.,OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.ajol.,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.preventionweb.net/ english/ (accessed 17 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://sta.jrc.ec.europa.eu/index.php/ mahb-home (accessed 17 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.unisdr.org/ (accessed 17 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
http://www.crd.york.ac.uk/prospero/ (accessed 18 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/78/3b/bmjopen-2012-001082.PMC3346945.pdf
(2003) or visit http://www.douglasresearch.qc.ca/pages/view?section_id =165).,Non-OADS,/arxiv_data1/oa_pdf/b7/f1/fpsyt-03-00042.PMC3346965.pdf
"Structural T1 images were analyzed using VBM ( Ashburner and Friston, 2000; Good et al., 2001 ) using software VBM8 version 369 created by C. Gaser (http://dbm.neuro.uni-jena.de/vbm/).First, the T1 images were normalized to a template space usinghigh-dimensional (DARTEL) spatial normalization and then seg-mented into gray matter (GM), white matter (WM), and cere-brospinal ﬂuid (CSF).",OADS,/arxiv_data1/oa_pdf/b7/f1/fpsyt-03-00042.PMC3346965.pdf
Available at: http://www.inspection.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/fmicb-03-00174.PMC3347039.pdf
Availableat: http://standards.sae.org/j211/1_200707/ www.frontiersin.org May 2012 | Volume 3 | Article 70 | 11,Non-OADS,/arxiv_data1/oa_pdf/c0/33/fneur-03-00070.PMC3347090.pdf
"http://www.manchester.ac.uk/mims/eprints , 2006 , MIMS EPrint.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JMSS-1-200.PMC3347226.pdf
"http://www.manchester.ac.uk/mims/eprints , 2008.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JMSS-1-200.PMC3347226.pdf
"http://www.worldscinet.com/m3as/ m3as.shtml , 2011.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JMSS-1-200.PMC3347226.pdf
"Image Dataset   In this paper , we used the PIDER Breast MRI dataset  (https://imaging.nci.nih.gov/ncia ).",OADS,/arxiv_data1/oa_pdf/bb/85/JMSS-1-156.PMC3347230.pdf
"EXPRIMENTAL RESULT   In this section, the performance of proposed method is  investigated using PIDER Breast MRI dataset  (https://imaging.nci.nih.gov/ncia ).",Non-OADS,/arxiv_data1/oa_pdf/bb/85/JMSS-1-156.PMC3347230.pdf
The FPMD program in the Quantum Espresso package(http://www.quantum-espresso.org/) was used for the calculations.,OADS,/arxiv_data1/oa_pdf/2e/22/srep00398.PMC3347315.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2e/22/srep00398.PMC3347315.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wu, M., Jiang, Y.L.J.",Non-OADS,/arxiv_data1/oa_pdf/2e/22/srep00398.PMC3347315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Eghtesad, S., Jhunjhunwala, S., Little, S.R.",Non-OADS,/arxiv_data1/oa_pdf/57/31/srep00399.PMC3347316.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Bilateral A1 fenestrations: Report of two cases and literature review Erinç Aktüre1, Anıl Arat2,3, David B. Niemann1,2, M. Shahriar Salamat4, Mustafa K. Başkaya1 Departments of 1Neurological Surgery, 2Radiology and 4Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin,  Madison, WI, USA, 3Department of Radiology, Ankara University Hospitals, Sıhhiye, Ankara, Turkey E-mail: Erinç Aktüre - e.akture@neurosurgery.wisc.edu; Anıl Arat - anilarat@aim.com; David B. Niemann - d.niemann@neurosurgery.wisc.edu;   M. Shahriar Salamat - ssalamat@wisc.edu; *Mustafa K. Ba şkaya - m.baskaya@neurosurgery.wisc.edu   *Corresponding author  Received: 6 February 12 Accepted: 26 March 12 Published: 16 April 12 This article may be cited as:   Aktüre E, Arat A, Niemann DB, Salamat MS, Baskaya MK.",Non-OADS,/arxiv_data1/oa_pdf/e4/01/SNI-3-43.PMC3347490.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/43/94928 Copyright: © 2012 Aktüre E.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e4/01/SNI-3-43.PMC3347490.pdf
"Surgical Neurology International 2012, 3:43  http://www.surgicalneurologyint.com/content/3/1/43the right one.",Non-OADS,/arxiv_data1/oa_pdf/e4/01/SNI-3-43.PMC3347490.pdf
"Surgical Neurology International 2012, 3:43  http://www.surgicalneurologyint.com/content/3/1/4376 reported cases, 25 were associated with an aneurysm  at the fenestrated segment itself, with one interpreted  as fusiform and the remaining being saccular.",Non-OADS,/arxiv_data1/oa_pdf/e4/01/SNI-3-43.PMC3347490.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Intracranial parafalcine chondroma in a pregnant patient   Jacky T .",Non-OADS,/arxiv_data1/oa_pdf/7d/99/SNI-3-44.PMC3347491.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/44/94930 Copyright: © 2012 Yeung JT.,Non-OADS,/arxiv_data1/oa_pdf/7d/99/SNI-3-44.PMC3347491.pdf
"Surgical Neurology International 2012, 3:44  http://www.surgicalneurologyint.com/content/3/1/44in a motor vehicle accident as a restrained passenger.",Non-OADS,/arxiv_data1/oa_pdf/7d/99/SNI-3-44.PMC3347491.pdf
"Surgical Neurology International 2012, 3:44  http://www.surgicalneurologyint.com/content/3/1/44position with her head rotated to the left.",Non-OADS,/arxiv_data1/oa_pdf/7d/99/SNI-3-44.PMC3347491.pdf
"Surgical Neurology International 2012, 3:44  http://www.surgicalneurologyint.com/content/3/1/44Poptani et al., showed that pyogenic abscesses display  strong resonances for lactate, alanine, and acetate with  absence of NAA, Choline (Cho), and creatine (Cr) peaks.",OADS,/arxiv_data1/oa_pdf/7d/99/SNI-3-44.PMC3347491.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial The transition of neurosurgeons through the technology and  information age James I. Ausman Editor-in-Chief, Surgical Neurology International, Rancho Mirage, CA, USA E-mail: *James I. Ausman - jia@surgicalneurologyint.com   *Corresponding author  Received: 23 March 12 Accepted: 23 March 12 Published: 25 April 12 This article may be cited as:   Ausman JI.",Non-OADS,/arxiv_data1/oa_pdf/a6/26/SNI-3-45.PMC3347492.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/45/95390 Copyright: © 2012 Ausman JI.,Non-OADS,/arxiv_data1/oa_pdf/a6/26/SNI-3-45.PMC3347492.pdf
"Surgical Neurology International 2012, 3:45  http://www.surgicalneurologyint.com/content/3/1/45deficit and was discharged in 3 days with improving  deficits.",Non-OADS,/arxiv_data1/oa_pdf/a6/26/SNI-3-45.PMC3347492.pdf
"Surgical Neurology International 2012, 3:45  http://www.surgicalneurologyint.com/content/3/1/45us to operate through smaller incisions and openings,  called minimally invasive surgery.",Non-OADS,/arxiv_data1/oa_pdf/a6/26/SNI-3-45.PMC3347492.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Spontaneous involution of a Rathke’s cleft cyst in a patient with  normal cortisol secretion Stephan A. Munich, Jody Leonardo1 Department of Neurosurgery, Rush University Medical Center, Chicago, IL, 1Department of Neurosurgery, School of Medicine and Biomedical Sciences, University  at Buffalo, State University of New York, Buffalo, NY , USA E-mail: Stephan A. Munich - stephan.munich@gmail.com; *Jody Leonardo - jleonardo@ubns.com   *Corresponding author  Received: 1 March 12 Accepted: 12 March 12 Published: 16 April 12 This article may be cited as:   Munich SA, Leonardo J. Spontaneous involution of a Rathke's cleft cyst in a patient with normal cortisol secretion.",Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/42/94925 Copyright: © 2012 Munich SA.,Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
"Surgical Neurology International 2012, 3:42  http://www.surgicalneurologyint.com/content/3/1/42regress following formation of the adenohypophysis and  neurohypophysis may result in a cyst that is filled with  proteinaceous fluid and lined by ciliated or non-ciliated,  cuboidal or columnar epithelium, mucous-producing  goblet cells, and cells of the anterior pituitary gland.",Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
"Surgical Neurology International 2012, 3:42  http://www.surgicalneurologyint.com/content/3/1/42the patient’s family requested close observation and  follow-up.",Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
"Surgical Neurology International 2012, 3:42  http://www.surgicalneurologyint.com/content/3/1/42with hypopituitarism.",Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
"Surgical Neurology International 2012, 3:42  http://www.surgicalneurologyint.com/content/3/1/42morbidity, the potential for spontaneous involution and  resultant conservative management is desired.",Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
"Surgical Neurology International 2012, 3:42  http://www.surgicalneurologyint.com/content/3/1/4215.",Non-OADS,/arxiv_data1/oa_pdf/36/3e/SNI-3-42.PMC3347493.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Bell’s palsy and partial hypoglossal to facial nerve transfer: Case  presentation and literature review Mariano Socolovsky, Miguel Domínguez Páez1, Gilda Di Masi, Gonzalo Molina, Eduardo Fernández2 Nerve and Plexus Surgery Program, Division of Neurosurgery, University of Buenos Aires School of Medicine, Buenos Aires, Argentina, 1Department of  Neurosurgery, Hospital Regional Universitario Carlos Haya, Málaga, Spain, 2Department of Neurosurgery, Catholic University, Rome, Italy E-mail: *Mariano Socolovsky - Socolovsky@fibertel.com.ar; Miguel Domínguez Páez - lenin_@hotmail.com; Gilda Di Masi - gildadimasi@gmail.com,   Gonzalo Molina - gmolina@intramed.net; Eduardo Fernández - e.fernandez@rm.unicatt.it   *Corresponding author  Received: 8 March 12 Accepted: 23 March 12 Published: 25 April 12 This article may be cited as:   Socolovsky M, Páez MD, Masi GD, Molina G, Fernández E. Bell's palsy and partial hypoglossal to facial nerve transfer: Case presentation and literature review.",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/1/46/95391 Copyright: © 2012 Socolovsky M.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"Surgical Neurology International 2012, 3:46  http://www.surgicalneurologyint.com/content/3/1/46spontaneous facial nerve palsy, has been exceptionally  cited in the literature [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"Surgical Neurology International 2012, 3:46  http://www.surgicalneurologyint.com/content/3/1/46the left eye, the facial symmetry was lost, and she could  not make any kind of active movement on the left side of  the mouth.",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"Surgical Neurology International 2012, 3:46  http://www.surgicalneurologyint.com/content/3/1/46DISCUSSION Spontaneous evolution of Bell’s palsy  According to The Copenhagen Facial Nerve Study,  spontaneous facial nerve palsy (Bell’s palsy) is a benign  condition which implies an acute unilateral partial or  total facial motor deficit of undetermined etiology,  having an incidence of 32/100,000, without seasonal, side,  or gender variations, and is more frequent between 15  and 60 years,.",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"Surgical Neurology International 2012, 3:46  http://www.surgicalneurologyint.com/content/3/1/46literature.",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"Surgical Neurology International 2012, 3:46  http://www.surgicalneurologyint.com/content/3/1/46face in facial paralysis: Review of the literature and personal approach.",Non-OADS,/arxiv_data1/oa_pdf/84/2e/SNI-3-46.PMC3347494.pdf
"(Accessed May 26, 2010,  at http://nobelprize.org/nobel_prizes/chemistry/laurea tes/2008/chalfie-lecture.html ).",Non-OADS,/arxiv_data1/oa_pdf/10/67/NAJMS-2-246.PMC3347630.pdf
"(Accessed April 28, 2009,  at:  http://www.who.int/social_determinants/en 2.",Non-OADS,/arxiv_data1/oa_pdf/23/f5/NAJMS-2-267.PMC3347634.pdf
"(Accessed   April 29, 2009,  at: http://www.who.int/social _determinants/resources /mekn_final_report_102007.pd 3.",Non-OADS,/arxiv_data1/oa_pdf/23/f5/NAJMS-2-267.PMC3347634.pdf
"(Accessed  May 10, 2010, athttp://muskie.usm.maine.edu/Publications/rural/pb3 3.pdf).",Non-OADS,/arxiv_data1/oa_pdf/23/f5/NAJMS-2-267.PMC3347634.pdf
"2nd Edition, WHO:  Copenhagen; 2003 ((Accessed  May 8, 2010,  at:  http://www.euro.who.int/document/e81384.pd",Non-OADS,/arxiv_data1/oa_pdf/23/f5/NAJMS-2-267.PMC3347634.pdf
"(Accessed September 2,  2009, at http://siteresources.worldbank.org/INTLSMS/Reso urces/3358986-1181743055198/3877319-1190214215722/binfo2000.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/47/21/NAJMS-2-221.PMC3347648.pdf
"(Accessed January 15 th, 2010  at http://www.unece.org/trans/danger/publi/ghs/officia ltext.html",Non-OADS,/arxiv_data1/oa_pdf/96/48/NAJMS-2-230.PMC3347649.pdf
"Papaya Natural Benefits and Curative properties  (Accessed March 15, 2010, at  http://www.best-home-remeies.com/herbalmedicin e/fruits/papaya.htm2.",Non-OADS,/arxiv_data1/oa_pdf/64/58/NAJMS-2-234.PMC3347650.pdf
This improved implementation for sMC simulation serves as a fast and accurate solver to address both forward and inverse problems andis available for use at http://www.virtualphotonics.org/ .,Non-OADS,/arxiv_data1/oa_pdf/63/e9/oe-19-20-19627.PMC3347703.pdf
The sMC iforward solver based on adaptive binning and NURBS interpolation (NURBS Forward Solver) is available for use in the Virtual Tissue Simulator athttp://www.virtualphotonics.org/.,Non-OADS,/arxiv_data1/oa_pdf/63/e9/oe-19-20-19627.PMC3347703.pdf
"Available from http://www.nih.go.jp/eiken/en glish/research/project_nhns.html (Cited 18 March, 2011).",Non-OADS,/arxiv_data1/oa_pdf/78/6c/nutd20126a.PMC3347755.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Coffee, adipocytokines and metabolic markers K Yamashita et al 6 Nutrition and Diabetes &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/78/6c/nutd20126a.PMC3347755.pdf
"ITU estimates two billion people online by end 2010, Press Release, 19 October 2010. http://www.itu.int/net/pressofﬁce/press_releases/2010/39.aspx (accessed 19 December 2010) 2010.",Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
304. http://www.who.int/mediacentre/factsheets/fs304/en/index.html(accessed 19 December 2010) 2006.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.who.int/peh-emf/research/agenda/en/index.html (accessed 19 December2010) 2010.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
"Report of a Short Term Mission within COST 244bis, 2001. ftp://ftp.cordis.lu/pub/ist/docs/ka4/cost_244_base_station_emf.pdf (accessed 17 February 2012) 2001.",OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
"Country Reports on EMF and Health: Sources, Regulations, and Risk Communication Approaches, Final Report, European Commission JointResearch Centre, February 2005. http://ec.europa.cu/health/ph_projects/2002/pollution/fp_pollution_2002_frep_01.pdf (accessed 17 February 2012) 2005.",Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
"15 Line P., Cornelius W.A., Bangay M.J., and Grollo M., Levels of Radiofrequency Radiation from GSM Mobile Telephone Base Stations, ARPANSA Technical Report129, 2000. http://www.arpansa.gov.au/pubs/eme/rfrep129.pdf (accessed 11 March2010) 2000.",OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.bipt.be/ (accessed 5 February 2003) 2003.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.hc-sc.gc.ca/ewh-semt/pubs/radiation/cell_base_stations/abstract-resume-eng.php (accessed 19 Decem-ber 2010) 2003.,OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.ic.gc.ca/eic/site/smt-gst.nsf/eng/sf09392.html (accessed 11 March 2010) 2002.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://hermes.physics.auth.gr/en/desc (accessed 18 February 2012) 2010.,OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
"Years 2006, 2007 and 2008. http://www.tele.soumu.go.jp/j/sys/ele/body/report/index.html(accessed 11 March 2010) 2010.",Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.nrl.moh.govt.nz/faq/nrlvodafone monitoringproject.asp#results (accessed 18 February 2012) 2010.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://korpa.or.kr/online/sub02/sub02_91.jsp (accessed 18 February 2012) 2010.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.minetur.gob.es/ telecomunicaciones/Espectro/NivelesExposicion/Paginas/Informes.aspx (accessed18 February 2012) 2010.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.stral-sakerhetsmyndigheten.se/Global/Publikationer/Rapport/Stralskydd/2008/ssi-rapp-2008-13.pdf (accessed 11 March 2010) 2008.,OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://forummobil.org/userdocs/documents/PM%20 Streetparade.pdf (accessed 18 February 2012) 2004.,OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.forummobil.ch/de/das-forum/medienmit teilungen/geringe-strahlenbelastung-durch-mobilfunk-1267432768 (accessed 11March 2010) 2006.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
"http://www.awel.zh.ch/internet/baudirektion/awel/de/luft_asbest_elektrosmog/elektrosmog/messungen.html, 2011 (accessed 18 February 2012).",Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.ofcom.org.uk/siteﬁnder/audits/ (accessed 18 February 2012)2010.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
http://www.narda-sts.de/pdf/hochfrequenz/DS_EF0391_EN.pdf (accessed 18 February 2012)2009.,Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
https://www.wirelessintelligence.com/ (ac- cessed 18 February 2012) 2011.,OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Analysis of base station exposure surveys Rowley and Joyner 315 Journal of Exposure Science and Environmental Epidemiology (2012), 304 - - 315 &2012 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/05/75/jes201213a.PMC3347802.pdf
": WMH and Depression in Mild Dementia www.karger.com/dee © 2012 S. Karger AG, Basel    The non-brain regions were removed from the T1 image, using the segmentation rou- tines in SPM5 (http://www.fil.ion.ucl.ac.uk/spm), and the WMH were segmented on a slice-by-slice basis from the FLAIR image, with the images in native space, using a threshold de-termined from the histogram of pixel intensities for each image slice.",Non-OADS,/arxiv_data1/oa_pdf/89/7b/dee-0002-0097.PMC3347877.pdf
"To explore the regional distribution of WMH throughout the brain, a region of interest  (ROI) template in standard MNI space was used (Montreal Neurological Institute, http://www.bic.mni.mcgill.ca).",OADS,/arxiv_data1/oa_pdf/89/7b/dee-0002-0097.PMC3347877.pdf
"Manual editing was then done to correct for this, by removing excess pixels using FSLView (http://www.fmrib.ox.ac.uk/fsl/index.html).",Non-OADS,/arxiv_data1/oa_pdf/89/7b/dee-0002-0097.PMC3347877.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2011  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2011 |  53  | e2920 | Page 1 of 5Video Article Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice Kelley Bromley-Brits*1, Yu Deng*1, Weihong Song1 1Department of Psychiatry, Brain Research Center, University of British Columbia *These authors contributed equally Correspondence to: Weihong Song at weihong@exchange.ubc.ca URL: http://www.jove.com/video/2920 DOI: doi:10.3791/2920 Keywords: Neuroscience, Issue 53, Morris Water Maze, spatial memory testing, hippocampal dependent learning, Alzheimer's Disease Date Published: 7/20/2011 Citation: Bromley-Brits, K., Deng, Y., Song, W. Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice.",Non-OADS,/arxiv_data1/oa_pdf/34/07/jove-53-2920.PMC3347885.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/2920/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/34/07/jove-53-2920.PMC3347885.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.4049/jimmunol.090243 2 Fontenot, J.D., J.L.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2005078 4 Fontenot, J.D., J.P. Rasmussen, L.M.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1126/science.117833 1 Goldstein, J.D., R.S.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1371/journal.pone.001903 8 Gregori, S., N. Giarratana, S. Smiroldo, and L. Adorini.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2010020 9 Hellström, M., L.K.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1038/   nature0557 1 Hozumi, K., C. Mailhos, N. Negishi, K. Hirano, T. Yahata, K. Ando, S.  Zuklys, G.A.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/   jem.2008013 4 Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1016/0092-8674(81)90016- 7 Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser,  S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1016/S1074-7613(02)00365- 5 Klinakis, A., C. Lobry, O. Abdel-Wahab, P. Oh, H. Haeno, S.  Buonamici, I. van De Walle, S. Cathelin, T. Trimarchi, E. Araldi,   et al.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1038/nature0999 9 Koch, U., E. Fiorini, R. Benedito, V. Besseyrias, K. Schuster-Gossler, M.  Pierres, N.R.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2008082 9 Kukreja, A., G. Cost, J. Marker, C. Zhang, Z.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2010265 7 Atkinson, M.A., and E.H. Leiter.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/   10.1038/944 2 Belghith, M., J.A.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1038/nm92 4 Billiard, F., J.R. Kirshner, M. Tait, A. Danave, S. Taheri, W. Zhang, J.C.  Waite, K. Olson, G. Chen, S. Coetzee, et al.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1002/eji.20104134 3 Brasel, K., T. De Smedt, J.L.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1084/jem.185.3.54 1 Carotta, S., A. Dakic, A. D’Amico, S.H.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.05.00 5 Caton, M.L., M.R.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2006264 8 Cheng, P., J. Zhou, and D. Gabrilovich.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
http://dx.doi.org/10.1111/j.0105-2896.2009.00871.,Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1126/science.286   .5447.209 8 Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G.D. Victora, T. Eisenreich,  K.H.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2009074 6 Di Santo, J.P. 2010.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"329:44– 45. http://dx.doi.org/10.1126/science.119166 4 Esensten, J.H., M.R.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"183:75– 82. http://dx.doi.org/10.4049/jimmunol.080415 4 Fancke, B., M. Suter, H. Hochrein, and M. O’Keeffe.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1182/blood-2007-05-08929 2 Feyerabend, T.B., G. Terszowski, A. Tietz, C. Blum, H. Luche, A. Gossler,  N.W.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
http://dx.doi.org/10.1016/j.immuni.2008.10.01 6,OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1016/   j.immuni.2010.01.00 4 Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/   10.1016/j.cell.2008.05.00 9 Sallusto, F ., A. Lanzavecchia, and C.R.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1016/S0167-5699   (98)01346- 2 Salomon, B., D.J.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1016/S1074-7613(00)80195- 8 Sancho, D., M. Gómez, and F. Sánchez-Madrid.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1016/j.it.2004.12.00 6 Shimoda, M., F. Mmanywa, S.K.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1084/jem.20062305 Steinman, R.M.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"13:1155– 1159. http://dx.doi.org/10.1038/nm164 3 Surh, C.D., and J. Sprent.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1038/372100a 0 Swee, L.K., N. Bosco, B. Malissen, R. Ceredig, and A. Rolink.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1093/intimm/dxq05 9 Tang, Q., K.J.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/   10.1084/jem.2004013 9 Tarbell, K.V., S. Yamazaki, K. Olson, P. Toy, and R.M.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.2004018 0 Thornton, A.M., P.E.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"184:3433– 3441. http://dx.doi.org/10.4049/jimmunol.090402 8 van Meerwijk, J.P., S. Marguerat, R.K. Lees, R.N.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi   .org/10.1084/jem.185.3.37 7 W askow , C., K. Liu, G. Darrasse-Jèze, P .",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1038/ni.161 5 Watanabe, N., Y.H.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
436:1181– 1185. http://dx.doi.org/10.1038/nature0388 6T cell development.,OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10   .1084/jem.2010232 7 Li, J., J.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1111/j.0105- 2896.2009.00879. x Liu, K., G.D. Victora, T.A.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10   .1126/science.117054 0 Luche, H., L. Ardouin, P. Teo, P. See, S. Henri, M. Merad, F. Ginhoux,  and B. Malissen.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1002/   eji.20114172 8 Maillard, I., T. Fang, and W.S.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1146/annurev.immunol.23   .021704.11574 7 Marguti, I., G.L.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
http://dx.doi   .org/10.1111/j.1365-2567.2008.02927.,Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/   jem.178.4.128 3 McHugh, R.S., M.J. Whitters, C.A.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1182/blood-2008-12-18064 6 Noguera-Troise, I., C. Daly, N.J. Papadopoulos, S. Coetzee, P. Boland,  N.W.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1038/   nature0535 5 Pajvani, U.B., C.J.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1038/nm.237 8 Pellegrinet, L., V. Rodilla, Z. Liu, S. Chen, U. Koch, L. Espinosa, K.H.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10   .1053/j.gastro.2011.01.00 5 Pénit, C., B. Lucas, and F. Vasseur.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80054- 0 Radtke, F., I. Ferrero, A. Wilson, R. Lees, M. Aguet, and H.R.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/jem.194.7.100 3 Wu, L., and K. Shortman.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1016/j.smim.2005.05.00 1 Wu, L., C.L.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"http://dx.doi.org/10.1084/   jem.184.3.90 3You, S., M. Belghith, S. Cobbold, M.A.",OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
"54:1415– 1422. http://dx.doi.org/10.2337/diabetes.54.5.141 5 Zhou, J., P. Cheng, J.I.",Non-OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
http://dx.doi.org/   10.1016/j.immuni.2009.03.02 1,OADS,/arxiv_data1/oa_pdf/26/cd/JEM_20111615.PMC3348095.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"4) 16S rRNA variable regions, as described in the Human  Microbiome Project Provisional 16S 454 Protocol (http://www.hmpdacc   .org/tools_protocols/tools_protocols.php).",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1371/ journal.pbio.006028 0 Dubberke, E.R., J.M.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"38:813– 819. http://dx.doi.org/10.1038/sj.bmt.170553 0 Ferrara, J.L., J.E.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1016/S0140-   6736(09)60237- 3 Gerbitz, A., M. Schultz, A. Wilke, H.J.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi   .org/10.1182/blood-2003-11-376 9 Heimesaat, M.M., A. Nogai, S. Bereswill, R. Plickert, A. Fischer,  C. Loddenkemper, U. Steinhoff, S. Tchaptchet, E. Thiel, M.A.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1136/gut.2009   .19743 4 Hill, G.R., J.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.2307/357306 6 Kau, A.L., P.P.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1038/nature1021 3 Kim, S.O., H.I.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
http://dx.doi.org/10.1111/j.1462-5822.2006.00763.,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1084/jem.148.6.168 7 Lozupone, C., M. Hamady, and R. Knight.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"7:371. http://dx.doi.org/10.1186/1471-   2105-7-37 1 Magurran, A.E.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi   .org/10.1038/nature1020 8 Manson, J.M., M. Rauch, and M.S.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1007/978-0-387-09550-9_ 2 Passweg, J.R., P.A.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"21:1231– 1238. http://dx.doi.org/10.1038/sj.bmt.170123 8 Penack, O., O.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1084/jem.2009062 3 Penack, O., E. Henke, D. Suh, C.G.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi   .org/10.1093/jnci/djq17 2 Petersen, F .B., C.D.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/   10.1128/AEM.00324-1 1 Cooke, K.R., L. Kobzik, T.R.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.3109/   0036554870903242 3 Pridmore, R.D., B. Berger, F. Desiere, D. Vilanova, C. Barretto, A.C. Pittet,  M.C.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://www.stembook.org/node/548 Russell, J.A., A. Chaudhry, K. Booth, C. Brown, R.C.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/   10.1016/S1083-8791(00)70073- 5 Sayegh, M.H., Z. Wu, W.W. Hancock, P.B.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
http://dx.doi.org/10.1034/ j.1600-6143.2003.00062.,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10   .1128/AEM.01541-0 9 Schroeder, M.A., and J.F.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10   .1152/physrev.00045.200 9 Steck, N., M. Hoffmann, I.G.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi   .org/10.1053/j.gastro.2011.05.03 5 Storb, R., R.L.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi   .org/10.1056/NEJM19830210308060 2 Ubeda, C., Y. Taur, R.R.",OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi   .org/10.1128/AEM.00062-0 7 Willing, B.P., S.L.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
"http://dx.doi.org/10.1038/nrmicro253 6 Woodmansey, E.J.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
http://dx.doi.org/10.1111/j.1365-2672.2007.03400.,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/JEM_20112408.PMC3348096.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months   after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760068 9 Brandeis, M., and T. Hunt.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/1527369 4 Cook, A.J.L., L. Oganesian, P. Harumal, A. Basten, R. Brink, and C.J.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1084/jem.2006213 1 Di Noia, J., and M.S.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/nature0098 1 Di Noia, J.M., and M.S.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/sj.emboj.760093 9 Di Noia, J.M., G.T.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10   .1084/jem.2007176 8 Dianov, G., A.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"26:215– 220. http://dx.doi.org/10.1016/j.it.2005.02.00 8 Doseth, B., T. Visnes, A. Wallenius, I. Ericsson, A. Sarno, H.S.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"286:16669– 16680. http://dx.doi.org/10.1074/jbc.M111.23005 2 Faili, A., S. Aoufouchi, Q. Guéranger, C. Zober, A. Léon, B. Bertocci, J.C.  Weill, and C.A.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/ni82 6 Fischer, J.A., S. Muller-Weeks, and S. Caradonna.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1074/jbc.M10629520 0 Gallant, P., and E.A.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1084/jem.2007128 9 Hagen, L., B. Kavli, M.M.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20112379/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1126/science.113673 6 An, Q., P. Robins, T. Lindahl, and D.E.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.4049/jimmunol   .090067 3 Otterlei, M., E. Warbrick, T.A.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1093/emboj/18.13.383 4 Peled, J.U., F.L.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.26.021607.09023 6 Petersen, S., R. Casellas, B. Reina-San-Martin, H.T.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/414660 a Pines, J., and T. Hunter.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1016/j.molcel.2004.10.01 1 Robertson, A.B., A. Klungland, T. Rognes, and I. Leiros.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1007/s00018-009-8736- z Sakaue-Sawano, A., H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, H.  Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, et al.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1016/j.cell.2007.12.03 3 Saribasak, H., R.W.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/   10.1084/jem.2011113 5 Schrader, C.E., J.E.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi   .org/10.1093/nar/gkq68 2 Shen, H.M., A. Tanaka, G. Bozek, D. Nicolae, and U. Storb.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607.09024 8 Storb, U., H.M. Shen, and D. Nicolae.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.4161/cc.8.19.965 8 Wu, X., and J. Stavnezer.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi   .org/10.1084/jem.2007028 5 Xue, K., C. Rada, and M.S.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760195 8 Hasham, M.G., N.M. Donghia, E. Coffey, J. Maynard, K.J.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/ni.190 9 Hevroni, D., and Z. Livneh.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1084/jem.184.1.27 7 Holst, J., A.L.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/   nprot.2006.6 1 Imai, K., G. Slupphaug, W.I.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1084/jem.2005222 7 Jolly, C.J., A.J.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/   10.1084/jem.2008035 6 Kavli, B., O. Sundheim, M. Akbari, M. Otterlei, H. Nilsen, F. Skorpen,  P.A.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/   10.1074/jbc.M20710720 0 Li, Z., D.I.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi   .org/10.1016/S1074-7613(00)80272- 1 Liu, M., J.L.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1038/nature0654 7 Mizuta, R., M. Mizuta, S. Araki, and D. Kitamura.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1074/jbc   .M20660520 0 Mol, C.D., A.S. Arvai, R.J. Sanderson, G. Slupphaug, B. Kavli, H.E.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1016/   0092-8674(95)90467- 0 Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and  T. Honjo.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)   00078- 7 Nakamura, J., and J.A.",OADS,/arxiv_data1/oa_pdf/a0/51/JEM_20112379.PMC3348097.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1016/S1074-7613   (00)00034- 0 Berg, R.E., and J. Forman.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1016/j.coi.2006.03.01 0 Björkström, N.K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M.  Evander, J. Michaëlsson, K.J.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1084/jem.2010076 2 Cooper, M.A., J.M.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1073/   pnas.081319210 6 Cousens, L.P., R. Peterson, S. Hsu, A. Dorner, J.D.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi   .org/10.1084/jem.189.8.131 5 Dokun, A.O., S. Kim, H.R.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/ni71 4 Fodil-Cornu, N., S.H.",Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi   .org/10.1016/j.immuni.2007.07.01 0 Kaplan, M.H., Y .L.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/382174a 0 Keppler, S.J., K. Theil, S. Vucikuja, and P. Aichele.",Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1002/eji.20083909 3 Lopez-Vergès, S., J.M.",Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/   10.1016/S1074-7613(00)80413- 6 Nguyen, K.B., T.P .",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/ni133 2 Orange, J.S., and C.A.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/ni.184 9 Paust, S., and U.H.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/ni.203 2 Paust, S., H.S.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/ni.195 3 Pearce, E.L., and H. Shen.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1016/   j.immuni.2009.11.01 2 Sun, J.C., and L.L.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/10.1038/nature0766 5 Sun, J.C., J.N.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
236:83– 94. http://dx.doi.org/10.1111/j.1600-065X.2010.00900.,Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/   10.1038/nri100 1 Vivier, E., D.H. Raulet, A. Moretta, M.A.",Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
"http://dx.doi.org/   10.4049/jimmunol.080348 4 Yokoyama, W.M., S. Kim, and A.R.",OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
http://dx.doi.org/10.1146/   annurev.immunol.22.012703.10471 1,Non-OADS,/arxiv_data1/oa_pdf/07/f1/JEM_20111760.PMC3348098.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20112583/DC1.,Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/   jem.2009196 4 Jongbloed, S.L., A.J.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/jem.2009214 0 Jonuleit, H., U. Kühn, G. Müller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop,  and A.H. Enk.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/   jem.192.9.121 3 King, M.A., L. Covassin, M.A.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
http://dx.doi.org/10.1111/ j.1365-2249.2009.03933.,Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1016/   j.immuni.2005.04.00 4 Klechevsky, E., R. Morita, M. Liu, Y .",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1016/   j.immuni.2008.07.01 3 Larregina, A.T., A.E.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi   .org/10.1038/ni73 1 Lenz, A., M. Heine, G. Schuler, and N. Romani.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"92:2587– 2596. http://dx.doi.org/10.1172/JCI11687 3 Liu, K., T. Iyoda, M. Saternus, Y .",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/   jem.2002121 5 Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi   .org/10.1126/science.820271 1 Lutz, M.B., and G. Schuler.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1016/S1471-4906(02)02281- 0 Merad, M., and M.G.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"113:3418– 3427. http://dx.doi.org/10.1182/blood-2008-12-18064 6 Narbutt, J., A. Lesiak, A. Sysa-Jedrzejowska, P. Smolewski, T. Robak, and  A. Zalewska.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"16:127– 134. http://dx.doi.org/10.1016/j.smim.2003.12.00 8 Anas, A., T. van der Poll, and A.F.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"14:209. http://dx.doi.org/10.1186/cc885 0 Azukizawa, H., A. Döhler, N. Kanazawa, A. Nayak, M. Lipp, B. Malissen, I.  Autenrieth, I. Katayama, M. Riemann, F. Weih, et al.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1002/eji.20104093 0 Bachem, A., S. Güttler, E. Hartung, F .",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"207:1273– 1281. http://dx.doi.org/10.1084/jem.2010034 8 Bedoui, S., P .G.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1038/ni.172 4 Burgdorf, S., V .",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10   .1084/jem.184.2.69 5 Chang, C.C., R. Ciubotariu, J.S.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1038/ni76 0 Contreras, V ., C. Urien, R. Guiton, Y .",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.4049/jimmunol.100082 4 Crozat, K., R. Guiton, V .",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/jem.2010022 3 Demedts, I.K., G.G.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1165/   rcmb.2004-0279O C Dhodapkar, M.V., R.M.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/jem.193.2.23 3 Fiore, N., G. Castellano, A. Blasi, C. Capobianco, A. Loverre, V .",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi   .org/10.1016/j.molimm.2007.04.02 9 Heath, W.R., and F.R.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
10:1237– 1244. http://dx.doi.org/10.1038/ni.182 2,Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1016/j.micinf.2005.03.02 5 Poulin, L.F., M. Salio, E. Griessinger, F. Anjos-Afonso, L. Craciun,   J.L.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1084/jem.2009261 8 Raife, T.J., D.J.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1172/   JCI11717 1 Reis e Sousa, C. 2006.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1038/nri184 5 Rizzitelli, A., D. Vremec, J.A.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/   10.1002/eji.20052623 1 Robbins, S.H., T. Walzer, D. Dembélé, C. Thibault, A. Defays, G. Bessou,  H. Xu, E. Vivier, M. Sellars, P. Pierre, et al.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1186/gb-2008-9-1-r1 7 Sagoo, P ., N. Ali, G. Garg, F .O.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1126/scitranslmed.300207 6Sancho, D., O.P.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1038/nature0775 0 Schwarz, T., and A. Schwarz.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1016/j.ejcb.2010.09.01 1 Skowera, A., R.J. Ellis, R. V arela-Calviño, S. Arif, G.C.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.21.120601.14104 0 Swamy, M., C. Jamora, W. Havran, and A. Hayday.",OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
"11:656– 665. http://dx.doi.org/10.1038/ni.190 5 Tsoumakidou, M., N. Tzanakis, H.A.",Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
84:267– 273. http://dx.doi.org/10.1111/j.1440-1711.2006.01428.,Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
http://dx.doi.org/10.1172/JCI3228 2,Non-OADS,/arxiv_data1/oa_pdf/86/24/JEM_20112583.PMC3348099.pdf
This article is distributed under the terms of an Attributio n– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1038/3510505 2 Bishop, K.A., M.B.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1210/me.2009-020 9 Brennan, P.J., R.V.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1038/   ni.214 3 Brigl, M., and M.B.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1016/ j.smim   .2009.10.00 6 Brigl, M., L. Bry, S.C. Kent, J.E.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/   10.1038/ni100 2 Brigl, M., P. van den Elzen, X. Chen, J.H.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1084/jem.2010255 5 Chang, S., and T.M.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1073/   pnas.050212910 2 Chen, X., X. Wang, J.M.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.06.01 7 Collins, P.L., M.A.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"188:1726– 1733. http://dx.doi.org/10.4049/jimmunol.110287 9 Cox, D., L. Fox, R. Tian, W. Bardet, M. Skaley, D. Mojsilovic, J.  Gumperz, and W. Hildebrand.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi   .org/10.1371/journal.pone.000532 5 Crowe, N.Y., M.J. Smyth, and D.I.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
http://dx.doi.org/10   .1084/jem.2002009 2Analysis of IL-12R and IL-18R cell surface expression and STAT-4  phosphorylation.,Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi   .org/10.1073/pnas.040084910 1 Stetson, D.B., M. Mohrs, R.L.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi   .org/10.1084/jem.2003063 0 Tahir, S.M., O. Cheng, A. Shaulov, Y .",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi   .org/10.1016/S1097-2765(01)00404- X Tyznik, A.J., E. Tupin, N.A.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1182/   blood-2008-05-15752 9 W ang, Z., C. Zang, J.A.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1038/ng.15 4 Wei, D.G., H. Lee, S.H.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1084/   jem.2005041 3 Wesley, J.D., M.S.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1084/jem.2010222 9 Wong, C.H., C.N.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1126/science.121030 1 Yang, J., H. Zhu, T.L.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1038/8426 4 Yu, K.O., J.S.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.4049/   jimmunol.080398 1Crump, N.T., C.A.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1073/   pnas.110009910 8 Eidson, M., J. Wahlstrom, A.M. Beaulieu, B. Zaidi, S.E.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1371/journal.pone.002444 1 Fitzpatrick, D.R., and C.B.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1016/S1521-6616   (03)00205- 5 Fox, L.M., D.G.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1371/journal.pbio.100022 8 Frazer, K.A., L. Pachter, A. Poliakov, E.M. Rubin, and I. Dubchak.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1093/nar/gkh45 8 Geissmann, F., T.O.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1371/journal.pbio.003011 3 Kawano, T., J. Cui, Y .",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1126/science   .278.5343.162 6 Kinjo, Y., D. Wu, G. Kim, G.W.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"434:520– 525. http://dx.doi.org/10.1038/nature0340 7 Kronenberg, M., and A. Rudensky.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1038/   nature0372 5 Lee, B.M., and L.C.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1002/jcb.2225 0 Lee, D.U., O. Avni, L. Chen, and A. Rao.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1016/j.immuni.2005.09.00 2 Mattner, J., K.L.",OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1038/nature0340 8 Mayor, C., M. Brudno, J.R. Schwartz, A. Poliakov, E.M. Rubin, K.A.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"16:1046– 1047. http://dx.doi.org/10.1093/bioinformatics/16.11.104 6 Moran, A.E., K.L.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
"http://dx.doi.org/10.1084/   jem.2011030 8 Nagarajan, N.A., and M. Kronenberg.",Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
http://dx.doi.org/10.1385/IR:27:2-3:46 3,Non-OADS,/arxiv_data1/oa_pdf/be/4d/JEM_20111024.PMC3348100.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1016/   S1074-7613(02)00389- 8 Bar-Or, A., P.A.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1002/ana.2136 3 Bar-Or, A., L. Fawaz, B.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1002/ana.2193 9 Barr, T.A., S. Brown, G. Ryan, J. Zhao, and D. Gray.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10   .1002/eji.20063648 3 Barr, T.A., S. Brown, P. Mastroeni, and D. Gray.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"111:2755– 2764. http://dx.doi.org/10.1182/blood-2007-09-11085 8 Bettelli, E., Y.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1038/nature0475 3 Blair, P.A., L.Y.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.11.00 9 Bouaziz, J.D., S. Calbo, M. Maho-Vaillant, A. Saussine, M. Bagot, A.  Bensussan, and P. Musette.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1002/eji.20104067 3 Burdin, N., C. Van Kooten, L. Galibert, J.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/   10.1016/j.jneuroim.2006.06.02 9 Duddy, M., M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H.J.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1038/nri183 8 Eugster, H.P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1002/(SICI)1521-4141(199807)28:07<2178:: AID-IMMU2178>3.0.CO;2- D Fillatreau, S., and S.M.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1586/   1744666X.3.4.56 5 Fillatreau, S., C.H.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1038/ni83 3commercially available antibody sets for IL-6, IL-10, IL-17, and IFN-  in  accordance with the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1038/ncprheum095 0 Balázs, M., F. Martin, T. Zhou, and J. Kearney.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1038/nri231 5 Good, K.L., V.L.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1002/eji.20104096 1 Haak, S., A.L.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi   .org/10.1177/175628561037114 6 Hauser, S.L., E. Waubant, D.L.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10   .1056/NEJMoa070638 3 Kala, M., S.N.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1016/j.expneurol.2009.10.01 5 Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta,  K. Sudo, and Y. Iwakura.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1146/   annurev.immunol.021908.13271 0 Kroenke, M.A., T.J. Carlson, A.V.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1084/jem.2008015 9 Lampropoulou, V., K. Hoehlig, T. Roch, P. Neves, E. Calderón Gómez,  C.H.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
http://dx.doi.org/10.1111/j.0105-2896.2009.00855.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1084/jem.2002129 3 Mendel, I., A. Katz, N. Kozak, A. Ben-Nun, and M. Revel.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1002/(SICI)1521- 4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2- #Neurath, M.F., and S. Finotto.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1016/j.cytogfr.2011.02.00 3 Neves, P., V. Lampropoulou, E. Calderon-Gomez, T. Roch, U. Stervbo,  P. Shen, A.A. Kühl, C. Loddenkemper, M. Haury, S.A. Nedospasov,   et al.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.10.01 6 O’Connor, B.P., V.S.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1084/jem.2003133 0 O’Connor, R.A., C.T.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1038/nrg239 5 Okuda, Y., S. Sakoda, C.C.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/   10.1002/ana.2164 1 Pasare, C., and R. Medzhitov.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1126/science.107823 1 Ramgolam, V.S., Y. Sha, K.L.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"186:4518– 4526. http://dx.doi.org/10.4049/jimmunol.100027 1 Samoilova, E.B., J.L.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi   .org/10.1038/551 4 Yanaba, K., J.D.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.03.01 7 Zepp, J., L. Wu, and X. Li.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
"32:232– 239. http://dx.doi.org/10.1016/j.it.2011.02.00 7 Zhou, D., R. Srivastava, S. Nessler, V. Grummel, N. Sommer, W. Brück,  H.P.",OADS,/arxiv_data1/oa_pdf/2c/43/JEM_20111675.PMC3348102.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first  six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.25.022106.14155 3 Hislop, A.D., U. Palendira, A.M. Leese, P.D.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/   10.1182/blood-2009-09-23883 2 Jonkman, M.F., and A.M. Pasmooij.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/   10.1056/NEJMc080989 6 Junying, J., K. Herrmann, G. Davies, D. Lissauer, A.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1086/51761 6 Ma, C.S., N.J. Hare, K.E.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.25.022106.14165 1 Morra, M., M. Simarro-Grande, M. Martin, A.S. Chen, A. Lanyi, O. Silander,  S. Calpe, J. Davis, T. Pawson, M.J. Eck, et al.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi   .org/10.1074/jbc.M10130520 0 Nichols, K.E., D.P.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi   .org/10 .1038/nm118 9 Nichols, K.E., C.S.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
http://dx.doi.org/10.1111/ j.0105-2896.2005.00230.,Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1182/blood-2003-10-365 5 Palendira, U., C. Low, A. Chan, A.D. Hislop, E. Ho, T.G.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1371/journal.pbio.100118 7 Plunkett, F.J., O. Franzese, L.L.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"126:855– 865. http://dx.doi.org/10.1016/j.mad.2005.03.00 6 Puck, J.M., R.L.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1056/NEJM19740214290070 4 Betts, M.R., J.M.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1016/   S0022-1759(03)00265- 5 Booth, C., K.C.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"118:5060) http://dx.doi.org/10.1182/blood-2010-06-28493 5 Brenchley, J.M., N.J. Karandikar, M.R.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"101:2711– 2720. http://dx.doi.org/10.1182/blood-2002-07-210 3 Cannons, J.L., S.G. Tangye, and P.L.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"29:665– 705. http://dx.doi.org/10.1146/annurev-immunol-030409-10130 2 Chaganti, S., C.S.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1182/blood-2007-10-11626 9 Chen, G., A.K.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1002/eji.20063641 7 Coffey, A.J., R.A. Brooksbank, O. Brandau, T. Oohashi, G.R.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"20:129– 135. http://dx.doi.org/10.1038/242 4 Dupré, L., G. Andolfi, S.G. Tangye, R. Clementi, F. Locatelli, M. Aricò,  A. Aiuti, and M.G.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1182/blood-2004-08-326 9 Hare, N.J., C.S.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1093/intimm/dxl03 9 Hirschhorn, R. 2003.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1136/   jmg.40.10.72 1 Hirschhorn, R., D.R.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
http://dx.doi.org/10.1038/ng0796-29 0,Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi   .org/10.1172/JCI11296 7 Purtilo, D.T., C.K.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1016/S0140-6736(75)92004- 8 Rieux-Laucat, F., C. Hivroz, A. Lim, V. Mateo, I. Pellier, F. Selz, A. Fischer,  and F. Le Deist.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/   10.1038/4438 5 Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik,  L. Notarangelo, R. Geha, M.G.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi   .org/10.1038/2668 3 Schwartzberg, P.L., K.L.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1038/   nri245 6 Snow, A.L., R.A. Marsh, S.M.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1182/blood-2008-04-15336 1 Stephan, V., V. Wahn, F. Le Deist, U. Dirksen, B.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1056/NEJM19961121335210 4 Stewart, D.M., F. Candotti, and D.L.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1007/s10875-007-9121- z Sumegi, J., D. Huang, A. Lanyi, J.D.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1016/j.jaci.2009.11.03 4 Uzel, G., E. Tng, S.D.",OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
"http://dx.doi.org/10.1182/   blood-2007-04-08255 2 Wada, T., and F. Candotti.",Non-OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
http://dx.doi.org/10.1016/j.jim.2008.07.01 7,OADS,/arxiv_data1/oa_pdf/b7/c1/JEM_20112391.PMC3348103.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first  six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20112012/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1016/j.semcdb.2004   .05.00 1 Armaka, M., M. Apostolaki, P. Jacques, D.L.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1084/jem.2007090 6 Bächner, D., M. Ahrens, D. Schröder, A. Hoffmann, J. Lauber, N. Betat,   P .",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/   10.1136/ard.2010.14855 1 Kontoyiannis, D., M. Pasparakis, T.T.",Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80038- 2 Mills, G.B., and W.H.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/   10.1038/nrc114 3 Müller-Ladner, U., T. Pap, R.E.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1038/ncprheum004 7 Nochi, H., H. Tomura, M. Tobo, N. Tanaka, K. Sato, T. Shinozaki, T.  Kobayashi, K. Takagishi, H. Ohta, F. Okajima, and K. Tamoto.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1002/1529- 0131(200007)43:7<1597::AID-ANR25>3.0.CO;2- 0 Sakai, T., J.M.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1074/jbc .274  .22.1548 0 Santos, A.N., D. Riemann, A.N.",Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1006/bbrc.1996   .1819 Stefan, C., S. Jansen, and M. Bollen.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi   .org/10.1016/j.tibs.2005.08.00 5 van Meeteren, L.A., and W.H.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1124/mol.107.03821 6http://dx.doi.org/10.1002/(SICI)1097-0177(199812)213:4<398:: AID-AJA5>3.0.CO;2- T Campbell, I.K., J.A.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi   .org/10.1186/ar11 0 Fotopoulou, S., N. Oikonomou, E. Grigorieva, I. Nikitopoulou, T.  Paparountas, A. Thanassopoulou, Z. Zhao, Y. Xu, D.L.",Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1016/j.ydbio.2010.01.00 7 Fuchs, B., J. Schiller, U. Wagner, H. Häntzschel, and K. Arnold.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1038/   nsmb.198 0 Kanda, H., R. Newton, R. Klein, Y. Morita, M.D.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1038/ni157 3 Karouzakis, E., R.E.",OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"http://dx.doi.org/10.1038/nrrheum.2009.5 5 Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis,  and G. Kollias.",Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
http://dx.doi.org/10.1046/j.1365-2249.2001.01432.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
"284:33561– 33570. http://dx.doi.org/10.1074/jbc.M109.01271 6 Kollias, G., P. Papadaki, F. Apparailly, M.J. Vervoordeldonk, R.   Holmdahl, V. Baumans, C. Desaintes, J.",Non-OADS,/arxiv_data1/oa_pdf/f3/d2/JEM_20112012.PMC3348105.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80147- 1 Hesse, J.E., M.R.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/0092-8674(87)90615- 5 Huang, Y ., W .",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1084/   jem.2008239 6 Jacobs, C., Y. Huang, T. Masud, W. Lu, G. Westfield, W. Giblin, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1093/hmg/ddq52 4 Kurosawa, A., H. Koyama, S. Takayama, K. Miki, D. Ayusawa, M. Fujii, S.  Iiizumi, and N. Adachi.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1089/dna.2007.064 9 Lees-Miller, S.P., K. Sakaguchi, S.J.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1126/science.785560 2 Lone, S., S.A. Townson, S.N.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/   j.molcel.2007.01.01 8 Ma, Y ., U. Pannicke, K. Schwarz, and M.R.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00671- 2 Ma, Y., U. Pannicke, H. Lu, D. Niewolik, K. Schwarz, and M.R.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
18:5322. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00309- 9 Moshous, D., C. Pannetier, R. Chasseval Rd, F. Deist Fl, M. Cavazzana- Calvo, S. Romana, E. Macintyre, D. Canioni, N. Brousse, A. Fischer,  et al.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1002/eji.20042555 5 Nijnik, A., L. Woodbine, C. Marchetti, S. Dawson, T. Lambe, C. Liu, N.P.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1038/nature0587 5 Pannicke, U., M. Hönig, I. Schulze, J. Rohr, G.A.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/   10.1002/humu.2116 8 Pascal, J.M., P.J.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
http://dx.doi.org/10.1038/nature0308 2anisotropy values were measured.,OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10   .1016/S0960-9822(98)00021- 9 Callebaut, I., D. Moshous, J.P. Mornon, and J.P. de Villartay.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi   .org/10.1093/nar/gkf47 0 Cotner-Gohara, E., I.K.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1074/jbc   .M70817520 0 Dudásová, Z., and M. Chovanec.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)81714- 6 Gauss, G.H., and M.R.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1038/sj.emboj.760125 5 Grawunder, U., D. Zimmer, S. Fugmann, K. Schwarz, and M.R.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1084/jem   .2003114 2 Przewloka, M.R., P.E.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/   10.1016/j.jmb.2006.02.06 1van der Burg, M., N.S.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1002/eji.20073762 4 West, K.L., N.C. Singha, P. De Ioannes, L. Lacomis, H. Erdjument- Bromage, P. Tempst, and P. Cortes.",Non-OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"http://dx.doi.org/10.1016/   j.immuni.2005.07.00 4 Weterings, E., N.S.",OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
http://dx.doi.org/10.1128/MCB.00971-0 8,Non-OADS,/arxiv_data1/oa_pdf/eb/8a/JEM_20111437.PMC3348108.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Un - ported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).Our belief is that   if we invest additional  editorial effort at the  point of decision, we  can avoid protracted  cycles of review and  re-review.The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/13/5b/JEM_20120731.PMC3348109.pdf
: dcleveland@ucsd.eduPrion-like spread of protein aggregates in neurodegeneration Magdalini Polymenidou and Don W. Cleveland © 2012 Polymenidou and Cleveland  This article is distributed under  the terms of an Attribution–Noncommercial–Share Alike–No Mirror  Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1007/BF0030880 9 Braak, H., U. Rüb, W.P.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1007/   s00702-002-0808- 2 Büeler, H., A. Aguzzi, A. Sailer, R.A. Greiner,  P. Autenried, M. Aguet, and C. Weissmann.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi   .org/10.1016/0092-8674(93)90360- 3 Castilla, J., P. Saá, C. Hetz, and C. Soto.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1016/j.cell.2005.02.01 1 Chandler, R.L.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/   10.1016/S0140-6736(61)92008- 6 Clavaguera, F., T. Bolmont, R.A. Crowther, D.  Abramowski, S. Frank, A. Probst, G. Fraser,  A.K.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1038/ncb190 1 de Calignon, A., M. Polydoro, M. Suárez- Calvet, C. William, D.H. Adamowicz, K.J.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi   .org/10.1016/j.neuron.2011.11.03 3 Deng, Y.P., R.L.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1016/j.jchemneu.2004.02.00 5 Desplats, P ., H.J.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1126/science.119451 6 Giasson, B.I., J.E.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)   00682- 7 Gómez-Isla, T., J.L.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi   .org/10.1038/459924 a Aguzzi, A., and M. Polymenidou.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1016/S0092-8674(03)01031- 6 Aguzzi, A., and L. Rajendran.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"121:715– 725. http://dx.doi.org/10.1172/JCI4336 6 Kane, M.D., W.J.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1016/j.brainres.2012.01.01 6 Kordower, J.H., Y. Chu, R.A. Hauser, T.B.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1038/nm174 7 Kril, J.J., and G.M.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi   .org/10.1007/s12031-011-9528- 0 Krüger, R., W. Kuhn, T. Müller, D. Woitalla, M.  Graeber, S. Kösel, H. Przuntek, J.T.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1038/   ng0298-10 6 Lagier-Tourenne, C., M. Polymenidou, and  D.W .",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1093/hmg/ddq13 7 Li, J.Y., E. Englund, J.L.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1038/nm174 6 Liu, L., V. Drouet, J.W.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1371/ journal.pone.003130 2 Luk, K.C., V.M.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1126/science.113186 4 Mougenot, A.L., S. Nicot, A. Bencsik, E.  Morignat, J. Verchère, L. Lakhdar, S.  Legastelois, and T. Baron.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.,OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10   .1074/jbc.M110.14846 0 Polymenidou, M., and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi   .org/10.1126/science.276.5321.204 5 Prusiner, S.B.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1126/science.680176 2 Ravits, J., P .",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"http://dx.doi.org/10.1212/01   .wnl.0000260965.20021.4 7 Singleton, A.B., M. Farrer, J. Johnson, A. Singleton,  S. Hague, J. Kachergus, M. Hulihan, T.  Peuralinna, A. Dutra, R. Nussbaum, et al.",OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
"327:1132– 1135. http://dx.doi.org/10.1126/science   .118374 8 Zarranz, J.J., J. Alegre, J.C. Gómez-Esteban, E.  Lezcano, R. Ros, I. Ampuero, L. Vidal, J.  Hoenicka, O. Rodriguez, B. Atarés, et al.",Non-OADS,/arxiv_data1/oa_pdf/86/11/JEM_20120741.PMC3348110.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/   10.1073/pnas.091386010 7 Alexander, A., J. Kim, and C.L.",OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.4161/auto.6.5.1250 9 Blanchet, F.P., A. Moris, D.S.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.04.01 1 Bodenmann, P., F. Althaus, B. Burnand, P. Vaucher, A. Pécoud, and B.  Genton.",OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"7:310.  http://dx.doi.org/10.1186/1471-2458-7-31 0 Borgherini, G., P. Poubeau, F. Staikowsky, M. Lory, N. Le Moullec, J.P.  Becquart, C. Wengling, A. Michault, and F. Paganin.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/   10.1086/51753 7 Cadwell, K., J.Y.",OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.1038/nature0741 6 Cadwell, K., K.K.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.2174/13816121079103396 9 Couderc, T., F. Chrétien, C. Schilte, O. Disson, M. Brigitte, F. Guivel- Benhassine, Y. Touret, G. Barau, N. Cayet, I. Schuffenecker, et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.1371/journal.ppat.004002 9cDNA clone provided by S. Higgs (Vanlandingham et al., 2005).",OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.1016/j.chom.2009.09.00 6 Joubert, P.E., I. Pombo Grégoire, G. Meiffren, C. Rabourdin-Combe, and M.  Faure.",OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
"http://dx.doi.org/10.1051/medsci/20112714 1 Jounai, N., F. Takeshita, K. Kobiyama, A. Sawano, A. Miyawaki, K.Q.",OADS,/arxiv_data1/oa_pdf/e7/67/JEM_20110996.PMC3348111.pdf
